id subject predicate object category relation description has_attribute source uuid:8eaa1f42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:8eaa5872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:8eaa8694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:8eaaafa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets GPCR (Prostaglandin E2 receptor EP1 subtype) DrugCentral uuid:8eaad950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.707']} DrugCentral uuid:8eab0740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (5-hydroxytryptamine receptor 3A) DrugCentral uuid:8eab313e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:8eab6078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily A member 5) DrugCentral uuid:8eab9098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:8eab9098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:8eabc5ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is blocker of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:8eabf3e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8eac221a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8eac506e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8eac7e40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8eacaf0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:8eacd87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:13 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levdobutamine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:8ead019e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8ead2ed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:8ead5edc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8ead8be6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48760 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin targets Enzyme (Folylpoly-gamma-glutamate synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:8eadb936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8eade6b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:24 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutanoic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:8eae13cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:24 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:8eae40ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:24 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:8eae6e26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:24 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:8eae9ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:25 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacitidine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8eaec9fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:25 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacitidine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:8eaef274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:8eaf1bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:8eaf442c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96J66 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil targets Transporter (ATP-binding cassette sub-family C member 11) DrugCentral uuid:8eaf6cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8eaf9a08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8F0 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil targets Enzyme (Uracil phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:8eafc780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O26232 biolink:molecularly_interacts_with DrugCentral:27 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azaribine targets Enzyme (Orotidine 5'-phosphate decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:8eaff48a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03962 biolink:molecularly_interacts_with DrugCentral:27 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azaribine targets Enzyme (Orotidine 5'-phosphate decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:8eb02234-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:8eb04fca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:8eb07e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:8eb0ab1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:8eb0d814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:8eb1092e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:34 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abacavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.276']} DrugCentral uuid:8eb138fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:34 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abacavir is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:8eb165e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:34 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abacavir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:8eb1936c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:35 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abarelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.49']} DrugCentral uuid:8eb1c94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:8eb1c94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:8eb1c94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:8eb22322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:8eb22322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:8eb22322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:8eb22322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:8eb22322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:8eb22322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:8eb22322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:8eb28e52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose is inhibitor of Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.697']} DrugCentral uuid:8eb2bc10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04746 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose is inhibitor of Enzyme (Pancreatic alpha-amylase) DrugCentral uuid:8eb2e492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04745 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Alpha-amylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8eb31192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8eb33e7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8eb36bd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:8eb398d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P94451 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:8eb3c600-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53051 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Oligo-1,6-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:8eb3f364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00690 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Pancreatic alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:8eb4203c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.609']} DrugCentral uuid:8eb44d64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:40 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acebutolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8eb47a5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:40 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acebutolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8eb4aae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:40 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acebutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:8eb4db76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:43 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclofenac targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:8eb50c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:43 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclofenac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8eb539f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:43 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclofenac targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.227']} DrugCentral uuid:8eb56708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:43 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:8eb58f4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:44 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acediasulfone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:8eb5bc1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4Z710 biolink:molecularly_interacts_with DrugCentral:44 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acediasulfone targets Unclassified (Dihydropteroate synthetase, putative) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:8eb5e994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0A113T0T6 biolink:molecularly_interacts_with DrugCentral:44 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acediasulfone targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:8eb61658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:47 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acemetacin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:8eb63fde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:47 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acemetacin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:8eb669d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:47 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acemetacin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:8eb69a4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:48 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acenocoumarol is inhibitor of Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:8eb6c706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:48 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acenocoumarol is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.114']} DrugCentral uuid:8eb6f3de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:49 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acefylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:8eb72250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:50 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceprometazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:8eb74ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:8eb777dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) DrugCentral uuid:8eb7a05e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:8eb7c89a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:8eb7f5a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:8eb82286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:8eb851ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:8eb87eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:8eb8abb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:8eb8d97e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:8eb906a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:8eb93388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20292 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Cytosolic other (Arachidonate 5-lipoxygenase-activating protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:8eb96060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.547']} DrugCentral uuid:8eb98db0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:8eb9bace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:8eb9e7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02144 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Unclassified (Myoglobin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:8eba155a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol is agonist of GPCR (Cannabinoid receptor 1) DrugCentral uuid:8eba3d78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:54 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetanilide targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:8eba6a8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9VTU8 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2, isoform A; LD26647p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:8eba97aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9V396 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 1; GH09688p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:8ebac5a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:8ebaf2a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8ebb1fcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8ebb4d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:8ebb7a08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:8ebba7f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29972 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Transporter (Aquaporin-1) DrugCentral uuid:8ebbd034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:8ebc00fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:8ebc2e58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:8ebc5b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8ebc88ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:8ebcb5d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8ebce4a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:8ebd1214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:8ebd3f14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:8ebd6bec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERQ8 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8ebd98d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:8ebdc6e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:8ebdf3f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:8ebe20d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:8ebe4e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:8ebe7b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:8ebea818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8ebed64e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8ebf045c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8ebf312a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29029 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Endochitinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:8ebf5df8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:8ebf8c74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:8ebfb956-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:8ebfe642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:8ec01324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:8ec04182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:8ec06e6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:8ec09b5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00921 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec0f8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8ec1c3b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8ec1c3b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8ec1c3b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8ec1c3b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8ec21c50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:8ec21c50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:8ec25594-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46510 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:8ec28276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.08']} DrugCentral uuid:8ec2b002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.56']} DrugCentral uuid:8ec2dcda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HVB9 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:8ec309a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:8ec33946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:8ec369b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75493 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase-related protein 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:8ec39b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:57 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohexamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.639']} DrugCentral uuid:8ec39b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:57 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohexamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.639']} DrugCentral uuid:8ec3d4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:8ec40a92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:8ec40a92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:8ec40a92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:8ec44868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07374 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid targets Enzyme (Urease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:8ec475cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0PXQ5 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid targets Enzyme (Urease subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:8ec4a29a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:59 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetophenazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:8ec4caea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:59 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetophenazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:8ec4f7b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:8ec525b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril is inhibitor of Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8ec55262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:8ec57f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07861 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:8ec5ac62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08049 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8ec5d8fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19621 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:8ec60586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42892 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Endothelin-converting enzyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8ec63222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00800 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Thermolysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:8ec65f72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:8ec68c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:8ec6b8be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:8ec6e62c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8ec712f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:8ec73faa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:8ec76d9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:8ec79af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:8ec7c7b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:8ec7f5b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:8ec82302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:8ec84fbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:8ec87c6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:8ec8a9d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:8ec8da40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:8ec90f2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8ec90f2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8ec94d5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:8ec94d5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:8ec98b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:8ec98b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:8ec9c8ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:8ec9c8ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:8eca0816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:8eca0816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:8eca45ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:8eca45ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:8eca9128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8eca9128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8eca9128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8eca9128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8eca9128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8ecaf12c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:H6TY12 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Nicotinic acetylcholine receptor alpha8 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:8ecb1e4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P99999 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine targets Enzyme (Cytochrome c) DrugCentral uuid:8ecb4668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine targets Secreted (Vascular endothelial growth factor A) DrugCentral uuid:8ecb6eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04179 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine targets Enzyme (Superoxide dismutase [Mn], mitochondrial) DrugCentral uuid:8ecb96ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48637 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine is modulator of Enzyme (Glutathione synthetase) DrugCentral uuid:8ecbbf8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine is modulator of Transporter (Cystine/glutamate transporter) DrugCentral uuid:8ecc063e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:8ecc063e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:8ecc063e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:8ecc063e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:8ecc063e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:8ecc063e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:8ecc063e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:8ecc063e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:8ecc7d4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:73 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acepromazine is antagonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:8ecca580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:73 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acepromazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:8ecccd9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:73 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acepromazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8eccfa94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8ecd2758-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:8ecd53f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P60045 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Acidic phospholipase A2 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:8ecd809a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19440 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Gamma-glutamyltranspeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:8ecdade0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ecdda72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:8ece070e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:8ece354e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:8ece646a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:8ece9232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:76 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acipimox is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:8ecebee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:78 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acitretin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) DrugCentral uuid:8ecee778-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:78 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acitretin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:8ecf143c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:78 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acitretin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) DrugCentral uuid:8ecf3ca0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:78 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acitretin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:8ecf6a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.152']} DrugCentral uuid:8ecf9718-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8ecfc454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase 1) DrugCentral uuid:8ecff104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase II) DrugCentral uuid:8ecff104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase II) DrugCentral uuid:8ed03920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:8ed03920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:8ed03920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:8ed03920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:8ed03920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:8ed08cf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:82 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acrivastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:8ed0b58a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:82 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acrivastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:8ed0e5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:82 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acrivastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:8ed112d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:8ed1404a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09250 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir targets Kinase (Thymidine kinase) DrugCentral uuid:8ed16868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:8ed19522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:8ed1c1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:8ed1ecca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09252 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:8ed21772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir is inhibitor of Kinase (Thymidine kinase) DrugCentral uuid:8ed23f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04407 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir is inhibitor of Kinase (Thymidine kinase) DrugCentral uuid:8ed268e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:87 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adapalene targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8ed2960c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:87 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adapalene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:8ed2c2f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:87 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adapalene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:8ed2f0f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:87 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adapalene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:8ed31e92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:88 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adefovir dipivoxil is inhibitor of Polyprotein (Protein P) DrugCentral uuid:8ed346ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54098 biolink:molecularly_interacts_with DrugCentral:88 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adefovir dipivoxil targets Enzyme (DNA polymerase subunit gamma-1) DrugCentral uuid:8ed36f50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:88 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adefovir dipivoxil targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:8ed39c00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:8ed3d760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:8ed3d760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:8ed3d760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:8ed3d760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:8ed429cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:8ed456d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.509']} DrugCentral uuid:8ed4837c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:8ed4b040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:8ed4dcfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55263 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (Adenosine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8ed50a22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:8ed536dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.29']} DrugCentral uuid:8ed563d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8ed59320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8ed5c03e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9TVW2 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (Adenosine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:8ed5ed2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:8ed61a52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23526 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Enzyme (Adenosylhomocysteinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.796']} DrugCentral uuid:8ed64b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:8ed64b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:8ed684ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BTU6 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is inhibitor of Kinase (Phosphatidylinositol 4-kinase type 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8ed6b1c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCG2 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is inhibitor of Kinase (Phosphatidylinositol 4-kinase type 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8ed6df46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04406 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Enzyme (Glyceraldehyde-3-phosphate dehydrogenase liver) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:8ed719e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:8ed719e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:8ed719e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:8ed719e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:8ed76ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TEK3 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Enzyme (Histone-lysine N-methyltransferase, H3 lysine-79 specific) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:8ed79b98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49652 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:8ed7c834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51575 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Ion channel (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:8ed7f5ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:8ed823e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8ed850ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47900 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:8ed87d92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8ed8aaa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:8ed8d756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:8ed90410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8ed93296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41148 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Membrane other (Endoplasmin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:8ed95fc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49137 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (MAP kinase-activated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:8ed98c96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:8ed9b95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8ed9e6d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:8eda1364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.836']} DrugCentral uuid:8eda401e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12931 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Unclassified (Heat shock protein 75 kDa, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:8eda6dbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29410 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (Adenylate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:8eda9aa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11142 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Unclassified (Heat shock cognate 71 kDa protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:8edac75a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMV8 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Unclassified (Heat shock 70 kDa protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:8edaf40a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7TN37 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:8edb2484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49653 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:8edb512a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJX6 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8edb7dda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35811 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8edbab0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8edbd7d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51579 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8edc049e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51578 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8edc31bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8edc5e8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8edc8b8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09467 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Fructose-1,6-bisphosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:8edcb88a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00636 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Fructose-1,6-bisphosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8edce7b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:8edd1460-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94759 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Ion channel (Transient receptor potential cation channel subfamily M member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:8edd4124-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:8edd6e4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:8edd9f5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:8edd9f5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:8eddd8d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00338 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (L-lactate dehydrogenase A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.19']} DrugCentral uuid:8ede05d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A9J4 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Ketopantoate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.2']} DrugCentral uuid:8ede3296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29410 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Kinase (Adenylate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:8ede60a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43598 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:8ede8de0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35820 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:8edebc02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam targets Transporter (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edf1c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:8edfc926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8ee007a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:8ee007a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:8ee007a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:8ee007a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:8ee007a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:8ee065fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8ee09504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:8ee0c646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:8ee0c646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:8ee10836-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:8ee10836-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:8ee10836-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:8ee14e54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:8ee17bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:8ee1a96c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:8ee1d75c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ajmaline is inhibitor of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:8ee1ff66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ajmaline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8ee22d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ajmaline is inhibitor of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:8ee25b8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ajmaline is inhibitor of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:8ee28832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:101 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alacepril is inhibitor of Enzyme (Angiotensin-converting enzyme) DrugCentral uuid:8ee2b500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alatrofloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:8ee2b500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alatrofloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:8ee2ee44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alatrofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:8ee2ee44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alatrofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:8ee32152-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50719 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole targets Structural (Tubulin alpha chain) DrugCentral uuid:8ee35226-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee35226-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee35226-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee3aa5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee3aa5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee3aa5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee3aa5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee3aa5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee3aa5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee3aa5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:8ee4156c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50719 biolink:molecularly_interacts_with DrugCentral:104 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole sulfoxide targets Structural (Tubulin alpha chain) DrugCentral uuid:8ee43eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salbutamol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.613']} DrugCentral uuid:8ee46b70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salbutamol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:8ee49816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salbutamol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.94']} DrugCentral uuid:8ee4c552-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salbutamol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:8ee4f23e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:8ee51a48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alclofenac targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:8ee5428e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:8ee56f70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.9']} DrugCentral uuid:8ee59c20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:8ee5c8c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:8ee5f68e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.721']} DrugCentral uuid:8ee624d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.959']} DrugCentral uuid:8ee6517e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8ee6868a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:8ee6868a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:8ee6868a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:8ee6c938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.347']} DrugCentral uuid:8ee6c938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.347']} DrugCentral uuid:8ee702ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldosterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:8ee72fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldosterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:8ee75cb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:8ee7895e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldosterone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.37']} DrugCentral uuid:8ee7b618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:8ee7e732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:8ee8161c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid targets Enzyme (Protein farnesyltransferase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:8ee842a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:8ee86fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:8ee89c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alexidine targets Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:8ee8c8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alexidine targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:8ee8f5a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q932Y6 biolink:molecularly_interacts_with DrugCentral:113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alexidine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:8ee922c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WUK0 biolink:molecularly_interacts_with DrugCentral:113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alexidine is inhibitor of Enzyme (Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.97']} DrugCentral uuid:8ee94f50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:8ee97bc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.951']} DrugCentral uuid:8ee9a96e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:8ee9d61e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:8eea0f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:8eea0f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:8eea0f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:8eea0f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:8eea63a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:8eea90a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:8eeabd5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:8eeaeab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:8eeb172c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:8eeb43aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:8eeb7028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:8eeb9dc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.61']} DrugCentral uuid:8eebca5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.678']} DrugCentral uuid:8eebf746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren is inhibitor of Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:8eec2414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9TSZ1 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8eec50d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6DLS0 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8eec7dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08424 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8eecaa9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06281 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:8eecd756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7M3D2 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8eed0406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:8eed308e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6DLW5 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:8eed5faa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alizapride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:8eed8f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alizapride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8eedbcfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alizapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8eede9f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:8eee17d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00492 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) DrugCentral uuid:8eee3ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:8eee6c7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:8eee9a8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9FBI2 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol targets Unclassified (Shiga toxin subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:8eeec73c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:8eeef3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8eef2222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8eef4f7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alosetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:8eef7bfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alosetron targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:8eefa8aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:8eefd5aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alosetron targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.218']} DrugCentral uuid:8ef0021e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfacalcidol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:8ef02eb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfacalcidol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:8ef05700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Transporter (Sodium- and chloride-dependent GABA transporter 1) DrugCentral uuid:8ef087ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:8ef087ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:8ef087ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef10f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8ef202bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8ef202bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8ef202bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8ef2489e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Transporter (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:8ef2756c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:8ef2a348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8ef3fc48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:8ef4293e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Unclassified (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:8ef455f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem is partial agonist of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) DrugCentral uuid:8ef47df8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.85']} DrugCentral uuid:8ef4acc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.457']} DrugCentral uuid:8ef4dc4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:8ef508e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.61']} DrugCentral uuid:8ef53eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:8ef53eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:8ef53eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:8ef58c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:8ef58c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:8ef58c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:8ef5db44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:8ef5db44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:8ef5db44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:8ef629f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:8ef629f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:8ef629f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:8ef67054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:8ef69d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:8ef6cb1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.86']} DrugCentral uuid:8ef6f8bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:8ef725da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02769 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:8ef7528a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:8ef77f12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:8ef7ac44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.678']} DrugCentral uuid:8ef7d926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.658']} DrugCentral uuid:8ef805fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:8ef83290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8ef86224-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8ef88eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:8ef8bb2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:8ef8e820-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8ef9148a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:8ef94126-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:8ef96dc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:8ef99ae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:8ef9c790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:8ef9f440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:8efa228a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8efa4f30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8efa7bae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8efaa854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8efad568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8efb024a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.35']} DrugCentral uuid:8efb2efa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8efb5cfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 altretamine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:8efb8986-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alvimopan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:8efbb636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alvimopan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8efbe354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alvimopan targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8efc12e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alvimopan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:8efc3f98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:8efc6c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:8efc993e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63231 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is inhibitor of Ion channel (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:8efcdfd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:8efcdfd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:8efcdfd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:8efcdfd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:8efcdfd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:8efcdfd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:8efcdfd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:8efd5950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q20MD5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:8efd85ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05778 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:8efdb292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DOF8 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:8efde1ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambenonium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:8efe09ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambenonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.34']} DrugCentral uuid:8efe3686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambenonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:8efe63ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:147 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambroxol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.744']} DrugCentral uuid:8efe909a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:147 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambroxol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.254']} DrugCentral uuid:8efebcfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:147 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambroxol targets Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:8efee50e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:147 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambroxol targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:8eff1204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amcinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:8eff4404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:8eff4404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:8eff4404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:8eff9292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:8eff9292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:8eff9292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:8effde5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifostine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:8f000af6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifostine targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) DrugCentral uuid:8f00331e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amikacin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.201']} DrugCentral uuid:8f0060a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37088 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Ion channel (Amiloride-sensitive sodium channel subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:8f008d3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:8f00b9ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:8f00e714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.408']} DrugCentral uuid:8f0113ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19634 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:8f014060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:8f016dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16515 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is blocker of Ion channel (Acid-sensing ion channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:8f019cc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8f01c94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08590 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:8f01f6cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:8f022c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8f022c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8f022c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8f0271a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9W6Q1 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:8f029f5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14940 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is inhibitor of Transporter (Sodium/hydrogen exchanger 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:8f02cca0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26431 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is inhibitor of Transporter (Sodium/hydrogen exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:8f02fa68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50482 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:8f03270e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06869 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:8f035580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55926 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:8f03823a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:160 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoacridine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:8f03aef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:160 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoacridine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:8f03dbf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:160 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoacridine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:8f0408fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amineptine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f0435ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminocaproic acid is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:8f046240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminocaproic acid is inhibitor of Enzyme (Tissue-type plasminogen activator) DrugCentral uuid:8f048ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:8f04b772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:8f04e40e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05108 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide is inhibitor of Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) DrugCentral uuid:8f050c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22443 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:8f053b48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:8f0567d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminohippuric acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:8f059494-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminohippuric acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:8f05c1a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminophenazone targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:8f05e9ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminophenazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:8f061202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminophenazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:8f063eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopicoline is inhibitor of Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:8f066b94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoquinuride targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:8f069858-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoquinuride targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:8f06c4fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoquinuride targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8f06f370-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoquinuride targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:8f071fee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:8f074c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8f077a16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.112']} DrugCentral uuid:8f07a752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:8f07d420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.177']} DrugCentral uuid:8f0800ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8f082dee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8f085ab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:8f088744-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:8f08b4da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8f08e2ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:8f091088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:8f093d24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8f096a56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.912']} DrugCentral uuid:8f09971a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.647']} DrugCentral uuid:8f09c3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.989']} DrugCentral uuid:8f09f070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.231']} DrugCentral uuid:8f0a1dca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.674']} DrugCentral uuid:8f0a4a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.045']} DrugCentral uuid:8f0a7748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:8f0aa556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:8f0ad224-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.984']} DrugCentral uuid:8f0afeb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:8f0b2b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.743']} DrugCentral uuid:8f0b594c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.168']} DrugCentral uuid:8f0b8610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.296']} DrugCentral uuid:8f0bb2fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.968']} DrugCentral uuid:8f0be13c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.498']} DrugCentral uuid:8f0c0e0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.701']} DrugCentral uuid:8f0c3ac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.004']} DrugCentral uuid:8f0c677e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.207']} DrugCentral uuid:8f0c958c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.176']} DrugCentral uuid:8f0cc246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.549']} DrugCentral uuid:8f0cef00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:8f0d1bf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.284']} DrugCentral uuid:8f0d48ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.791']} DrugCentral uuid:8f0d75a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:8f0da2a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.088']} DrugCentral uuid:8f0dcf42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.039']} DrugCentral uuid:8f0dfbca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37268 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:8f0e2852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.368']} DrugCentral uuid:8f0e56c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.191']} DrugCentral uuid:8f0e8392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:8f0eb100-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:8f0ede0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.347']} DrugCentral uuid:8f0f0a9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f0f37ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.407']} DrugCentral uuid:8f0f6488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.115']} DrugCentral uuid:8f0f9188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.879']} DrugCentral uuid:8f0fbf8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:8f0fec5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.967']} DrugCentral uuid:8f101ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.943']} DrugCentral uuid:8f104a74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.932']} DrugCentral uuid:8f10774c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:8f10a410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8f10d3ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:8f110090-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8f112d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75151 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase PHF2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:8f115a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29375 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:8f118736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6ZMT4 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:8f11b3d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.953']} DrugCentral uuid:8f11e064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.081']} DrugCentral uuid:8f120f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:8f123c80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.382']} DrugCentral uuid:8f126926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:8f12969e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.758']} DrugCentral uuid:8f12c376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:8f12f062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:8f131d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.625']} DrugCentral uuid:8f134a76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:8f137744-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:8f13a408-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:8f13d202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:8f13fe6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:8f142b12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:8f145830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:8f1484d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:8f14b258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8f14df12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.367']} DrugCentral uuid:8f150c9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.456']} DrugCentral uuid:8f15394e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:8f15663a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8f1593da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:8f15c10c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8f15edbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:8f161b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8f164816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:8f167606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:8f16a32e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.686']} DrugCentral uuid:8f16d1be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:8f16fe96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:8f172ba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:8f175832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:8f17879e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.83']} DrugCentral uuid:8f17b43a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8f17e0e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:8f180dc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:8f183a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8f1866d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.585']} DrugCentral uuid:8f189382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.066']} DrugCentral uuid:8f18c0dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:8f18edb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f191b90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:8f194908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:8f1975c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f19a254-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:8f19cf22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8f19fc0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:8f1a28b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.771']} DrugCentral uuid:8f1a556e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:8f1a82a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8f1aaf46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:8f1adbe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8f1b08a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:8f1b3948-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8f1b69ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8f1b98de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8f1bc5e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:8f1bf2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f1c1ffc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.854']} DrugCentral uuid:8f1c5e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f1c5e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f1c5e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f1c5e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f1c5e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f1cbe6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:8f1cec98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptylinoxide targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8f1d1ac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f1d476a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f1d7410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8f1dadf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:8f1dadf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:8f1dadf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:8f1dadf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:8f1df6e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.646']} DrugCentral uuid:8f1e2464-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.871']} DrugCentral uuid:8f1e518c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:8f1e7e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:8f1eaa9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.583']} DrugCentral uuid:8f1eda8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.358']} DrugCentral uuid:8f1f073a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f1f33fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:8f1f611c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f1f8e08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:8f1fb608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:8f1fde26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f200bd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8f2038bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.507']} DrugCentral uuid:8f20656c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8f209320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8f20c034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:8f20ecbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amodiaquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:8f21193a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50135 biolink:molecularly_interacts_with DrugCentral:186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amodiaquine targets Enzyme (Histamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:8f21478e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y251 biolink:molecularly_interacts_with DrugCentral:186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amodiaquine targets Enzyme (Heparanase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.28']} DrugCentral uuid:8f217448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amodiaquine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8f21a0e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:8f21ce70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:8f21fb16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:8f222816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:8f22503e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.469']} DrugCentral uuid:8f227fb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:8f22b0ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:8f22dd7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.75']} DrugCentral uuid:8f230a92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.182']} DrugCentral uuid:8f233756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8f236410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8f2390ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8f23be24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.593']} DrugCentral uuid:8f23ead4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.734']} DrugCentral uuid:8f24175c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:8f24457e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.542']} DrugCentral uuid:8f247210-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:8f249ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.423']} DrugCentral uuid:8f24cbd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.616']} DrugCentral uuid:8f24f924-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.211']} DrugCentral uuid:8f2525b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.336']} DrugCentral uuid:8f25525c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.365']} DrugCentral uuid:8f257fb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8f25ac70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:8f25da24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.842']} DrugCentral uuid:8f2606d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:8f263488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y345 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Transporter (Sodium- and chloride-dependent glycine transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.036']} DrugCentral uuid:8f266124-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:8f268dac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:8f26bad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:8f26e77a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:8f27142a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8f274120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:8f277730-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8f277730-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8f277730-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8f27b57e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:8f27e2ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:8f280f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:8f283c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:8f287e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f287e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f287e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f287e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f287e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f287e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f287e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f28e8d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amperozide targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:8f291568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amperozide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:8f29445c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:8f296ebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.753']} DrugCentral uuid:8f299ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:8f29cab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:8f29f2c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:8f2a1f58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:8f2a4762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:8f2a7444-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:8f2aa284-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f2ad24a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b02f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:8f2b3596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2b9cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8f2c7898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8f2c7898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8f2c7898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8f2c7898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8f2cd536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:8f2cd536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:8f2cd536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:8f2d1cc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:8f2d494e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:8f2d7266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.09']} DrugCentral uuid:8f2d9f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin targets Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:8f2de570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f2de570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f2de570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f2de570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f2de570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f2de570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f2de570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f2e4f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f2e7bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:8f2ea460-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.172']} DrugCentral uuid:8f2ed0f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:8f2efda2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:8f2f2a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.44']} DrugCentral uuid:8f2f591e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:8f2f85d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:8f2fb27e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:8f2fdf74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:8f300c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:8f3045b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:8f3045b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:8f3045b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:8f3045b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:8f3099e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:8f30c664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8f30f31e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8f312258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase I, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:8f314fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:8f317c26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:8f31a912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8f31d9dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:8f31d9dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:8f3212e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagrelide is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:8f323f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagrelide targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:8f326cd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anastrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:8f329ab6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androisoxazole targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:8f32c2b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:8f32f0a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:8f331d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:8f334998-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:8f337648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.17']} DrugCentral uuid:8f33a366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:8f33cfe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8f33fc4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:8f342a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:8f345806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37058 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:8f3484a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8f34b1f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54939 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:8f34e186-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05121 biolink:molecularly_interacts_with DrugCentral:217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anecortave targets Secreted (Plasminogen activator inhibitor 1) DrugCentral uuid:8f350986-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:8f35319a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:8f3559fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:8f358208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:8f35a9fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68371 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Structural (Tubulin beta-4B chain) DrugCentral uuid:8f35d226-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anileridine is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:8f35fada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P38435 biolink:molecularly_interacts_with DrugCentral:222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anisindione is inhibitor of Enzyme (Vitamin K-dependent gamma-carboxylase) DrugCentral uuid:8f362302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anisindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:8f364fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octatropine methylbromide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:8f36780c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octatropine methylbromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:8f36a1ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:224 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 antazoline is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:8f36c9d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:224 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 antazoline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:8f36f64c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75342 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (Arachidonate 12-lipoxygenase, 12R-type) DrugCentral uuid:8f371e4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BEG3 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:8f374b4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:8f37782e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:8f37a4e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:8f37d260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:8f37ff06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:8f382bf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:8f38588e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:8f388868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:8f38b50e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:8f38e308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8f39110c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8f393dd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f396aa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:8f399816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8f39c49e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:8f39f126-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:8f3a1e62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:8f3a4cf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:8f3a798e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:8f3aa62a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:8f3ad384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:8f3b0016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:8f3b2cda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:8f3b59b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:8f3b8720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:8f3bb3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:8f3be076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8f3c0eac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:8f3c3cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:8f3c692e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8f3c95ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3ccf40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f3ccf40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f3ccf40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f3ccf40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3d5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:8f3e3808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f3e3808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f3e3808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f3e8268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8f3e8268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8f3ecc8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8f3ecc8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8f3ecc8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8f3ecc8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8f3ecc8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8f3f344c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:8f3f344c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:8f3f344c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:8f3f7b46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34949 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Enzyme (Mannose-6-phosphate isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:8f3fa7e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8f3fd726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00987 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Nuclear other (E3 ubiquitin-protein ligase Mdm2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:8f4003d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:8f4030a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.938']} DrugCentral uuid:8f405e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f408ad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:8f40c032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:8f40c032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:8f40c032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:8f410696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprepitant targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:8f412ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprepitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:8f415b96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29371 biolink:molecularly_interacts_with DrugCentral:230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprepitant targets GPCR (Neuromedin-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:8f418a26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5DUB1 biolink:molecularly_interacts_with DrugCentral:230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprepitant targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:8f41b6e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:8f41decc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:8f4206d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.757']} DrugCentral uuid:8f4233cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25786 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Enzyme (Proteasome subunit alpha type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:8f42609a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32418 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Transporter (Sodium/calcium exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:8f428d86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.359']} DrugCentral uuid:8f42c382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:8f42c382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:8f42c382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:8f430ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:234 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aranidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:8f430ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:234 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aranidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:8f4342ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arbutamine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:8f436cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:8f439988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:8f43c638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:8f43f2ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:8f441fb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00735 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:8f444c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.851']} DrugCentral uuid:8f4478f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:8f44a63e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:8f44d320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:8f44ffbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.131']} DrugCentral uuid:8f452d84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:8f455aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:8f458752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:8f45b3ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:8f45e116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:8f460db2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:8f463a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:8f46678a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:8f469462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:8f46c108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:8f46edae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.991']} DrugCentral uuid:8f471ba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:8f474880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.681']} DrugCentral uuid:8f47753a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:8f47a226-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.169']} DrugCentral uuid:8f47cfa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.455']} DrugCentral uuid:8f47fc26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:8f4828b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:8f4855e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.633']} DrugCentral uuid:8f48827c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:8f48af0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f48dcea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.421']} DrugCentral uuid:8f4909fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:8f493690-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:8f49646c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.202']} DrugCentral uuid:8f49919e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.463']} DrugCentral uuid:8f49be58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:8f49eb08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:8f4a1862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8f4a4526-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8f4a72da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:8f4a9fc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:8f4acfb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:8f4afc78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8f4b296e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8f4b5678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8f4b8332-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:8f4bafd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8f4bdca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:8f4c0a28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8f4c380e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:8f4c64e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:244 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arsenic trioxide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:8f4c93da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:244 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arsenic trioxide is inhibitor of Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:8f4cbdce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.312']} DrugCentral uuid:8f4cea7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.998']} DrugCentral uuid:8f4d1724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:8f4d4460-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:8f4d7106-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:8f4d9dc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.741']} DrugCentral uuid:8f4dcb38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.025']} DrugCentral uuid:8f4df7d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:8f4e2466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.481']} DrugCentral uuid:8f4e50f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:8f4e8154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:8f4eae40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.865']} DrugCentral uuid:8f4edb54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.359']} DrugCentral uuid:8f4f089a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.253']} DrugCentral uuid:8f4f3554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.126']} DrugCentral uuid:8f4f6204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.027']} DrugCentral uuid:8f4f8f72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.819']} DrugCentral uuid:8f4fbc5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:8f4fea4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:8f5016fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:8f504638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:8f5072de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:8f50a088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8f50cd9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:8f50fae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:8f51279c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.297']} DrugCentral uuid:8f515442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.219']} DrugCentral uuid:8f5181c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:8f51ae74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:8f51db06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.784']} DrugCentral uuid:8f520892-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.671']} DrugCentral uuid:8f52352e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:8f5261e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:8f528e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.577']} DrugCentral uuid:8f52bbca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:8f52e3d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:8f5318cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f5318cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f5318cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f535f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:8f538c4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:8f53b908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.218']} DrugCentral uuid:8f53e6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.065']} DrugCentral uuid:8f541358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.701']} DrugCentral uuid:8f543ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.546']} DrugCentral uuid:8f546c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.883']} DrugCentral uuid:8f549954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:8f54c5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8f54f386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:8f5521c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:8f554eda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:8f557b76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.673']} DrugCentral uuid:8f55a95c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.868']} DrugCentral uuid:8f55d8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.733']} DrugCentral uuid:8f56055a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:8f56321e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:8f5660ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:8f5691a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49355 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8f5691a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49355 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8f56cad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75530 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Unclassified (Polycomb protein EED) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:8f56f85c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:8f572502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:8f57519e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.58']} DrugCentral uuid:8f577f66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asulacrine targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:8f57aa9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.629']} DrugCentral uuid:8f57d7ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:8f5804c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.921']} DrugCentral uuid:8f583208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.921']} DrugCentral uuid:8f585ea4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.575']} DrugCentral uuid:8f588bb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:8f58b96c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8f58e64e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:8f591312-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8f593fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.27']} DrugCentral uuid:8f596f24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.12']} DrugCentral uuid:8f599bca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8f59c87a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:8f59f584-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:8f5a21e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:8f5a4f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.93']} DrugCentral uuid:8f5a7bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:8f5aa934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:8f5ad5ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:8f5b029e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.69']} DrugCentral uuid:8f5b307a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.97']} DrugCentral uuid:8f5b5d02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8f5b898a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.282']} DrugCentral uuid:8f5bb61c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:8f5be308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:8f5c0fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:8f5c3c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8f5c6daa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.478']} DrugCentral uuid:8f5c6daa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.478']} DrugCentral uuid:8f5caaf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:8f5caaf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:8f5ce5a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13118 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Nuclear other (Krueppel-like factor 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:8f5d149e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:8f5d3d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:8f5d69c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:8f5d97ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:8f5dc470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8f5df120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:8f5e1db2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:8f5e4b0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q1W675 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:8f5e779e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:8f5ea430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43264 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone targets Enzyme (Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial) DrugCentral uuid:8f5eccee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02768 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone is inhibitor of Enzyme (Cytochrome b) DrugCentral uuid:8f5ef7aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:8f5f2446-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q54A96 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:8f5f50d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:8f5f793c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:8f5fa5ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:8f5fdb2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:8f5fdb2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:8f5fdb2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:8f60217a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:8f604e20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8f607aee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:8f60a88e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:8f60d50c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:8f610180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.907']} DrugCentral uuid:8f612e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:8f615b62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.97']} DrugCentral uuid:8f61881c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:8f61b5e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:8f61e320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:8f620fda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:8f623c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:8f626908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:8f6298ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.59']} DrugCentral uuid:8f62c8d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:8f62f814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:8f63267c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:8f63530e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:8f637fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:8f63ac50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:8f63d9aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.99']} DrugCentral uuid:8f640650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:8f6443fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:8f6443fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:8f6443fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:8f6443fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:8f6443fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:8f64a40c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.99']} DrugCentral uuid:8f64d954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8f64d954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8f64d954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8f652832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:8f652832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:8f652832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:8f656ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapropazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:8f659786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapropazone targets Enzyme (Xanthine dehydrogenase/oxidase) DrugCentral uuid:8f65bfcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azasetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.268']} DrugCentral uuid:8f65ec72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azatadine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:8f66145e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azatadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:8f66437a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:8f666b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:8f669352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:8f66bb34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63000 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Enzyme (Ras-related C3 botulinum toxin substrate 1) DrugCentral uuid:8f66e37a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51580 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Enzyme (Thiopurine S-methyltransferase) DrugCentral uuid:8f670b48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelaic acid targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) DrugCentral uuid:8f673352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:8f67605c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:8f678884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8f67b502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8f67e194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8f6810b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.168']} DrugCentral uuid:8f683d38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:8f6869a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8f689698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:8f68c46a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8f68f57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:8f68f57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:8f692856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8f6955a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08703 biolink:molecularly_interacts_with DrugCentral:274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:8f698242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70344 biolink:molecularly_interacts_with DrugCentral:274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:8f69aeca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97414 biolink:molecularly_interacts_with DrugCentral:274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azimilide is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8f69dd78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.39']} DrugCentral uuid:8f6a0a3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azithromycin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.7']} DrugCentral uuid:8f6a36d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azithromycin targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:8f6a6374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azithromycin is agonist of GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:8f6aa5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:8f6aa5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:8f6aa5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:8f6aa5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:8f6aa5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:8f6aa5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:8f6b0536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.736']} DrugCentral uuid:8f6b320e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07806 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:8f6b5e96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.317']} DrugCentral uuid:8f6b8b28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:8f6bb8aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8f6be532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4ZYU9 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:8f6c1232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q83TT7 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Unclassified (AmpC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:8f6c3f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3S5C3 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Transporter (Efflux transporter; SugE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:8f6c6c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q48435 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:8f6c9856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:8f6cc4fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:8f6d0bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f6d0bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f6d0bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f6d0bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f6d0bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f6d0bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f6d0bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8f6d7aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacitracin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.269']} DrugCentral uuid:8f6daa2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacitracin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.716']} DrugCentral uuid:8f6dd9d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacitracin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:8f6e0cc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P60932 biolink:molecularly_interacts_with DrugCentral:281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacitracin targets Unclassified (Undecaprenyl-diphosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:8f6e3f3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets GPCR (GABA B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6e3f3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets GPCR (GABA B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6e7cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen is agonist of GPCR (GABA-B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:8f6e7cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen is agonist of GPCR (GABA-B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:8f6eb686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f6f2350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8f700fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 balsalazide is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:8f7037ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 balsalazide is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:8f705f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 balsalazide is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:8f708830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 balsalazide is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:8f70b012-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:8f70d7ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:8f71042c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.25']} DrugCentral uuid:8f713230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:8f715eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:8f718b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bamipine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:8f71b732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 barnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:8f71b732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 barnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:8f71ea54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.427']} DrugCentral uuid:8f7216c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:8f72431e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:8f72715e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8f729df0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8f72ca64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:8f72f7b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:8f7324f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:8f735178-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Y34 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate is agonist of GPCR (Probable G-protein coupled receptor 97) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:8f737de2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04401 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Unclassified (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:8f73aab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8f73d742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belotecan is inhibitor of Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.561']} DrugCentral uuid:8f7403ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benazepril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:8f7430d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benazepril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8f745d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benazepril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:8f748aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:8f74b6f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:8f74e510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:8f751170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:8f753dee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:8f756ad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:8f759776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:8f75bf62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.3']} DrugCentral uuid:8f75eb90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:8f761430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:8f763c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:8f7663ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benoxaprofen is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:8f768ba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benoxaprofen targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:8f76b958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.57']} DrugCentral uuid:8f76e5fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:8f771236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:8f773f0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:8f776b64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.18']} DrugCentral uuid:8f77981e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8f77c474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:8f77f1ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:8f781e38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.131']} DrugCentral uuid:8f784a8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.105']} DrugCentral uuid:8f787856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:8f78a830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:8f78d5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:8f79037a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:8f793048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:8f795cc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.486']} DrugCentral uuid:8f79891c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:8f79bec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:8f79bec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:8f79bec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:8f7a0446-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:8f7a2ce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:8f7a5a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:8f7a8baa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:8f7a8baa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:8f7ac57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:8f7af306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03313 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Unclassified (Genome polyprotein [Cleaved into: P1; Capsid protein VP0) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:8f7b1f66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52789 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Kinase (Hexokinase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:8f7b4bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzarone targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:8f7b7812-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8f7ba558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:8f7bd1c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:8f7bfe9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:8f7c2cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:8f7c5c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:8f7c8932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:8f7cb5d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.976']} DrugCentral uuid:8f7ce2a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.908']} DrugCentral uuid:8f7d103c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.711']} DrugCentral uuid:8f7d3c7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:8f7d692e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:8f7d95a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.32']} DrugCentral uuid:8f7dc216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:8f7dee80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:8f7e1efa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8f7e4b5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15392 biolink:molecularly_interacts_with DrugCentral:321 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benziodarone targets Unclassified (Baculoviral IAP repeat-containing protein 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:8f7e7936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:321 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benziodarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:8f7ea71c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:8f7ecf30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:8f7ef712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:8f7f2048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:8f7f48f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:8f7f70d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:8f7f994c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UI33 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 11 subunit alpha) DrugCentral uuid:8f7fc142-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:8f7fecee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01118 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 7 subunit alpha) DrugCentral uuid:8f8014f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['3.495']} DrugCentral uuid:8f80413a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzonatate targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:8f80696c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzphetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:8f809144-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzphetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:8f80b912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzphetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:8f80e158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzphetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:8f8109e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:8f813658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8f8162c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.445']} DrugCentral uuid:8f818f54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.241']} DrugCentral uuid:8f81bdf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.865']} DrugCentral uuid:8f81ea6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:8f8216f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:8f8243ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:8f826b9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.17']} DrugCentral uuid:8f829b92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:8f82c356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:8f82ebec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:8f8313c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:8f834042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:8f836dc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:8f839a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:8f83c710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.157']} DrugCentral uuid:8f83f640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:8f842372-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:8f844fdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.888']} DrugCentral uuid:8f847c50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:8f84a93c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.654']} DrugCentral uuid:8f84d5f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:8f850256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.926']} DrugCentral uuid:8f852ede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.636']} DrugCentral uuid:8f855f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:8f858e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:8f85baf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:8f85e7e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:8f861448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:8f8641d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.253']} DrugCentral uuid:8f866efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:8f869c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:8f86c8b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:8f86f52a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:8f8722a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:8f874f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:8f877bb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:8f87a830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:8f87d512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q695T7 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:8f880172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzyl benzoate targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:8f882dc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzyl benzoate targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:8f885b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepotastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:8f88830e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:8f88aad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:8f88d728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:8f8904fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.149']} DrugCentral uuid:8f893182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:8f895e3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8f898b3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:8f89b79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:8f89ec76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:8f89ec76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:8f89ec76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:8f8a321c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is gating inhibitor of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f8a5fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:8f8a8780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:8f8aaf30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:8f8add5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:8f8b09d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8f8b3662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:8f8b6358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:8f8b8f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2Q167 biolink:molecularly_interacts_with DrugCentral:345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betacarotene targets Unclassified (Core protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:8f8bbd30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betahistine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:8f8be9b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betahistine is inverse agonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:8f8c16ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:8f8c4354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone targets Cytosolic other (Annexin A1) DrugCentral uuid:8f8c6b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:8f8c934a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone benzoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:8f8cbe88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:8f8ce6ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone dipropionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:8f8d136a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone valerate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:8f8d3bec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamipron targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:8f8d6860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamipron targets Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:8f8d9506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:8f8dc1f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:8f8def2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.98']} DrugCentral uuid:8f8e1b98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:8f8e4816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.53']} DrugCentral uuid:8f8e7606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.76']} DrugCentral uuid:8f8ea586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:357 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betazole is agonist of GPCR (Histamine H2 receptor) DrugCentral uuid:8f8ecd4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:8f8efaa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:8f8f279a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:8f8f5404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:8f8f806e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:8f8fad96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VH27 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol targets GPCR (Muscarinic receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f8fd9b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betanidine is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:8f900188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bevantolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:8f90294c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:8f905854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene is antagonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:8f908536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:8f90b1a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:8f90deaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:8f910b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8f91374c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:8f9163b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:8f9190e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:8f91bd66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:8f91e9c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05343 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:8f92170c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43174 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Enzyme (Cytochrome P450 26A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:8f924696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NR63 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Enzyme (Cytochrome P450 26B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:8f92731e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:8f92a050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13133 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear other (Oxysterols receptor LXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:8f92cd0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Enzyme (Lipoprotein lipase) DrugCentral uuid:8f92f4ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:8f932156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.178']} DrugCentral uuid:8f934fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:8f937c0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.48']} DrugCentral uuid:8f93a89c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:8f93d52e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) DrugCentral uuid:8f93fdec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:8f9425a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:8f944d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:8f94756a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:8f949da6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:8f94c5b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:8f94f242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8f951ef2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:8f954c38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:8f9578b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:8f95a516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63449 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:8f95d342-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifemelane targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:8f960038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifonazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:8f962ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifonazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:8f96598e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifonazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:8f96863e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifonazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:8f96b33e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bimatoprost targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8f96dfb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bimatoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:8f970ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biotin targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:8f97394e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.32']} DrugCentral uuid:8f97664e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:8f9793da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:8f97c134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.62']} DrugCentral uuid:8f97ed80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.201']} DrugCentral uuid:8f9819cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:8f984280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisacodyl targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:8f986ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisacodyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.011']} DrugCentral uuid:8f989ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisacodyl targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8f98c908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15559 biolink:molecularly_interacts_with DrugCentral:376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisantrene targets Enzyme (NAD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:8f98f5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:8f992268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:8f994ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:8f997c72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:8f99a90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:8f99d58c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisulepine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:8f99fd78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bitolterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:8f9a25dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bivalirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:8f9a5246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blonanserin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:8f9a7e92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blonanserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:8f9aabba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blonanserin is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.854']} DrugCentral uuid:8f9ad860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blonanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.092']} DrugCentral uuid:8f9b04fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:8f9b3166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.345']} DrugCentral uuid:8f9b60fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.014']} DrugCentral uuid:8f9b8da0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.463']} DrugCentral uuid:8f9bba0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.262']} DrugCentral uuid:8f9be6b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:8f9c12fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:8f9c4074-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.65']} DrugCentral uuid:8f9c6cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:8f9c9a2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8f9cc6ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:8f9cf32a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:8f9d2156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:8f9d4dc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:8f9d7a3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:8f9da69e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:8f9dd376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:8f9dffd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.745']} DrugCentral uuid:8f9e2c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99460 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Cytosolic other (26S proteasome non-ATPase regulatory subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:8f9e59a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25786 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit alpha type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.208']} DrugCentral uuid:8f9e86a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:8f9eb2fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:8f9edf78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:8f9f0fb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08311 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Cathepsin G) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:8f9f3d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:8f9f6a10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:8f9f96e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17538 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Chymotrypsinogen B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:8f9fc366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28062 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:8f9fefe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:8fa01c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:8fa049da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:8fa0769e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:8fa0a330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:8fa0d274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:8fa0ff06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:8fa12b70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A5PKW4 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Unclassified (PH and SEC7 domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:8fa160f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:8fa160f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:8fa160f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:8fa1a622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00766 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Alpha-chymotrypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:8fa1d282-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IJT1 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:8fa1ff8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28063 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.78']} DrugCentral uuid:8fa22c00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28065 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:8fa25860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40306 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:8fa284c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:8fa2ad60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:8fa2d9fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:8fa30670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8fa33352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:8fa35fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q29010 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:8fa38c4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:8fa3b886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21451 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:8fa3e572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bretylium targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:8fa40d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bretylium targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:8fa434f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bretylium is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:8fa45caa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.387']} DrugCentral uuid:8fa48bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:8fa4b8f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:8fa4e5bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:8fa51532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:8fa54188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.073']} DrugCentral uuid:8fa56dd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:8fa59c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:8fa5c888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:8fa5f51a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:8fa629f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8fa629f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8fa629f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8fa67ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:8fa67ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:8fa67ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:8fa6c8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:8fa6f5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:8fa72246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:8fa74eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8fa77be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:8fa7a860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:8fa7d506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8fa8017a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8fa82f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:8fa85bde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:8fa888ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:8fa8b598-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:8fa8e1f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:8fa90e4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:8fa93bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8fa96902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:8fa99576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:8fa9c1f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:8fa9ef80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8faa1c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:8faa4886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:8faa74fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:8faaa2a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:8faacf2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:8faafc22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:8fab2968-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:8fab5622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:8fab8282-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8fabaf00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:8fabdf48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:8fac0bd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:8fac3844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivudine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8fac651c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06479 biolink:molecularly_interacts_with DrugCentral:397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8fac9168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:8facbdb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:8facea0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:8fad171e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:8fad436a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:8fad6fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:8fad9ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:8fadcb50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:8fadf7a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:8fae2d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fae2d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fae2d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fae6b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromfenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8fae97c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromfenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:8faec938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromfenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8faec938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromfenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8faf0254-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromhexine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:8faf2ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromhexine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:8faf5b50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromhexine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.708']} DrugCentral uuid:8faf8a58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromhexine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:8fafb6c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.858']} DrugCentral uuid:8fafe32c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:8fb0100e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:8fb03cc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:8fb06928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:8fb09592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:8fb0c300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:8fb0ef60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8fb11bac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8fb14a50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:8fb176ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8fb1a31a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:8fb1d0c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8fb1fe96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8fb22b32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8fb25846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:8fb2856e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:8fb2b1ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:8fb2deb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8fb30c64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:8fb338ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.86']} DrugCentral uuid:8fb36588-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:8fb39242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.708']} DrugCentral uuid:8fb3bf38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:8fb3eba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:8fb41802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8fb4455c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:8fb471b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:8fb49e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7TSF2 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets Transporter (Vesicular glutamate transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:8fb4ca7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8fb501c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:8fb501c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:8fb501c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:8fb55852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8fb55852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8fb55852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8fb55852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8fb55852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8fb5bd2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:8fb5bd2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:8fb5f636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:8fb6234a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:8fb64fc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromopride targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:8fb67c32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8fb6a8a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:8fb6d89e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:8fb707c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8fb7342e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8fb7611a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:8fb78db6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.119']} DrugCentral uuid:8fb7ba2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.745']} DrugCentral uuid:8fb7e7ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:8fb814e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:8fb8417a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.319']} DrugCentral uuid:8fb86e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:8fb89ce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:8fb8cd16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.218']} DrugCentral uuid:8fb90682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:8fb90682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:8fb90682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:8fb94d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:409 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brotizolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:8fb97978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 broxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:8fb9a6f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buclizine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:8fb9cf54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:8fb9f754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:8fba23aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:8fba500a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.5']} DrugCentral uuid:8fba7f58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:8fbaac76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:8fbad8c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.701']} DrugCentral uuid:8fbb05ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.963']} DrugCentral uuid:8fbb320e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:8fbb5e82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:8fbb8aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04401 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Unclassified (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:8fbbb828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:8fbbfe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8fbbfe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8fbbfe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8fbbfe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8fbbfe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8fbbfe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8fbbfe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:8fbc7970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:8fbca148-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8fbcce70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:8fbcfaee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:8fbd22c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:8fbd4ab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-1D adrenergic receptor) DrugCentral uuid:8fbd7456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:8fbd9d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:8fbdc55a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:8fbdf1ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufuralol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:8fbe1ff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufuralol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:8fbe4c78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufuralol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:8fbe746e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufuralol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ks', 'has_quantitative_value': ['4.59']} DrugCentral uuid:8fbea10a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bumetanide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:8fbecdf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bumetanide targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:8fbefa9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bumetanide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:8fbf2706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bumetanide is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:8fbf53fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bunazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:8fbf7bca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bunazosin targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:8fbfa3b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bunazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:8fbfcbd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bunazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) DrugCentral uuid:8fbff488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.399']} DrugCentral uuid:8fc0212e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.263']} DrugCentral uuid:8fc04db6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:8fc07ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.585']} DrugCentral uuid:8fc0a75c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:8fc0d3d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.593']} DrugCentral uuid:8fc1003a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:8fc12d62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8fc159d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8fc18654-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:8fc1b3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:8fc1e45a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.293']} DrugCentral uuid:8fc21268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8fc23ed2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.514']} DrugCentral uuid:8fc26bb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:8fc29828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.233']} DrugCentral uuid:8fc2c474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:8fc2f188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8fc31df2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:8fc34a48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z0V1 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:8fc37694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:8fc3a3da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupranolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:8fc3d062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupranolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8fc3fe3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8fc42b34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.29']} DrugCentral uuid:8fc457c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:8fc48480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:8fc4b11c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:8fc4de76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:8fc50afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.89']} DrugCentral uuid:8fc5377c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:8fc5658a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:8fc594c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:8fc5c17e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:8fc5ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:8fc61ae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.796']} DrugCentral uuid:8fc64c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:8fc67a06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:8fc6a2ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:8fc6cf42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:8fc6fba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.846']} DrugCentral uuid:8fc7282a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:8fc75c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:8fc75c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:8fc7994a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8fc7994a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8fc7d27a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buserelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.569']} DrugCentral uuid:8fc7fef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.52']} DrugCentral uuid:8fc82b44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01776 biolink:molecularly_interacts_with DrugCentral:436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:8fc857b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:8fc884e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:8fc8b154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:8fc8de40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:8fc90c30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:8fc93aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:8fc96770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:8fc993da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:8fc9c08a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.435']} DrugCentral uuid:8fc9ecfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:8fca19a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:8fca46cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.277']} DrugCentral uuid:8fca746c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:8fcaa202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.471']} DrugCentral uuid:8fcace80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:8fcafe78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:8fcb2b0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:8fcb5792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:8fcb847e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8fcbb0fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:8fcbdd66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:8fcc09e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:8fcc3716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8fcc6362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:8fcc8fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8fccbd3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:8fcce9b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:8fcd1654-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:8fcd42be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:8fcd7c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:8fcd7c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:8fcd7c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:8fcd7c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:8fcdd6e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8fcdd6e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8fcdd6e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8fce2e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:8fce2e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:8fce2e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:8fce2e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:8fce2e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:8fce972c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:8fce972c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:8fce972c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:8fcee538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:8fcee538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:8fcee538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:8fcf2b2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:438 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 busulfan targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.283']} DrugCentral uuid:8fcf6026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fcf6026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fcf6026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fcfa810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:8fcfa810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:8fcfa810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:8fcfe686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:8fd01304-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.779']} DrugCentral uuid:8fd04018-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.125']} DrugCentral uuid:8fd06f48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:8fd09e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:8fd0ca9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.161']} DrugCentral uuid:8fd0f788-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:8fd11f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.805']} DrugCentral uuid:8fd14c42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:8fd178b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92206 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.347']} DrugCentral uuid:8fd1a6d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:450 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butoconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:8fd1ced8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butorphanol is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:8fd1fb88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butorphanol is partial agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:8fd2281a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butorphanol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:8fd25754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:455 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butriptyline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:8fd283d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:455 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butriptyline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:8fd2b046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:455 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.405']} DrugCentral uuid:8fd2dd1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:8fd304e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:8fd32cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:8fd3546a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:8fd37d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:8fd3a9a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:8fd3d638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:8fd403ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8fd43272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:8fd45f0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:8fd48c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:8fd4b94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:8fd4e5d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:8fd51278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:8fd53f96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8fd56c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:8fd59888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8fd5c65a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8fd5f594-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8fd6232a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:8fd64fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:8fd67c94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:461 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cadralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:8fd6a480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:461 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cadralazine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:8fd6d126-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:8fd6fdb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:8fd72af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:8fd7577c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8fd78486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:8fd7b244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:8fd7de90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:8fd80af0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00489 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Enzyme (Glycogen phosphorylase, muscle form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:8fd83728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8fd86400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:8fd890a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:8fd8bd10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:8fd8ee8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:8fd8ee8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:8fd93484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:8fd93484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:8fd93484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:8fd93484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:8fd98790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2T3 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Enzyme (Guanine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:8fd9b468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:8fd9e0c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60614 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:8fda0d82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcifediol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:8fda36cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:465 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcipotriene is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.51']} DrugCentral uuid:8fda6354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:8fda8b4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8fdab84a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:8fdae022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02774 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Secreted (Vitamin D-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:8fdb0c96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:8fdb3900-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42392 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.6']} DrugCentral uuid:8fdb66b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28037 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:8fdb9300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3RGC1 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.15']} DrugCentral uuid:8fdbc0c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9PTN2 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Nuclear hormone receptor (Vitamin D3 receptor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:8fdbed32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camphor targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:8fdc1a64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camphor is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:8fdc4390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:8fdc6bc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat is inhibitor of Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:8fdc946c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06870 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Kallikrein-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:8fdcbcb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01177 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:8fdce4d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:8fdd0ce4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:8fdd369c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:8fdd5e9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:8fdd8688-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04756 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Hepatocyte growth factor activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:8fddaf28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15393 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat is inhibitor of Enzyme (Transmembrane protease serine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:8fddd7c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:472 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camylofin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:8fde002c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:8fde2822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:8fde5036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:8fde79d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34976 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:8fdea20c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBT6 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase kappa) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:8fdeca34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNA4 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase iota) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:8fdef270-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y253 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase eta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:8fdf1dae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:8fdf45fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:8fdf6e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:8fdf9630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:8fdfbed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:8fdfe6e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:8fe00f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:8fe037de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:8fe05ff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:8fe08824-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canrenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:8fe0b024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capecitabine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:8fe0d55e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:8fe10128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8fe12c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8fe15484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:8fe17d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:8fe1a646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:8fe1ce5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:8fe1f678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8fe21f4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P44514 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Succinyl-diaminopimelate desuccinylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:8fe2475e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q79MP6 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:8fe27076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q93T40 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Beta-lactamase II) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:8fe2989e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9K2N0 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Unclassified (Beta-lactamase class B VIM-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:8fe2c242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C7C422 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Beta-lactamase NDM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.85']} DrugCentral uuid:8fe2ea6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.81']} DrugCentral uuid:8fe31292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:8fe33aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:8fe3631e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:8fe38b46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:8fe3b35a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.94']} DrugCentral uuid:8fe3db64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:8fe4040e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8fe42c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8fe45468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:8fe47d8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:8fe4a652-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:8fe4ce3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:8fe4f65c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:8fe51e8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.577']} DrugCentral uuid:8fe54670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:8fe56e5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:8fe5967a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:8fe5bf24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:8fe5e742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:8fe60f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8fe6374c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:8fe6614a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:8fe6897c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:8fe6b190-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.74']} DrugCentral uuid:8fe6d9a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8fe705f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:8fe705f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:8fe73d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:8fe73d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:8fe7758a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:8fe7758a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:8fe7ad7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:8fe7ad7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:8fe7e4ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8fe7e4ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:8fe81bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:8fe81bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:8fe86030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:8fe86030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:8fe86030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:8fe86030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:8fe86030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:8fe8b4d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:8fe8d920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.495']} DrugCentral uuid:8fe9012a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.125']} DrugCentral uuid:8fe9293e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:8fe95256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:8fe97b0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:8fe9a698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fe9a698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fe9a698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:8fe9e1c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:8fe9e1c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:8fea163c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H461 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine is allosteric modulator of GPCR (Frizzled-8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:8fea3e32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:8fea6628-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:8fea8e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:8feac988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feac988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feac988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feac988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feac988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feac988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feac988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feb2734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenoxolone is inhibitor of Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:8feb4fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:8feb77b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51661 biolink:molecularly_interacts_with DrugCentral:493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:8feba0e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.71']} DrugCentral uuid:8febc900-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:8febf42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:8fec1c5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:8fec44d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:8fec6d74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:8fec96c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:8fecbee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbetocin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:8fece6fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbetocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.232']} DrugCentral uuid:8fed0fcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbetocin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.149']} DrugCentral uuid:8fed37ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbidopa is inhibitor of Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:8fed5be4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbidopa targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.168']} DrugCentral uuid:8fed83d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbidopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:8fedaca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbidopa targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:8fedd4b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22079 biolink:molecularly_interacts_with DrugCentral:497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbimazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:8fedfcc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbimazole is inhibitor of Enzyme (Thyroid peroxidase) DrugCentral uuid:8fee20b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbinoxamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:8fee4608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carboprost is agonist of GPCR (Prostaglandin F2-alpha receptor) DrugCentral uuid:8fee6df4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:8fee6df4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:8feeb8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feeb8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feeb8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feeb8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feeb8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feeb8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8feeb8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fef172c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:510 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carubicin targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:8fef3b26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:8fef6326-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.213']} DrugCentral uuid:8fef8ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6P7S1 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Enzyme (Acid ceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:8fefb4de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13510 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Enzyme (Acid ceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:8fefdcd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6N5 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Unclassified (Sulfide:quinone oxidoreductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:8ff00506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmustine is inhibitor of Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:8ff02eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50416 biolink:molecularly_interacts_with DrugCentral:513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocarnitine targets Enzyme (Carnitine O-palmitoyltransferase 1, liver isoform) DrugCentral uuid:8ff052a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocarnitine targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:8ff07aa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18886 biolink:molecularly_interacts_with DrugCentral:513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocarnitine targets Enzyme (Carnitine palmitoyltransferase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:8ff0a3e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:515 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carperitide targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10']} DrugCentral uuid:8ff0cd1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18910 biolink:molecularly_interacts_with DrugCentral:515 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carperitide targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:8ff0f52e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:516 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfenazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:8ff1193c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:516 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfenazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:8ff13d2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carpipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:8ff166da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carpipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:8ff18f20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:8ff1b72a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:8ff1df34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:8ff20810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:8ff23010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:8ff25824-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:8ff2804c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carteolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:8ff2a996-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carteolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:8ff2d1aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carumonam targets Enzyme (Peptidoglycan synthase FtsI) DrugCentral uuid:8ff2f5ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92736 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is inhibitor of Ion channel (Ryanodine receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:8ff31d9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.742']} DrugCentral uuid:8ff34748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:8ff36f98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:8ff397c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.126']} DrugCentral uuid:8ff3c042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:8ff3e8ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:8ff410ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:8ff439dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.928']} DrugCentral uuid:8ff4629a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.273']} DrugCentral uuid:8ff48ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.476']} DrugCentral uuid:8ff4b2ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:8ff4db08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:8ff50420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:8ff52c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.152']} DrugCentral uuid:8ff5545c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:8ff57c7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:8ff5a4e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:8ff5cd06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:8ff5f51a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:8ff61d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:8ff64600-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.054']} DrugCentral uuid:8ff66e1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:8ff6975e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:8ff6bf90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Ion channel (Potassium channel subfamily K member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8ff6eae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.706']} DrugCentral uuid:8ff715b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:8ff73dd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:8ff76620-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:8ff78e52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.09']} DrugCentral uuid:8ff7b670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:8ff7de70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:8ff80724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00206 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Membrane receptor (Toll-like receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:8ff83028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:8ff85832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefacetrile targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:8ff87c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:8ff8a102-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:8ff8e266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff8e266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff8e266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff8e266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff8e266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff8e266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff8e266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff9404e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46059 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil targets Transporter (Solute carrier family 15 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.14']} DrugCentral uuid:8ff97f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff97f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff97f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff97f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff97f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff97f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff97f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ff9dd74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46059 biolink:molecularly_interacts_with DrugCentral:527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole targets Transporter (Solute carrier family 15 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.09']} DrugCentral uuid:8ffa1cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffa1cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffa1cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffa1cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffa1cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffa1cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffa1cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffa7b8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:8ffab992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffab992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffab992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffab992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffab992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffab992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffab992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffb18ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54286 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir targets Enzyme (Pencillin binding protein 2a; Penicillin binding protein 2'; Penicillin binding protein, PBP2; Penicillin-binding protein 2; Penicillin-binding protein 2'; Peptidase) DrugCentral uuid:8ffb3ce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14TG6 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:8ffb60b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:8ffb9fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffb9fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffb9fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffb9fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffb9fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffb9fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffb9fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffbfdde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:8ffc25ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14TG6 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:8ffc4ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q54906 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil targets Enzyme (Penicillin-binding protein) DrugCentral uuid:8ffc8614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffc8614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffc8614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffc8614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffc8614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffc8614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffc8614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffcfb94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffcfb94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffcfb94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffcfb94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffcfb94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffcfb94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffcfb94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffd5a30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42971 biolink:molecularly_interacts_with DrugCentral:536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefetamet pivoxil targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:8ffd7e2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefetamet pivoxil targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:8ffda2a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:8ffdcbd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:8ffe0afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffe0afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffe0afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffe0afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffe0afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffe0afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffe0afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffe6f56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19174 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime targets Enzyme (1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:8ffeae8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffeae8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffeae8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffeae8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffeae8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffeae8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8ffeae8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fff0c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:8fff4700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fff4700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fff4700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fff4700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fff4700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fff4700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fff4700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:8fffa52e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:8fffcd42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:8ffff646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:900020bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:90004592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:90006da6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:9000ad2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9000ad2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9000ad2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9000ad2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9000ad2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9000ad2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9000ad2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90010ae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:900147d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900147d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900147d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900147d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900147d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900147d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900147d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9001a572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:9001e30c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9001e30c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9001e30c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9001e30c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9001e30c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9001e30c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9001e30c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900240fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:90026976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.512']} DrugCentral uuid:90029180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.659']} DrugCentral uuid:9002b976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9002e176-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:90030a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.617']} DrugCentral uuid:9003332e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:90035b2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:90037f0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:9003a8a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9003d108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:9003f8fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:9004388c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9004388c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9004388c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9004388c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9004388c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9004388c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9004388c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90049610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:9004b9ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:9004e2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32241 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam targets GPCR (Vasoactive intestinal polypeptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:90052166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90052166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90052166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90052166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90052166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90052166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90052166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90058200-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:9005a5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) DrugCentral uuid:9005c954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9005f15e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:900619a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9006419a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:900680a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900680a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900680a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900680a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900680a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900680a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900680a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9007001c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9007001c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9007001c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9007001c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9007001c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9007001c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9007001c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900762aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefprozil targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:900786b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25098 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9007afee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.522']} DrugCentral uuid:9007d7da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:90080020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:90082e42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:90085638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:90087f00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5A7N4 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Unclassified (tRNA 2'-phosphotransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9008a7be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftazidime is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.261']} DrugCentral uuid:9008cfc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftazidime is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.534']} DrugCentral uuid:9008f7d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftazidime is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:90092158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q1J5W5 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten targets Enzyme (Penicillin-binding protein) DrugCentral uuid:9009484a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60FU1 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:900983d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900983d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900983d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900983d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900983d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900983d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900983d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9009e340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:900a0712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime targets Enzyme (Beta-lactamase) DrugCentral uuid:900a4240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900a4240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900a4240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900a4240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900a4240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900a4240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900a4240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900aa0fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.142']} DrugCentral uuid:900ac9f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.513']} DrugCentral uuid:900af33e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.744']} DrugCentral uuid:900b1d82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.213']} DrugCentral uuid:900b4582-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:900b6d6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:900b92b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:900bba9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:900be294-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:900c2182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c2182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c2182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c2182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c2182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c2182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c2182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c9cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c9cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c9cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c9cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c9cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c9cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900c9cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:900d0214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:900d2a14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:900d521e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.854']} DrugCentral uuid:900d7b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.477']} DrugCentral uuid:900da390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:900dcbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:900df3c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.917']} DrugCentral uuid:900e1c80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:900e4548-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:900e6d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.856']} DrugCentral uuid:900e94f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:900ec018-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:900ee80e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:900f1004-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:900f3e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:900f6626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:900f8e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:900fb612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:900fdef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:90100766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.033']} DrugCentral uuid:9010304c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:90105964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:90108380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:9010ab8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9010d38a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9010fc70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:901124f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:90114cde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:901174ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.627']} DrugCentral uuid:90119cc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.29']} DrugCentral uuid:9011c560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9011f35a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8SPQ9 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:90121b46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9012444a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:90126eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:901297d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9012c0dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9012e936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8HZR1 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:9013110e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:90133904-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90136118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:901389e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:9013b3f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:9013dc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:90140500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:90142fee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:901457f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:901486f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:9014af1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:9014d76e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O78750 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9014ff78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:90152782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:901550d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:901579c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:9015a1e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:9015c9f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9015f2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:90161ac0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O78749 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:901643b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:90166ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9016941e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:9016bc28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celiprolol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9016e450-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celiprolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:90170c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celiprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:90173b30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42971 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:90175f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16348 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin targets Transporter (Solute carrier family 15 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:90179e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90179e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90179e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90179e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90179e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90179e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90179e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90181884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90181884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90181884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90181884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90181884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90181884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90181884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:90187892-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9018a0b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:9018c496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:9018ed7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:90191612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Transporter (Solute carrier family 22 member 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:90193e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:90196612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35236 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9019a726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9019a726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9019a726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9019a726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9019a726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9019a726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9019a726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901a0ebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:901a3790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:901a5ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:901a87e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:901aafcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:901ad808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:901b00f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:901b28e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:901b50c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:901b7ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:901b9f90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:901bc79a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:901befae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:901c184e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:901c404e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:901c6844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:901c9616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:901cbfba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:901ce7a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:901d0f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:901d377e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:901d7a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901d7a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901d7a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901d7a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901d7a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901d7a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901d7a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901dd800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:901dfc90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:901e247c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:901e64aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901e64aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901e64aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901e64aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901e64aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901e64aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901e64aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:901ec396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerivastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:901ee786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerivastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:901f0f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerivastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:901f39fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:578 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerulenin targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:901f66d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00488 biolink:molecularly_interacts_with DrugCentral:578 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerulenin targets Enzyme (Coagulation factor XIII A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:901f8ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:578 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerulenin targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:901fb77e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceruletide is agonist of GPCR (Cholecystokinin receptor type A) DrugCentral uuid:901fdb6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetirizine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:90200382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetirizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:90202cae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetirizine targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.05']} DrugCentral uuid:90205508-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetrorelix targets GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:90207902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetrorelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9020a116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:9020c902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.983']} DrugCentral uuid:9020f26a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:90211b96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.883']} DrugCentral uuid:9021436e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.201']} DrugCentral uuid:90216c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9021954e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.93']} DrugCentral uuid:9021bd58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.026']} DrugCentral uuid:9021e67a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14091 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets Enzyme (Cathepsin E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.78']} DrugCentral uuid:90221348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13443 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets Enzyme (Disintegrin and metalloproteinase domain-containing protein 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:90223ba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:589 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloramphenicol targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:902263ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62580 biolink:molecularly_interacts_with DrugCentral:589 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloramphenicol targets Enzyme (Chloramphenicol acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:90228bac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:589 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloramphenicol targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9022b3ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q88N29 biolink:molecularly_interacts_with DrugCentral:589 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloramphenicol targets Unclassified (Probable HTH-type transcriptional regulator TtgR) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:9022de90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorcyclizine targets Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.22']} DrugCentral uuid:902306ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.682']} DrugCentral uuid:90232eb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:90235776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:90237f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9023a88e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9023d0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9023f960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21761 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:90242944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:90242944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:90242944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:90246ff8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:90246ff8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:90246ff8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:9024bc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:9024bc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:9024bc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:902503d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:902503d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:902503d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:90254a90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:90254a90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:90254a90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9025c3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9026b114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9026b114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9026b114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9026b114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9026b114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9026b114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9027150a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9027150a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:90274bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:90274bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:90278012-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9027a862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9027d06c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9027f876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90282094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:90284ace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:902872e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:90289aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9028c2ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9028eb96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15056 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (Synaptojanin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:90291396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:90293c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.764']} DrugCentral uuid:9029649a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:90298cfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:9029b51c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.163']} DrugCentral uuid:9029e4e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:9029e4e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:9029e4e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:902a1f52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroprocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:902a4356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloropyramine targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:902a713c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:902a9946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:902ac1fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:902aea90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:902b13a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:902b3ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:902b652e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:902b8d4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:902bb56a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:902bde64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:902c098e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:902c3198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:902c59d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:902c827e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05227 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Cytosolic other (Histidine-rich protein PFHRP-II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:902cab5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:902cd7d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:902cffe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:902d2846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:902d506e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N6S8 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Cysteine proteinase falcipain 2a) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:902d7864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorothiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:902d9c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['5.43']} DrugCentral uuid:902dc5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorotrianisene targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:902dea24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorotrianisene is modulator of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:902e0e0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:902e361e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:902e5e78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:902e868c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:902eaf4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15296 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Arachidonate 15-lipoxygenase, type II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:902ed74a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:902effa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.818']} DrugCentral uuid:902f27ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:902f50bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:902f7dd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:902fa878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.967']} DrugCentral uuid:902fd1fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.06']} DrugCentral uuid:902ffa1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:90302b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:90302b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:90302b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:903069f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:903091f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96JM7 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Unclassified (Lethal(3)malignant brain tumor-like protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:9030b9e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05BQ5 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Unclassified (MBT domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:9030e26a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:90310a6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.842']} DrugCentral uuid:90313288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.975']} DrugCentral uuid:90315b28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphentermine is substrate of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.471']} DrugCentral uuid:903186fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphentermine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.404']} DrugCentral uuid:9031b12c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorproethazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:9031d936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorproethazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.987']} DrugCentral uuid:903201ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorproethazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:90322ecc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.233']} DrugCentral uuid:903256e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:90327f12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9032a780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9032cf76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.724']} DrugCentral uuid:9032f762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:903320e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:90334a64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:90337278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:90339aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9033c2c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9033ebe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:903413f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:90343c12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:90346426-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:90348ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.553']} DrugCentral uuid:9034b4bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9034e1d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:90350aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:90353338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:90355b56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.759']} DrugCentral uuid:903584b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:9035adea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:9035d5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.746']} DrugCentral uuid:9035fe1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.251']} DrugCentral uuid:90362626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:90364e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:9036769e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:90369f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.827']} DrugCentral uuid:9036c752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.345']} DrugCentral uuid:9036f11e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:90371a68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:90374286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:90376b44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:90379a92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.708']} DrugCentral uuid:9037c2b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9037eace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.092']} DrugCentral uuid:903812f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:90384898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:90384898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:90384898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:903886d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.133']} DrugCentral uuid:9038aef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.928']} DrugCentral uuid:9038dace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.463']} DrugCentral uuid:9039060c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:90392e16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:903956ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.061']} DrugCentral uuid:90398258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.713']} DrugCentral uuid:9039aa76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.569']} DrugCentral uuid:9039d280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9039fb84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:903a2370-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.043']} DrugCentral uuid:903a4c06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:903a741a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.797']} DrugCentral uuid:903a9e9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.305']} DrugCentral uuid:903acc12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:903af53e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.835']} DrugCentral uuid:903b1d5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:903b470a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.673']} DrugCentral uuid:903b6f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.777']} DrugCentral uuid:903b973c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:903bbf28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:903be7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:903c0fb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:903c37dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:903c619e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:903c8aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:903cb2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:903cdae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35433 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903d0356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:903d2b7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:903d5374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.854']} DrugCentral uuid:903d7b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903dbba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:903dbba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:903dbba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:903dbba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:903dbba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:903dbba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:903dbba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:903e3ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903e3ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903e3ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903e3ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903e3ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903e3ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903e3ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:903eba2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:903eba2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:903eba2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:903eba2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:903eba2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:903f1326-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:903f1326-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:903f562e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:903f562e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:903f562e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:903f562e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:903f562e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:903fb448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:903fb448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:903fb448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:903ffa52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:903ffa52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:903ffa52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:904054f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:904054f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:904054f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:904054f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:904054f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:904054f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:904054f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:904054f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:9040cc84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:9040f470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:90411c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04925 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Unclassified (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:904144de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17405 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Sphingomyelin phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:90416ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpropamide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:904198ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpropamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:904198ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpropamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:9041ccc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9041fb5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:9042237c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.367']} DrugCentral uuid:90424d70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9042758e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:90429e4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9042c64c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:9042ee74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:90431700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:90433f14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:90436714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:90439022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:9043ba16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.194']} DrugCentral uuid:9043e23e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:90440a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:90443252-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.97']} DrugCentral uuid:90445b92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:904483a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortetracycline targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9044ab92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortetracycline targets Surface antigen (Major prion protein) DrugCentral uuid:9044cf6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM07 biolink:molecularly_interacts_with DrugCentral:624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortetracycline targets Enzyme (Protein-arginine deiminase type-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9044f7c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.56']} DrugCentral uuid:90451ff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:904543d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:90456bea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:904594d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:9045bcc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:9045e4e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:90460d02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:904635c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90465e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9046862e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:9046ae38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9046d6a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9046feba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone is activator of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:904726a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:90474e9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29475 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:90477aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29474 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, endothelial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9047a32e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29476 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.554']} DrugCentral uuid:9047cb42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone is activator of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9047f360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone is opener of Ion channel (Calcium-activated potassium channel subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.523']} DrugCentral uuid:90481bec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:904843ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:90486be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:904894d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9048bd04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9048e522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90490d2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:90493680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.31']} DrugCentral uuid:90495ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:904987de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9049b01a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9049d8c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:904a00e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:904a2982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:904a5196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:904a79fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:904aa204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.39']} DrugCentral uuid:904aca18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:904af22c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:904b1c7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:904b45a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:904b6eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96394 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Arginase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:904b96be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:904bbf5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4QEW7 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:904be768-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:904c0f90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:904c37cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:904c604e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cibenzoline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:904c8844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cibenzoline targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) DrugCentral uuid:904cac34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cibenzoline targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:904cd434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:904cff22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:904d272c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:904d4f2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:904d77ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:904da008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:904dc81c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:904df030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:904e1902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:904e40ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:904e7be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:904e7be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:904e7be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:904e7be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:904e7be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:904e7be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:904e7be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:904edf9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclesonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:904f0b96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:636 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclopirox is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:904f33aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:636 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclopirox is inhibitor of Unclassified (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:904f5c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:636 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclopirox targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:904f8440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicloprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:904fac54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicloprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:904fd472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cidofovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:904ff8b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16444 biolink:molecularly_interacts_with DrugCentral:640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilastatin is inhibitor of Enzyme (Dipeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:905020da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22412 biolink:molecularly_interacts_with DrugCentral:640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilastatin targets Enzyme (Dipeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:905048da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilazapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:905070ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02294 biolink:molecularly_interacts_with DrugCentral:642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilnidipine is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:90509fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:90509fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:9050cdaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilostazol is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9050f58c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilostazol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:90511e04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilostazol is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9051460e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:90516e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:90519640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:9051becc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9051e6cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine is inhibitor of Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:90520ed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9052373a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinacalcet targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:90526048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinacalcet targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9052885c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinacalcet is positive allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9052b034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31424 biolink:molecularly_interacts_with DrugCentral:647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinacalcet is allosteric modulator of GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:9052d848-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinalukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:9053020a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinalukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) DrugCentral uuid:905325e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.035']} DrugCentral uuid:90534dfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:90537618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.777']} DrugCentral uuid:90539ea4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9053c6b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:9053eee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.552']} DrugCentral uuid:90541712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.208']} DrugCentral uuid:90544138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.987']} DrugCentral uuid:905469a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.333']} DrugCentral uuid:905492dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:9054bb0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:9054e688-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.064']} DrugCentral uuid:90550eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.849']} DrugCentral uuid:905536c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:90555ed8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:90558764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:9055af78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:9055d7fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:905600d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.885']} DrugCentral uuid:90562976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.242']} DrugCentral uuid:90565194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.299']} DrugCentral uuid:905679a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.793']} DrugCentral uuid:9056a252-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9056ca3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.97']} DrugCentral uuid:9056faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9056faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9056faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:90573974-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinoxacin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:9057657a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:9057657a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:90579360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9057bb42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AFI2 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:9057e3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q45066 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:90580bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:905833ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:90585be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9058846e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9058e5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9059bdc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9059bdc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9059f524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37340 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Unclassified (Multidrug resistance protein mdtK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:905a1d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:905a45ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:905a6de2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:905a95c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:905abdd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.379']} DrugCentral uuid:905ae63c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.19']} DrugCentral uuid:905b0e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:905b3646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:905b5e5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:905b87b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:905bb1b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:905bd9d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.396']} DrugCentral uuid:905c01f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:905c2a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.281']} DrugCentral uuid:905c527e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:905c7b0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.947']} DrugCentral uuid:905ca30a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.155']} DrugCentral uuid:905ccb50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:905cf44a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.472']} DrugCentral uuid:905d1c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:905d445e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.063']} DrugCentral uuid:905d6e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:905d9684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:905dbe84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:905de68e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:905e0f42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:905e377e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:905e5f6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:905e88aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:905eb532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:905eb532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:905ef7ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:905ef7ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:905ef7ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:905ef7ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:905ef7ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:905f5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:905f5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:905f5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:905f5ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:905fabd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:905fabd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:905fabd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:905ff3e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:905ff3e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:905ff3e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:90603222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:90606256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:90606256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:90606256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9060a086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.777']} DrugCentral uuid:9060c89a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9060f0a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.935']} DrugCentral uuid:90611bd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:90614432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.191']} DrugCentral uuid:90616c3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.931']} DrugCentral uuid:90619446-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9061bcf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.456']} DrugCentral uuid:9061e4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:90620d04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:90623554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:90625d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:90628572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9062ad68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:9062d612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9062fe9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:906327f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:9063501a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:906379dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9063a20e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9063ca36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q48255 biolink:molecularly_interacts_with DrugCentral:666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citric acid targets Enzyme (3-dehydroquinate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9063f24a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15474 biolink:molecularly_interacts_with DrugCentral:666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citric acid targets Enzyme (3-dehydroquinate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:90641ad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EPK8 biolink:molecularly_interacts_with DrugCentral:666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citric acid is activator of Ion channel (Transient receptor potential cation channel subfamily V member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:906442e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cladribine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:906466d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cladribine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.441']} DrugCentral uuid:90648ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cladribine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9064b91e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cladribine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:9064e380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:668 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clarithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:90650b80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'MPC', 'has_quantitative_value': ['8.719']} DrugCentral uuid:9065339e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.187']} DrugCentral uuid:90655c5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:90658470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59401 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9065ac66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9065d452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9065fcde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13661 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase OXA-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:906624d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:90664ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4KCT8 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:906674d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9066a026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9066c826-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:9066f044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9F663 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Carbepenem-hydrolyzing beta-lactamase KPC) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:906718f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:906740ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:906768e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD64 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:906791ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6GWS8 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9067ba42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9067e260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0ZX81 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:90680a60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4TVR4 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:90683288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90685c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2XPY6 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:90688490-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A3M1 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9068aca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9068d4a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9068fefc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q670S6 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:906926fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:90694f38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:90697774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:90699fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:9069c800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:9069f00a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:906a1828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:906a417c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:906a6990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:906a997e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:906a997e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:906a997e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:906ae028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:906ae028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:906ae028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:906b1e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.115']} DrugCentral uuid:906b47ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:906b7038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:906b9856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:906bc06a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:906be892-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.514']} DrugCentral uuid:906c1308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.036']} DrugCentral uuid:906c3dce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:906c660a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:906c8e32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:906cb718-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:906cdf40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.604']} DrugCentral uuid:906d077c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:906d2fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:906d581c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:906d8044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.703']} DrugCentral uuid:906da862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.084']} DrugCentral uuid:906dd170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.558']} DrugCentral uuid:906df998-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:906e21b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:906e49f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.269']} DrugCentral uuid:906e729c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:906e9bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:906ec3fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:906eec86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:906f14ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:906f3e16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:906f6648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:906f8e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:906fb79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:906fdfb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.396']} DrugCentral uuid:907007c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:90702fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN4 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:90705896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:907080b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13507 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:9070a8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y210 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9070d0fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:9070f986-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:907121a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:907149d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:907171d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:90719cd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:674 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clevidipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:9071c0dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:674 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clevidipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:9071e4d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:907208d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:90723198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clindamycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:9072557e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:681 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clioquinol targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:90727d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:681 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clioquinol targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:9072a57e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:681 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clioquinol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:9072cdf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:681 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clioquinol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9072fdb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9072fdb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9072fdb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:907335fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05141 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Enzyme (ADP/ATP translocase 2) DrugCentral uuid:90735a8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12235 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Transporter (ADP/ATP translocase 1) DrugCentral uuid:90737e68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12236 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Enzyme (ADP/ATP translocase 3) DrugCentral uuid:9073a23a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) DrugCentral uuid:9073c648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT1 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid is inhibitor of Transporter (Solute carrier family 17 member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:9073ef06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B1LRJ1 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Unclassified (Type IV secretion-like conjugative transfer relaxase protein TraI) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:90741738-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine is inhibitor of Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:90743c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9074647c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90748cf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P60891 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine targets Kinase (Ribose-phosphate pyrophosphokinase 1) DrugCentral uuid:9074b0da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HA47 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine targets Kinase (Uridine-cytidine kinase 1) DrugCentral uuid:9074d542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BZX2 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine targets Kinase (Uridine-cytidine kinase 2) DrugCentral uuid:9074f946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9075220e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L2G3 biolink:molecularly_interacts_with DrugCentral:692 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofazimine targets Enzyme (Uncharacterized oxidoreductase CzcO-like) DrugCentral uuid:907547fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:692 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofazimine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9075701a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:9075981a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9075c0c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibric acid targets Enzyme (Lipoprotein lipase) DrugCentral uuid:9075e4b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibric acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:90760cb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibric acid targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:907634be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clometacin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:90765d2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.461']} DrugCentral uuid:90768554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.455']} DrugCentral uuid:9076ad7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9076d586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.745']} DrugCentral uuid:9076fed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:907729aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:907751c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:907779e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.025']} DrugCentral uuid:9077a2a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.062']} DrugCentral uuid:9077caf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:9077f312-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:90781b44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.142']} DrugCentral uuid:907843c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:90786bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.187']} DrugCentral uuid:90789402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.407']} DrugCentral uuid:9078bc16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.889']} DrugCentral uuid:9078e5d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.358']} DrugCentral uuid:90790dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:90793600-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.896']} DrugCentral uuid:90795e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.371']} DrugCentral uuid:907986dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.668']} DrugCentral uuid:9079aef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.206']} DrugCentral uuid:9079d6e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:907a0008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.519']} DrugCentral uuid:907a289e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:907a5134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.979']} DrugCentral uuid:907a7934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:907aa24c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.778']} DrugCentral uuid:907acc5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:907af468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:907b1d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:907b465c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:907b6e70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:907b967a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:907bbe7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:907be6fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:907c0efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.243']} DrugCentral uuid:907c3724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.703']} DrugCentral uuid:907c5f42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:907c88aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:907cb0d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:907cd8f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:907d010e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:907d29cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:907d51e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:907d79f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.412']} DrugCentral uuid:907da1fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.007']} DrugCentral uuid:907dcaa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.696']} DrugCentral uuid:907df2b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:907e1ac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:907e42c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:907e6e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:907e9668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:907ebe4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.319']} DrugCentral uuid:907ee6cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:907f0fc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:907f37a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:907f5fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:907f8834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Glutathione S-transferase P) DrugCentral uuid:907fac1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:907fd406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:907ffd64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:908026d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.937']} DrugCentral uuid:908052d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:90807e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:9080a656-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9080cf14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9080f728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90815128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90821a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90821a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90821a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90821a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90826b1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:90826b1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:90826b1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:9082b20c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:9082b20c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:9082b20c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:9082f03c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P39051 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:90831864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:908348a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:908348a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:908348a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9083c052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9084ab3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9084ab3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9084ab3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9084ab3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9084ab3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9084ab3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90854472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90862018-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:90864a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9086728e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:90869aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9086c2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9086eb38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9087134c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:90873b6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9087637e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:90878de0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:9087b5ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9087ddfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:9088061c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:90882e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:90885676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.41']} DrugCentral uuid:90887f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:9088a6f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9088cf66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9088f770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:90891f66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:90894856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88703 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:90897178-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.796']} DrugCentral uuid:90899964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:9089c916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9089c916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9089c916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:908a082c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70507 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:908a3040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:908a582c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonixin targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:908a80c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloperastine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:908aa8cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clopidogrel targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.524']} DrugCentral uuid:908ad0ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clopidogrel is antagonist of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:908af8fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clopidogrel targets Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:908b2aa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:908b2aa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:908b2aa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:908b71b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:908b71b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:908b71b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:908bb1f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:908bb1f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:908bb1f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:908bf1c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:908bf1c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:908bf1c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:908c2904-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.825']} DrugCentral uuid:908c510e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:908c7a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:908ca2d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:908ccaf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:908d034c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:908d034c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:908d034c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:908d034c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:908d034c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:908d5fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:908d5fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:908d5fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:908d9eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.186']} DrugCentral uuid:908dc6ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.379']} DrugCentral uuid:908deef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:908e16f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.136']} DrugCentral uuid:908e3f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:908e6796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.391']} DrugCentral uuid:908e8fbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:908eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.351']} DrugCentral uuid:908ee2fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:908f0af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:908f32de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.174']} DrugCentral uuid:908f5ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.514']} DrugCentral uuid:908f8392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.104']} DrugCentral uuid:908faba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.995']} DrugCentral uuid:908fd4aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:908ffd36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.132']} DrugCentral uuid:90902554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:90904d9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.235']} DrugCentral uuid:909075ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.429']} DrugCentral uuid:9090a060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.046']} DrugCentral uuid:9090cb12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.466']} DrugCentral uuid:9090f33a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.294']} DrugCentral uuid:90911b4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:9091443e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.287']} DrugCentral uuid:90916c7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.677']} DrugCentral uuid:909194ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.785']} DrugCentral uuid:9091bcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:9091e57e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.267']} DrugCentral uuid:90920d9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:909235ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.106']} DrugCentral uuid:90925de2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:9092883a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9092b03a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:9092d434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.156']} DrugCentral uuid:9092fc34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.521']} DrugCentral uuid:909324f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.132']} DrugCentral uuid:90934cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.598']} DrugCentral uuid:9093751a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:90939900-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:9093c1a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9093ea9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.712']} DrugCentral uuid:909412a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:90943b30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.645']} DrugCentral uuid:909466aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:90948eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:9094b6be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.159']} DrugCentral uuid:9094df68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:90950786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.058']} DrugCentral uuid:90952f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.089']} DrugCentral uuid:9095579a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:90958012-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9095a812-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.497']} DrugCentral uuid:9095d01c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.178']} DrugCentral uuid:9095f81c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.854']} DrugCentral uuid:9096218e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:90964c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9096754e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:90969d4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.471']} DrugCentral uuid:9096c60c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.112']} DrugCentral uuid:9096ee2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.906']} DrugCentral uuid:90971670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:90973e70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:909766e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.942']} DrugCentral uuid:90978ee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:9097b6d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9097e000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:909808dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:909830d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:909858dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.99']} DrugCentral uuid:909880f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9098a990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9098d1b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9098f9b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:909921b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPN5 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Putative cytochrome P450 130) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:90994a1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00766 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Alpha-chymotrypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:90997244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:90999b34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9099c460-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9099ec6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:909a103c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:909a3846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4ZYU9 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:909a612c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3S5C3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Transporter (Efflux transporter; SugE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:909a892c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q48435 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:909ab118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62594 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:909ae8a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:909ae8a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:909ae8a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:909ae8a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:909ae8a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:909b3408-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:721 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxazolam targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:909b5c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:909b8408-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.783']} DrugCentral uuid:909badfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:909bd624-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:909bff64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.154']} DrugCentral uuid:909c278c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:909c5036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:909c7840-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:909ca05e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:909cc89a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:909cf13a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:909d1962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:909d4162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:909d6a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:909d94aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.78']} DrugCentral uuid:909dbcbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:909de50e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:909e0de0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:909e35e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.594']} DrugCentral uuid:909e5df4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:909e85ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:909eae44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:909ed644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.181']} DrugCentral uuid:909efe1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:909f261c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.591']} DrugCentral uuid:909f5006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:909f7842-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.792']} DrugCentral uuid:909fa13c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.356']} DrugCentral uuid:909fc932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:909ff1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:90a01a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:90a042a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:90a06aae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:90a09344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:90a0bb4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:90a0e358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:90a10b62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22310 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (UDP-glucuronosyltransferase 1-4) {'has_attribute_type': 'IAO:0000004', 'name': 'app Km', 'has_quantitative_value': ['4.208']} DrugCentral uuid:90a135ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:90a15df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:90a1860a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:90a1ae1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.445']} DrugCentral uuid:90a1d7e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:90a1fff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:90a22812-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:90a2509e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:90a278bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:90a2a12a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:90a2c93e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:90a2f2b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:90a31d58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:90a3454e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:90a36d62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:90a3960c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:90a3befc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:90a3e6f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:90a40f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:90a43774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:90a45fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:90a487ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:90a4b01e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90a4d9e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:90a501d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:90a529d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:90a551f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:90a57ad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:90a5a2da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:90a5cac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:90a5f2e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:90a61bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:90a644ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:90a66cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:90a69686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:90a6beae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q91ZY2 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:90a6e6ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q91ZY1 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90a712dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:90a712dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:90a7567a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:90a7567a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:90a7567a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:90a7567a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:90a7567a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:90a7b87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:90a7b87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:90a7b87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:90a7b87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:90a80a66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:90a80a66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:90a80a66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:90a84ca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:90a84ca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:90a890d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:90a890d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:90a890d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:90a890d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:90a890d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:90a8ec88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:90a8ec88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:90a8ec88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:90a94638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90a94638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90a94638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90a94638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90a94638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90a94638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90a94638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90a94638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90a9c4be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:90a9c4be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:90a9c4be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:90aa02d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90aa2ada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:90aa55d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.21']} DrugCentral uuid:90aa7f1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP23 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Cytosolic other (Calmodulin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:90aaa71c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:90aacb16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:90aaf3ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:90ab1bac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:90ab44ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:90ab6d28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:90ab95b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.67']} DrugCentral uuid:90abbdbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:90abe60e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:90ac0e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:90ac3a46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:90ac639a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UI33 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel protein type 11 subunit alpha) DrugCentral uuid:90ac8780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:90acafe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:90acd3d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:90acfc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:90ad253c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:90ad4e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:90ad77b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:90ad9fc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:90adcbd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:90adcbd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:90ae0a10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:90ae0a10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:90ae0a10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:90ae482c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27922 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:90ae7022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GJT6 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:90ae98ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:90aec0d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:90aee912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:90af1d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:90af1d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:90af1d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:90af1d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:90af6658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:90af8e58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.801']} DrugCentral uuid:90afb662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:90afdd2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.49']} DrugCentral uuid:90b0050e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.194']} DrugCentral uuid:90b02d04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07437 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine is inhibitor of Structural (Tubulin beta chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:90b0555e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:90b07d5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02550 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:90b0a6c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6B856 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin beta-2B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:90b0cee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine is inhibitor of Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:90b0f860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27957 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Unclassified (Tubulin polymerization-promoting protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:90b1206a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68371 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin beta-4B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:90b1504e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:90b1504e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:90b1504e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:90b19392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:90b19392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:90b1c6c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08828 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Enzyme (Adenylate cyclase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:90b1f6a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:90b1f6a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:90b1f6a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:90b23504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11166 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Transporter (Solute carrier family 2, facilitated glucose transporter member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90b25d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19754 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Enzyme (Adenylate cyclase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:90b28554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:90b2adae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:90b2d644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:90b2fe62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:90b32694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:90b34ec6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:90b37838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Cytosolic other (Annexin A1) DrugCentral uuid:90b39c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:90b3c446-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:90b3ec50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:90b41568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:90b44146-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:90b44146-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:90b475d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortivazol is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:90b499b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:737 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cotinine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:90b4be0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:90b4e614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:90b50e1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:90b5370e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:90b56256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:90b58a6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:90b5b274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:90b5daf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:90b6042c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:90b62c5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90b65486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:90b67cfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:90b6a51c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:90b6cd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:90b6f512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:90b71f10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q33BM1 biolink:molecularly_interacts_with DrugCentral:741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cromoglicic acid targets GPCR (G protein-coupled receptor GPR35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:90b74724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES90 biolink:molecularly_interacts_with DrugCentral:741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cromoglicic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:90b76f10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cromoglicic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:90b79724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25815 biolink:molecularly_interacts_with DrugCentral:741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cromoglicic acid targets Cytosolic other (Protein S100-P) DrugCentral uuid:90b7bb78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:90b7e38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.237']} DrugCentral uuid:90b80ba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:90b833aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:90b85d44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:90b88576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:90b8ad80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.602']} DrugCentral uuid:90b8d594-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:90b90136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:90b92c6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:90b95668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:90b97ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:90b9a6f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.531']} DrugCentral uuid:90b9cef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.235']} DrugCentral uuid:90b9f6f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:90ba1f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.623']} DrugCentral uuid:90ba47a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:90ba6fc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.993']} DrugCentral uuid:90ba9866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.353']} DrugCentral uuid:90bac1c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:90bae9e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.385']} DrugCentral uuid:90bb121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.799']} DrugCentral uuid:90bb3a1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.924']} DrugCentral uuid:90bb62b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.342']} DrugCentral uuid:90bb8abe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:90bbb2dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.206']} DrugCentral uuid:90bbdc08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:90bc048a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:90bc2870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:90bc5160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.728']} DrugCentral uuid:90bc7974-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:90bca32c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:90bccb5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.541']} DrugCentral uuid:90bcf368-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.812']} DrugCentral uuid:90bd1b90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:90bd441c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:90bd6c30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:90bd943a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.829']} DrugCentral uuid:90bdbc3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:90bde480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:90be0c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.222']} DrugCentral uuid:90be3494-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.509']} DrugCentral uuid:90be5c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:90be87e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclofenil targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:90beaffa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclofenil targets Nuclear other (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:90bed804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:90bf007c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:90bf28ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:90bf50c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:90bf78b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:90bfa126-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:90bfc930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:90bff158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclopentolate is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:90c01516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclophosphamide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:90c03fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c067a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:90c08f96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c0b796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c0e004-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:90c1087c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c1307c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WQA8 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Enzyme (Alanine racemase) DrugCentral uuid:90c1544e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05586 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:90c17ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60391 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c1a5de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WP31 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine is inhibitor of Enzyme (D-alanine--D-alanine ligase) DrugCentral uuid:90c1ca0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WQA9 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine is inhibitor of Enzyme (Alanine racemase) DrugCentral uuid:90c1ee04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:90c217ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:90c2572c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c2572c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c2572c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c2572c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c2572c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c2572c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c2572c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90c2c22a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:90c2ea48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:90c31248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:90c33a52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:90c362ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:90c38af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is modulator of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:90c3b40a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:90c3dc0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:90c404be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:90c42cb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:90c454c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:90c47da4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02790 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:90c4a5ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:90c4cdc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23284 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.01']} DrugCentral uuid:90c4f5e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:90c51e58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:90c5466c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:90c56ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08752 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:90c596d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:90c5bf84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:90c5e78e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:90c60f98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHG7 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:90c637ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:90c65c3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90c6843c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:90c6ac3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide is allosteric modulator of Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:90c6d432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide is allosteric modulator of Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:90c70934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:90c70934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:90c70934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:90c70934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:90c7540c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclovalone targets Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:90c77c20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclovalone targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:90c7a790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05412 biolink:molecularly_interacts_with DrugCentral:762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclovalone targets Transcription factor (Transcription factor AP-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:90c7d094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycrimine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:90c7f47a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:90c81c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:90c84556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:90c86d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.855']} DrugCentral uuid:90c89592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:90c8b982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:90c8e204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:90c90a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:90c9325e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.419']} DrugCentral uuid:90c95afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.812']} DrugCentral uuid:90c984de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.652']} DrugCentral uuid:90c9ad06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:90c9d506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:90c9fdba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:90ca25c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:90ca4df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:90ca761e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.222']} DrugCentral uuid:90ca9ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:90cac6dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.185']} DrugCentral uuid:90caeee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:90cb16d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:90cb409e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:90cb6a06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:90cb9242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.559']} DrugCentral uuid:90cbba4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:90cbe2e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.733']} DrugCentral uuid:90cc0b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:90cc331e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:90cc6302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:90cc6302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:90cc6302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:90cc9c0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:90ccc428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.899']} DrugCentral uuid:90ccec46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:90cd1626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:90cd3e62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90cd6676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:90cd8e8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:90cdb716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:90cddf3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:90ce0766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34968 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:90ce2f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:90ce584c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:90ce806a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:90ceb814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:90ceb814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:90ceb814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:90ceb814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:90ceb814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:90cf225e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:90cf225e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:90cf225e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:90cf225e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:90cf225e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:90cf7efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:90cf7efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:90cf7efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:90cfc4f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:90cfc4f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:90cfc4f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:90d0030e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTS6 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Enzyme (Histone-lysine N-methyltransferase SETD7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:90d02b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.053']} DrugCentral uuid:90d05386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:90d07bb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:90d0a3b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.678']} DrugCentral uuid:90d0d00e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:90d0fb42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.315']} DrugCentral uuid:90d1255e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90d14e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:769 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cysteine targets Transporter (Cystine/glutamate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:90d17630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15309 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine targets Enzyme (Prostatic acid phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'GI50', 'has_quantitative_value': ['7']} DrugCentral uuid:90d19e44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:90d1c644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06746 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine targets Enzyme (DNA polymerase beta) DrugCentral uuid:90d1f272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:90d1f272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:90d1f272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:90d22aee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00987 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine targets Nuclear other (E3 ubiquitin-protein ligase Mdm2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:90d252f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacarbazine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.255']} DrugCentral uuid:90d27af8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14181 biolink:molecularly_interacts_with DrugCentral:773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacarbazine targets Enzyme (DNA polymerase alpha subunit B) DrugCentral uuid:90d2a212-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62993 biolink:molecularly_interacts_with DrugCentral:774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dactinomycin targets Cytosolic other (Growth factor receptor-bound protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90d2cd46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dactinomycin targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:90d2f776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60631 biolink:molecularly_interacts_with DrugCentral:774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dactinomycin targets Cytosolic other (Growth factor receptor-bound protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90d32020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96IV0 biolink:molecularly_interacts_with DrugCentral:774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dactinomycin targets Enzyme (Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.05']} DrugCentral uuid:90d348f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:90d370f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:90d3992e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:90d3c2d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:90d3ee38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:90d41674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04070 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Vitamin K-dependent protein C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:90d43e9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:90d467e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:90d48ff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:90d4bfc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:90d4bfc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:90d4bfc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:90d4fe7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:90d526b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28731 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Unclassified (Thrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:90d54ec2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.243']} DrugCentral uuid:90d576d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:90d59f4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.163']} DrugCentral uuid:90d5c866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.087']} DrugCentral uuid:90d5f084-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.248']} DrugCentral uuid:90d618b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:90d643c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.976']} DrugCentral uuid:90d66bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:90d69430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.425']} DrugCentral uuid:90d6bc3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.708']} DrugCentral uuid:90d6e50c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.894']} DrugCentral uuid:90d70d3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.462']} DrugCentral uuid:90d73552-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.265']} DrugCentral uuid:90d75d66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:90d785fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.207']} DrugCentral uuid:90d7ae06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.294']} DrugCentral uuid:90d7d624-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:90d7fa14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:90d82098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:90d84884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Enzyme (Steryl-sulfatase) DrugCentral uuid:90d86c6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:90d8947e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.053']} DrugCentral uuid:90d8bd28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:90d8e5aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:90d90dbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dantrolene is antagonist of Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.757']} DrugCentral uuid:90d935d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15413 biolink:molecularly_interacts_with DrugCentral:780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dantrolene is antagonist of Ion channel (Ryanodine receptor 3) DrugCentral uuid:90d95a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dantrolene targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:90d9824e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.929']} DrugCentral uuid:90d9aa4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.762']} DrugCentral uuid:90d9d37a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:90d9fc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.485']} DrugCentral uuid:90da24c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole is antagonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:90da48aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.279']} DrugCentral uuid:90da70dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.388']} DrugCentral uuid:90da997c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:90dabd8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:90dae594-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:90db0d9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:90db35ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:90db5e16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:90db863e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C0X1 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone is inhibitor of Enzyme (Dihydropteroate synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:90dbaf56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:90dbd94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:90dc0136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:90dc2670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4Z710 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Unclassified (Dihydropteroate synthetase, putative) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:90dc4f42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0A113T0T6 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:90dc7756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:90dc9f56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q57P83 biolink:molecularly_interacts_with DrugCentral:783 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daptomycin targets Transporter (Outer membrane porin protein OmpD) DrugCentral uuid:90dcc33c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:90dceb96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:90dd1396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:90dd3b82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:90dd6396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:90dd8d44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:90ddb828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:90dde154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:90de097c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:90de3262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:90de5a76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:90de82bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:90deaae4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.6']} DrugCentral uuid:90ded398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:90defc2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:90df244c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:90df4c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Breakpoint cluster region protein) DrugCentral uuid:90df7230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:90df9a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:90dfc280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:90dfeaa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.1']} DrugCentral uuid:90e01384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.07']} DrugCentral uuid:90e03b8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:90e063ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:90e08b98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:90e0b410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:90e0dc1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90e10424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:90e12d3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:90e15834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.33']} DrugCentral uuid:90e1808e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:90e1a884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:90e1d232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.46']} DrugCentral uuid:90e1fa5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:90e223b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:90e24bcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:90e27458-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:90e29c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:90e2c476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:90e2eca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:90e3173c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:90e33f5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:90e36764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:90e38f78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:90e3b82c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:90e3e036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:90e40818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.77']} DrugCentral uuid:90e43022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:90e45890-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:90e4809a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:90e4a8a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:90e4d0e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:90e4f99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90e52194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:90e54976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:90e572ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:90e59ab6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:90e5c3a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.03']} DrugCentral uuid:90e5ebb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:90e61446-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.51']} DrugCentral uuid:90e63c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:90e6648c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:90e68c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.59']} DrugCentral uuid:90e6b554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:90e6dd54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.35']} DrugCentral uuid:90e70568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:90e72d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.25']} DrugCentral uuid:90e75608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:90e77e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.16']} DrugCentral uuid:90e7a626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.47']} DrugCentral uuid:90e7ce30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:90e7f6ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:90e82024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:90e84860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:90e87088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:90e89964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:90e8c15a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:90e8e964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:90e91164-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06240 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase LCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.19']} DrugCentral uuid:90e939b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:90e961b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:90e989be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.41']} DrugCentral uuid:90e9b2b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:90e9dbee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:90ea03f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:90ea2c02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:90ea552e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:90ea801c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:90eaaa6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.68']} DrugCentral uuid:90ead26a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:90eafaba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:90eb22ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:90eb4ace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:90eb72d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:90eb9baa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27037 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activin receptor type-2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:90ebc3be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:90ebebbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:90ec1468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:90ec3e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:90ec667a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:90ec8e84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:90ecb684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:90ecdee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99640 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:90ed06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:90ed2eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:90ed56c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:90ed7f60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36894 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Bone morphogenetic protein receptor type-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:90eda846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:90edd03c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5VT25 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90edf846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:90ee232a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:90ee4b5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:90ee7384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:90ee9bde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:90eec3e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:90eeec2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.16']} DrugCentral uuid:90ef144c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:90ef3ce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:90ef64ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:90ef8ce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16277 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:90efb4d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.41']} DrugCentral uuid:90efdda0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:90f005a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:90f02d96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:90f05582-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:90f07dfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:90f0a604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:90f0ce18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:90f0f60e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:90f11eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:90f146ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:90f16ea4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:90f197a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:90f1c084-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:90f1e87a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:90f2107a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:90f23898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:90f2612e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:90f28938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:90f2b1c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:90f2e608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:90f2e608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:90f2e608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:90f2e608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:90f332fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase; MEK1/2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:90f332fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase; MEK1/2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:90f369e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:90f369e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:90f3a0ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01538 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Transcription factor (Myelin transcription factor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:90f3c8ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:90f3eca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:90f4108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:90f43530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:90f45920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:90f47d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:90f4a4d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:90f4cd24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deanol targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:90f4f538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28570 biolink:molecularly_interacts_with DrugCentral:787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deanol targets Transporter (Creatine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:90f51e50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:788 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 debrisoquine targets Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:90f54222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:788 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 debrisoquine targets Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:90f567ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:90f58fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:90f5b7c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:90f5dfca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:90f60c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:90f60c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:90f64f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:90f64f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:90f64f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:90f64f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:90f64f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:90f69a32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:790 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decitabine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:90f6c228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:790 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decitabine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:90f6e618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:792 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deferoxamine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:90f70e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:792 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deferoxamine targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:90f736b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:90f75ed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.84']} DrugCentral uuid:90f786f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasterone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:90f7aef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GRG7 biolink:molecularly_interacts_with DrugCentral:795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasterone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:90f7d7b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.921']} DrugCentral uuid:90f7ffc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.97']} DrugCentral uuid:90f827d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.276']} DrugCentral uuid:90f84fee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:90f87852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:90f8a05c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:90f8c942-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:90f8f26e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:90f92590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:90f92590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:90f92590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90f99e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:90fa6de2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demecarium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:90fa91dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demeclocycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:90fab5b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demeclocycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:90fadb9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demeclocycline targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:90fb0536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denopamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:90fb2d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denopamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:90fb5568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deptropine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:90fb7e44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WSF8 biolink:molecularly_interacts_with DrugCentral:808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deptropine targets Unclassified (Soluble acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:90fbae1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:90fbae1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:90fbae1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:90fbec30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deserpidine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:90fc1098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:90fc3492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:90fc588c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:90fc7c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:90fca134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:90fcca4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:90fcca4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:90fde92c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:90fe1140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.631']} DrugCentral uuid:90fe3954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:90fe615e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:90fe8b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.755']} DrugCentral uuid:90feb47e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.081']} DrugCentral uuid:90fedc92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.194']} DrugCentral uuid:90ff04b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:90ff2d82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:90ff558c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:90ff7d82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:90ffa58c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:90ffc9e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:90fff1ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:91001a08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9100428a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:91006b52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:91009366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:9100bb66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:9100e37a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:91010d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:91013140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:91015922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.6']} DrugCentral uuid:91018118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:9101aa8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9101d2c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:9101fb02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9102242e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:91024c9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9102749c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9102cf32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:91038f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:91038f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:91038f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9103cd56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:9103f664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48545 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:91041fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:91046306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:91046306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:91046306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:91046306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:91046306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:91046306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:91046306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:91046306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:9104cc1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:9104f442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:91051c6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.956']} DrugCentral uuid:910544f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.025']} DrugCentral uuid:91056d1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:91059596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9105bdbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:9105e8a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.009']} DrugCentral uuid:910610b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.189']} DrugCentral uuid:910638e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:91066106-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.967']} DrugCentral uuid:91068a78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:9106b26e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9106da6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:910702e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:91072afa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:910752f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:91077afa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.511']} DrugCentral uuid:9107a552-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:9107cdd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75899 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets GPCR (Gamma-aminobutyric acid type B receptor subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.027']} DrugCentral uuid:9107f5ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28476 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-2) DrugCentral uuid:9108216c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:9108216c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:9108216c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91089660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91095bcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:91098610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:9109af14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9109d728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:910a002c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:910a2908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:910a5130-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:910a7962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin is agonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:910aa180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desogestrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:910ac5e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desogestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:910b560c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoximetasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.932']} DrugCentral uuid:910b8564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoximetasone targets Cytosolic other (Annexin A1) DrugCentral uuid:910ba972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoximetasone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:910bd186-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:910bfa3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.498']} DrugCentral uuid:910c2258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:910c4a94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:910c72bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11']} DrugCentral uuid:910c9b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:910cc366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:910ceba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycorticosterone acetate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) DrugCentral uuid:910d0fb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycorticosterone pivalate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:910d3a94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.886']} DrugCentral uuid:910d6532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.88']} DrugCentral uuid:910d8d28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Cytosolic other (Annexin A1) DrugCentral uuid:910db10e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:910dd9ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:910e0186-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05112 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Cytokine (Interleukin-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:910e2a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:910e5258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:910e7c4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.786']} DrugCentral uuid:910ea44c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:910ecc56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.517']} DrugCentral uuid:910ef73a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:910f21ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54915 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:910f4afa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:910f6eea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:910f9762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:910fbf62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:910fe776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:91100f8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:91103848-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:9110605c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:9110885c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9110b05c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9110d9ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:911101b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:911129b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:911151a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:911179f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:9111a1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:9111c9e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9111f1ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexbrompheniramine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:91121640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:91123f3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:911276a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:911276a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:911276a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:911276a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:911276a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:9112cf68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:9112f786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:91131f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:911347f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:91137008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:91139808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.607']} DrugCentral uuid:9113c01c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.384']} DrugCentral uuid:9113e86c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:9114106c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.042']} DrugCentral uuid:9114386c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.257']} DrugCentral uuid:91146080-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:91148cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9114b512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.733']} DrugCentral uuid:9114dcfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.577']} DrugCentral uuid:911504f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.326']} DrugCentral uuid:91152d4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.156']} DrugCentral uuid:9115554e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:91157d58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.898']} DrugCentral uuid:9115a616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.706']} DrugCentral uuid:9115cf10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:9115f72e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:91161f42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:833 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:911648a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:833 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9116732a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexloxiglumide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:91169b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9116c320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9116ebca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:911713e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:91173bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:91176406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:91178c7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:9117b492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9117e43a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:9117e43a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:9117e43a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:91182b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:91182b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:91182b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:91186978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:91189164-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:9118b61c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9118de26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:91190630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:91193d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:91193d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:91193d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:91193d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:91193d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:91199474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9119bc88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:9119e4a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:911a0ef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:911a371c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:911a5f44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:911a8762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:911ab00c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:911ad82a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.824']} DrugCentral uuid:911b0052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:911b28d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:911b50de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:911b7906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:911ba192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:911bcb04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:911bfcfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:911bfcfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:911bfcfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:911c3f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:911c3f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:911c6d34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:911c9124-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:911cba1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:911ce228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:911d0ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:911d2eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:911d56b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:911d7aa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:911da3de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:911dc7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.87']} DrugCentral uuid:911defb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:911e179c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:911e3fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:911e6800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:911e8fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:911eb7d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:911fd690-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan is agonist of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'D2', 'has_quantitative_value': ['6.458']} DrugCentral uuid:911ffe72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.842']} DrugCentral uuid:912026d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ks', 'has_quantitative_value': ['4.48']} DrugCentral uuid:91204eea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:912076e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan is blocker of Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:91209ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:9120c7bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9120efd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:91212eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:91212eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:91212eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:91212eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:91212eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:91212eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:91212eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:9121a1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9121a1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9121a1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9121e08e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:91220960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:91223156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:844 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextropropoxyphene targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:9122553c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:844 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextropropoxyphene is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:912279a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:844 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextropropoxyphene targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:9122a28a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:9122cfa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor) DrugCentral uuid:9122cfa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor) DrugCentral uuid:91231580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91231580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91231580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91231580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91231580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91231580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91231580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:912382ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dezocine is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:9123aafe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dezocine is antagonist of GPCR (Kappa-type opioid receptor) DrugCentral uuid:9123cf66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42574 biolink:molecularly_interacts_with DrugCentral:849 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diacerein targets Enzyme (Caspase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9123f752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55210 biolink:molecularly_interacts_with DrugCentral:849 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diacerein targets Enzyme (Caspase-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:91241f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q17339 biolink:molecularly_interacts_with DrugCentral:849 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diacerein targets Unclassified (Female germline-specific tumor suppressor gld-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:91244720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02083 biolink:molecularly_interacts_with DrugCentral:849 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diacerein targets Enzyme (N-acylethanolamine-hydrolyzing acid amidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:91247768-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:91247768-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:91247768-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:9124b55c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:9124dd48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:9125085e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is allosteric modulator of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:91253144-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:91255994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:912581ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9125ab9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:9125d41e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9125fc1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:912624d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.67']} DrugCentral uuid:91264cdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:912674e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:91269cd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9126c626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9126f01a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19969 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:91271fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:91271fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:91271fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:91276658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:91276658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:91276658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:9127adf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:9127adf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:9127adf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:9127f406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:9127f406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:9127f406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:91283aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:91283aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:91283aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:9128820e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:9128820e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:9128820e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9128faea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9129de4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9129de4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9129de4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9129de4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9129de4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9129de4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:912a462a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:912a462a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:912a462a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:912a8dd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:912a8dd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:912a8dd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:912ad3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:912ad3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:912ad3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912b4804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:912c14f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:912c14f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:912c14f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:912c5c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:912c5c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:912c5c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:912ca244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:912ca244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:912ca244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:912ce84e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:912ce84e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:912ce84e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:912d2e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:912d2e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:912d2e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:912d74c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:912d74c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:912d74c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:912db440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazoxide targets Enzyme (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.64']} DrugCentral uuid:912de028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazoxide is opener of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:912de028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazoxide is opener of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:912e1458-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazoxide is activator of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:912e3f5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibekacin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.921']} DrugCentral uuid:912e685e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:912e8c4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:912eb872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:912eb872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:912eb872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:912ef67a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:912f1e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazone is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.081']} DrugCentral uuid:912f4684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15118 biolink:molecularly_interacts_with DrugCentral:862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3']} DrugCentral uuid:912f6f24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15119 biolink:molecularly_interacts_with DrugCentral:862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.699']} DrugCentral uuid:912f9724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15120 biolink:molecularly_interacts_with DrugCentral:862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.097']} DrugCentral uuid:912fbf2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16654 biolink:molecularly_interacts_with DrugCentral:862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.301']} DrugCentral uuid:912fe814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorophen targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:91301168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorophen targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:91303968-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorophen targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9130615e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:913089cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9130b1e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:9130d9e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:913101c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:91312a58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:9131523a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:91317a1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:9131a208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.577']} DrugCentral uuid:9131cabc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.423']} DrugCentral uuid:9131f398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:91321b98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:913243a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:91326bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:913293fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9132bbfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:9132e488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:91330e5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:9133367c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:91335e90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:9133869a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9133b098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9133d898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:91340098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:913428a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:9134511a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:91347924-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9134a11a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9134c9ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:9134f1ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:913519d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:913541ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:91356adc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:913592dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9135badc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is antagonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9135e3e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:91360c4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9136344e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:91365c3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:91368430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:9136acda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9136d4da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9136fcda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:913724ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:91374f00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9137770a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:91379f32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAW7 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:9137c750-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19224 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:9137efdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60656 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:913817f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAW8 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:91384090-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9138689a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:9138911c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:9138b8ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9138e0c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:913909bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:913934d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:913958a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:91398086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:9139a87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:9139d194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:913a08d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:913a08d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:913a08d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:913a08d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:913a08d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:913a538a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.971']} DrugCentral uuid:913a7b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15559 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (NAD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:913aa376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.388']} DrugCentral uuid:913acb58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.354']} DrugCentral uuid:913af59c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16549 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Proprotein convertase subtilisin/kexin type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:913b1e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:913b461e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:913b6e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07374 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Urease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:913b966e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WMN1 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (ATP phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:913bbe82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05982 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (NULLD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:913be6aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.509']} DrugCentral uuid:913c0ebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.686']} DrugCentral uuid:913c3772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.773']} DrugCentral uuid:913c5f7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:913c877c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.082']} DrugCentral uuid:913caf86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:913cdae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:913d0562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.386']} DrugCentral uuid:913d2d62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:913d55da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.079']} DrugCentral uuid:913d7ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:913da6de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.033']} DrugCentral uuid:913dcefc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.386']} DrugCentral uuid:913df7a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.767']} DrugCentral uuid:913e2032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.327']} DrugCentral uuid:913e4828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70676 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Unclassified (SMR1-alpha2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:913e7168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:913e9b48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.61']} DrugCentral uuid:913ecb90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:913ecb90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:913ecb90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:913f097a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72549 biolink:molecularly_interacts_with DrugCentral:869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 didanosine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:913f31f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dienestrol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:913f59fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dienogest is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:913f7dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:913fa5c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylcarbamazine targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:913fca54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylcarbamazine targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:913ff20e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E1G1C3 biolink:molecularly_interacts_with DrugCentral:873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylcarbamazine is positive modulator of Ion channel (Nematode GABA-A receptor) DrugCentral uuid:913ff20e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E1G1C3 biolink:molecularly_interacts_with DrugCentral:873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylcarbamazine is positive modulator of Ion channel (Nematode GABA-A receptor) DrugCentral uuid:91401fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylpropion is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:91404394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylpropion is inhibitor of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:914068ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.316']} DrugCentral uuid:91409254-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.894']} DrugCentral uuid:9140ba5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.252']} DrugCentral uuid:9140e25e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:91410afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:9141340c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:91415c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:9141843e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.276']} DrugCentral uuid:9141ad06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.178']} DrugCentral uuid:9141d510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.439']} DrugCentral uuid:9141fd10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:9142251a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:91424f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.575']} DrugCentral uuid:91427786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.223']} DrugCentral uuid:91429f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.272']} DrugCentral uuid:9142c79a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:9142f01c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.437']} DrugCentral uuid:914317f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.408']} DrugCentral uuid:91434076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.317']} DrugCentral uuid:91436876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.657']} DrugCentral uuid:9143913e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9143b934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.778']} DrugCentral uuid:9143e256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:91440b32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:914435da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.274']} DrugCentral uuid:91445de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.739']} DrugCentral uuid:91448602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:9144ae52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.019']} DrugCentral uuid:9144d666-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.593']} DrugCentral uuid:9144fe52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:91452742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Estrogen-related receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:91454fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:914577b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.983']} DrugCentral uuid:91459fce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.847']} DrugCentral uuid:9145c7ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.361']} DrugCentral uuid:9145f14a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95718 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Steroid hormone receptor ERR2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9146194a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.483']} DrugCentral uuid:91464208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:91466a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:91469334-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.528']} DrugCentral uuid:9146bbc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.052']} DrugCentral uuid:9146e3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.214']} DrugCentral uuid:91470bc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:91473474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:91475c7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08580 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:91478488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 difenoxin is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:9147a878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9147d2d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9147fada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:914822e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd1', 'has_quantitative_value': ['7.125']} DrugCentral uuid:91484ada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9148735c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:91489b70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:9148c384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.648']} DrugCentral uuid:9148ebde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.857']} DrugCentral uuid:91491578-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:9149395e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50997 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:91496172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9149a66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9149a66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9149a66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9149a66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9149a66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9149a66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9149a66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9149a66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:914a1ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.783']} DrugCentral uuid:914a454c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.136']} DrugCentral uuid:914a6d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:914a951a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50997 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:914abcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:914b0086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:914b0086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:914b0086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:914b0086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:914b0086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:914b0086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:914b0086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:914b0086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:914b785e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51450 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:914ba040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.007']} DrugCentral uuid:914bc854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:914bf05e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.187']} DrugCentral uuid:914c18e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.526']} DrugCentral uuid:914c40fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:914c68f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:914c9112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:914cb9da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.085']} DrugCentral uuid:914ce1ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.114']} DrugCentral uuid:914d09e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.121']} DrugCentral uuid:914d32b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:914d5dd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:914d8680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.728']} DrugCentral uuid:914dae80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.261']} DrugCentral uuid:914dd734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.369']} DrugCentral uuid:914dff48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:914e2734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:914e507e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.299']} DrugCentral uuid:914e7978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:914ea15a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:914ec95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydrocodeine is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:914eed36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.087']} DrugCentral uuid:914f172a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.462']} DrugCentral uuid:914f422c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:914f6b44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.309']} DrugCentral uuid:914f9358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.127']} DrugCentral uuid:914fbc16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:914fe416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.385']} DrugCentral uuid:91500c20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.373']} DrugCentral uuid:91503420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.377']} DrugCentral uuid:91505cac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.903']} DrugCentral uuid:915084d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9150acc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:9150d0a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.442']} DrugCentral uuid:9150fb76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:91512394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.605']} DrugCentral uuid:91514ba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1D) DrugCentral uuid:91516f8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:91519810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.183']} DrugCentral uuid:9151c024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:9151e414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:91520c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:915234dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.896']} DrugCentral uuid:91525cfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:915284f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.79']} DrugCentral uuid:9152acf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.14']} DrugCentral uuid:9152d89c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:91530308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.804']} DrugCentral uuid:91532b1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.922']} DrugCentral uuid:9153542a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.529']} DrugCentral uuid:91537d24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.412']} DrugCentral uuid:9153a542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:9153cd4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.424']} DrugCentral uuid:9153f6fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.644']} DrugCentral uuid:91541f22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.364']} DrugCentral uuid:915447c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:91546fe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.83']} DrugCentral uuid:9154989e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9154c0a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:9154e48e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.752']} DrugCentral uuid:91550ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.742']} DrugCentral uuid:91553560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:91555d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:91558588-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.821']} DrugCentral uuid:9155ad88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.69']} DrugCentral uuid:9155d5ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:9155f9be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 5A) DrugCentral uuid:91561d9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:915645ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:91566e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.349']} DrugCentral uuid:915696b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.416']} DrugCentral uuid:9156bea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9156e68a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.18']} DrugCentral uuid:91570f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9157372a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:91575f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:91578806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9157b06a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9157d87e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:91580844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:91580844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:91580844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:915847d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:91586ba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:91588f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:9158b348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:9158d76a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:9158fb3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:91591f0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:91594ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:91594ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:91594ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:91598e8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54699 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Transporter (Equilibrative nucleoside transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9159b658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:9159da2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:9159fdf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:915a24c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:915a488e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:915a708e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:915a9884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.736']} DrugCentral uuid:915ac0ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:915ae942-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:915b114c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:915b3a14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:915b6282-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:915b8a78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.017']} DrugCentral uuid:915bb28c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:915bdc26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:915c0412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:915c2c12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:915c5412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:915c7c76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:915cac46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:915cac46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:915cac46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:915cf1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:915cf1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:915cf1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:915d308a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:915d588a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:915d8076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JIS7 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:915da880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:900 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimemorfan is inhibitor of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:915dd1ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.791']} DrugCentral uuid:915df9a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.312']} DrugCentral uuid:915e2198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.695']} DrugCentral uuid:915e49f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.703']} DrugCentral uuid:915e71fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:915e9ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.479']} DrugCentral uuid:915ec422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:915eeccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:915f14f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:915f3d08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.785']} DrugCentral uuid:915f6508-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:915f8ee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:915fb92c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.644']} DrugCentral uuid:915fe140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.749']} DrugCentral uuid:91600940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.821']} DrugCentral uuid:916031a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:916059ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7KQK5 biolink:molecularly_interacts_with DrugCentral:902 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetacrine targets Unclassified (Apical membrane antigen 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:9160819a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:9160aa30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:9160d294-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:9160fa9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9161229e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:91614abc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:91617eb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:91617eb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:91617eb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:9161c640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:9161c640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:9161f412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:911 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dioxyline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:91621c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:911 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dioxyline targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:91624502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:91626cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9162957a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9162bd8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9162e5a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:91630d98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:916336d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:91635ee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:916386f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9163af0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9163d76e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:9163ff78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43117 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:916427fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9164511c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9164799e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9164a1d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:9164c9c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9164f1e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:91651c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9165445a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:91656c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:91659450-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:9165bcf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9165e50e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:91660d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:91663612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:91665f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:91668720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9166af2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9166d81a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:91670042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:91672856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:9167510a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43117 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:91677982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9167a182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:9167c9a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9167f18c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:91681a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9168422c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:91686a36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:91689268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:9168bc84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9168e52e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphemanil is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:9169091e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphemanil is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:91692d0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:91695572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.018']} DrugCentral uuid:91697d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:9169a59a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:9169cdb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:9169f694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.81']} DrugCentral uuid:916a1fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:916a48ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:916a70ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:916a9b76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:916ac380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:916aeb80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.585']} DrugCentral uuid:916b1376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.932']} DrugCentral uuid:916b433c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:916b6b46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.678']} DrugCentral uuid:916b9b0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:916b9b0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:916b9b0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:916bd9aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:916c01aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.658']} DrugCentral uuid:916c29d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:918 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenoxylate is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.167']} DrugCentral uuid:916c5272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:918 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenoxylate targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:916c7af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.076']} DrugCentral uuid:916ca2fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:916ccb08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.377']} DrugCentral uuid:916cf3a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:916d19e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:916d4204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipivefrine is agonist of GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:916d65fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipivefrine is agonist of GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:916d8af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipivefrine is agonist of GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:916daece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprafenone targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:916dd2b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprafenone targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:916df780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprafenone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:916e1b8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:916e464a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:916e6e5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:916e969a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:916ebed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.802']} DrugCentral uuid:916ee7a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:916f0fda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:916f37f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:916f6070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 7B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:916f8898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60658 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:916fb0b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.158']} DrugCentral uuid:916fd9ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:9170034a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:91703248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:91703248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:91706bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:91706bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9170b2ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9170b2ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9170b2ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9170b2ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9170b2ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9170b2ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:91711b40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:91711b40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:91711b40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:917159e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:91718206-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86TP1 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Protein prune homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:9171a9f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9171d2d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DTD1 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9171faf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:91721edc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.036']} DrugCentral uuid:917246e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:91726fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:91729394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:9172b75c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:9172db38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48544 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:9173034c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:91732b9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.604']} DrugCentral uuid:9173541e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 distigmine is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:91737822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:9173a040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.846']} DrugCentral uuid:9173cb4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Transporter (Translocator protein) DrugCentral uuid:9173ef3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.967']} DrugCentral uuid:91741746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.115']} DrugCentral uuid:91743f5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.735']} DrugCentral uuid:9174680e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.156']} DrugCentral uuid:91749018-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.658']} DrugCentral uuid:9174b958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.129']} DrugCentral uuid:9174e2ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.833']} DrugCentral uuid:91750af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.434']} DrugCentral uuid:91753338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.434']} DrugCentral uuid:91755b42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:9175846e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.957']} DrugCentral uuid:9175ac96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:9175d4be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:9175fcbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.862']} DrugCentral uuid:91762572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05091 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram is inhibitor of Enzyme (Aldehyde dehydrogenase, mitochondrial) DrugCentral uuid:91764962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.319']} DrugCentral uuid:91767158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.738']} DrugCentral uuid:91769976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25025 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (C-X-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:9176c1ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9176ea0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.821']} DrugCentral uuid:9177120c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.794']} DrugCentral uuid:91773a16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.669']} DrugCentral uuid:91776374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.357']} DrugCentral uuid:91778b9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.333']} DrugCentral uuid:9177b3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11884 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Aldehyde dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9177dbc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99685 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9178046e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:91782c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9178546e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29375 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Lysine-specific demethylase 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:91787c82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9178a522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:9178cdea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9178f702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:91791f02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:91794acc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57764 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Unclassified (Gasdermin-D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:917975d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9VTU8 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 2, isoform A; LD26647p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:91799df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9V396 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 1; GH09688p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:9179c6be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9179eeb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:917a16c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:917a3ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:917a6754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:917a8fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05181 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Cytochrome P450 2E1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:917ab920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:917ae15c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:917b0a4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:917b3260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57764 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Unclassified (Gasdermin-D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:917b5a60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:917b826a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R4D5 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:917bab1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R455 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:917bd31e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:917bfb32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7Z2W7 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:917c231e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:917c4b8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:917c738c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.976']} DrugCentral uuid:917c9b8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:917cc38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:917cef1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:917d17c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.771']} DrugCentral uuid:917d3fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:917d67f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:917d90be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:917db8e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:917de0fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:917e0990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:917e31b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:917e59e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.256']} DrugCentral uuid:917e81e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:917eab34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:917ed35c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:917efb8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.258']} DrugCentral uuid:917f23b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.401']} DrugCentral uuid:917f4c60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.301']} DrugCentral uuid:917f7488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:917f9ca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:917fc4ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:917fed3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:91801532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.223']} DrugCentral uuid:91803d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:9180653c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:91808e90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9180b7c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9180e0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:918108e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:91813174-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:9181555a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:91817936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.086']} DrugCentral uuid:9181a14a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.283']} DrugCentral uuid:9181c9c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets GPCR (Growth hormone-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918210c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:918298de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:9182ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:91837d44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dofetilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:9183a5a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dofetilide targets Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:9183c998-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dofetilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9183f1a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.766']} DrugCentral uuid:918419b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:91844436-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.988']} DrugCentral uuid:91846c36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:91849418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:9184b92a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:9184e1d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.586']} DrugCentral uuid:918509e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:91853256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:91855b14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:91858364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:9185ab82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.013']} DrugCentral uuid:9185d3aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:9185fd12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:91862580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:91864d6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:9186756c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:91869e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:9186c62a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:9186ee3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.553']} DrugCentral uuid:91871e18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:91871e18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:91871e18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:91875702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:91877f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:9187a720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9187d06a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:9187fbbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.93']} DrugCentral uuid:91882538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:91884d24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:918875ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:91889dce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:9188c5ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9188ede2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:91891628-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.046']} DrugCentral uuid:91893ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:918966dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:91898ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9189b95c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9189e198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:918a0970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:918a3152-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:918a59ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:918a82d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:918aaac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:918ad2ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:918afb00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32738 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Choline O-acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:918b22f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:918b4c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:918b74ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:918b9cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:918bc4e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:918bece0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:918c158a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.19']} DrugCentral uuid:918c3d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:918c658a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:918c8d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.18']} DrugCentral uuid:918cb5b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.084']} DrugCentral uuid:918cddc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:918d05da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:918d2dda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:918d579c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:918d82ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.375']} DrugCentral uuid:918dae0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:918dd622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:918dfecc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:918e26d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:918e4ec2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:918e769a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:918e9ef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:918ec6ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:918eeee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:918f16cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:918f4228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:918f6af0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:918f9372-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09172 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Dopamine beta-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3']} DrugCentral uuid:918fc7d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:918fc7d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:918fc7d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:918fc7d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9190186a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9190186a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9190186a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:91905c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:91905c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:91909eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:91909eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:91909eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:91909eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:91909eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9190fb86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9190fb86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9190fb86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:919154b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:919154b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:919154b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:919154b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:919154b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:919154b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:919154b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:919154b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9191cbc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9191f3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:91921b9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8I2J3 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (M18 aspartyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:919243ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopexamine targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:919267aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopexamine targets GPCR (D(1A) dopamine receptor) DrugCentral uuid:91928bae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9192b3cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9192de38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:919308d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:919330e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:919358d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:91938162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9193a958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:9193d158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9193f93a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:919421b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:919449bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:919472f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:91949bc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:9194c3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9194ebe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:919513ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:91953c82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:91956496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:91958c96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9195b5b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:9195de3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:919606bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:91962eda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:91965702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:919680e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9196a8f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:9196d114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9196f932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:919721d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:919749e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:919771e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:91979a0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.066']} DrugCentral uuid:9197c2ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.337']} DrugCentral uuid:9197ea90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.588']} DrugCentral uuid:91981290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.378']} DrugCentral uuid:91983a9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:919864e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:91988ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.744']} DrugCentral uuid:9198b4de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:9198dcc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:91990556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:91992d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:91995538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.275']} DrugCentral uuid:91997d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxapram targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9199a650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxapram is blocker of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:9199ca22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxapram is blocker of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:9199ede0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:919a15ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:919a3eee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:919a6842-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:919a9038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:919ab90a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.845']} DrugCentral uuid:919ae10a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.631']} DrugCentral uuid:919b0932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:919b3146-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:919b59be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:919b81d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.827']} DrugCentral uuid:919ba9dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:919bd1e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:919bfc34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:919c257e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.381']} DrugCentral uuid:919c4d74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.81']} DrugCentral uuid:919c756a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:919c9df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:919cc5ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:919cedb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:919d15a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:919d3e0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:919d65f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.53']} DrugCentral uuid:919d8ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:919db6c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:919de120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:919e090c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:919e30f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:919e58f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 7) DrugCentral uuid:919e7d74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.629']} DrugCentral uuid:919ea574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:919ecd60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.325']} DrugCentral uuid:919ef538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:919f1d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:919f454c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:919f6d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:919f9538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:919fc0a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:919fe8a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:91a010bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:91a03952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:91a06288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:91a08a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:91a0b29c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11']} DrugCentral uuid:91a0dace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.886']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a13488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91a1eeaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:91a2175e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:957 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxercalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:91a23b26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxifluridine targets Enzyme (Thymidylate synthase) DrugCentral uuid:91a25f02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:91a28720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:91a2af84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.433']} DrugCentral uuid:91a2d770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:91a2fb7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:91a323f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:91a34886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:91a36c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:91a39016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.914']} DrugCentral uuid:91a3b7ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.496']} DrugCentral uuid:91a3e08e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.288']} DrugCentral uuid:91a4087a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.605']} DrugCentral uuid:91a43052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:91a45834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:91a48200-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91a4a9f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:91a4d1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:91a4fafa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61823 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Ribonuclease pancreatic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:91a52412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.867']} DrugCentral uuid:91a54c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.805']} DrugCentral uuid:91a5741c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:91a59c12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:91a5c548-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43870 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Unclassified (Type-2 restriction enzyme HindIII) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:91a5ed3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O52691 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Unclassified (Type-2 restriction enzyme ScaI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:91a6152a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:91a63d0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WIQ1 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (UDP-galactopyranose mutase) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:91a66570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:91a68d52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:91a6b110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:91a6d8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08254 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Enzyme (Stromelysin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:91a7025a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline is inhibitor of Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:91a72a50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45452 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline is inhibitor of Enzyme (Collagenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:91a75246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02980 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Transporter (Tetracycline resistance protein, class B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:91a77a1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:91a7a336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09237 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline is inhibitor of Enzyme (Matrilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.14']} DrugCentral uuid:91a7cb22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxylamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:91a7eefe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:965 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drostanolone propionate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:91a812da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.199']} DrugCentral uuid:91a83b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:91a86348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.602']} DrugCentral uuid:91a88c42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:91a8b442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:91a8df62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:91a90802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.132']} DrugCentral uuid:91a93020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.069']} DrugCentral uuid:91a95834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.623']} DrugCentral uuid:91a980fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.996']} DrugCentral uuid:91a9a8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.027']} DrugCentral uuid:91a9d110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:91a9f96a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:91aa2174-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.782']} DrugCentral uuid:91aa496a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.592']} DrugCentral uuid:91aa717e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.076']} DrugCentral uuid:91aa9a96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.175']} DrugCentral uuid:91aac2aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:91aaec08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.695']} DrugCentral uuid:91ab1430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.78']} DrugCentral uuid:91ab3cb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:91ab6c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:91ab6c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:91ab6c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:91abaabc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drospirenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.5']} DrugCentral uuid:91abd32a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drospirenone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:91abfb3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drospirenone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.5']} DrugCentral uuid:91ac232a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:969 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drotaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:91ac47ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:969 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drotaverine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:91ac6cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91acb3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:91ad25ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:91ad4e26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:91ad7630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:91ad9e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:91adc694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:91adee8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:91ae1694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:91ae3f98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:91ae69b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:91ae918c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:91aeb98c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.402']} DrugCentral uuid:91aee1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:91af09f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:91af31c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.352']} DrugCentral uuid:91af59b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.428']} DrugCentral uuid:91af82a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.09']} DrugCentral uuid:91afabc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:91afd4a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:91affcca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:91b025ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dutasteride targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91b04dc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dutasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:91b075ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18405 biolink:molecularly_interacts_with DrugCentral:973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dutasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:91b09dc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dyclonine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:91b0c65a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dyclonine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:91b0ea4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:975 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dydrogesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:91b1125e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:975 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dydrogesterone targets Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.561']} DrugCentral uuid:91b13a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprophylline is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) DrugCentral uuid:91b15ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprophylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:91b18270-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:91b1aa5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:91b1d266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.506']} DrugCentral uuid:91b1fb24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:91b22324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:91b24b2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:91b27324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:91b29bd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:91b2c3d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.588']} DrugCentral uuid:91b2ebd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.701']} DrugCentral uuid:91b313ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.905']} DrugCentral uuid:91b33c3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:91b36428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.472']} DrugCentral uuid:91b38c28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.384']} DrugCentral uuid:91b3b40a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.543']} DrugCentral uuid:91b3df34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:91b40784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.554']} DrugCentral uuid:91b42fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:91b45860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.937']} DrugCentral uuid:91b480d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.615']} DrugCentral uuid:91b4a8ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.719']} DrugCentral uuid:91b4d0c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.397']} DrugCentral uuid:91b4f9be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.106']} DrugCentral uuid:91b521b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.743']} DrugCentral uuid:91b549b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:91b571d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:91b59c7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.126']} DrugCentral uuid:91b5c484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.253']} DrugCentral uuid:91b5ec84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:91b6148e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.976']} DrugCentral uuid:91b63d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.191']} DrugCentral uuid:91b66556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.633']} DrugCentral uuid:91b68d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.849']} DrugCentral uuid:91b6b574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.871']} DrugCentral uuid:91b6ddce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:91b705a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:91b72d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:91b7557e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:979 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebrotidine is antagonist of GPCR (Histamine H2 receptor) DrugCentral uuid:91b77b4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 echothiophate is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:91b79f20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.131']} DrugCentral uuid:91b7c720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.543']} DrugCentral uuid:91b7effc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.636']} DrugCentral uuid:91b818b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.336']} DrugCentral uuid:91b840c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:91b868a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.086']} DrugCentral uuid:91b890b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:91b8b914-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.052']} DrugCentral uuid:91b8e100-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:91b908e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.648']} DrugCentral uuid:91b930c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.617']} DrugCentral uuid:91b95b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.034']} DrugCentral uuid:91b98376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.939']} DrugCentral uuid:91b9ab76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.362']} DrugCentral uuid:91b9d38a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.202']} DrugCentral uuid:91b9fc3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:91ba2452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.572']} DrugCentral uuid:91ba4c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.792']} DrugCentral uuid:91ba74a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.805']} DrugCentral uuid:91ba9d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.197']} DrugCentral uuid:91bac574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.936']} DrugCentral uuid:91baed7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.421']} DrugCentral uuid:91bb16d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.529']} DrugCentral uuid:91bb4170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.336']} DrugCentral uuid:91bb697a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.178']} DrugCentral uuid:91bb92a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:91bbbb32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.006']} DrugCentral uuid:91bbe42c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:91bc0c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.485']} DrugCentral uuid:91bc342c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.359']} DrugCentral uuid:91bc5ca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.463']} DrugCentral uuid:91bc84cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:91bca8a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.294']} DrugCentral uuid:91bcd0b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:91bcf952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.864']} DrugCentral uuid:91bd2152-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:91bd4934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:91bd710c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.489']} DrugCentral uuid:91bd9998-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.189']} DrugCentral uuid:91bdc1ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:91bde9a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:91be118e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.916']} DrugCentral uuid:91be39de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.857']} DrugCentral uuid:91be61c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:91be89ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:91beb1ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:91bedbdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:91bf03c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:91bf2bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:91bf5418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.999']} DrugCentral uuid:91bf7c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.431']} DrugCentral uuid:91bfa418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.503']} DrugCentral uuid:91bfcc22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49146 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Neuropeptide Y receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.959']} DrugCentral uuid:91bff580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.498']} DrugCentral uuid:91c01d94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:91c04580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:91c06e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:91c096d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:91c0bed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:91c0e6ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91c10ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:91c13756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:91c15f56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:91c18878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:91c1b0a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:91c1d90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:91c20122-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edatrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:91c22918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edatrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:91c24cf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edatrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:91c275f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edatrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:91c29e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:91c2c652-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Ceramide glucosyltransferase) DrugCentral uuid:91c2ea42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q79MP6 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:91c312d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XAY4 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Unclassified (Beta-lactamase VIM-1; Class B carbapenemase VIM-1; Metallo-beta-lactamase; Metallo-beta-lactamase VIM-1; Metallobeta-lactamase; VIM-1; VIM-1 metallo-beta lactamase; VIM-1 metallo-beta-lactamase; VIM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:91c33ad8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:J3SE37 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:91c362b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:91c38ab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:91c3b396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:91c3dc90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edrophonium is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.79']} DrugCentral uuid:91c404a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edrophonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91c42cc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:91c457c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:91c47e34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz is inhibitor of Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:91c4a83c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:91c4d050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:91c4f8fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:91c5217c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:91c54990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11926 biolink:molecularly_interacts_with DrugCentral:990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eflornithine is inhibitor of Enzyme (Ornithine decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:91c57208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09057 biolink:molecularly_interacts_with DrugCentral:990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eflornithine targets Enzyme (Ornithine decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:91c59a1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9TZZ6 biolink:molecularly_interacts_with DrugCentral:990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eflornithine is inhibitor of Enzyme (Ornithine decarboxylase) DrugCentral uuid:91c5bdf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54898 biolink:molecularly_interacts_with DrugCentral:992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efonidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:91c5e602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efonidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.621']} DrugCentral uuid:91c612c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efonidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:91c612c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efonidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:91c64052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:91c66866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:91c6907a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.05']} DrugCentral uuid:91c6b938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:91c6e138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:91c70938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elliptinium targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:91c7311a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elliptinium targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:91c75a96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elliptinium targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:91c78a48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:91c78a48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:91c78a48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8064e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:91c8df60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emedastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:91c9077e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:91c92fec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:91c957f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.578']} DrugCentral uuid:91c98000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:91c9a7f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:91c9d1fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75884 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets Enzyme (Putative hydrolase RBBP9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:91c9f9fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1003 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emtricitabine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:91ca1ede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1005 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:91ca46c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1005 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:91ca6f38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:1005 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:91ca9742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:91cabf2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:91cae738-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:91cb0f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5EGZ1 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:91cb377e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09470 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.94']} DrugCentral uuid:91cb5f6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:91cb8328-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:91cbaae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:91cbcec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:91cbf330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:91cc1716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 endralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:91cc3ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is positive modulator of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:91cc5f96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:91cc83a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:91cca79e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:91cccbfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:91ccefe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:91cd13be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q53I07 biolink:molecularly_interacts_with DrugCentral:1010 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfuvirtide targets Viral envelope protein (Envelope glycoprotein) DrugCentral uuid:91cd37ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O40239 biolink:molecularly_interacts_with DrugCentral:1010 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfuvirtide is inhibitor of Membrane other (Transmembrane glycoprotein gp41) DrugCentral uuid:91cd5b8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76270 biolink:molecularly_interacts_with DrugCentral:1010 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfuvirtide targets Unclassified (GP41) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:91cd8470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43700 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin targets Enzyme (DNA gyrase subunit A) DrugCentral uuid:91cda842-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21281 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin targets Enzyme (V-type proton ATPase subunit B, brain isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:91cdd416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5EP76 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:91cdd416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5EP76 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:91ce062a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48371 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:91ce062a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48371 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:91ce33a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.345']} DrugCentral uuid:91ce6840-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:91ce6840-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:91ce6840-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:91ce6840-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:91ceb1c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:91ced9ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:91cf020a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:91cf2a1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.03']} DrugCentral uuid:91cf5412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:91cf77e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:91cf9fda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:91cfc7e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:91cff098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:91d018c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:91d040ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:91d068c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:91d090f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil targets GPCR (Prostacyclin receptor) DrugCentral uuid:91d0b4e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:91d0ddfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:91d10622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:91d12f1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91d15744-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:91d17f30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:91d1a7d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:91d1cfc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:91d1f85c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.523']} DrugCentral uuid:91d2214c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17394 biolink:molecularly_interacts_with DrugCentral:1019 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entecavir targets Polyprotein (Protein P) DrugCentral uuid:91d245aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:1019 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entecavir is inhibitor of Polyprotein (Protein P) DrugCentral uuid:91d26990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:1019 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entecavir targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:91d2917c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:91d2b95e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:91d2e29e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:91d30ae4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:91d332f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:91d35b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91d38352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00796 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Sorbitol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:91d3ab52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02928 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat is inhibitor of Enzyme (Cytochrome P450 4A11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:91d3d370-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat is inhibitor of Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.678']} DrugCentral uuid:91d3fb66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eperisone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:91d42410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eperisone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.859']} DrugCentral uuid:91d44c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eperisone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:91d4742e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eperisone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:91d49c38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1024 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ephedrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:91d4c668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:91d4ed00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:91d514ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:91d538b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:91d55d30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:91d5810c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:91d5a902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (Histamine H2 receptor) DrugCentral uuid:91d5ccb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:91d5f510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:91d61cf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:91d645e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:91d66dd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.401']} DrugCentral uuid:91d69844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:91d6c06c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.26']} DrugCentral uuid:91d6e894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:91d710d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:91d73966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.434']} DrugCentral uuid:91d76198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:91d789ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.401']} DrugCentral uuid:91d7b288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.449']} DrugCentral uuid:91d7db82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:91d803a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:91d82bb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.484']} DrugCentral uuid:91d853be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:91d87eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:91d8a6ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:91d8cee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:91d8f74c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:91d91f74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:91d94792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10608 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:91d96fa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:91d9a020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:91d9a020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:91d9a020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:91d9e5ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:91d9e5ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:91d9e5ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:91da2568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8I2J3 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets Enzyme (M18 aspartyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:91da50b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1030 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epirubicin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.878']} DrugCentral uuid:91da7b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1030 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epirubicin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.286']} DrugCentral uuid:91daa376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:1030 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epirubicin targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:91dacbd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:91daf3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:91db1c02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:91db4416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:91db6cb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:91db94c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear other (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:91dbbcd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:91dbe4f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoprostenol is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:91dc0d92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:1034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoprostenol targets GPCR (P2Y purinoceptor 12) DrugCentral uuid:91dc3290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoprostenol is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:91dc5aae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoprostenol is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:91dc82ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:91dcab30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:91dcd330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:91dcff0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:91dcff0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:91dd39ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:91dd39ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:91dd39ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:91dd7e34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:1040 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eptifibatide is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:91dd7e34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:1040 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eptifibatide is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:91ddb14c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:91ddda3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:91de02a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:91de2abe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.333']} DrugCentral uuid:91de52dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:91de7b4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.58']} DrugCentral uuid:91dea368-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:91decb7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:91def39a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:91df1c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.714']} DrugCentral uuid:91df444e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:91df6d02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.367']} DrugCentral uuid:91df95b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:91dfbf1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.889']} DrugCentral uuid:91dfe750-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:91e00f64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:91e0376e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:91e05fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.621']} DrugCentral uuid:91e087f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.722']} DrugCentral uuid:91e0affa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:91e0d804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:91e100c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.099']} DrugCentral uuid:91e128cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:91e1519e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.354']} DrugCentral uuid:91e1798a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:91e1a504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:91e1cd36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:91e1f568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:91e21d7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:91e241a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.754']} DrugCentral uuid:91e269c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.836']} DrugCentral uuid:91e291c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:91e2ba52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.064']} DrugCentral uuid:91e2e2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:91e30af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:91e33324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:91e35c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.742']} DrugCentral uuid:91e38716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.487']} DrugCentral uuid:91e3af34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:91e3d748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:91e40042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:91e4286a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:91e45088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:91e4787e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.514']} DrugCentral uuid:91e4a11e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.342']} DrugCentral uuid:91e4c91e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.041']} DrugCentral uuid:91e4f128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:91e5191e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.11']} DrugCentral uuid:91e542e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:91e56be4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:91e5940c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:91e5bc34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:91e5e4ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:91e60cc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08786 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Cholecystokinin A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:91e634ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O32393 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Unclassified (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:91e65cc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35364 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:91e685a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:91e6adb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:91e6d5a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00206 biolink:molecularly_interacts_with DrugCentral:1044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eritoran targets Membrane receptor (Toll-like receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:91e6fdb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:91e7292a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:91e7536e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:91e77b8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:91e7a512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:91e7cd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:91e7f51c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:91e81d08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:91e845a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:91e86d9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:91e895b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:91e8bda8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:91e8e71a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:91e90f1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:91e93710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:91e9600a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:91e98878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:91e9b08c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:91e9d896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:91ea0096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:91ea295e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:91ea5168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:91ea79f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:91eaa208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:91eaccba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:91eaf4b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:91eb1cc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:91eb44c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:91eb6d32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:91eb9528-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:91ebbd3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:91ebe5fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:91ec0e18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:91ec362c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:91ec5e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:91ec878a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:91ecafd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:91ecd7d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:91ecffd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:91ed282a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:91ed5110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:91ed7a32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:91eda246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:91edcb04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:91edf322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:91ee1b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:91ee434a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:91ee6e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:91ee9692-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:91eebea6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:91eee6ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:91ef0f14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:91ef371e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:91ef5f32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:91ef8732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:91efaff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:91efd80e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:91f00018-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:91f028c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:91f050d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:91f078d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:91f0a0d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:91f0c962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:91f0f162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:91f11944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:91f142ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:91f16b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:91f1939c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:91f1bbb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:91f1e3ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:91f20d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:91f23536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:91f25d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:91f28554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:91f2adc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:91f2d5c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:91f2fdcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:91f325d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:91f34e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:91f377ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:91f39fde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:91f3c7fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31152 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:91f3f2a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:91f41ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:91f442c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:91f46ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:91f4933a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:91f4bb3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:91f4e330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:91f50bee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:91f534de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:91f55cf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:91f58510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:91f5ae78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:91f5d9c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:91f603f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:91f62c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:91f6547c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:91f67c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:91f6a4a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:91f6ccae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:91f6f562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94956 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib is inhibitor of Transporter (Solute carrier organic anion transporter family member 2B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:91f71d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:91f74558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:91f76920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:91f78e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:91f7b27c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:91f7d662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:91f7fa48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem is inhibitor of Enzyme (D-alanyl-D-alanine carboxypeptidase DacB) DrugCentral uuid:91f81ea6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem is inhibitor of Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:91f84296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem is inhibitor of Enzyme (Penicillin-binding protein 1B) DrugCentral uuid:91f8665e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:91f88e4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:91f8b6ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:91f8dee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:91f906f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:91f92fda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:91f95a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:91f98228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:91f9aa46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.186']} DrugCentral uuid:91f9d264-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:91f9fad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.412']} DrugCentral uuid:91fa22e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.706']} DrugCentral uuid:91fa4afa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:91fa7304-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:91fa9bc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:91fac3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:91faebf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esmolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:91fb13fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esmolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:91fb3d52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esmolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:91fb693a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esomeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:91fb693a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esomeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:91fb9eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:91fb9eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:91fb9eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:91fbdde8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:91fbdde8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:91fbdde8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:91fc1cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:91fc1cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:91fc1cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:91fc5b92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:91fc5b92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:91fc5b92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:91fc9490-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.243']} DrugCentral uuid:91fcbc90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.538']} DrugCentral uuid:91fce486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.725']} DrugCentral uuid:91fd0e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.926']} DrugCentral uuid:91fd3602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:91fd5df8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:91fd85da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol is activator of Ion channel (Calcium-activated potassium channel subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:91fdae16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:91fdd5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:91fdfdda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:91fe27a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:91fe5046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.83']} DrugCentral uuid:91fe785a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:91fea064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95718 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Steroid hormone receptor ERR2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:91fec86e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:91fef2bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.947']} DrugCentral uuid:91ff1ac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.372']} DrugCentral uuid:91ff42f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:91ff6b48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:91ff9348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08537 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:91ffbb48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19785 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:91ffe352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:92000fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:92000fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:920043d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:92006be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.767']} DrugCentral uuid:9200941e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.133']} DrugCentral uuid:9200be44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.637']} DrugCentral uuid:9200e66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.446']} DrugCentral uuid:92010e8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:9201369e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:92015f20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.94']} DrugCentral uuid:92018734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.638']} DrugCentral uuid:9201af34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.156']} DrugCentral uuid:9201d748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.902']} DrugCentral uuid:9202009c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol cypionate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:92022482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol mustard targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:92024cb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol valerate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:920270ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estramustine phosphate is modulator of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:920298e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:1066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estramustine phosphate targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:9202c0ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:1066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estramustine phosphate targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9202e908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:1066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estramustine phosphate targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:920310fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9203398a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:92036180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:92038a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:9203b2c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9203dbf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.63']} DrugCentral uuid:920403f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:92042d0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:92045662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:92047e58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9204a694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:9204cec6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:9204f73e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:9205272c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9205272c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9205272c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9205662e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:9205662e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:9205662e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:9205a5d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:9205a5d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:9205a5d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:9205e4c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:9205e4c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:9205e4c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:920624f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:920624f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:920624f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:92066420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:92066420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:92066420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:92069b5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid is inhibitor of Transporter (Solute carrier family 12 member 1) DrugCentral uuid:9206bfce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Enzyme (Glutathione S-transferase P) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9206e7c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08263 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Enzyme (Glutathione S-transferase A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:920710b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.939']} DrugCentral uuid:920738be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:92076212-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:92078ad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9207b29e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9207da80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:92080406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:92082c38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WNL8 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase A) DrugCentral uuid:92085154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WNL6 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase B) DrugCentral uuid:92087544-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WNL5 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase C) DrugCentral uuid:920899c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:9208c1e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WNL9 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol is inhibitor of Enzyme (Probable arabinosyltransferase A) DrugCentral uuid:9208e5ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:92090996-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:92092d54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (Glycine receptor subunit alpha-2) DrugCentral uuid:92095946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:92095946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:92095946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:920998ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:920998ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:920998ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:9209d128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:9209f932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:920a213c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.964']} DrugCentral uuid:920a495a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:920a7222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:920a9a36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.022']} DrugCentral uuid:920ac254-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:920aeb30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:920b13bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.353']} DrugCentral uuid:920b3bc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:920b63ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.985']} DrugCentral uuid:920b8bf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.83']} DrugCentral uuid:920bb628-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:920be06c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:920c088a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.81']} DrugCentral uuid:920c3094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:920c593e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.246']} DrugCentral uuid:920c812a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.857']} DrugCentral uuid:920ca92a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:920cd12a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:920cf9a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:920d218e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WIE4 biolink:molecularly_interacts_with DrugCentral:1083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethionamide targets Enzyme (Catalase-peroxidase) DrugCentral uuid:920d4588-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:1083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethionamide is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) DrugCentral uuid:920d6964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethionamide targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:920d9452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:920dbc7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.78']} DrugCentral uuid:920de48e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:920e0c98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.111']} DrugCentral uuid:920e3560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:920e5d56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:920e8132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:920ea522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.61']} DrugCentral uuid:920ecda4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:920ef6a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:920f1f48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:920f4770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:920f7204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:920f9a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:920fc222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1087 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethosuximide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9210099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:921084be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:9210acf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9210d50e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9210fd40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:92112612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:92114e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:92117630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:92119e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9211c702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:9211ef16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9212172a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:92123f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:92126892-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:921291c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9212b9d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9212e1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:92130c02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9213340c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:92135c20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:92138434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9213ad06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9213d506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9213fcfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:921424f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:92144dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:921475e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:92149df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9214c5ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9214f2b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9214f2b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:921525dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:92154dd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:9215765e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:92159e54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:9215c64a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:1091 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl biscoumacetate targets Enzyme (Vitamin K epoxide reductase complex subunit 1) DrugCentral uuid:9215ea26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:9216128a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:92163a76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.983']} DrugCentral uuid:92166370-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:92168b8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:9216b0e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:9216d8e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.889']} DrugCentral uuid:921700f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:921728fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:921751a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:9217758a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:92179966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.368']} DrugCentral uuid:9217c152-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:9217e9de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:921811e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:92183704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:92185ae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:92188056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:9218a892-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9218d06a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:9218f860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B1LRJ1 biolink:molecularly_interacts_with DrugCentral:1098 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidronic acid targets Unclassified (Type IV secretion-like conjugative transfer relaxase protein TraI) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9219210a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etilamfetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9219491e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1101 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etilefrine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:92197538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:92197538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:92197538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9219bb60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:9219bb60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:9219bb60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:9219fa3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:9219fa3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:9219fa3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:921a3a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:921a3a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:921a3a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:921a7596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etodolac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:921a9d96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etodolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.577']} DrugCentral uuid:921ac596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:1107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etofylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:921aee36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:921b1604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:921b3dfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:921b65fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:921b962e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:921b962e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:921b962e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:921bdbd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:921bdbd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:921bdbd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:921c1a22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etonogestrel targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:921c4006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etonogestrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:921c63d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etonogestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:921c8bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:921cb4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.051']} DrugCentral uuid:921cdd54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.071']} DrugCentral uuid:921d0554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:921d2d54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.282']} DrugCentral uuid:921d56ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.21']} DrugCentral uuid:921d7f02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:921da2e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:921dcae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:921def3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:921e1340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:921e3708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Canalicular multispecific organic anion transporter 2) DrugCentral uuid:921e5ada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:921e82d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.497']} DrugCentral uuid:921eab34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:921ed320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:921efb02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.102']} DrugCentral uuid:921f2302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:921f4bb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:921f73c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:921f9c42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:921fc53c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:921fed5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:92201546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:92203d5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (Canalicular multispecific organic anion transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:922065aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:92208d96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:9220b168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9220d92c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9221023a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:92212a94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:1116 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etretinate is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) DrugCentral uuid:92214f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:1116 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etretinate is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) DrugCentral uuid:92217346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etryptamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.63']} DrugCentral uuid:92219c54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etryptamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:9221c760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etryptamine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9221f258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 everolimus targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:92221864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:1118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 everolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:922240b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:1118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 everolimus is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92226896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exemestane targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:92228dc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exemestane is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.692']} DrugCentral uuid:9222b5da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:1123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exenatide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.18']} DrugCentral uuid:9222de66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32301 biolink:molecularly_interacts_with DrugCentral:1123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exenatide targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:92230670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHC9 biolink:molecularly_interacts_with DrugCentral:1125 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ezetimibe is antagonist of Membrane other (Niemann-Pick C1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:92232e8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6T3U3 biolink:molecularly_interacts_with DrugCentral:1125 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ezetimibe targets Unclassified (Niemann-Pick C1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:92235698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fadrozole is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:92237f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fadrozole is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9223a788-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15539 biolink:molecularly_interacts_with DrugCentral:1126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fadrozole targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9223cf9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fadrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:9223f79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:92241bc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09252 biolink:molecularly_interacts_with DrugCentral:1128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famciclovir targets Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:92243f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.93']} DrugCentral uuid:9224679a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:92248fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9224b86c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9224e08a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9225092a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:9225313e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:92255b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:92258346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9225ab64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:9225d382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9225fc0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9226240e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92264c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:9226740e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:92269cb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:9226c486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.304']} DrugCentral uuid:9226ec86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:92271468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:1130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famprofazone targets Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:92273f74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:92276774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.44']} DrugCentral uuid:92278f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9227b7ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9227dfe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:922807ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13500 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Cytokine (C-C motif chemokine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:92282fc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:92285990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:92288168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62868 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9228a972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:9228d1a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:9228fa4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 febuxostat targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:92292258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:1137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 febuxostat is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:92294b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:1137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 febuxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9229735c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:1137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 febuxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:92299bb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felbamate is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 2A) DrugCentral uuid:9229bfb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felbamate is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.284']} DrugCentral uuid:9229e7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felbinac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:922a0bb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felbinac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.049']} DrugCentral uuid:922a3454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:922a5cb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:922a84b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:922aa8a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:922ace28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.339']} DrugCentral uuid:922af66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.168']} DrugCentral uuid:922b1e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:922b466e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine is activator of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:922b76d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:922b76d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:922b76d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:922bb4e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbufen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:922bdcd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbufen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:922c0554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbufen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:922c294e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbufen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:922c4d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:922c753e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline targets GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:922c9e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:922cc82c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:922cf040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35384 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline is positive allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:922d1912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.004']} DrugCentral uuid:922d416c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:922d6976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.428']} DrugCentral uuid:922d9180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:922db96c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.172']} DrugCentral uuid:922de22a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.845']} DrugCentral uuid:922e0b56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:922e3360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:922e5b6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.042']} DrugCentral uuid:922e8644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:922eb146-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:922edc5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.717']} DrugCentral uuid:922f04ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.016']} DrugCentral uuid:922f2cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.726']} DrugCentral uuid:922f5506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.489']} DrugCentral uuid:922f7ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:922fa592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:922fcd92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.195']} DrugCentral uuid:922ff57e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.735']} DrugCentral uuid:92301d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:923046e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:923071ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.673']} DrugCentral uuid:92309ce0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:9230c562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:9230eed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.331']} DrugCentral uuid:92311864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.032']} DrugCentral uuid:92314082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.164']} DrugCentral uuid:92316882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:923191ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.808']} DrugCentral uuid:9231b9e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9231e1ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:923209e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:92323366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:92325b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9232835c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:9232ab5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9232d44c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9232fc60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9233246a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:92334d64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:923375be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9233a58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9233a58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9233a58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9233e4ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:9234103c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:92343814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9234601e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:92348878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:9234b456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:9234b456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:9234e890-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N695 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen is inhibitor of Transporter (Sodium-coupled monocarboxylate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:9235109a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9235399e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:92356194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.001']} DrugCentral uuid:92358976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:9235b16c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9235dbec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:92360400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:92362c28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:9236540a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:92367c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9236a46e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:9236cc64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:9236f572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:92371d9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:923745b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:92376dae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9237a314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:9237a314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:9237a314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:9237a314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:9237f486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9237f486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9238279e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:92384fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:923878b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:9238a098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentiazac targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9238c88e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fexofenadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:9238f0fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fexofenadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.699']} DrugCentral uuid:92391906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fexofenadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:92394232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:1170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fexofenadine targets Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.699']} DrugCentral uuid:92396b54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:923993b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9239bbae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14060 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9239e3b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24008 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:923a0c1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:923a37f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:923a37f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:923a6b12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:923a9312-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18405 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:923abba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.704']} DrugCentral uuid:923aef56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:923aef56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:923aef56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:923aef56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:923b340c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 7) DrugCentral uuid:923b340c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 7) DrugCentral uuid:923b694a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 8) DrugCentral uuid:923b694a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 8) DrugCentral uuid:923b96ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:923bbed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:923be73a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide targets Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.745']} DrugCentral uuid:923c1034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:923c3834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.77']} DrugCentral uuid:923c6020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:923c88d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63881 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:923cb0d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:923cd956-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fleroxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:923d0160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floctafenine is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:923d2a82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floctafenine is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.268']} DrugCentral uuid:923d5296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:1180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flopropione is inhibitor of Enzyme (Catechol O-methyltransferase) DrugCentral uuid:923d7668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:923d9a30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxacillin targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:923dc276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:1183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxacillin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:923dea6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxuridine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:923e0e5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:1184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxuridine targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:923e363e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:923e5ef2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:923e8800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:923eb000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:923ed800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:923f0320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:923f2d1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:923f5514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:923f7d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:923fa596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7Z1V1 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Sterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:923fcd50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flucytosine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:923ff62c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0CS13 biolink:molecularly_interacts_with DrugCentral:1188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flucytosine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:92401a08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12461 biolink:molecularly_interacts_with DrugCentral:1188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flucytosine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:92403ee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02829 biolink:molecularly_interacts_with DrugCentral:1188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flucytosine targets Cytosolic other (ATP-dependent molecular chaperone HSP82) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:924066ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:92408ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9240b6b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:9240e29e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:92410b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:92413320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:92415bac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:924183b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate is inhibitor of Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:9241a77e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludrocortisone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:9241cf6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludrocortisone acetate targets Cytosolic other (Annexin A1) DrugCentral uuid:9241f422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludrocortisone acetate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:92421c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:92424490-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:92426c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:92429580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:9242bd80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9242e56c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:92430d4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:92433580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:92435d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:92438558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9243ad4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6UVM3 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is activator of Ion channel (Potassium channel subfamily T member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:9243d6d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9243feca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94759 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:92442800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9244500a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9244792c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:9244a12c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZQ8 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:9244c92c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7TN37 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9244f140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:924519a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:924541ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:924569a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:924591b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is agonist of GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.863']} DrugCentral uuid:9245ba44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1194 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9245e230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92460a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9246323a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:92465b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:92468334-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9246b2fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:9246b2fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:9246b2fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:9246f972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:9246f972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:9246f972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:924740a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:924740a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:924740a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:92478752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:92478752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:92478752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9247ffc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9248e886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9248e886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9248e886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9248e886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9248e886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9248e886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:92495122-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:92495122-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:92495122-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:92499718-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:92499718-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:92499718-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9249dd04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9249dd04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9249dd04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:924a2926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:924a2926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:924a2926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924aa3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:924b761e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumetasone pivalate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:924b9a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.621']} DrugCentral uuid:924bc2d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:924beae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.713']} DrugCentral uuid:924c12ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:924c3af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.662']} DrugCentral uuid:924c6362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:924c8b62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.304']} DrugCentral uuid:924cb376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:924cdb62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:924d03f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:924d2bee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:924d540c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:924d7bf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.455']} DrugCentral uuid:924da65a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:924dce46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:924df740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:924e1f54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.151']} DrugCentral uuid:924e47cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.504']} DrugCentral uuid:924e6fd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.103']} DrugCentral uuid:924e97d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:924ebfcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:924ee88a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:924f1102-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.333']} DrugCentral uuid:924f390c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.532']} DrugCentral uuid:924f621a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.357']} DrugCentral uuid:924f8a56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:924fb24c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:924fda42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:9250030a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:92502b0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:92505300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:92507ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9250a3d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9250cd1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9250fe04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9250fe04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9250fe04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:92513d1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y256 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:925164f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:92518cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9251b5e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9251de96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:925206b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:92522ed2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunisolide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:925256b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunisolide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:92527fcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9252a7ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9252d01c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9252f844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:92532a26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:92532a26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:92532a26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:92537008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:92537008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:92537008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:9253b6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:9253b6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:9253b6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:9253fca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:9253fca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:9253fca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:925443ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:925443ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:925443ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:92548a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:92548a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:92548a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925503f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9255dba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:9255dba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:9255dba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:9256221c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9256221c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9256221c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9256690c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9256690c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9256690c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9256aed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9256aed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9256aed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9256f584-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9256f584-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9256f584-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:925733be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1204 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluocinolone acetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.848']} DrugCentral uuid:92575c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1204 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluocinolone acetonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.475']} DrugCentral uuid:9257842c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1205 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluocinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.622']} DrugCentral uuid:9257ac2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1205 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluocinonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.538']} DrugCentral uuid:9257d436-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorescein targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.042']} DrugCentral uuid:9257fcc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:1207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorescein targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:925824ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:1207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorescein targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:92584cb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:1207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorescein targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:925874cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorometholone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.801']} DrugCentral uuid:92589e70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorometholone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.067']} DrugCentral uuid:9258c79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorometholone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:9258ef9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:9259179c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:92593ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:925968be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:925990b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.091']} DrugCentral uuid:9259b8b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9259e154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:925a095e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:925a3154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:925a5954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:925a84e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:925aaf6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:925ad758-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:925affbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.959']} DrugCentral uuid:925b27a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.047']} DrugCentral uuid:925b4fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:925b779e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:925ba02a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.538']} DrugCentral uuid:925bc816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:925bf016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.444']} DrugCentral uuid:925c180c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:925c4106-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:925c6992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:925c9188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:925cb97e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:925ce1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:925d09ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:925d31f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:925d5ae6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:925d839a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:925dab90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:925dd390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:925dfb86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:925e30e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:925e30e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:925e30e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:925e30e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:925e8308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:925e8308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:925e8308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:925ec958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:925ec958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:925ec958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:925f076a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:925f2f74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25122 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:925f586e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:925f8064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxymesterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:925fa864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:925fd064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:925ffa76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.65']} DrugCentral uuid:92602258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:92604a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.058']} DrugCentral uuid:9260723a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:92609788-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:9260bf9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9260e77e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.066']} DrugCentral uuid:92610f74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:92613832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:92616032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:92618828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:9261b118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9261e868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9261e868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9261e868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9261e868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9261e868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:92623c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.075']} DrugCentral uuid:926264fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.649']} DrugCentral uuid:92628d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.269']} DrugCentral uuid:9262b59a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.503']} DrugCentral uuid:9262dd9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.067']} DrugCentral uuid:92630630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:92632e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:926355f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.711']} DrugCentral uuid:92637f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.838']} DrugCentral uuid:9263a806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.044']} DrugCentral uuid:9263d01a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:9263f810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:9264216e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.464']} DrugCentral uuid:92644964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:92647178-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.191']} DrugCentral uuid:9264996e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.087']} DrugCentral uuid:9264c20e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:9264e9fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.887']} DrugCentral uuid:926511fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.793']} DrugCentral uuid:926539dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:92656344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:92658b9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.575']} DrugCentral uuid:9265b39e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.999']} DrugCentral uuid:9265db9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.315']} DrugCentral uuid:9266040c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.447']} DrugCentral uuid:92662c0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.655']} DrugCentral uuid:92665402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:92667c0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:9266a48e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.539']} DrugCentral uuid:9266cca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.788']} DrugCentral uuid:9266f498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:92671c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.535']} DrugCentral uuid:92674542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.019']} DrugCentral uuid:92676d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:92679542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.005']} DrugCentral uuid:9267bd42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.072']} DrugCentral uuid:9267e59c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:92680e82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:9268368c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.397']} DrugCentral uuid:92685e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:92688704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.097']} DrugCentral uuid:9268aefa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.708']} DrugCentral uuid:9268d6dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.125']} DrugCentral uuid:9268fedc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:926929ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.67']} DrugCentral uuid:9269538c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:92697ba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.061']} DrugCentral uuid:9269a3f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.049']} DrugCentral uuid:9269cc04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:9269f422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:926a1c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:926a449a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:926a6c9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:926a94a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:926ac456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:926ac456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:926ac456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:926b1e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:926b1e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:926b1e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:926b1e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:926b1e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:926b1e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:926b1e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:926b1e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:926b94a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine decanoate is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:926bb87a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:926be084-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.268']} DrugCentral uuid:926c0884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.503']} DrugCentral uuid:926c314c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.225']} DrugCentral uuid:926c5938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.837']} DrugCentral uuid:926c8138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:926ca938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.048']} DrugCentral uuid:926cd228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:926cfa32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:926d2228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:926d4a96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.087']} DrugCentral uuid:926d7296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.611']} DrugCentral uuid:926d9a82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.887']} DrugCentral uuid:926dc26e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:926deb0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:926e1430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.961']} DrugCentral uuid:926e3c1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.145']} DrugCentral uuid:926e63fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.841']} DrugCentral uuid:926e8da2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.274']} DrugCentral uuid:926eb5b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.447']} DrugCentral uuid:926eddac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:926f06c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:926f2f0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.539']} DrugCentral uuid:926f570a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:926f7f00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:926fa700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:926fcf5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:926ff750-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:1215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupirtine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:92701f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:1215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupirtine targets Ion channel (Potassium voltage-gated channel subfamily KQT member 3) DrugCentral uuid:9270430e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:1215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupirtine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:92706c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1216 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluprednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:927090ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludroxycortide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.695']} DrugCentral uuid:9270b8de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludroxycortide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:9270e0de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurazepam targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.222']} DrugCentral uuid:9271111c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9271111c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9271111c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:92714f42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:9271774c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:92719fec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:9271c7d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:9271efce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:927217d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:92724212-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:92726ad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:927292c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9272bba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:9272e410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:92730c10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.436']} DrugCentral uuid:927333fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.244']} DrugCentral uuid:92735bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:927384b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9273ade6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9273d604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9273feb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:927428de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:927450de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:927478f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9274a16a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.951']} DrugCentral uuid:9274c988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9274f188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.208']} DrugCentral uuid:92751988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.056']} DrugCentral uuid:92754214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:927569f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:92759200-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9275b9f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:9275e3ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.082']} DrugCentral uuid:92760c30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:92763430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:92765c30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.049']} DrugCentral uuid:92768480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9276ad84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.74']} DrugCentral uuid:9276d570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:9276fe06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.77']} DrugCentral uuid:92772692-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47712 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate targets Enzyme (Cytosolic phospholipase A2) DrugCentral uuid:92774a78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.12']} DrugCentral uuid:92777264-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutrimazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:92779a46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutrimazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:9277c516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:9277ebae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:927813ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.96']} DrugCentral uuid:92783be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:92786444-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:92788d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9278b5a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9278de10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:92790750-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:92792f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.951']} DrugCentral uuid:92795732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:92798158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9279a962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:9279d158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:9279f958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 folic acid targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:927a218a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 folic acid targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:927a496c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leucovorin targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.071']} DrugCentral uuid:927a716c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:1232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leucovorin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:927aa3e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:927aa3e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:927aa3e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:927adfc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:927adfc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:927b12de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:1236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fondaparinux is activator of Secreted (Antithrombin-III) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:927b3aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1238 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formestane targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:927b6428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:927b8c50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:927bb446-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:927bdc46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:927c04b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:927c2cc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:927c561c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:927c8182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosamprenavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:927ca6e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosamprenavir is inhibitor of Enzyme (Pol polyprotein) DrugCentral uuid:927ccad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 foscarnet is inhibitor of Enzyme (DNA polymerase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:927cf2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08546 biolink:molecularly_interacts_with DrugCentral:1241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 foscarnet targets Enzyme (DNA polymerase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:927d1ac0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 foscarnet targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:927d45cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 foscarnet targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:927d6e08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfluconazole targets Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:927d91d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q836E5 biolink:molecularly_interacts_with DrugCentral:1243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1) DrugCentral uuid:927db78c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q831A8 biolink:molecularly_interacts_with DrugCentral:1243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2) DrugCentral uuid:927ddbfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A749 biolink:molecularly_interacts_with DrugCentral:1243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfomycin is inhibitor of Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:927e03e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HVW7 biolink:molecularly_interacts_with DrugCentral:1243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:927e2bc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosinopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:927e539a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosinopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:927e7db6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosphenytoin is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:927ea1a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 frovatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:927ec9ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 frovatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:927ef1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 frovatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:927f1dd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fructose targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:927f45ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ftivazide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:927f6d98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:927f957a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:927fbe06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:927fe606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.68']} DrugCentral uuid:92800e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant is antagonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:928036b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:92805e88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:92808692-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9280ae60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:9280d7b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:928101ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:928129c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furaltadone targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:928151bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:928179e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:92819e42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9281c638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9281ee1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:928216ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:92823e9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:9282678c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:92828f78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9282b99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:9282e25c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:92830a5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9283325c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:92835aa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:9283827a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9283aa8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9283d266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9283fb2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96618 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Holo-[acyl-carrieir-protein] synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9284231a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92844b10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fusidic acid targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:928472de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fusidic acid targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:92849e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9284c6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23978 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9284efe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31648 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:92851842-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:92854038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9285682e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24046 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:92859006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48066 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:9285b8ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48065 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent betaine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:9285e0a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31650 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9286087e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31646 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:92863150-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31649 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:92865a22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23574 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:92868218-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid is agonist of GPCR (Gamma-aminobutyric acid type B receptor subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9286aa0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSD5 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:9286d1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:9286f5e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:9287199e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets GPCR (Adenosine receptor A1) DrugCentral uuid:92873d70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75899 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets GPCR (Gamma-aminobutyric acid type B receptor subunit 2) DrugCentral uuid:92876142-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:9287850a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.523']} DrugCentral uuid:9287ae36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:9287d640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9287fe40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:92882726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08532 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:92884f44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O77773 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Ion channel (Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9288774e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.928']} DrugCentral uuid:92889f58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9288c7bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9288efb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:928917a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:92893f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:92896802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:92898fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9289b7d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9289dfbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:928a0a46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:928a3246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:928a5a32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:928a8214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:928aaba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:928ad3ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:928afbae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine is blocker of Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:928b23ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine is negative allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:928b541e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:928b541e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:928b541e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:928b9208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:928bb9d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:928be3a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:928c0b98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:928c3370-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:928c5b34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:928c838e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:928ca760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets Kinase (Thymidine kinase) DrugCentral uuid:928ccb28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13255 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:928cf314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41594 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:928d1bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10210 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets Enzyme (Capsid scaffolding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:928d4396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:928d6c36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganirelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:928d9008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:928dbb82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:928de7e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:928de7e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:928e1974-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:928e1974-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:928e4b38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:928e4b38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:928e7e50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:928ea632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:928ece28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:928ef6e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:928f1ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:928f46d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:928f6ed2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:928f993e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:928fc120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:928fe902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:92901274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:92903a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:92906274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:92908a60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9290b2c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9290dab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:929102a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92912a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:929153c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:92917fb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9291a7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9291cfa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9291f85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:92922050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:92924850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9292703c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:92929896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9292c08c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9292e882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9293106e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:92933b20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:929365f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:92938df0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9293b6cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9293dfa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9294079e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9294302a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92945884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9294808e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9294a884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9294d070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9294f92e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:929521a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9295499c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92957282-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:92959b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9295c318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9295ec44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9296143a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:92963ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9296649e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:92968ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9296b4a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9296deec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:92970700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:92972f1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9297571e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:92977fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9297a7c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9297cfb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9297f7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:92981ffa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:929847e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31152 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:92986fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:929897d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:9298c2e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9298ed5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:92991554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:92993dfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:929966e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:92998ed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:9299b6c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9299dff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:929a0e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:929a35f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:929a5df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:929a87ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:929ab026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:929ad826-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:929b001c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:929b28bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine targets Enzyme (Thymidylate synthase) DrugCentral uuid:929b4c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:929b7074-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:929b9464-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:929bb890-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30085 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine targets Kinase (UMP-CMP kinase) DrugCentral uuid:929be568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:929be568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:929be568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:929c1c72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Enzyme (Lipoprotein lipase) DrugCentral uuid:929c4030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:929c6b0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:929c92f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.523']} DrugCentral uuid:929cbb1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:929ce3a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:929d0bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:929d33b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:929d5cfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:1286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemifloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:929d8184-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P72525 biolink:molecularly_interacts_with DrugCentral:1286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemifloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) DrugCentral uuid:929da57e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gestodene targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:929dc93c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gestodene targets Enzyme (Cytochrome P450 3A5) DrugCentral uuid:929ded0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1292 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gestrinone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:929e1522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12882 biolink:molecularly_interacts_with DrugCentral:1293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gimeracil is inhibitor of Enzyme (Dihydropyrimidine dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:929e3dea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glafenine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:929e65d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glafenine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:929e91aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:929e91aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:929ec9ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.046']} DrugCentral uuid:929ec9ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.046']} DrugCentral uuid:929f0108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:929f0108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:929f38da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.222']} DrugCentral uuid:929f38da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.222']} DrugCentral uuid:929f7070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:929f7070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:929fa770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:929fa770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:929fde98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1301 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glipizide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.097']} DrugCentral uuid:929fde98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1301 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glipizide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.097']} DrugCentral uuid:92a0180e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliquidone is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:92a0180e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliquidone is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:92a04f2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glisoxepide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.959']} DrugCentral uuid:92a04f2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glisoxepide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.959']} DrugCentral uuid:92a08320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:92a0acf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:92a0d4f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:92a0fd0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P39086 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:92a1250a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:92a14d78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13255 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:92a1756e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00367 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutamate dehydrogenase 1, mitochondrial) DrugCentral uuid:92a1994a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49448 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutamate dehydrogenase 2, mitochondrial) DrugCentral uuid:92a1bd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:92a1e670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41594 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:92a20e70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14833 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:92a23670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:92a25e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13002 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:92a28710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13003 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:92a2af10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14831 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:92a2d6e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15303 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:92a2ff4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14416 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:92a3272e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43003 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:92a34f2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43004 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:92a3772e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43005 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:92a3a05a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19491 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:92a3cae4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.595']} DrugCentral uuid:92a3f2d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16099 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.738']} DrugCentral uuid:92a41abc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14832 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid is agonist of GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:92a44352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00222 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid is agonist of GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:92a46c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:92a493fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42260 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:92a4bc06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22756 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:92a4e46a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31423 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:92a50c38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35349 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:92a5341a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19490 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:92a55bf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19492 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:92a58618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:92a5adf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42264 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.31']} DrugCentral uuid:92a5d5e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03469 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutamate racemase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:92a5fdc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70579 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:92a62672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47743 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:92a64e4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31424 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:92a67762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23385 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:92a69f4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31421 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:92a6c794-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31422 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:92a6ef76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56068 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutamate racemase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:92a71780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35921 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:92a73f76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:1311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:92a76b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2Q3 biolink:molecularly_interacts_with DrugCentral:1312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutathione targets Enzyme (Glutathione S-transferase kappa 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:92a79b56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:92a79b56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:92a79b56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:92a7d27e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:92a7fb00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:92a823d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.795']} DrugCentral uuid:92a84bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:92a873be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:92a8a032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:92a8a032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:92a8d322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:92a8fb18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:92a9244e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96P20 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Unclassified (NACHT, LRR and PYD domains-containing protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:92a94c44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:92a97458-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Nuclear other (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:92a9a05e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ESQ5 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is inhibitor of Ion channel (Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:92a9a05e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ESQ5 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is inhibitor of Ion channel (Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:92a9d826-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.523']} DrugCentral uuid:92a9d826-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.523']} DrugCentral uuid:92aa0b48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:92aa332a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48067 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Transporter (Sodium- and chloride-dependent glycine transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:92aa7290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92aa7290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92aa7290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92aa7290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92aa7290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92aa7290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92aa7290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92aadc94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:92ab07f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:1325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:92ab313a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:1325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:92ab5944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:1325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:92ab81ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:1325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycyrrhizic acid targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:92abaaa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:1327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 goserelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:92abce88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 goserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:92abf282-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:92ac1a78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:92ac42f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:92ac6ae6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:92ac92f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07820 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Cytosolic other (Induced myeloid leukemia cell differentiation protein Mcl-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:92acbaf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:92ace3c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00346 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Malate dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:92ad0b90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0PJ46 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Lactate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:92ad3354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6VVP7 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Malate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:92ad5b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11708 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Malate dehydrogenase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:92ad83a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00338 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (L-lactate dehydrogenase A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:92adaba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92843 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Cytosolic other (Apoptosis regulator Bcl-W) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:92add3ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52732 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Kinesin-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:92adfc1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11166 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Transporter (Solute carrier family 2, facilitated glucose transporter member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:92ae241c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29372 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (DNA-3-methyladenine glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:92ae4bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07195 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (L-lactate dehydrogenase B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:92ae73f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:92ae9d48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92aec868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:92aef1bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:92af1da4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:92af1da4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:92af5558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:92af5558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:92af8870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:92afb07a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:92afd8de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:92b004d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:92b004d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:92b0364e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:92b0364e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:92b063d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10875 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin targets Structural (Tubulin beta chain) DrugCentral uuid:92b08a90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:92b0b3a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:92b0e38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:92b0e38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:92b0e38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:92b11b7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guaiacol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:92b1441c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guaiacol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:92b16c30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanadrel is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:92b18fda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanadrel targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:92b1b3f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:92b1d7d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:92b1fb82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:92b21f4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:92b243d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:92b26798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-1D adrenergic receptor) DrugCentral uuid:92b28b6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:92b2b02c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.065']} DrugCentral uuid:92b2d82c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:92b300ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:92b328f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.926']} DrugCentral uuid:92b350e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:92b37944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:92b3a158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:92b3c94e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:92b3f158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.164']} DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b4b156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b68972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92b741b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ulobetasol propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:92b76590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halofantrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:92b78d7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:92b7b590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.003']} DrugCentral uuid:92b7e006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:92b8081a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is inverse agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:92b83010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.947']} DrugCentral uuid:92b85806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:92b8804c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:92b8a838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:92b8d02e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:92b8f8a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92b9209c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92b948a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:92b9711e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:92b999f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:92b9c1fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:92b9e9e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:92ba11d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:92ba3a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:92ba6240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:92ba8a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is inverse agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:92bab236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:92badbbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:92bb03c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.999']} DrugCentral uuid:92bb2bd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:92bb53bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:92bb7ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.182']} DrugCentral uuid:92bba498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.569']} DrugCentral uuid:92bbccac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:92bbf4ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:92bc1d4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:92bc452e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:92bc760c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:92bc760c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:92bc760c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:92bcb518-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.648']} DrugCentral uuid:92bcdd04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:92bd050e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:92bd2d2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:92bd5716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:92bd7f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.305']} DrugCentral uuid:92bda716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:92bdcf16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:92bdf7b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.76']} DrugCentral uuid:92be1fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:92be478e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:92be6f7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92be9914-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:92bec10a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:92bee914-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:92bf11c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:92bf3a4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:92bf625e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:92bf8a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:92bfb326-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:92bfdb26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:92c0031c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:92c02b30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:92c05466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:92c07c70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:92c0a470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:92c0cc7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:92c0f560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:92c11d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:92c14560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:92c16d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50129 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:92c195d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:92c1bde2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:92c1e5ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62744 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Unclassified (AP-2 complex subunit sigma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:92c21efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:92c21efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:92c21efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:92c21efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:92c21efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:92c28038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92c28038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92c28038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92c28038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92c2d61e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:92c2d61e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:92c2d61e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:92c2d61e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:92c326dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:92c326dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:92c326dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:92c36962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:92c36962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:92c3abe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92c3abe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92c3abe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92c3abe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92c3abe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92c40886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92c40886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92c40886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92c44e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:92c44e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:92c44e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:92c4aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92c4aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92c4aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92c4aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92c4aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92c4aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92c4aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92c4aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:92c527f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:92c527f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:92c527f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:92c567e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:92c58fd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:92c5b7da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:92c5e0a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:92c608b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60493 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Unclassified (Zinc finger protein 664) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:92c630d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is inverse agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:92c658e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halopredone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:92c67e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:92c6a686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.339']} DrugCentral uuid:92c6ce9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.366']} DrugCentral uuid:92c6f686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.561']} DrugCentral uuid:92c71f8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:92c7478a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:92c76f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:92c7979e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:92c7c160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:92c7e956-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.231']} DrugCentral uuid:92c8116a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.805']} DrugCentral uuid:92c83a6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:92c86552-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.338']} DrugCentral uuid:92c88f96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:92c8b7aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:92c8dffa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:92c903f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:92c927e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:92c94bde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:92c96fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:92c9983c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:92c9983c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92c9ffa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:92cabcd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:1358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 heparin is activator of Secreted (Antithrombin-III) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:92cae4da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:1358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 heparin targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.14']} DrugCentral uuid:92cb0cee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:1358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 heparin targets Unclassified (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.14']} DrugCentral uuid:92cb34d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:92cb5d7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:92cb8566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:92cbad84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:92cbd566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:92cbfe24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:92cc2606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:92cc4de8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:92cc75de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:92ccb170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:92ccb170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:92ccb170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:92ccb170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:92ccb170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:92ccb170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:92cd04fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.212']} DrugCentral uuid:92cd2e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.191']} DrugCentral uuid:92cd55f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.043']} DrugCentral uuid:92cd7dee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.686']} DrugCentral uuid:92cda5da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.636']} DrugCentral uuid:92cdd01e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.441']} DrugCentral uuid:92cdf80a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.618']} DrugCentral uuid:92ce1ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.994']} DrugCentral uuid:92ce48c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.442']} DrugCentral uuid:92ce7154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:92ce9a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.521']} DrugCentral uuid:92cec280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:92ceea6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.882']} DrugCentral uuid:92cf1320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.126']} DrugCentral uuid:92cf3b20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.911']} DrugCentral uuid:92cf6302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06149 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (D-lactate dehydrogenase) DrugCentral uuid:92cf86e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.614']} DrugCentral uuid:92cfb1cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.459']} DrugCentral uuid:92cfd9c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.479']} DrugCentral uuid:92d001b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:92d02a08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.605']} DrugCentral uuid:92d051f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.057']} DrugCentral uuid:92d079ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:92d0a1e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.479']} DrugCentral uuid:92d0cabc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.708']} DrugCentral uuid:92d0f2d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) DrugCentral uuid:92d116a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:92d13ea2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:92d167ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11142 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (Heat shock cognate 71 kDa protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:92d19276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMV8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (Heat shock 70 kDa protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:92d1ba6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:92d1e262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:92d20a9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:92d23384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:92d25c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6IQ20 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene is inhibitor of Unclassified (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:92d28442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:92d2acec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexafluronium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:92d2d0e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexafluronium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:92d2f904-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexafluronium targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:92d32500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:92d32500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:92d35cbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:92d35cbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:92d393aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:92d393aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:92d3d2a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92d3d2a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92d3d2a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92d3d2a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:92d41d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:92d44520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:92d46da2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1368 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexestrol is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:92d49d7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:92d49d7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:92d49d7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:92d4dc4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:92d4dc4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:92d4dc4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:92d51c98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:92d51c98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:92d51c98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:92d55c9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:92d55c9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:92d55c9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:92d59bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:92d59bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:92d59bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:92d5da48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:92d5fe1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:92d62624-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:92d64eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:92d676c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:92d69ece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:92d6cea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:92d6cea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:92d6cea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:92d710c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylresorcinol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:92d738a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylresorcinol targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:92d7608e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylresorcinol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:92d788f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine is agonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:92d7b0e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:92d7d8c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:92d8008e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.508']} DrugCentral uuid:92d82a3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:92d85214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:92d87b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:92d8a340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:92d8cc8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:92d8f480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58406 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:92d91c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q91ZY2 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:92d9446c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q91ZY1 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:92d96cda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.84']} DrugCentral uuid:92d994b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q91ZY3 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:92d9bcd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histidine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:92d9e4bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:92da0d70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:92da3570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:92da5d66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:92da8584-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:92daae7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hycanthone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:92dad67e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:92dafe42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:92db220a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 1) DrugCentral uuid:92db4640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:92db6a12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBC3 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 3B) DrugCentral uuid:92db8dda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:92dbb5b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.438']} DrugCentral uuid:92dbdec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:92dc06b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:92dc2eac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92dc568e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0LPN4 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Ion channel (Ryanodine receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.152']} DrugCentral uuid:92dc8064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92736 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine is blocker of Ion channel (Ryanodine receptor 2) DrugCentral uuid:92dca454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:92dccc7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.01']} DrugCentral uuid:92dcf468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:92dd1ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:92dd40a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:92dd648e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:92dd8c98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:92ddb538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:92ddde6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:92de068c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:92de2f40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocodone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:92de58b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocodone is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:92de80bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortamate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:92dea4b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:92decc98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Cytosolic other (Annexin A1) DrugCentral uuid:92def0d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.95']} DrugCentral uuid:92df18ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:92df40b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.881']} DrugCentral uuid:92df68c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:92df9150-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.37']} DrugCentral uuid:92dfb946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone cypionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:92dfdd36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroflumethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.37']} DrugCentral uuid:92e00518-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:92e02e4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:92e05658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:92e08ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:92e08ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:92e08ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:92e08ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:92e0d42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:1394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyamfetamine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.1']} DrugCentral uuid:92e0fc48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:92e12434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyamfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.529']} DrugCentral uuid:92e14cc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:92e174d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:92e19cd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:92e1c0c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:92e1ea0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.81']} DrugCentral uuid:92e21204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:92e23a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:92e261fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:92e28a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:92e2b236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:92e2da40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:92e2fe1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:92e326da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYK1 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine is antagonist of Membrane receptor (Toll-like receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:92e35006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine is antagonist of Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:92e3786a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:92e3a060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:1398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxystilbamidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:92e3cac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:92e3f51a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:92e41e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:92e44218-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:92e4664e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:92e48e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:92e4b680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:92e4de80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:92e50720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.409']} DrugCentral uuid:92e52f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:92e556f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:92e57eda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:92e5aa18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:92e5d376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:92e5fb8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37058 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:92e623da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:92e64bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:92e67402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:92e69c16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:92e6c4d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:92e6ed4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:92e715ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:1404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibandronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:92e73de2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:1404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibandronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:92e76786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02769 biolink:molecularly_interacts_with DrugCentral:1404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibandronic acid targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:92e790ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:1404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibandronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:92e7b8d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:1406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:92e7e0bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:92e809de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:92e831de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08493 biolink:molecularly_interacts_with DrugCentral:1406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:92e859d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:92e881d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:92e8aa60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:92e8d274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:92e8fa60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:92e923a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:92e9484e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:92e9704e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:92e998c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:92e9c094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:92e9e8ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:92ea10da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:92ea38c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:92ea60bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02769 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:92ea893e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:92eab134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:92ead90c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:92ebc132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:92ebc132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:92ebfbca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N695 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen is inhibitor of Transporter (Sodium-coupled monocarboxylate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:92ec23ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VD48 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:92ec4cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen is blocker of Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.53']} DrugCentral uuid:92ec74d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuproxam targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:92eca246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuproxam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:92eca246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuproxam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:92ecd586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibutilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:92ed0010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75907 biolink:molecularly_interacts_with DrugCentral:1413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icosapent ethyl is inhibitor of Enzyme (Diacylglycerol O-acyltransferase 1) DrugCentral uuid:92ed2428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idarubicin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:92ed4818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idarubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:92ed6bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idarubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:92ed9066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idebenone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:92edb87a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idebenone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:92ede07a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idebenone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:92ee0870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idebenone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:92ee312e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:1417 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idoxuridine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:92ee5956-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:1417 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idoxuridine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:92ee8156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:92eea96a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.41']} DrugCentral uuid:92eed318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:92eefb18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:92ef22fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:92ef4b7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:92ef74da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:92ef9cda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:92efc4c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:92efee42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:92f01638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:92f03e38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:92f06638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.99']} DrugCentral uuid:92f094be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:92f094be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:92f0cf92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:92f0cf92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:92f0cf92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:92f10dc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00960 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate [NMDA] receptor subunit epsilon 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:92f13612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60490 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Unclassified (3-beta-hydroxysteroid-delta(8),delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.57']} DrugCentral uuid:92f15e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:92f18630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:92f1ae3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:92f1d716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:92f1fef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:92f226d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:92f24eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:92f278d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:92f2a0ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:92f2c8f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:92f2f10a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:92f3195a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:92f34164-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:92f36946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:92f391f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:92f3b9c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:92f3e1be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:92f409a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:92f433c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:92f45bee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:92f483da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:92f4abd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:92f4d416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:92f4fc16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:92f5254c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:92f54d4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:92f575e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:92f599b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:92f5c1b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:92f5e9be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:92f61330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:92f63b12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:92f662fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:92f68b12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:92f6b376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:92f6db6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:92f7034e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:92f72b3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:92f753d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:92f77bb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:92f7a3bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:92f7cb9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:92f7f47a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:92f81d56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:92f84542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:92f86d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:92f89588-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:92f8bd6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:92f8e560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:92f90e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:92f93614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:92f95e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:92f985ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:92f9aef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:92f9d736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:92f9ff22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:92fa2718-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:92fa4f54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:92fa7736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:92fa9f18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:92fac70e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:92faefea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:92fb193e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:92fb4152-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:92fb6948-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:92fb9346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:92fbbc18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:92fbe404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:92fc0ce0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:92fc3530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:92fc5d26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:92fc858a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:92fcad76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:92fcd602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:92fcfdf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:92fd25bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:92fd4d94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15046 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Lysine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:92fd7882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:92fda078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:92fdc85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:92fdf0b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:92fe18aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:92fe4096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:92fe688c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:92fe9140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:92feb92c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:92fee10e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:92ff08f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.97']} DrugCentral uuid:92ff324e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:92ff5cc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:92ff84a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:92ffac88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:92ffd4d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:92fffda0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:93002582-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:93005138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:93005138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:930088ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:930088ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9300bf7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9300bf7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9300f41c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05030 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:93011f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imidapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:93014aa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem targets Enzyme (Penicillin-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:93017306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem targets Enzyme (Penicillin-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:93019b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9301c356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:93020276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:93020276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:93020276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:93020276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:93020276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:93020276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:93020276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:930260e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:930288ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.284']} DrugCentral uuid:9302b0e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9302da8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.854']} DrugCentral uuid:9303028e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.432']} DrugCentral uuid:93032a8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:93035374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.825']} DrugCentral uuid:93037be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:9303a3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.495']} DrugCentral uuid:9303cbd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9303f3b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.412']} DrugCentral uuid:93041c46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.614']} DrugCentral uuid:93044428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:93046c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:93049400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:9304bcf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:9304e4e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.081']} DrugCentral uuid:93050ce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.071']} DrugCentral uuid:930534e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:93055d4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:93058536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:9305ad2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9305d50e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9305fdae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:930626e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:93064ef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:93067702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9306a236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34968 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9306ca36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9306f25e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:93071ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:930743bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:93076bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:930793a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:9307d340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9307d340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9307d340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9307d340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9307d340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9307d340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9307d340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:93084d16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:93084d16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:93084d16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:93084d16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:93084d16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9308d574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:930997de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:930997de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:930997de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9309e6c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9309e6c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9309e6c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9309e6c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9309e6c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:930a4404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:930a4404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:930a4404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:930a89f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:930a89f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:930a89f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:930ad00e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:930ad00e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:930ad00e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:930b0e52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48545 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:930b363e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:930b5ef2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17405 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Enzyme (Sphingomyelin phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:930b86f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imiquimod targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:930bafe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imiquimod targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:930bd7ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imiquimod targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:930c015e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYK1 biolink:molecularly_interacts_with DrugCentral:1429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imiquimod is agonist of Membrane receptor (Toll-like receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:930c2b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:1431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 incadronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:930c533e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8MTZ4 biolink:molecularly_interacts_with DrugCentral:1431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 incadronic acid targets Unclassified (Vacuolar-type proton translocating pyrophosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:930c7b48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:1431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 incadronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:930ca3a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indalpine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:930ccbb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:930cf3de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.54']} DrugCentral uuid:930d1bca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:930d446a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:930d6c92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:930d9492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:930dbc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51787 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Ion channel (Potassium voltage-gated channel subfamily KQT member 1) DrugCentral uuid:930de190-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:930e099a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:930e319a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:930e59a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:930e8334-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:930eab5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.535']} DrugCentral uuid:930ed35c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:930efb5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:930f2410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indecainide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:930f47ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indenolol targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:930f6bc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indenolol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:930f8fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:930fbb00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.222']} DrugCentral uuid:930fe314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.733']} DrugCentral uuid:93100b14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:931033a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:93105c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:931083fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9310abf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9310d3dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.27']} DrugCentral uuid:9310fc9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:931124ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:93114cae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1438 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:931174a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indobufen targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:93119ace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indobufen targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:9311bf86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9311e7fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:93121076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:9312392a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:93126134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:93128902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:9312b1c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BPW9 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9312d9a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:93130198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:9313297a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:931352c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:93137c9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.691']} DrugCentral uuid:9313a486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:9313cd80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9313f602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:93141de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:931445da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:93146f10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.19']} DrugCentral uuid:931497b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9314bfb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9314e79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:93150fb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:931539f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:931563de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:93158bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9315b3c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:9315e016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9315e016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9316178e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9316178e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:93164e84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase (cyclooxygenase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:93164e84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase (cyclooxygenase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:93168246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29477 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9316aa46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:9316d228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17516 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:9316fb22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:93172318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:93174b18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:93177430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08659 biolink:molecularly_interacts_with DrugCentral:1442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoprofen targets Unclassified (Luciferin 4-monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:93179c76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:9317c480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:9317ec9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:931814a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:93183d5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:93186566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:93188d84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9318b584-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9318deba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:93190e8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:93190e8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:93190e8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:9319548a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:9319548a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:9319548a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:9319945e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 intoplicine targets Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9319bc4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:1446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 intoplicine targets Enzyme (DNA topoisomerase I, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9319e440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:1446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 intoplicine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:931a0d26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.278']} DrugCentral uuid:931a3530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.724']} DrugCentral uuid:931a5d30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.609']} DrugCentral uuid:931a8512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.804']} DrugCentral uuid:931aadd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.067']} DrugCentral uuid:931ad5bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.279']} DrugCentral uuid:931afec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.439']} DrugCentral uuid:931b26b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.043']} DrugCentral uuid:931b4f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.532']} DrugCentral uuid:931b76e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:931b9ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:931bc6c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:931bef92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.292']} DrugCentral uuid:931c181e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.181']} DrugCentral uuid:931c4028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:931c683c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:931c91f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:931cba08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.74']} DrugCentral uuid:931ce1fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:931d09f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipriflavone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.531']} DrugCentral uuid:931d3262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipriflavone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:931d5a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iprindole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:931d8276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iprindole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.899']} DrugCentral uuid:931daa76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iprindole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:931dd302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iprindole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.185']} DrugCentral uuid:931dfb16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iproniazid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:931e2302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:1480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iproniazid targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:931e4bde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iproniazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:931e73de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iproniazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:931e9bde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:931ec3d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:931eed14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:931f18fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:931f18fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:931f5510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:931f5510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:931f5510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:931f93e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:931fbbf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:931fdfc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:932007bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:93202c7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.336']} DrugCentral uuid:93205488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:9320785a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:93209c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:9320c062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9320e862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan is inhibitor of Enzyme (DNA topoisomerase 1) DrugCentral uuid:93210c5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.218']} DrugCentral uuid:9321345c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:93215d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:93218510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9321acfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9321d4e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9321fdc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:93222592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:1483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irofulven targets Kinase (Serine/threonine-protein kinase Chk2) DrugCentral uuid:932249d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:1486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isepamicin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.87']} DrugCentral uuid:932271dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1490 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isocarboxazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:93229612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1490 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isocarboxazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:9322bae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoetarine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9322e2e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.109']} DrugCentral uuid:93230b1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:93232fbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:932353c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:932377b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:93239ba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:9323c384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:9323c384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93243120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9324e854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:93251130-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:93253930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.15']} DrugCentral uuid:93256112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:93258a02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9325b496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q29550 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Liver carboxylesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9325dcd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:932604aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WIE4 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Catalase-peroxidase) DrugCentral uuid:932628ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:932650ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:932678e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9326a0c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WNX1 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9326c8d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9326f16c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:93271962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:93274176-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9327698a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:93279478-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9327bc8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.752']} DrugCentral uuid:9327e464-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:93280cbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:932834be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:93285ca0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:93288522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9328adcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9328d5a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04274 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:9328fee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:932926e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:93295074-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:93297b08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59533 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 38) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9329a40c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59534 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 39) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9329cc0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59535 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 40) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9329f470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59536 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 41) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932a1c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59537 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 43) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932a4466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59538 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 31) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932a6c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59539 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 45) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932a9510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932abd10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59541 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 30) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932ae510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59542 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 19) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932b0cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59543 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932b3600-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59544 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 50) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932b5df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59551 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 60) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932b85f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTR8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 42) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932bade2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYV7 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 16) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932bd650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932bfe50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYV9 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 13) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932c2650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW0 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932c4e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW1 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932c76fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW2 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932c9ef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW3 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932cc772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW4 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932cf058-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW5 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932d18a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW6 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932d40a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW7 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:932d689e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isopropamide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:932d8dce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isopropamide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:932db1aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:932de13e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:932de13e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:932de13e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:932de13e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:932e21da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:932e522c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:932e522c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:932e522c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:932e522c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:932e9462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:932ebc58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:932ee64c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.628']} DrugCentral uuid:932f0e4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['8.229']} DrugCentral uuid:932f364c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08319 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Enzyme (Alcohol dehydrogenase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:932f5e9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BPW9 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.523']} DrugCentral uuid:932f86ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Enzyme (11-cis retinol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:932faeba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14756 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Enzyme (17-beta-hydroxysteroid dehydrogenase type 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:932fd6d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin is inhibitor of Nuclear hormone receptor (Retinoic acid receptor beta) DrugCentral uuid:932ffb36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.597']} DrugCentral uuid:93302322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.335']} DrugCentral uuid:93304b18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40220 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:93307304-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:93309bb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1509 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9330c3c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1509 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9330eb9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:93310f6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:933134a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:93315cc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:933184b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:9331acce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:9331d56e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9331fd5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JIS7 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:93322550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01815 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:93324de6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9332774e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.046']} DrugCentral uuid:9332a052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['9.246']} DrugCentral uuid:9332c85c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9332f048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:933318a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9333408e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:93336884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:93339066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9333b8f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9333e228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:93340a28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:93345352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9334c5b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:1519 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kanamycin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.678']} DrugCentral uuid:9334ee2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A6R0 biolink:molecularly_interacts_with DrugCentral:1519 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kanamycin targets Unclassified (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:93351620-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29033 biolink:molecularly_interacts_with DrugCentral:1519 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kanamycin targets Unclassified (Gap junction beta-2 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:93353dee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C3TDZ2 biolink:molecularly_interacts_with DrugCentral:1520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bekanamycin targets Enzyme (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:933565e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A6R0 biolink:molecularly_interacts_with DrugCentral:1520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bekanamycin targets Unclassified (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:93358ea2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9335cdc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9335cdc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9335cdc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9335cdc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9335cdc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9335cdc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9335cdc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:933653d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:933653d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:933653d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:933653d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:933653d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:933653d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:933653d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9336c966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:9336c966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:9336c966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:9336c966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:93370afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:933732de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:93375b6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki'} DrugCentral uuid:9337850e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9337acfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:9337d4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9337fdb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:933825ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:93384dc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:933875cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:93389e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9338c63a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:9338ee30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.701']} DrugCentral uuid:93391630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:93393f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.747']} DrugCentral uuid:9339672a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:93398f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9339b70c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:9339e222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:933a0c98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:933a34a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:933a5d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:933a8506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.903']} DrugCentral uuid:933aacfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:933ad4e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:933afedc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:933b26f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:933b4f04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.33']} DrugCentral uuid:933b7722-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:933ba0bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:933bcbe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:933bf620-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:933c25e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:933c25e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:933c25e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:933c6c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:933c6c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:933c6c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:933caa66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:933cd3ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BRU6 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:933cfb88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:933d2496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:933d4cb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.585']} DrugCentral uuid:933d75b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:933da966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:933da966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:933da966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:933da966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:933dfdda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:933dfdda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:933dfdda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:933dfdda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:933e48b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.821']} DrugCentral uuid:933e70a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:933e9966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:933ec206-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:933eea10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:933f1224-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:933f3a24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:933f62e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.084']} DrugCentral uuid:933f8af6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.667']} DrugCentral uuid:933fb30a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.028']} DrugCentral uuid:933fdb5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:93400350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.729']} DrugCentral uuid:93402b46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:93404f04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:934077cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:93409fcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:9340c7d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9340f044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9341193e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9341412a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:93416920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9341918e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:9341b9c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.665']} DrugCentral uuid:9341e2a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'app Ki', 'has_quantitative_value': ['7.197']} DrugCentral uuid:93420a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:93423274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:93425c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:93428530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9342ad26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.266']} DrugCentral uuid:9342d51c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.897']} DrugCentral uuid:9342ffa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.211']} DrugCentral uuid:93432abc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:93435546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:93437d3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.66']} DrugCentral uuid:9343a58c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07973 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.506']} DrugCentral uuid:9343cd6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08686 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 21) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9343f564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15150 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 11B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:93441d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14137 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:934445f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09128 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 24A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:93446dd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18125 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 7A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:934495d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64654 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 51) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9344bef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11715 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 17A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:9344e9f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:934511ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35084 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:934539ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:9345620a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is inhibitor of Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:93458a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.896']} DrugCentral uuid:9345b1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9345dac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:9346034a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:93462b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:93465714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:93465714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:93468a18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9346b524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.72']} DrugCentral uuid:9346dd24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:9347051a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.214']} DrugCentral uuid:93472d56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:93475538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:93477d1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.361']} DrugCentral uuid:9347a510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:9347cdc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:9347f196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.839']} DrugCentral uuid:93481b62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.047']} DrugCentral uuid:93484362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:93486cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.076']} DrugCentral uuid:934897b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:9348bfa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.489']} DrugCentral uuid:9348e79a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:93490ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.509']} DrugCentral uuid:934937ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.391']} DrugCentral uuid:93495ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:934987cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.016']} DrugCentral uuid:9349b062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.359']} DrugCentral uuid:9349d952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:934a015c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.075']} DrugCentral uuid:934a2966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:934a53d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.737']} DrugCentral uuid:934a7c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:934aa422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:934acc40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.234']} DrugCentral uuid:934af4c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:934b1ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.117']} DrugCentral uuid:934b44cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.478']} DrugCentral uuid:934b6cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.648']} DrugCentral uuid:934b959e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:934bbda8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.894']} DrugCentral uuid:934be5a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:934c0dbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:934c37c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.491']} DrugCentral uuid:934c5fc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:934c87b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:934cb00a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47154 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Enzyme (CAAX prenyl protease 1) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:934cd7f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:934cffce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.046']} DrugCentral uuid:934d27ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.245']} DrugCentral uuid:934d5046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:934d783c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.642']} DrugCentral uuid:934da032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:934dc918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:934df2b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.771']} DrugCentral uuid:934e1c6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:934e485c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:934e485c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:934e7606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00214 biolink:molecularly_interacts_with DrugCentral:1535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lactose targets Unclassified (Galectin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.21']} DrugCentral uuid:934e9e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00182 biolink:molecularly_interacts_with DrugCentral:1535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lactose targets Unclassified (Galectin-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.64']} DrugCentral uuid:934ec656-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17931 biolink:molecularly_interacts_with DrugCentral:1535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lactose targets Unclassified (Galectin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.03']} DrugCentral uuid:934eee38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:1539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamivudine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:934f121e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:1539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamivudine is inhibitor of Polyprotein (Protein P) DrugCentral uuid:934f36c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamivudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:934f5eb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:934f8690-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.839']} DrugCentral uuid:934fae68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:934fd456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:934ffc56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:93502456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:93504c60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:935070be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:935098aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.744']} DrugCentral uuid:9350c096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:9350e878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:93511118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:935140ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:935140ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:935140ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:93517fcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9351aa42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1545 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 landiolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:9351ce1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:9351f61e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:93521e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:93524696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:93526e82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:93529678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:9352be78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9352e6fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide targets GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:93530ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:935336d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30936 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:93535eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.275']} DrugCentral uuid:93538a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.473']} DrugCentral uuid:9353b422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9353dc9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCT1 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Phosphoethanolamine/phosphocholine phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:935404f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:93542d12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:935458fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:935458fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:935486a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:9354af3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:9354d744-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:9354ff30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:935522ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:93554828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:93557118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:93559918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:9355c136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9355e97c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Transporter (Solute carrier organic anion transporter family member 1B1) DrugCentral uuid:93560d62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:93563562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:93565d58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:935685ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9356adf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9356d5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9356fdee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9357288c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:93575276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:93577a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00750 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9357a280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75747 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9357cada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9357f2da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:93581ae4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:1549 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arginine hydrochloride targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:93584366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5T6X5 biolink:molecularly_interacts_with DrugCentral:1549 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arginine hydrochloride is agonist of GPCR (G-protein coupled receptor family C group 6 member A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:93586bb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75746 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Calcium-binding mitochondrial carrier protein Aralar1) DrugCentral uuid:93588f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17174 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartate aminotransferase, cytoplasmic) DrugCentral uuid:9358b328-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45381 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartoacylase) DrugCentral uuid:9358d6dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08243 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Asparagine synthetase [glutamine-hydrolyzing]) DrugCentral uuid:9358fcfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00966 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Argininosuccinate synthase) DrugCentral uuid:9359209c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03154 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aminoacylase-1) DrugCentral uuid:9359457c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00505 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartate aminotransferase, mitochondrial) DrugCentral uuid:93596a3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14868 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartate--tRNA ligase, cytoplasmic) DrugCentral uuid:93598e6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12797 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartyl/asparaginyl beta-hydroxylase) DrugCentral uuid:9359b250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43003 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:9359dabe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43004 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:935a02b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43005 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:935a2b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UJS0 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Calcium-binding mitochondrial carrier protein Aralar2) DrugCentral uuid:935a661e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:935a661e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:935a661e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:935a661e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:935a661e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:935a661e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:935a661e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:935ad310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35921 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:935afd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O59010 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Glutamate transporter homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:935b255e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.757']} DrugCentral uuid:935b4d4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.187']} DrugCentral uuid:935b75b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:935b9dc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:1551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:935bc5c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.287']} DrugCentral uuid:935bee4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.338']} DrugCentral uuid:935c163a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:935c3e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide is inhibitor of Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:935c6612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:935c8ec6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.684']} DrugCentral uuid:935cb78e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:935cdf7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35435 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:935d077a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:935d2fca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letrozole targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:935d57ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letrozole targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:935d7fc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leucine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:935da7c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leuprorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:935dd056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:1559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leuprorelin targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:935df84c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:935e206a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:935e4842-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:935e7ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:935e7ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:935e7ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:935e7ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:935ecb82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N587 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Ion channel (Acetylcholine receptor subunit alpha-type unc-63) DrugCentral uuid:935eef68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:935f17f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96760 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole is agonist of Ion channel (Nicotinic acetylcholine receptor alpha subunit) DrugCentral uuid:935f3bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.568']} DrugCentral uuid:935f6452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09487 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:935f8c48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09923 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Enzyme (Intestinal-type alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:935fb4de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:935fdcde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:936004ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:93602cb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:93605682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9360b028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9361684c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam targets Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:93618cd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:9361b0ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:9361d49e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02563 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam is inhibitor of Unclassified (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9361fca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L0J3 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam is modulator of Transporter (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9362269c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:93624a82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.279']} DrugCentral uuid:93627282-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95665 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine is agonist of GPCR (Neurotensin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:93629ba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63384 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine targets GPCR (Neurotensin receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9362c41c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70310 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine is agonist of GPCR (Neurotensin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9362ec1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocetirizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:9363152a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:93633d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.541']} DrugCentral uuid:936365c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:93638dca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:9363b5c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.646']} DrugCentral uuid:9363dec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa is agonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:936402d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa is agonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:936426a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.04']} DrugCentral uuid:93644e9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:93647690-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9364a2c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:9364a2c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:9364d432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:9364d432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:936501dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y256 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:93652a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadyl acetate is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:93654e58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadyl acetate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:936576da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.225']} DrugCentral uuid:93659ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:9365c928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:9365ef98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['12.796']} DrugCentral uuid:93661798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.91']} DrugCentral uuid:93663f98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:936667fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.339']} DrugCentral uuid:9366902e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:9366b824-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:9366e024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:936709dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:936731b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:936759be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:936781c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:9367aaa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9367d2ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9367faae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55242 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:93683b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:93683b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:93683b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:93683b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:93683b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:93683b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:93683b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9368bce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9368bce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9368bce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9368bce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9368bce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9368bce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9368bce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:93693324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:93693324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:93693324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:93693324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:93698950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:93698950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:93698950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9369ccf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9369f53e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosalbutamol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:936a1d84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosimendan targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) DrugCentral uuid:936a4160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosimendan targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) DrugCentral uuid:936a6546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15842 biolink:molecularly_interacts_with DrugCentral:1576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosimendan targets Ion channel (ATP-sensitive inward rectifier potassium channel 8) DrugCentral uuid:936a895e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63316 biolink:molecularly_interacts_with DrugCentral:1576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosimendan is opener of Cytosolic other (Troponin C, slow skeletal and cardiac muscles) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.155']} DrugCentral uuid:936ab226-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:936ada3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:936b0262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:936b2b0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:936b565e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:936b7e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:936bb5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:936bb5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:936bb5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:936bb5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:936bb5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:936c1396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:936c1396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:936c1396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:936c595a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:936c595a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:936c595a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:936c9942-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:936cc160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:936ce578-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:936d0e90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:936d36ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:936d5e9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.296']} DrugCentral uuid:936d8686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:936daac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.559']} DrugCentral uuid:936dda78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:936dda78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:936dda78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:936e2032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:936e2032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:936e2032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:936e5f02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:936e8702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:936eaef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:936ed6f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:936f07b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:936f07b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:936f07b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:936f4606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 limaprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) DrugCentral uuid:936f69d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:1582 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lincomycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:936f8e18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:936fb604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:936fdeea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75NA5 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:937006d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24046 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:9370373c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:9370373c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:9370373c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:93707d00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:93707d00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:93707d00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:9370bf22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:9370bf22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:9370bf22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:9370fe7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9370fe7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9370fe7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:937144ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:937144ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:937144ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:93718a60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:9371b256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9371da60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:937202a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31040 biolink:molecularly_interacts_with DrugCentral:1584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linezolid targets Enzyme (Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:93722aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine is agonist of Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.24']} DrugCentral uuid:937252c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine is agonist of Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:93727ad8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9372a652-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:9372d0d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:9372f9c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:93732262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937383e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:937490d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:93756162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1587 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisinopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:93758958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1587 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisinopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:9375b1e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.491']} DrugCentral uuid:9375da02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:93760216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:93762a20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:93765612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.936']} DrugCentral uuid:93767e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9376a69e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.061']} DrugCentral uuid:9376cf52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9376f752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.259']} DrugCentral uuid:93771f3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:93774752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.625']} DrugCentral uuid:93777010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:93779806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:9377bff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:9377e8e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:937812f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93783e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:93786966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.203']} DrugCentral uuid:9378940e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9378be2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9378e63e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.037']} DrugCentral uuid:93790e48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.78']} DrugCentral uuid:93793652-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:93795eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.338']} DrugCentral uuid:937986de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:9379aeca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9379d792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.33']} DrugCentral uuid:9379ffd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:937a27d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:937a4fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.489']} DrugCentral uuid:937a78a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:937aa0a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:937ac8aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.268']} DrugCentral uuid:937af0a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:937b18dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:937b40d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:937b68be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.444']} DrugCentral uuid:937b9096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:937bba4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.481']} DrugCentral uuid:937be690-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.886']} DrugCentral uuid:937c0ed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.468']} DrugCentral uuid:937c36d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:937c5f76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:937c8780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:937caf76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:937cd776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:937d07c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:937d07c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:937d07c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:937d4d8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:937d4d8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:937d4d8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:937d8c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:937db448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43700 biolink:molecularly_interacts_with DrugCentral:1594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomefloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:937de026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomefloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:937de026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomefloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:937e0ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1595 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomerizine targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:937e3774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:1597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonazolac targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:937e5f6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:937e8774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:937eaf6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:937ed800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) DrugCentral uuid:937efbe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:937f2472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.932']} DrugCentral uuid:937f4c5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:937f76ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.343']} DrugCentral uuid:937f9ea2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:937fc684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.519']} DrugCentral uuid:937fee7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:938016c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) DrugCentral uuid:93803a9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:93806260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.599']} DrugCentral uuid:93808a60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:9380ba80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:9380ba80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:9380ba80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:9380f18a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:93811994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.345']} DrugCentral uuid:938143ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) DrugCentral uuid:938167b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) DrugCentral uuid:93818b72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) DrugCentral uuid:9381af44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9381d7ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:9381ffc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:938227a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:93824f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:93827802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:9382a002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9382c7f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9382f7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9382f7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9382f7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:938337e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:93835fb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:938388dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9383b1fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:9383da08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:9383fdf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:9384260c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80W54 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Enzyme (CAAX prenyl protease 1 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:93844e8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9384767a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.59']} DrugCentral uuid:93849e8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.54']} DrugCentral uuid:9384ce5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:9384ce5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:9384ce5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:93850eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:93850eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:93850eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:93854e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:93854e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:93854e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:93858dbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93858dbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93858dbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:9385c4b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:9385ff86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9385ff86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9385ff86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9385ff86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9385ff86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9385ff86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9385ff86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:93865e90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9386867c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:9386af58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:9386d776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:9386ff80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:93872762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:93874fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:9387779e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:93879f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9387c8a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9387f110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2J7 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Transporter (Sodium-dependent neutral amino acid transporter B(0)AT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:93881924-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:9388411a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorazepam targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:93887112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:93887112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:93887112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:9388b38e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:9388d760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:9388fb46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:93891f90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:93894362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:93896748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.498']} DrugCentral uuid:93898f3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9389b7a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9389df8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:938a0784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:938a309c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:938a5a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:938a8308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:938aaafe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:938ad308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34976 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:938afb80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WV26 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:938b275e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:938b275e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:938b65fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:938b65fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:938b65fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:938b65fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:938bb3a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:938bb3a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:938bee8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:938bee8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:938bee8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:938c3248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:938c3248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:938c6862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCN6 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Unclassified (Platelet glycoprotein VI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:938c9044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loteprednol etabonate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:938cb556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.061']} DrugCentral uuid:938cddc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:938d05ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.807']} DrugCentral uuid:938d2dba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:938d55a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.67']} DrugCentral uuid:938d7edc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:938da6c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets GPCR (Hydroxycarboxylic acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:938dcedc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:938df6dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:938e201c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:938e4826-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:938e701c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.697']} DrugCentral uuid:938e9894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:938ec094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:938ee880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01237 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:938f108a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:938f38f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20701 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Adhesion (Leukocyte adhesion glycoprotein LFA-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:938f60c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95214 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Acyl-CoA:cholesterol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:938f88a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.268']} DrugCentral uuid:938fb0c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:938fda9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:939002f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.244']} DrugCentral uuid:93902af6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:93905328-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:93907ba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9390a396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9390cb78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:9390f364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:93911bc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9391438c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:93916c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:9391945e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.682']} DrugCentral uuid:9391bd58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.297']} DrugCentral uuid:9391e562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:93920d3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.376']} DrugCentral uuid:939235b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:93925e16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.087']} DrugCentral uuid:9392860c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.829']} DrugCentral uuid:9392af24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.411']} DrugCentral uuid:9392d738-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9392ffb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:939327b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:93934fb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:939378a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.276']} DrugCentral uuid:9393a0fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:9393c904-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.854']} DrugCentral uuid:9393f104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:93941954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5JUK3 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:93944140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:93946936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:93949118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:9394b986-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9394e172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:93950954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9395391a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9395391a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9395391a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:93957b8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:1614 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxiglumide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:9395a38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:1614 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxiglumide is antagonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9395cb82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9395f3dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:93961bc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lucanthone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:939643aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1617 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumefantrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:93966b78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumiracoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9396942c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumiracoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9396bc40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumiracoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9396e436-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:93970c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:9397362a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.979']} DrugCentral uuid:93975e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.856']} DrugCentral uuid:93978666-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.12']} DrugCentral uuid:9397ae66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9397d6ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9397fec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:939826c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:93984ea2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9398785a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9398a064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.81']} DrugCentral uuid:9398c940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:9398f1d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:93991bc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:939943d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:93996bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:93999474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:9399bc88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9399e4a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:939a0cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:939a3596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:939a6566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:939a6566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:939a6566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:939aa3a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysine targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:939acc86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:939af7b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:939b219a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:939b4986-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:939b7258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:939b9a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:939bbe3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:939be634-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:939c0eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:939c3698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:939c5e84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:939c867a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:939caf2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:939cd71a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:939cffec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:939d27ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:939d5046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:939d7846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:939da046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:939dc85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:939df12c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:939e1922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:939e4280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:939e6a94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:939e9564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:939ebd5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:939ee578-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:939f0d8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:939f3604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:939f5e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:939f8618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:939faea4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:1626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 malathion targets GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.538']} DrugCentral uuid:939fd6ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2PZ98 biolink:molecularly_interacts_with DrugCentral:1626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 malathion is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:939ffa6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 manidipine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:93a0264a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 manidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:93a0264a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 manidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:93a05502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.308']} DrugCentral uuid:93a07f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:93a0a714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.165']} DrugCentral uuid:93a0cf1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.364']} DrugCentral uuid:93a0f840-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:93a12040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.27']} DrugCentral uuid:93a1482c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:93a1702c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:93a198e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:93a1c0e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:93a1e8c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.854']} DrugCentral uuid:93a210a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.876']} DrugCentral uuid:93a23b6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.298']} DrugCentral uuid:93a265d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.367']} DrugCentral uuid:93a28dcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.777']} DrugCentral uuid:93a2b5cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.406']} DrugCentral uuid:93a2de3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:93a30626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:93a32e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:93a3568a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:93a37ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.939']} DrugCentral uuid:93a3a68a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:93a3ce62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.355']} DrugCentral uuid:93a3f75c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:93a42150-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:93a4495a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:93a46d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:93a49590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:93a4be12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:93a4e72a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:93a50f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:1635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maraviroc is antagonist of GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:93a537de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51682 biolink:molecularly_interacts_with DrugCentral:1635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maraviroc targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:93a55ff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maraviroc targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:93a587e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61813 biolink:molecularly_interacts_with DrugCentral:1635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maraviroc targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:93a5afde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:93a5d946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:93a60150-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:93a62946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:93a65128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:93a67982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:93a6a178-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:93a6c98c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:93a6f18c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:93a71a4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:93a74236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:93a76a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:93a79240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:93a7bc52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:93a7e434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:93a80c0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:93a833f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:93a85c48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BEG3 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:93a8842a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48999 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:93a8aff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:93a8aff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:93a8e4ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15296 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase, type II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:93a90cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:93a9349c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:93a95c88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:K4CF70 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Fatty acid hydroperoxide lyase, chloroplastic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:93a98578-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:93a9ad6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:1638 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maxacalcitol targets Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:93a9d672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:1638 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maxacalcitol is agonist of Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:93a9fe68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:93aa276c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:93aa4f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:93aa7780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:93aa9f8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:93aac852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:93aaf14c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:93ab19e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:93ab4250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:93ab6d66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:93ab9570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:93abbd52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BJF5 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole targets Kinase (Calmodulin-domain protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:93abed72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93abed72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93abed72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93ac3ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93ac3ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93ac3ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93ac3ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93ac3ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93ac3ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93ac3ba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:93ac9b5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebhydrolin is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.119']} DrugCentral uuid:93acc346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebhydrolin targets GPCR (Histamine H4 receptor) DrugCentral uuid:93ace72c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebhydrolin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:93ad0f18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebhydrolin targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:93ad3a74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.161']} DrugCentral uuid:93ad62c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:93ad8e8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:93ad8e8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:93adc5c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.602']} DrugCentral uuid:93adc5c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.602']} DrugCentral uuid:93adfcca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is negative allosteric modulator of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:93adfcca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is negative allosteric modulator of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:93ae33b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:93ae33b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:93ae6b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:93ae6b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:93aeab52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:93aeab52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:93aeab52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:93aeab52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:93aef59e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:93af2046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:93af485a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:93af7064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:93af98be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:1648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecillinam is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.035']} DrugCentral uuid:93afc0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclozine is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:93afe8b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclozine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:93b00c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35627 biolink:molecularly_interacts_with DrugCentral:1649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclozine is agonist of Nuclear hormone receptor (Constitutive androstane receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:93b03602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:1649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclozine targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:93b05ea2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:93b086ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:93b0aeb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:93b0d756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:93b0ff74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:93b1277e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:93b14f74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:93b177d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:93b19fc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:93b1c7d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:93b1efec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.503']} DrugCentral uuid:93b218aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:93b240aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:93b268a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:93b29460-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:93b29460-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b30530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:93b3df3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:93b3df3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:93b3df3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:93b42546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:93b42546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:93b42546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:93b46b3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:93b46b3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:93b46b3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:93b4b222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:93b4b222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:93b4b222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:93b4f156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxalol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'pA2', 'has_quantitative_value': ['7.82']} DrugCentral uuid:93b519d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxalol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'pA2', 'has_quantitative_value': ['6.08']} DrugCentral uuid:93b541ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.561']} DrugCentral uuid:93b56a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:93b59228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:93b5bb18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:93b5e322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.59']} DrugCentral uuid:93b60b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:93b63336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:93b65d70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:93b68606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:93b6ae10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:93b6d61a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:93b6fe74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.032']} DrugCentral uuid:93b72674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:93b75374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:93b75374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:93b78754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1662 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medrysone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:93b7ab30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:93b7d33a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:93b7fb30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:93b82416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:93b84c16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:93b8751a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:93b89d4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:93b8c5c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:93b8edd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:93b915c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:93b93d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:93b96632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:93b98e32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:93b9b632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:93b9de5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:93ba088a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:93ba2c7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:93ba5466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:93ba7838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:93baa088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P90584 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Unclassified (Protein kinase Pfmrk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:93bac87e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:93baec5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.057']} DrugCentral uuid:93bb1478-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:93bb3912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:93bb611c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:93bb8912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.842']} DrugCentral uuid:93bbb126-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meglutol targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:93bbdac0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:93bc02de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.56']} DrugCentral uuid:93bc2ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:93bc5356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:93bc7c96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35398 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Nuclear hormone receptor (Nuclear receptor ROR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:93bca48c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:93bccc78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:93bcf5ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:93bd1eda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:93bd4ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:93bd4ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:93bd4ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:93bd8cc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:93bdb7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:93bddfc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:93be07d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:93be2fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:93be585e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:93be8054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:93bea836-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:93bed0d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:93bef8d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:93bf1cbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:93bf44c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.717']} DrugCentral uuid:93bf6de8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:93bf987c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:93bfc086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.063']} DrugCentral uuid:93bfe868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:93c010ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:93c038ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.357']} DrugCentral uuid:93c0619e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.469']} DrugCentral uuid:93c089a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:93c0ae10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:93c0d61a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:1678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melphalan targets Transporter (L-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:93c0fe2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine targets Ion channel (5-hydroxytryptamine receptor 3A) DrugCentral uuid:93c1223c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:93c14780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05586 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:93c1714c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:93c1992e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:93c1c53e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:93c1c53e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:93c1fcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:93c1fcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:93c23096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:93c25882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:93c28258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:93c2aa76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:93c2d29e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:93c2faa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30305 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (M-phase inducer phosphatase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:93c324a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:93c34d00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30307 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Dual specificity phosphatase Cdc25C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:93c37500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15374 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Ubiquitin carboxyl-terminal hydrolase isozyme L3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:93c39d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:93c3c56e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64346 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Dual specificity protein phosphatase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:93c3ed5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28563 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Dual specificity protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:93c41654-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (M-phase inducer phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:93c43e4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:93c46712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione sodium bisulfite targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:93c48f08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1685 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menatetrenone targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:93c4b6e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:93c4ded6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.119']} DrugCentral uuid:93c50960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:93c53160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:93c5596a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.485']} DrugCentral uuid:93c5817e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:93c5aa1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.069']} DrugCentral uuid:93c5d214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.742']} DrugCentral uuid:93c5fa00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.167']} DrugCentral uuid:93c6228c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.504']} DrugCentral uuid:93c64a8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:93c6728c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:93c69a82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:93c6c3cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:93c6eece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:93c7193a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:93c74144-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:93c76a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.411']} DrugCentral uuid:93c79216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:93c7ba16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:93c7e1e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UDY8 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Enzyme (Mucosa-associated lymphoid tissue lymphoma translocation protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:93c80b6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepenzolate is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:93c82f32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepenzolate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:93c85750-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepenzolate is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:93c88086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepenzolate targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:93c8aa52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:93c8d25c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:93c8fa48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:93c91e24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.625']} DrugCentral uuid:93c94692-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:93c96a8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:93c99282-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:93c9baa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:93c9e368-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:93ca1716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:93ca1716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:93ca1716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:93ca1716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:93ca6cf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:93ca6cf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:93ca6cf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:93ca6cf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:93cab680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:93cade76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephentermine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cb2566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:93cba9d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93cba9d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93cba9d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93cbe0fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:93cc04d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:93cc28b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:93cc4eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:93cc74d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:93cc99e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:93ccbdcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:93cce216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprednisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:93cd05de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.821']} DrugCentral uuid:93cd3644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:93cd3644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:93cd3644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:93cd7672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:93cd7672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:93cd7672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:93cdbc36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:93cdbc36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:93cdbc36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:93cdfb1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93cdfb1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93cdfb1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93ce3562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meproscillarin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:93ce5a38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:93ce8206-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:93cea9f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:93ced242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:93cefa24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.06']} DrugCentral uuid:93cf21f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.237']} DrugCentral uuid:93cf4a9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:93cf729c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:93cf9aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.276']} DrugCentral uuid:93cfc2a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.955']} DrugCentral uuid:93cfec0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:93d01454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:93d03c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:93d06440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q389T8 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:93d08ca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.789']} DrugCentral uuid:93d0b47c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:93d0d844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:93d0fc20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Enzyme (Purine nucleoside phosphorylase) DrugCentral uuid:93d120b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06203 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine is inhibitor of Enzyme (Amidophosphoribosyltransferase) DrugCentral uuid:93d1448c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51580 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Enzyme (Thiopurine S-methyltransferase) DrugCentral uuid:93d169b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.1']} DrugCentral uuid:93d1919e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:93d1b570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:93d1dcb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:93d20232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:93d225fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:93d249f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem is inhibitor of Enzyme (D-alanyl-D-alanine carboxypeptidase DacB) DrugCentral uuid:93d26efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:93d296e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9K2N0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Unclassified (Beta-lactamase class B VIM-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:93d2bef2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C7C422 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Beta-lactamase NDM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.96']} DrugCentral uuid:93d2e6e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XEC0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:93d30fb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:93d337b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:93d35b96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:93d38008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:93d3a52e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:93d3cd38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:93d3f52e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:93d41d1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WU19 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine targets Enzyme (Hydroxyacid oxidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:93d4457e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:93d46d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.724']} DrugCentral uuid:93d49574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:93d4bd60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:93d4e678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.125']} DrugCentral uuid:93d50e78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.804']} DrugCentral uuid:93d5365a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:93d55e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:93d58934-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.744']} DrugCentral uuid:93d5b12a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:93d5d920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:93d60198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:93d6298e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:93d6518e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:93d67a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.041']} DrugCentral uuid:93d6a328-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.647']} DrugCentral uuid:93d6cb28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:93d6f346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:93d71b6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.282']} DrugCentral uuid:93d74648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:93d7705a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.958']} DrugCentral uuid:93d7988c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orciprenaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:93d7c096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orciprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:93d7e8fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1721 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metaraminol is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:93d80cea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:93d8351c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:93d85d30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:93d885da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:93d8adf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.504']} DrugCentral uuid:93d8d60c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:93d8fe0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:93d927ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:93d94fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:93d97878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:93d9a05a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:93d9c8be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:93d9f096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.124']} DrugCentral uuid:93da1896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.583']} DrugCentral uuid:93da4082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:93da6a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:93da923a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:93daba62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:93dae352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:93db0e54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:93db3866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:93db6066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:93db88ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.872']} DrugCentral uuid:93dbb0ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:93dbd8ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:93dc00de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:93dc297e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.867']} DrugCentral uuid:93dc517e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:93dc797e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:93dca17e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:93dcca78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:93dcf28c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:93dd1bd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:93dd43ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:93dd77f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93dd77f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93dd77f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93dd77f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93ddc8a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:93ddc8a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:93ddc8a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:93de08c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y478 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Kinase (5'-AMP-activated protein kinase subunit beta-1) DrugCentral uuid:93de2c92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:93de546a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.697']} DrugCentral uuid:93de7c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.401']} DrugCentral uuid:93dea546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['2.499']} DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93df8bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:93e1981e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:93e1c0be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:93e1e8e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:93e20cc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:93e235a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:93e25f10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:93e28710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:93e2aede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:93e2d760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43351 biolink:molecularly_interacts_with DrugCentral:1727 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metacycline targets Nuclear other (DNA repair protein RAD52 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:93e2ff60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.78']} DrugCentral uuid:93e32774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:93e350aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:93e37918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:93e39cf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:93e3c0da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:93e3f47e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:93e3f47e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:93e3f47e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:93e3f47e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:93e442b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylmethadol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:93e46ada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylmethadol is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:93e48eac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.383']} DrugCentral uuid:93e4b724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:93e4df2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.133']} DrugCentral uuid:93e5072e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:93e52f1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:93e558f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:93e58104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:93e5a92c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.611']} DrugCentral uuid:93e5d140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:93e5fd28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:93e6256e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:93e64d64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.88']} DrugCentral uuid:93e6753c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:93e6ad04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:93e6ad04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:93e6ad04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:93e6ad04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:93e6ad04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:93e6f796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:93e7204a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:93e74868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:93e77086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:93e79930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:93e7c31a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.409']} DrugCentral uuid:93e7edc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.843']} DrugCentral uuid:93e815d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:93e83dd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:93e8678e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.939']} DrugCentral uuid:93e88fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.228']} DrugCentral uuid:93e8b78e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:93e8df70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:93e9082e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:93e937f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:93e937f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:93e937f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:93e97ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:93e97ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:93e97ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:93e9c5f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:93e9c5f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:93e9c5f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:93ea0bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:93ea0bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:93ea0bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:93ea527e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:93ea527e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:93ea527e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:93ea987e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:93ea987e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:93ea987e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:93eadf0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:93eadf0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:93eadf0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:93eb2136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:93eb2136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:93eb5c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:93eb5c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:93eb5c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:93eba912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:93eba912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:93eba912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ec2112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93ecd88c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:93ed00aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:93ed28d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:93ed51a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:93ed79ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:93eda1c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:93edc9cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:93edf2da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:93ee1bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:93ee43de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:93ee6c88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:93ee94a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:93eebcba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:93eee4c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:93ef0dbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:93ef35e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:93ef5e04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:93ef8618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:93efae90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:93efd6a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:93effed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:93f026f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:93f04fbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:93f077da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:93f0a11a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:93f0c942-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:93f0f2aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:93f11ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:93f142dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f19570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:93f23c78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:93f23c78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:93f26f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:93f297ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:93f2c1f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:93f2ed58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methdilazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:93f3117a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07944 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin targets Enzyme (Beta-lactam-inducible penicillin-binding protein) DrugCentral uuid:93f33560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18843 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin targets Enzyme (NH(3)-dependent NAD(+) synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:93f36d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:93f36d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:93f36d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:93f36d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:93f36d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:93f3b882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:1745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamazole is inhibitor of Enzyme (Thyroid peroxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:93f3e096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:1745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:93f40990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22079 biolink:molecularly_interacts_with DrugCentral:1745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:93f4315e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15101 biolink:molecularly_interacts_with DrugCentral:1745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamazole targets Enzyme (Dopamine beta-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:93f4597c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1747 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methocarbamol is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:93f48154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital targets Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:93f4af30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93f4af30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93f4af30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:93f4ec84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:93f4ec84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:93f51a10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:93f53e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:93f561f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:93f585ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:93f5a980-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:93f5d20c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:93f5f5e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:93f61dc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:93f6417e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:93f66b5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:93f6932c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:93f6bb0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:93f6e2fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:93f70b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:93f7332c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.14']} DrugCentral uuid:93f75b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:93f782f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:93f7ab86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.89']} DrugCentral uuid:93f7d372-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:93f7fb40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:93f82304-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.68']} DrugCentral uuid:93f84cb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:93f87494-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:93f89d7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:93f8c57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WNX1 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.08']} DrugCentral uuid:93f8edb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q81R22 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.91']} DrugCentral uuid:93f915ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:93f93d8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00380 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:93f965fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:93f98dfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:93f9b606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:93f9dee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:93fa0804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomepromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.237']} DrugCentral uuid:93fa3392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomepromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:93fa5bb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:93fa83ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:93faac28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:93fad432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:93fb040c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:93fb040c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:93fb040c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:93fb42f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is agonist of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fba056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:93fc61ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:93fc8a5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:93fcb284-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:93fcda7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.01']} DrugCentral uuid:93fd0298-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:93fd2b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:93fd5afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:93fd5afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:93fd5afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:93fd921c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylclothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:93fdb74c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metildigoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:93fddc54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa is agonist of GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:93fe0134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:93fe24fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.282']} DrugCentral uuid:93fe4d56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.286']} DrugCentral uuid:93fe7542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.672']} DrugCentral uuid:93fe9d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:93fec51a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:93feed92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:93ff157e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:93ff3e82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Thioredoxin reductase 1, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:93ff668c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15770 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Glutathione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:93ff8fd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:93ffb7cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:93ffdfae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9400083a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:940030b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:940058a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.225']} DrugCentral uuid:940080b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.633']} DrugCentral uuid:9400a8d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9400d18e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is partial agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9400f998-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:940121c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.928']} DrugCentral uuid:940149ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.678']} DrugCentral uuid:94017454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:94019c5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:9401c44a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9401ec54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:940214d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.033']} DrugCentral uuid:94023cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:940264cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:94028d44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9402b562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:9402dd62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9403053a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.93']} DrugCentral uuid:94032fce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:94035ada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:94038316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:9403ab02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.58']} DrugCentral uuid:9403d492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:9403fc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:940424ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:94044cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:9404755a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:94049d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.97']} DrugCentral uuid:9404c55a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:9404f912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9404f912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9404f912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9404f912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:940547b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:940547b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:94057ae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9405a344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9405cb44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9405f34e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:94061bee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:940644b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:94066cb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.252']} DrugCentral uuid:940694d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:9406bce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9406e7c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.615']} DrugCentral uuid:940711ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:94073a10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:94076210-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:94078a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1768 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:9407b256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1768 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone targets Cytosolic other (Annexin A1) DrugCentral uuid:9407d63c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1768 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9407fe46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:1768 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:940826fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:94084ae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1771 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone succinate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:94087678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:94087678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:94087678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:9408aecc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.326']} DrugCentral uuid:9408d9ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:94090322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.214']} DrugCentral uuid:94092b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:94095390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:94097bb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9409a3c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9409cbe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.663']} DrugCentral uuid:9409f494-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:940a1ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:940a449e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:940a6c94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.213']} DrugCentral uuid:940a96a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.334']} DrugCentral uuid:940abf96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:940ae796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:940b0f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.054']} DrugCentral uuid:940b3804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:940b6018-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:940b8822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:940bb068-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07820 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Cytosolic other (Induced myeloid leukemia cell differentiation protein Mcl-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:940bd9da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:940c01ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:940c29f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:940c52ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:940c7b38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:940ca360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:940ccb74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:940cf3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:940d23bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:940d23bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:940d23bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:940d61ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:940d8a5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35364 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:940db278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:940dda78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:940e028c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.45']} DrugCentral uuid:940e2bc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:940e5462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:940e7d48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metiazinic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:940ea692-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metipranolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:940ecaf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metipranolol is antagonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:940eeeea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metixene is antagonist of GPCR (5-hydroxytryptamine receptor 2C) DrugCentral uuid:940f12da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metixene is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:940f36ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metixene targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:940f5f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metochalcone targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:940f8756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:940faf60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:940fd774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:941000a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:94102af8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.397']} DrugCentral uuid:9410530c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:94107b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9410a33e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:9410c6fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.509']} DrugCentral uuid:9410eed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:941116e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:94113f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9411679c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9411900a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:9411b814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:9411e21c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:94120a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:94123280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:94125a9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:941287d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:941287d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9412ca92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9412ca92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9412ca92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9412ca92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9412ca92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:94132b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:94132b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:94132b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:94132b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:94137bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:94137bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:94137bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9413c5e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:9413c5e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:9413c5e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:94140bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:94140bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:94140bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:94144e26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:94144e26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:941481de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9414a9e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1783 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metolazone targets Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.45']} DrugCentral uuid:9414d1fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1783 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metolazone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:9414f77c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1783 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metolazone targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:94151fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metopimazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:94154808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metopimazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:9415704e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metopimazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:94159af6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9415c31e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9415eb1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9416133c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.79']} DrugCentral uuid:94163baa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.83']} DrugCentral uuid:94166b8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:94166b8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:94166b8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9416a982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:9416d22c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:9416fa4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4LW95 biolink:molecularly_interacts_with DrugCentral:1790 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metronidazole targets Enzyme (Thioredoxin reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:941722fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:94174af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:941776f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15150 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9417a22e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15393 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9417ccea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.84']} DrugCentral uuid:9417f54e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07101 biolink:molecularly_interacts_with DrugCentral:1792 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metirosine is inhibitor of Enzyme (Tyrosine 3-monooxygenase) DrugCentral uuid:94181948-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9418412a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:94186506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:94188acc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:9418aebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:9418d2a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9418fba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:941924a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94194f52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:94197766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:94199f8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:9419c81a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:9419f010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:941a181a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.51']} DrugCentral uuid:941a401a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:941a68a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:941a909c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62205 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:941ab89c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2APX8 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:941ae0a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:941b0a86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:941b3286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:941b5a7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:941b827c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:941ba694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:941bcea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:941bf69e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:941c1ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:941c4734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:941c6f3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:941c975c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:941cbf48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:941ce9d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:941d11dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:941d39dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:941d61d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:941d8ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:941db2ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:941ddaa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:941e02a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:941e2b3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:941e547a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:941e7c70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02768 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:941ea588-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:941ed0c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14778 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Membrane receptor (Interleukin-1 receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:941efb6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41222 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:941f3a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:941f3a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:941f3a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:941f3a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:941f3a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:941f3a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:941f3a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:941f989e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:941fc0a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:941fe966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.319']} DrugCentral uuid:94201166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:94203966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.149']} DrugCentral uuid:94206166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:94208b6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:9420b38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:9420dbbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:942103b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.175']} DrugCentral uuid:94212c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:94215422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:94217c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:9421a418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9421ccb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.245']} DrugCentral uuid:9421f4b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.003']} DrugCentral uuid:94221ca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.125']} DrugCentral uuid:94224490-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.465']} DrugCentral uuid:94226f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:942297a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.526']} DrugCentral uuid:9422bf92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.541']} DrugCentral uuid:9422e800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:94230ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:942337e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:94235fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:94238878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:9423b1a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9423d99a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:942401ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:94242b34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:94245348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:94247c4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:9424a44c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9424ccc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:9424f4b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:94251d3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:94254546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:94256de6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:94259604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:9425bdfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9425e604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:94261052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:94263852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:94266052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:9426885c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9426b0ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9426d8de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:942700f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:94272da2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:94272da2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:94276c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:94276c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:94276c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:94276c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9427bd62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9427bd62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9427bd62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:94280952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:94280952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:94280952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:94284b42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:94284b42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:94288670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:94288670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:94288670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:9428ca18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9428ca18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9428fd30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NG02 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (G-protein coupled receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:942925e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:94294df8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:94297602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:94299ef2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9429c742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9429ef38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:942a174c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:942a3fc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:942a67d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:942a8fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:942ab7d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:942ae064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:942b085a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:942b31e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:942b59e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:942b83e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:942bacba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07652 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is gating inhibitor of Ion channel (Voltage-dependent R-type calcium channel subunit alpha-1E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:942bd4b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54282 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is gating inhibitor of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:942bfce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:942c2532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15390 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:942c4d32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:942c7550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.602']} DrugCentral uuid:942c9d32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AIC4 biolink:molecularly_interacts_with DrugCentral:1798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 micafungin targets Unclassified (Beta-1,3-glucan synthase) DrugCentral uuid:942cc1c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:1798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 micafungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) DrugCentral uuid:942ce5a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.715']} DrugCentral uuid:942d0d9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.137']} DrugCentral uuid:942d35b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.588']} DrugCentral uuid:942d5f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:942d8706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:942daf10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.505']} DrugCentral uuid:942dd71a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:942dff92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:942e2792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:942e50be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:942e74c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:942e9d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:942ec59e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.535']} DrugCentral uuid:942eed9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.183']} DrugCentral uuid:942f16ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.952']} DrugCentral uuid:942f3fb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.452']} DrugCentral uuid:942f67c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.555']} DrugCentral uuid:942f8ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:942fb85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.785']} DrugCentral uuid:942fe06e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.964']} DrugCentral uuid:94300878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.178']} DrugCentral uuid:94303082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9430594a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:94308154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.175']} DrugCentral uuid:9430a9f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.351']} DrugCentral uuid:9430d1f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.386']} DrugCentral uuid:9430fad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.869']} DrugCentral uuid:943122d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94314abc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.136']} DrugCentral uuid:943172bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.799']} DrugCentral uuid:94319b2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.271']} DrugCentral uuid:9431c32a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.825']} DrugCentral uuid:9431eb48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:9432135c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:94323846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.923']} DrugCentral uuid:94326050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:94328850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.729']} DrugCentral uuid:9432b046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:9432da44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:94330550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.534']} DrugCentral uuid:94332e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9433567c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:94337ef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9433a708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:9433cef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.381']} DrugCentral uuid:9433f6f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.562']} DrugCentral uuid:943420c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:943448b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:943470b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:943498ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.109']} DrugCentral uuid:9434c430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.792']} DrugCentral uuid:9434ec4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.326']} DrugCentral uuid:9435146c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.029']} DrugCentral uuid:94353d02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.922']} DrugCentral uuid:94356520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.674']} DrugCentral uuid:94358d3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.792']} DrugCentral uuid:9435b552-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.692']} DrugCentral uuid:9435ddfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.711']} DrugCentral uuid:94360606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:94362e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:9436567e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22443 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9436800e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9436a7fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9436d004-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9436f80e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9437216c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:94374980-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9437718a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:9437999e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:K4CF70 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Fatty acid hydroperoxide lyase, chloroplastic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:9437c234-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9437ea20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['6']} DrugCentral uuid:94381216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.353']} DrugCentral uuid:94383a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943864f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:943894d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:943894d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:943894d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:9438dade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:9438dade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:9438dade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:94392188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:94392188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:94392188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943999c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:943a7ace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:943a7ace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:943a7ace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:943ac16e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:943ac16e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:943ac16e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:943b0782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:943b0782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:943b0782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:943b4db4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:943b4db4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:943b4db4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:943b9472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:943b9472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:943b9472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:943bd3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midodrine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:943bf958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midodrine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:943c239c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.001']} DrugCentral uuid:943c4bd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.957']} DrugCentral uuid:943c73d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:943c9c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.918']} DrugCentral uuid:943cc50e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone is antagonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:943cee62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:943d166c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:943d3f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:943d6752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:943d8f52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:943db770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone is antagonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:943de20e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:943e0a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:943e324a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.081']} DrugCentral uuid:943e5a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.255']} DrugCentral uuid:943e82ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.256']} DrugCentral uuid:943eaaea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.374']} DrugCentral uuid:943ed308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:943efbb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63449 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.46']} DrugCentral uuid:943f23a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21447 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transporter (P-glycoprotein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:943f4bb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1Q298 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:943f73b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1U3 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:943f9df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol is inhibitor of Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:943fc8e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04746 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Pancreatic alpha-amylase) DrugCentral uuid:943fed10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:9440152e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol is inhibitor of Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:94403d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:94406592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:94408da6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35574 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9440b5b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9440de3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09848 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:94410632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q58D55 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:94412e50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0HJB3 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Alpha-mannosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:94415664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56526 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:9441806c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9441a876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat is inhibitor of Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:9441d080-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9441f880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:944220da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q69ZF3 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:944248d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:944270c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCG7 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9442993e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9442c1de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35573 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9442eb00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70699 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9443130a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5THE3 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:94433b14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9LGC6 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Putative alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:944365ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70282 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Trehalase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:94438df8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:I3LIR5 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:9443b6de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88693 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:9443df4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9444076a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:9444301e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:944458be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:944481cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:9444aa58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:9444d262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9444fa62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:94452334-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:94454b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:94457348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:94459b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:9445c398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9445eb8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:94461398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O89085 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:94463fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:94463fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:94467f36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94467f36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94467f36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94467f36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9446c856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:1810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miltefosine targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9446f132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miltefosine targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9447190a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Serine hydroxymethyltransferase, cytosolic) DrugCentral uuid:94473de0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:944765cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08543 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:94478e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9447b612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9447de12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:94480626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minaprine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:94482ebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:944857f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minaprine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:94487ffc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02980 biolink:molecularly_interacts_with DrugCentral:1813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minocycline targets Transporter (Tetracycline resistance protein, class B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.638']} DrugCentral uuid:9448a7fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z7H2 biolink:molecularly_interacts_with DrugCentral:1813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minocycline targets Unclassified (30S ribosomal protein S4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ka', 'has_quantitative_value': ['6']} DrugCentral uuid:9448d2b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z8T8 biolink:molecularly_interacts_with DrugCentral:1813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minocycline targets Unclassified (30S ribosomal protein S9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ka', 'has_quantitative_value': ['5.756']} DrugCentral uuid:9448fb58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48048 biolink:molecularly_interacts_with DrugCentral:1814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minoxidil targets Ion channel (ATP-sensitive inward rectifier potassium channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:9449275e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minoxidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) DrugCentral uuid:9449275e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minoxidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) DrugCentral uuid:944954d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:94497d4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:9449a58a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9449cda8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:9449f63e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:944a1e8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:944a46ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:944a6ef2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:944a9832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:944ac23a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:944aea4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:944b1258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:944b3bb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:944b5f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:944b838c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:944babbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:944bd47c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:944bfc90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:944c24ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:944c4cc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:944c76a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:944ca8ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:944ca8ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:944ca8ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:944ce6fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:944d0f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:944d3768-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:944d5f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 misoprostol targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.028']} DrugCentral uuid:944d8b6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitiglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:944d8b6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitiglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:944dbf44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitomycin targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:944de8a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:944e10ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:944e38de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:944e6214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.512']} DrugCentral uuid:944e8a1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.186']} DrugCentral uuid:944eb250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:944edab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:944f043a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) DrugCentral uuid:944f282a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10109 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets Unclassified (Adrenodoxin, mitochondrial) DrugCentral uuid:944f4c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05108 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane is inhibitor of Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) DrugCentral uuid:944f700a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.532']} DrugCentral uuid:944f98be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.841']} DrugCentral uuid:944fc0c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.306']} DrugCentral uuid:944fe8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.729']} DrugCentral uuid:94501172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.744']} DrugCentral uuid:94503b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:94506366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.047']} DrugCentral uuid:94508b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:9450afb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC90', 'has_quantitative_value': ['5.959']} DrugCentral uuid:9450d79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.287']} DrugCentral uuid:9450ff9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kact', 'has_quantitative_value': ['5.155']} DrugCentral uuid:945127a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.269']} DrugCentral uuid:945150aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:945178be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.691']} DrugCentral uuid:9451a0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:9451c8aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:9451f21c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:94521aa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.748']} DrugCentral uuid:94524294-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:94526a8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:945292ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9452bb02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:9452e41a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:94530c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:945334ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:94535c9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29372 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Enzyme (DNA-3-methyladenine glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:94538474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9453ad78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mivacurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:9453db90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:9453db90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:9453db90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:945412cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mizolastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.456']} DrugCentral uuid:94543ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mizolastine targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:94545f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mizolastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:9454872a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9454af2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9454d7ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:945500a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:945528b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:945550b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9455789c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:9455a29a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9455cc7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:9455f47a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:94561856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.396']} DrugCentral uuid:945640ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:94566496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:94568cbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:9456b5c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moexipril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:9456de6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9457066c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:94572e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:94575662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9457815a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.157']} DrugCentral uuid:9457ac02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9457d40c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:9457fc02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.421']} DrugCentral uuid:94582498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:94584cac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:945874a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:94589d38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:9458c54c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:9458ed4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.254']} DrugCentral uuid:94591556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:94593e3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9459679a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:94598fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.763']} DrugCentral uuid:9459b7b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9459e012-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:945a081c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:945a3030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:945a586c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molsidomine targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:945a8116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mometasone furoate targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:945aaa38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mometasone furoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:945ad242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mometasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:945afa38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.429']} DrugCentral uuid:945b236e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.992']} DrugCentral uuid:945b4b82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.414']} DrugCentral uuid:945b738c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:945b97f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.311']} DrugCentral uuid:945bc062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:945be880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.833']} DrugCentral uuid:945c108a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.574']} DrugCentral uuid:945c38b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:945c6184-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:945c89ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.713']} DrugCentral uuid:945cb1ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.853']} DrugCentral uuid:945cd9d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.495']} DrugCentral uuid:945d054e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.115']} DrugCentral uuid:945d30a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:945d5c06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:945d84ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.958']} DrugCentral uuid:945dad00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.772']} DrugCentral uuid:945dd546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:945dfd50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.328']} DrugCentral uuid:945e260e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.495']} DrugCentral uuid:945e4e04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:945e760e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.817']} DrugCentral uuid:945e9f12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:945ec938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.068']} DrugCentral uuid:945ef3ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.895']} DrugCentral uuid:945f1c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:945f455c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:945f6df2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6NS65 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast is antagonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:945f95e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:945fbde8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:945fe5fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.134']} DrugCentral uuid:94600eb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moracizine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:946032aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.86']} DrugCentral uuid:94605aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:946082c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9460ac6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:9460d462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:9460fc62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:94612476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:94614cee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:946174ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:94619d7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:9461c638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9461ee38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9462162e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79350 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:94623e38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47748 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:946273da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:946273da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:946273da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:946273da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9462d398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:9462d398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:9462d398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:9462d398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:9462d398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:94633392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:94633392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:94633392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:94633392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:94637c80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q98UH1 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu opioid receptor-like OR2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:9463a520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B3DH72 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor, delta 1b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9463cd20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O57585 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor homologue) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:9463f52a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapramine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:94641d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapramine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:94644886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:946473e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:94649c50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.891']} DrugCentral uuid:9464c464-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9464f024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:9465184c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.694']} DrugCentral uuid:94654074-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.725']} DrugCentral uuid:9465689c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.683']} DrugCentral uuid:94659150-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:9465b964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9465e286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94660b4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:94663358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94665f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:94665f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:946692b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9466bb8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:1851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latamoxef is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.938']} DrugCentral uuid:9466e398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:1851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latamoxef is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.716']} DrugCentral uuid:94670bb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:1851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latamoxef is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.637']} DrugCentral uuid:946733ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:946757f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9467800a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:9467ac06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:9467ac06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:9467deba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin is inhibitor of Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9467deba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin is inhibitor of Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:94681218-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:94683a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.397']} DrugCentral uuid:94686268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:94688b12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9468b312-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9468db08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:9469033a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine is agonist of Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:94692c02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00956 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:94695416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41252 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:94697c0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41972 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin is inhibitor of Enzyme (Isoleucine--tRNA ligase) DrugCentral uuid:9469a006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99YW3 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin is inhibitor of Enzyme (Isoleucine--tRNA ligase) DrugCentral uuid:9469c612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56690 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9469ef5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolate mofetil is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:946a1784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:1859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolate mofetil is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:946a3f98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid targets Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:946a6806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid targets Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:946a9434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase (IMPDH)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:946a9434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase (IMPDH)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:946ac760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5KP44 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid targets Unclassified (Inosine-5'-monophosphate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:946af032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabilone is agonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:946b1850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:1862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabilone targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:946b4046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:1862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabilone targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:946b6850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:1862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabilone targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:946b9172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:946bb558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.34']} DrugCentral uuid:946bdd62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.732']} DrugCentral uuid:946c0580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:946c2de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.001']} DrugCentral uuid:946c55e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nadolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:946c7e16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nadolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:946ca62a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nadolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:946ccec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:946cf698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:946d1ea2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is inhibitor of Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:946d4684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06870 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Kallikrein-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:946d70a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:946d9a8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:946dc32a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00736 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is inhibitor of Enzyme (Complement C1r subcomponent) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:946deb2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09871 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Complement C1s subcomponent) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:946e1398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16515 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:946e3ba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:946e63a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:946e8b84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:946eb442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15661 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is inhibitor of Enzyme (Tryptase alpha/beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:946edc38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:946f0438-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04756 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Hepatocyte growth factor activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:946f2c38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15393 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is inhibitor of Enzyme (Transmembrane protease serine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:946f57f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafarelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.699']} DrugCentral uuid:946f81d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:946fb66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:946fb66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:946fb66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:946fb66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:946fb66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:94700194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftidrofuryl targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:947029b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:947051e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:94707af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Enzyme (Squalene monooxygenase) DrugCentral uuid:94709ee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:9470c2dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:9470eadc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O07855 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Enzyme (Dehydrosqualene desaturase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:9471139a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9471436a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9471436a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9471436a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:94718aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:94718aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:94718aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:9471c97a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:9471f18e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:947219ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:9472429c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalbuphine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:94726ac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalbuphine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:947292f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalbuphine is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9472bb14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalbuphine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9472e4ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalidixic acid targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:947313fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalidixic acid is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:947313fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalidixic acid is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:94734502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.53']} DrugCentral uuid:94736d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:94739660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:9473be88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:9473e69c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:94740eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9474378c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:94745f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:947487a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:9474b1c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9474dc00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:94750504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:947538a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:947538a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:947538a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:947538a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:94758e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:94758e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:94758e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:94758e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:9475d72c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:9475fff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:94762902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:947650e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:947678e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:9476a404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9476cc36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9476f404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:94771bf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:94774436-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:94776c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:94779422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:9477bc2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9477e4c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79350 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:94780c9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51682 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.98']} DrugCentral uuid:94784020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:94784020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:94784020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:94784020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:94788c92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:9478b050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9478d864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:947900c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:947928be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.678']} DrugCentral uuid:947950b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:947978d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:94799e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9479c6ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9479ef92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:947a1792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:947a4096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:947a68aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone phenpropionate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:947a90be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone phenpropionate is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.5']} DrugCentral uuid:947ab8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:947ae140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:947b095e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:947b3136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:947b592c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:947b81cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:947ba9c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:947bd1a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:947bf986-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:947c292e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:947c292e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:947c5c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:947c8414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:947cac78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.796']} DrugCentral uuid:947cd45a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:947cfc6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:947d2478-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:947d511e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:947d511e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:947d883c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:947d883c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:947dbb7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:947de49e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:947e0ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:947e34a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:947e5cc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:947e850c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:1889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nedocromil targets GPCR (Cysteinyl leukotriene receptor 1) DrugCentral uuid:947ea8f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nedocromil is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.013']} DrugCentral uuid:947ed0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:947ef8d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:947f22d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.699']} DrugCentral uuid:947f4b04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.444']} DrugCentral uuid:947f7318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:947f9b5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:947fc57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.143']} DrugCentral uuid:947fedac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.789']} DrugCentral uuid:948015ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.635']} DrugCentral uuid:94803e6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:948066d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.444']} DrugCentral uuid:94808eec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:9480b6d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9480dec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9481076e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:94812f82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9481578c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:94817f96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9481ab4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:9481d388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9481fb92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9482240a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:948247dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:94826ff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:948297dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:9482c09a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.481']} DrugCentral uuid:9482e8a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.252']} DrugCentral uuid:948310ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:948338a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.232']} DrugCentral uuid:9483622a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.189']} DrugCentral uuid:94838a66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:9483b342-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9483db24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.057']} DrugCentral uuid:94840388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.209']} DrugCentral uuid:94842b92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.592']} DrugCentral uuid:94845392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.909']} DrugCentral uuid:94847b7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.078']} DrugCentral uuid:9484a40a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.842']} DrugCentral uuid:9484cbec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.632']} DrugCentral uuid:9484f400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.255']} DrugCentral uuid:94851d04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:94854388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.101']} DrugCentral uuid:94856e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.098']} DrugCentral uuid:9485961c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.676']} DrugCentral uuid:9485be30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.648']} DrugCentral uuid:9485e694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.739']} DrugCentral uuid:94860e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:948636a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.615']} DrugCentral uuid:94865eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:9486877a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.236']} DrugCentral uuid:9486b024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:9486d856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:94870146-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:94872978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:9487518c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:948779a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:9487a20e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9487cafe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:9487f2fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.31']} DrugCentral uuid:94881af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:9488439e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:94886b94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:94888f66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08312 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Enzyme (Phenylalanine--tRNA ligase alpha subunit) DrugCentral uuid:9488b342-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07395 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Enzyme (Phenylalanine--tRNA ligase beta subunit) DrugCentral uuid:9488d854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:948900ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95237 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Enzyme (Lecithin retinol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:948928ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.81']} DrugCentral uuid:948950c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48442 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:9489791c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:9489a11c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9489c908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:9489f112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:948a199e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:948a41a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:948a69a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:948a91a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:948abf98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:948abf98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:948af7ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:948af7ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:948b2b04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1900 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepinalone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:948b5390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nesiritide is agonist of Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:948b7776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:948ba052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:948bc870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:948bf138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:948c1938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:948c414c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets GPCR (Hydroxycarboxylic acid receptor 2) DrugCentral uuid:948c65aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets GPCR (Hydroxycarboxylic acid receptor 3) DrugCentral uuid:948c8a94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40261 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (Nicotinamide N-methyltransferase) DrugCentral uuid:948cae5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15274 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (Nicotinate-nucleotide pyrophosphorylase [carboxylating]) DrugCentral uuid:948cd260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96EB6 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacetylase sirtuin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:948cfa4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IXJ6 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacetylase sirtuin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:948d22a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:948d4a9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53686 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent deacetylase HST2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:948d72a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NTG7 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent deacetylase sirtuin 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:948d9a9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:948dc332-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8I6E4 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Unclassified (Putative silent information regulator 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:948deb46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:948e133c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.377']} DrugCentral uuid:948e3b50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:948e6580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:948e900a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:948eb404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:948edc04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:948f0468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.553']} DrugCentral uuid:948f2c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.553']} DrugCentral uuid:948f5486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:948f7c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:948fa698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:948fceac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54698 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:948ff6ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:94902672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:94902672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:94902672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9490726c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9490726c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9490726c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9490b876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:9490b876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:9490b876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:9490fb10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:9490fb10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:949128ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:949150c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15385 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:94917982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.046']} DrugCentral uuid:9491a182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:9491c982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:9491f196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:94921bc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:949243bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:94926bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:949293bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:9492bcb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:9492e5b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:94930db0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:9493366e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:94935e78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:94938678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5JUK3 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9493ae82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9493d7c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:949400b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1919 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicorandil targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:949428c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48048 biolink:molecularly_interacts_with DrugCentral:1919 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicorandil targets Ion channel (ATP-sensitive inward rectifier potassium channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:949450c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1919 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicorandil targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:94947902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9494a120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9494c92a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.356']} DrugCentral uuid:9494f120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:949519f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:949541e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:949569f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.03']} DrugCentral uuid:94959206-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9495bbfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49582 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9495e422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43144 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:94960c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit beta-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:94963472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04757 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:94965d12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12389 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:94968530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WSF8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Unclassified (Soluble acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9496ae2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:9496d60c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21687 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Enzyme (Lycopene cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9496feac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:949726c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25162 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit beta-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:94974eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09482 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:949776e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70174 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9497a6cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9497a6cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9497de26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9497de26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9498153a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9498153a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:94984d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:94984d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9498840c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9498840c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9498bbde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9498bbde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:94991d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:9499cfd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9499cfd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:949a08ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:949a08ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:949a3fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:949a3fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:949a771c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:949a771c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:949aaeda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:949aaeda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:949af160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:949af160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:949af160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:949af160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:949af160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:949b5498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:949b5498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:949b5498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:949b5498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:949baa88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:949baa88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:949baa88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:949baa88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:949bf7c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:949bf7c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:949c364c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:949c364c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:949c364c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:949c364c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:949c8fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:949c8fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:949c8fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:949c8fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:949c8fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:949ce3b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:949d0dc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:949d38da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:949d6116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62897 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:949d88f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:949db260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.089']} DrugCentral uuid:949dda6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.65']} DrugCentral uuid:949e033c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:949e2b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:949e53aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:949e7bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.019']} DrugCentral uuid:949ea3dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.348']} DrugCentral uuid:949ecbe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:949ef530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:949f1d44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:949f4530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:949f6db2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:949f959e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:949fbd80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.672']} DrugCentral uuid:949fe59e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:94a00e34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:94a0362a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:94a05e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:94a08634-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.355']} DrugCentral uuid:94a0aed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is antagonist of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:94a0d6d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16389 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:94a0feca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:94a126ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.731']} DrugCentral uuid:94a14f10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:94a17724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94a19f10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is antagonist of Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:94a1c800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.821']} DrugCentral uuid:94a1f0a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:94a218aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:94a240aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:94a268b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:94a293a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:94a2be54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:94a2e654-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:94a30e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:94a3367c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35505 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:94a3664c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:94a3664c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:94a3664c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:94a3ad96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:94a3ad96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:94a3ad96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:94a3ec16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:94a4140c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:94a43c16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:94a4651a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16388 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:94a48d1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63142 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:94a4b5b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:94a4ddd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:94a50646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifekalant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:94a52f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifekalant targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:94a5575e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifekalant targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:94a57f54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifekalant targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:94a5a7f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.037']} DrugCentral uuid:94a5cff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.973']} DrugCentral uuid:94a5f7fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:94a62080-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:94a648f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51800 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid is activator of Ion channel (Chloride channel protein ClC-Ka) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:94a670ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6UVM3 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid is activator of Ion channel (Potassium channel subfamily T member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:94a698e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:94a6c17a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51801 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid is activator of Ion channel (Chloride channel protein ClC-Kb) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:94a6e966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.55']} DrugCentral uuid:94a71170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:1928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifuroxazide targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:94a7395c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:94a76210-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:94a78a1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:94a7b224-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:94a7da2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:94a802ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:94a82af6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94a85314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:94a87b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:94a8a36e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:94a8cb96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.83']} DrugCentral uuid:94a8f3a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:94a91d8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:94a94648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.33']} DrugCentral uuid:94a96e5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:94a9967a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:94a9be84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:94a9e9cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:94aa12d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:94aa3ac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:94aa62c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:94aa8bde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:94aab3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.13']} DrugCentral uuid:94aadbca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.387']} DrugCentral uuid:94ab047e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:94ab2c7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:94ab5474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:94ab7c6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:94aba5d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:94abd02a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.069']} DrugCentral uuid:94abf82a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:94ac2016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:94ac4870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:94ac7066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:94ac9852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.318']} DrugCentral uuid:94acc048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:94ace8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.096']} DrugCentral uuid:94ad11e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:94ad39f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:94ad61ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:94ad8bea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:94adb3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:94addbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.141']} DrugCentral uuid:94ae03cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:94ae2c3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:94ae5426-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:94ae7c1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:94aea41c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:94aecd3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:94aef52a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:94af1ece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:94af46e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:94af7036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:94af9822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:94afc022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:94afe912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:94b01130-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:94b03926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:94b0611c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:94b08a20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:94b0b234-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:94b0da2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:94b10310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:94b12c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:94b15428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:94b17c28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:94b1a4be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:94b1cd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:94b1f57c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:94b21d68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:94b2455e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:94b26e80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:94b2969e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:94b2be9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:94b2eaa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:94b2eaa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:94b32230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1933 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:94b34bf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:94b36fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:94b39404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:94b3bbdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:94b3bbdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:94b3e95e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:94b4114a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:94b439f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.927']} DrugCentral uuid:94b461ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:94b489c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:94b4b1a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:94b4dcec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.632']} DrugCentral uuid:94b504ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:94b52cf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:94b55514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2A865 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:94b57d96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:L8I2E6 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Dipeptidyl peptidase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.16']} DrugCentral uuid:94b5a58c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.364']} DrugCentral uuid:94b5cd96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:94b5f5a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:94b61e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.072']} DrugCentral uuid:94b64654-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:94b66e22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:94b691fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:94b6babc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:94b6deb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:94b70292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94b72a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.252']} DrugCentral uuid:94b7530a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94b77b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:94b7a2ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:94b7cb6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94b7f404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:94b81c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:94b84422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:94b86c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:94b89594-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.642']} DrugCentral uuid:94b8be8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.638']} DrugCentral uuid:94b8e684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) DrugCentral uuid:94b90a6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.395']} DrugCentral uuid:94b93364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:94b95b78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:94b97f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:94b9a772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94b9d86e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:94b9d86e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:94b9d86e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:94ba169e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01815 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:94ba3ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99246 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:94ba6928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitazoxanide targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:94ba913c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q968X7 biolink:molecularly_interacts_with DrugCentral:1943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitazoxanide is inhibitor of Enzyme (Pyruvate dehydrogenase [NADP(+)]) DrugCentral uuid:94bab522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q24982 biolink:molecularly_interacts_with DrugCentral:1943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitazoxanide is inhibitor of Enzyme (Pyruvate:ferredoxin oxidoreductase) DrugCentral uuid:94bad8fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0P8E1 biolink:molecularly_interacts_with DrugCentral:1943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitazoxanide targets Enzyme (Pyruvate-flavodoxin oxidoreductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:94bb01ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32754 biolink:molecularly_interacts_with DrugCentral:1944 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitisinone is inhibitor of Enzyme (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:94bb29e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02110 biolink:molecularly_interacts_with DrugCentral:1944 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitisinone targets Enzyme (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:94bb51d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32755 biolink:molecularly_interacts_with DrugCentral:1944 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitisinone targets Unclassified (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:94bb82ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:94bb82ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:94bb82ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:94bbd43e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:94bbd43e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:94bbd43e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:94bbd43e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:94bbd43e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:94bbd43e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:94bc379e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:94bc5fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.081']} DrugCentral uuid:94bc87f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is blocker of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:94bcafee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:94bcd424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.921']} DrugCentral uuid:94bcfc24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:94bd241a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:94bd4c06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.056']} DrugCentral uuid:94bd74a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:94bd9ca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94bdc4a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:94bded32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:94be15fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94be3df0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94be6604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21556 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:94be9642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:94be9642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:94be9642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:94bed49a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:94bf083e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:94bf083e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:94bf083e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:94bf083e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:94bf4bc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:1949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrofurantoin targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:94bf6fb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrofurantoin targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:94bf97d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:1950 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrofurazone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:94bfbbd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P83512 biolink:molecularly_interacts_with DrugCentral:1950 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrofurazone targets Enzyme (Snake venom metalloproteinase Bap1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:94bfe718-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:94c0199a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:94c0199a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:94c0199a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:94c0199a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:94c05aae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:94c0833a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:94c0ab3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:94c0d31c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:94c0fba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:94c123b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:94c14bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nizatidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:94c173bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nizatidine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.251']} DrugCentral uuid:94c19cde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:94c1c81c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:94c1f0bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:94c218a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:94c24134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:94c2692a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['2.947']} DrugCentral uuid:94c29148-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.963']} DrugCentral uuid:94c2b948-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:94c2e1fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:94c30af6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:94c33300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:94c35ef2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Enzyme (Hemoglobin HbA) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.678']} DrugCentral uuid:94c35ef2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Enzyme (Hemoglobin HbA) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.678']} DrugCentral uuid:94c3957a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norelgestromin is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:94c3b9e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:94c3e20a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:94c40a8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.3']} DrugCentral uuid:94c43296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:94c45ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:94c48412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:94c4acd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:94c4d4da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.367']} DrugCentral uuid:94c4fcf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:94c5250c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.071']} DrugCentral uuid:94c54e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:94c57656-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:94c59e4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:94c5c674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:94c5eef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94c61714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:94c63f0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:94c6671e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:94c68fc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10608 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:94c6b7c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:94c6dfbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:94c71092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:94c71092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:94c71092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:94c757f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:94c757f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:94c757f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:94c7a99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94c7a99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94c7a99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94c7a99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94c7a99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94c7a99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94c810fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94c810fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94c810fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:94c84fca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01337 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:94c877c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:94c89fca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.618']} DrugCentral uuid:94c8c7d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.706']} DrugCentral uuid:94c8f10a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.636']} DrugCentral uuid:94c91d4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:94c945ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['11.26']} DrugCentral uuid:94c96db0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.97']} DrugCentral uuid:94c9960a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:94c9be82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.914']} DrugCentral uuid:94c9eb6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:94c9eb6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:94ca1e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:94ca4758-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.533']} DrugCentral uuid:94ca6f76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:94ca978a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:94cac03e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['11.26']} DrugCentral uuid:94caeb68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:94cb13ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.97']} DrugCentral uuid:94cb3bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.149']} DrugCentral uuid:94cb646c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.441']} DrugCentral uuid:94cb8c80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1965 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethynodrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:94cbb066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1965 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethynodrel targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:94cbd83e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:94cc00de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:94cc28ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:94cc50d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:94cc78ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AFI2 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:94cca1ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:94ccc9d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:94ccf1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:94cd19e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:94cd425a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:94cd6a64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:94cd9354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cdf650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94cec922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37340 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Unclassified (Multidrug resistance protein mdtK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.01']} DrugCentral uuid:94cef136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norgestimate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:94cf15a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13507 biolink:molecularly_interacts_with DrugCentral:1968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norgestimate is blocker of Ion channel (Short transient receptor potential channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:94cf3dd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y210 biolink:molecularly_interacts_with DrugCentral:1968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norgestimate is blocker of Ion channel (Short transient receptor potential channel 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:94cf65a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:94cf8db2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:94cfb670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:94cfde98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:94d00828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.36']} DrugCentral uuid:94d0303c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.509']} DrugCentral uuid:94d059c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.356']} DrugCentral uuid:94d081cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:94d0a9e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:94d0d1fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:94d0fa6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:94d12280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:94d14a76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:94d172da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.033']} DrugCentral uuid:94d19b84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.639']} DrugCentral uuid:94d1c398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:94d1eb8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:94d214b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:94d23d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.076']} DrugCentral uuid:94d2650a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:94d28d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.071']} DrugCentral uuid:94d2b56e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:94d2dd82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.921']} DrugCentral uuid:94d30596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['6.225']} DrugCentral uuid:94d32ef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:94d357a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:94d37fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:94d3a7b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.943']} DrugCentral uuid:94d3cfd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:94d3f99c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:94d42192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:94d449a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:94d471c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78508 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.796']} DrugCentral uuid:94d49a3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 noscapine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.087']} DrugCentral uuid:94d4c21e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 noscapine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:94d4ea1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 noscapine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:94d51214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 noscapine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:94d53abe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:94d562b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:94d58aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A4L9 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:94d5b296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7X1P7 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (ParE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:94d5dcc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C3SLN2 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:94d608c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:94d608c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:94d63fb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5HK04 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:94d63fb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5HK04 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:94d66e48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C559 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:94d69634-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A0K8 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:94d6be48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0QNE0 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNULL gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:94d6e65c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C3SLN3 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNULL gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:94d7171c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:94d7171c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:94d7171c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:94d75542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:94d77d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.699']} DrugCentral uuid:94d7a736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:94d7cf68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:94d7f786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide targets GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:94d81f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide targets GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:94d84812-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:94d87030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.98']} DrugCentral uuid:94d89858-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:94d8c1a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:94d8ea88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30936 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94d91292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08858 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:94d93a9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:94d96288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:94d98d12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:94d9b526-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:94d9dd1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:94da0148-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:94da295c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03362 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Polyprotein (Gag-Pro-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94da8b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:94db6038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47154 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Enzyme (CAAX prenyl protease 1) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:94db8aa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:94dbb286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:94dbdaf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:94dc0308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:94dc2b26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.523']} DrugCentral uuid:94dc5330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.492']} DrugCentral uuid:94dc7be4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:94dca3ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:94dccbf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.9']} DrugCentral uuid:94dcf42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.319']} DrugCentral uuid:94dd1e78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:94dd4696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:94dd6f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:94dd97fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:94ddc1ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:94ddea88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:94de13a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:94de3bb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:94de647c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:94de8c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.356']} DrugCentral uuid:94deb45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.506']} DrugCentral uuid:94dedc68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.102']} DrugCentral uuid:94df0666-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.136']} DrugCentral uuid:94df2e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.682']} DrugCentral uuid:94df5670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:94df7e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:94dfa6ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.233']} DrugCentral uuid:94dfcee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.121']} DrugCentral uuid:94dff706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:94e01fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:94e0480a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:94e07032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:94e09850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:94e0c1c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.916']} DrugCentral uuid:94e0ebca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.509']} DrugCentral uuid:94e113e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:94e13c10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.558']} DrugCentral uuid:94e16492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:94e18cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.364']} DrugCentral uuid:94e1b4c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:94e1dcc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:94e20672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:94e22e9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:94e256cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:94e27eea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:94e2a8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:94e2d0f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:94e2f910-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94e32250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:94e34adc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:94e3730e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:94e39b2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:94e3c34a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:94e3f3a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:94e3f3a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:94e3f3a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:94e439ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:94e439ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:94e439ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:94e479b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:94e4a1ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:94e4ca6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1985 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olmesartan medoxomil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:94e4f260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:1985 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olmesartan medoxomil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:94e51aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olopatadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.284']} DrugCentral uuid:94e542f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olopatadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94e56f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olprinone is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:94e56f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olprinone is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:94e59e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olsalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:94e5c280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olsalazine is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:94e5ea6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olsalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:94e5ea6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olsalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:94e61802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:94e640e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:94e668fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:94e690fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07861 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:94e6b8f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:94e6e14c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:94e70938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.31']} DrugCentral uuid:94e7312e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.051']} DrugCentral uuid:94e7591a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.347']} DrugCentral uuid:94e781c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:94e7a9ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:94e7d192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:94e7fd8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:94e7fd8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:94e83722-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19156 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:94e83722-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19156 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:94e86a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:94e89226-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:94e8ba8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:94e8e67c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:94e8e67c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:94e91980-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:94e9427a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:94e96b06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.678']} DrugCentral uuid:94e99310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:94e9bb2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:94e9e432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:94ea0ca0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:94ea34be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:94ea5cd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:94ea8554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:94eaadfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:94ead61c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:94eafe3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:94eb2702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35563 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:94eb4f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:94eb7748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:94eb9f52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:94ebc874-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:94ebf092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:94ec1c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:94ec1c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:94ec541a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:94ec541a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:94ec8f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:94ec8f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:94ec8f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:94ecd228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:94ecd228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:94ed0676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:94ed2e8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opipramol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:94ed569e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opipramol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:94ed7ff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opipramol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:94eda9be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:94edd1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Lipoprotein lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.18']} DrugCentral uuid:94edf9e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:94ee21dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4D2 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:94ee4a4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:94ee724a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NCG7 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:94ee9a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95870 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Abhydrolase domain-containing protein 16A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:94eec2cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N2K0 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Monoacylglycerol lipase ABHD12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:94eeeac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13093 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Platelet-activating factor acetylhydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:94ef12a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00591 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:94ef3a86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BV23 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Monoacylglycerol lipase ABHD6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:94ef63a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6WQJ1 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:94ef8bee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Lipoprotein lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.18']} DrugCentral uuid:94efb47a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11150 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Hepatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:94efdc70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5X9 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Endothelial lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:94f004ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16233 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat is inhibitor of Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.9']} DrugCentral uuid:94f02cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07098 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat is inhibitor of Enzyme (Gastric triacylglycerol lipase) DrugCentral uuid:94f0509c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.886']} DrugCentral uuid:94f07888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.092']} DrugCentral uuid:94f0a204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.174']} DrugCentral uuid:94f0ca04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.614']} DrugCentral uuid:94f0f20e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.578']} DrugCentral uuid:94f11a0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.903']} DrugCentral uuid:94f1440c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.666']} DrugCentral uuid:94f16ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.553']} DrugCentral uuid:94f196be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.283']} DrugCentral uuid:94f1bec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:94f1e736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:94f20f40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.165']} DrugCentral uuid:94f23736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:94f25f36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.873']} DrugCentral uuid:94f287f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:94f2afd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:94f2d7e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:94f2ffe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.889']} DrugCentral uuid:94f32a4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:94f3538c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.764']} DrugCentral uuid:94f37b8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:94f3a3fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.201']} DrugCentral uuid:94f3cc0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:94f3f404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:94f43360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94f43360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94f43360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94f43360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94f43360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94f43360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94f43360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:94f49fbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06818 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.83']} DrugCentral uuid:94f4c79e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16207 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:94f4f0de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:94f518f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:94f540f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:94f568e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:94f5912e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75VQ4 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.81']} DrugCentral uuid:94f5b91a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6Q793 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:94f5e11a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:94f60938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2LFS1 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:94f631ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4LRQ6 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:94f659ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q20MD3 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:94f681ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:94f6a9ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:94f6d4b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03469 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.86']} DrugCentral uuid:94f6fcc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07599 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:94f724b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.96']} DrugCentral uuid:94f74d0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XV28 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:94f77516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11172 biolink:molecularly_interacts_with DrugCentral:2002 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oteracil is inhibitor of Enzyme (Uridine 5'-monophosphate synthase) DrugCentral uuid:94f79906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ouabain targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.169']} DrugCentral uuid:94f7c0fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ouabain targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.009']} DrugCentral uuid:94f7e8de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ouabain targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:94f80e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:2004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ouabain targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:94f83668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:94f85e5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:94f886fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:94f8ac10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:94f8e392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:94f8e392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:94f8e392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:94f8e392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:94f8e392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:94f92e2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxametacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:94f95638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxametacin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:94f98234-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxametacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:94f98234-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxametacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:94f9b56a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2011 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxandrolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:94f9da04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:94fa0222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.068']} DrugCentral uuid:94fa2a18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin targets GPCR (fMet-Leu-Phe receptor) DrugCentral uuid:94fa4e08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin is inhibitor of Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:94fa795a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:94faa434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:94faccb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:94faf4b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.056']} DrugCentral uuid:94fb1d10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.148']} DrugCentral uuid:94fb4510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:94fb6d1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:94fb95ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:94fbbef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:94fbeee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:94fbeee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:94fbeee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:94fc2d04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2017 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxcarbazepine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:94fc5a36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2026 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphencyclimine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:94fc7f52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2026 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphencyclimine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:94fca45a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxprenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:94fcce26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxprenolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:94fcf798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxprenolol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:94fd20e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:94fd4a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.991']} DrugCentral uuid:94fd7420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.589']} DrugCentral uuid:94fd9d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.298']} DrugCentral uuid:94fdc808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.837']} DrugCentral uuid:94fdf166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:94fe1d3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:94fe494a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:94fe728a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.168']} DrugCentral uuid:94fe9bf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:94fec5aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:94feef12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:94ff185c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:94ff4232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:94ff6b90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:94ff9606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:94ffbf64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:94ffeb56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:950016b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95003fde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9500693c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:95009312-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9500bc52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9500e5ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:95010ef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:95013c54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:95016670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:95018fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:9501baa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.493']} DrugCentral uuid:9501e4ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:95020e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:95023794-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:95026192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.111']} DrugCentral uuid:95028afa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.342']} DrugCentral uuid:9502b44e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.019']} DrugCentral uuid:9502dd98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:95030750-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:950330ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:950359ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:95038400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9503ae80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9503d7de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.379']} DrugCentral uuid:95040272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:95042c5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.162']} DrugCentral uuid:9504559c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.041']} DrugCentral uuid:95047efa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:9504a844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9504d210-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:9504fb46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:950524ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:95054df8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:95057a4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:9505ae7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9505ae7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9505ae7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9505f794-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9505f794-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9505f794-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:950637d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:950661d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:95068b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2033 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetholone targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:9506b08a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2033 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetholone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:9506d5a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2033 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetholone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:9506ff04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:95072862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:95075530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:95077f74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:9507a8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9507d2bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.27']} DrugCentral uuid:9507fc1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9508256e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:95084ec2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:95087852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:9508ada4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:9508ada4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:9508ada4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:9508ada4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:9508fcfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:9508fcfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:9509381e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone targets GPCR (fMet-Leu-Phe receptor) DrugCentral uuid:95095f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16647 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone targets Enzyme (Prostacyclin synthase) DrugCentral uuid:95098878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:95098878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:9509b83e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9509e192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:950a069a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:950a2bb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.84']} DrugCentral uuid:950a5578-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:2041 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytetracycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:950a7a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:2041 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytetracycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:950a9f6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:950ac896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:950af4ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:950b1eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:950b47ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01178 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets Secreted (Oxytocin-neurophysin 1) DrugCentral uuid:950b6df0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:950b97e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:950bc138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin is agonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:950bea96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozagrel targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:950c1458-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49430 biolink:molecularly_interacts_with DrugCentral:2043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozagrel targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:950c3c6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:950c6462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:950c8c26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:950cb5b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Transporter (Bile salt export pump) DrugCentral uuid:950cd992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:950cfde6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07437 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Structural (Tubulin beta chain) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950d2654-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.621']} DrugCentral uuid:950d4f76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.954']} DrugCentral uuid:950d774e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.643']} DrugCentral uuid:950d9f62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:950dc744-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.794']} DrugCentral uuid:950df002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:950e1870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:950e4052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13509 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Structural (Tubulin beta-3 chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:950e6852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950eb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:950f341c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:2045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palmidrol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:950f5c1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:2045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palmidrol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:950f841c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:2045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palmidrol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:950fac1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:2045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palmidrol is agonist of GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:950fd494-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palonosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.5']} DrugCentral uuid:9510007c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palonosetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:9510007c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palonosetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:951033ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:2047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pamabrom targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:95105d56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pamidronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:9510859c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pamidronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9510adba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07010 biolink:molecularly_interacts_with DrugCentral:2048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pamidronic acid targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9510d5c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9510fe78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:95112682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:95114e8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:951176be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q81VW8 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:95119fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9511c7a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WNC6 biolink:molecularly_interacts_with DrugCentral:2050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminosalicylic acid targets Kinase (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) DrugCentral uuid:9511eb80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminosalicylic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['2.92']} DrugCentral uuid:95121786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminosalicylic acid is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:95121786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminosalicylic acid is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:9512502a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:9512502a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:9512502a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:951293b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:951293b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9512d310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9512d310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9512d310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9512d310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:95131d3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:95134110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:95136988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9513919c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9513b99c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9513e1b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:95140ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:95140ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:95143c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:9514684c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9514684c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:95149bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9514c3be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9514ebc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:95150fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:9515384e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9515604e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9515883a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.118']} DrugCentral uuid:9515b12a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.088']} DrugCentral uuid:9515da7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9516051c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95162d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9516553a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM07 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Protein-arginine deiminase type-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:95167d9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:9516a58a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9516cd80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9516f576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QYJ6 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:951725e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:951725e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:951725e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:951767e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:951767e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9517a2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:9517a2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:9517a2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:9517e634-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:95180eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:95183e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:95183e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:95183e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:95187752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.854']} DrugCentral uuid:95189f66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9518c77a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9518f13c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9519191e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:95194196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:951969aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11884 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline targets Enzyme (Aldehyde dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:9519940c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paricalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9519bcde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9519e4c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.647']} DrugCentral uuid:951a0cc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.068']} DrugCentral uuid:951a352e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:951a5d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.398']} DrugCentral uuid:951a8538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.52']} DrugCentral uuid:951aad38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:951ad5f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:951afe00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.724']} DrugCentral uuid:951b2614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:951b4e1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:951b77ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:951b9fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:951bc7d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:951bf030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:951c18a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:951c40a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:951c6894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25098 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:951c9134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:951cb93e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:951ce24c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:951d0a38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.36']} DrugCentral uuid:951d3364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:951d5bd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:951d83e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:951dac72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:951ddc74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:951ddc74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:951ddc74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:951e23dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:951e23dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:951e23dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:951e62c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:951e8ac0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:951eb2c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21146 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:951edab6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:951f03e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:2071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pefloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.785']} DrugCentral uuid:951f2d9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pefloxacin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.097']} DrugCentral uuid:951f5586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pefloxacin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.785']} DrugCentral uuid:951f7d68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed is inhibitor of Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.468']} DrugCentral uuid:951fa5d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.181']} DrugCentral uuid:951fcdb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:951ff1a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9520199e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Serine hydroxymethyltransferase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:95204252-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:95206a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9520934c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9520bb60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9520e478-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95210c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9521346e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45352 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:95215c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:952184c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9521acbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9521d4be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E2QDN0 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase (EC 2.1.1.45) (TS) (TSase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:9521fc96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.86']} DrugCentral uuid:95222536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:95224d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64737 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed is inhibitor of Enzyme (Trifunctional purine biosynthetic protein adenosine-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:95227536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22102 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed is inhibitor of Enzyme (Trifunctional purine biosynthetic protein adenosine-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:95229d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2075 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemoline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:9522c8ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9522f3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:95231f18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:952347cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02763 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol targets Secreted (Alpha-1-acid glycoprotein 1) DrugCentral uuid:95236b94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:952394d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2079 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:9523b946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:2079 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penciclovir targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9523e1e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:2079 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penciclovir targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:952409dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:952431f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:95245a0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:95248344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:9524ac52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9524d45c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9524fc5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:952524fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:95254d1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9525752e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:95259d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9525c5f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9525ee14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:95261632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:95263e50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:9526679a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:95268fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9526b7c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9526dfe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:952708c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:952730e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:95276852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:95276852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:95276852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:95276852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:95276852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9527bd98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P44514 biolink:molecularly_interacts_with DrugCentral:2081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penicillamine targets Enzyme (Succinyl-diaminopimelate desuccinylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9527e57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:9528094c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:952832aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9528730a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9528730a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9528730a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9528730a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9528730a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9528730a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9528730a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9528d2b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9528faa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:95293574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95293574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95293574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95293574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95293574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95293574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95293574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95299492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:2088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:9529bc74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentagastrin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9529e46a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:2088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:952a0d1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:2088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:952a3500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.287']} DrugCentral uuid:952a5d00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:952a84f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:952aad50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:952ad564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.765']} DrugCentral uuid:952afd64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.867']} DrugCentral uuid:952b2582-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.295']} DrugCentral uuid:952b4efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:952b780c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.683']} DrugCentral uuid:952ba00c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:952bc802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:952bf3c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.101']} DrugCentral uuid:952c1bcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:952c43a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:952c6c12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:952c9476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:952cbc76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04271 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Cytosolic other (Protein S100-B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:952ce476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:952d0ce4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:952d34da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19801 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Amiloride-sensitive amine oxidase [copper-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:952d5dfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:952d8606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:952daf46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:952dd746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:952dff50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:952e273c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:952e667a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:952e667a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:952e667a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:952e667a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:952e667a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:952e667a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:952e667a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:952ed506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:952ed506-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:952f094a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21673 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Spermidine/spermine N(1)-acetyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:952f314a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75365 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Protein-tyrosine phosphatase 4A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:952f5940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:952f8262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04631 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Unclassified (Protein S100-B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.36']} DrugCentral uuid:952faa6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:952fd276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:952ffa6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12974 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Protein tyrosine phosphatase type IVA 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9530232a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q93096 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Protein tyrosine phosphatase type IVA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:95304b52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:9530733e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.553']} DrugCentral uuid:9530a390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:9530a390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:9530a390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95311bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9531f646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9531f646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9531f646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:95323426-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:2096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentolonium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:95325bf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentolonium is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:95325bf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentolonium is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:95328a0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:2098 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentostatin is inhibitor of Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.8']} DrugCentral uuid:9532b202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56658 biolink:molecularly_interacts_with DrugCentral:2098 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentostatin targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:9532da2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxifylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:95330252-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:2099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxifylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:9533276e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxifylline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:95334fd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxifylline is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) DrugCentral uuid:9533739a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:95339bae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9533c3fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:9533ebfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:953413ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:95343bae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9534641c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:95348d02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:9534b50c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9534dd20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:95350610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:95352e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:953555e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:95357dde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9535a642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:9535ce24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:9535f6b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:95361eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9536476e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.838']} DrugCentral uuid:9536709a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:953698ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:9536c0ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:9536eb1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:95371310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:95373b10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:95376356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:95378bd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9537bc16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:9537bc16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:9537bc16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:9537fdfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9537fdfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:95384172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:95384172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:95384172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:95384172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:95384172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:95389aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:95389aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:9538d2a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9538fab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:953922ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.962']} DrugCentral uuid:95394b58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:95397358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.486']} DrugCentral uuid:95399b76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:9539c394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9539ec52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:953a1470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.105']} DrugCentral uuid:953a3c7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.027']} DrugCentral uuid:953a6470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:953a8a22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:953ab236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) DrugCentral uuid:953ad608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50416 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 1, liver isoform) DrugCentral uuid:953af9ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23786 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:953b2248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.828']} DrugCentral uuid:953b4a3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.391']} DrugCentral uuid:953b739c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:953ba34e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:953ba34e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:953ba34e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:953be494-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18886 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine palmitoyltransferase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:953c0d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32198 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine palmitoyltransferase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:953c3520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 periciazine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:953c5f96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 periciazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:953c8976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 periciazine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:953cb176-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 periciazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:953cd96c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2108 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perindopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:953d01bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:953d299e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.704']} DrugCentral uuid:953d51b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.824']} DrugCentral uuid:953d79bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:953da27a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:953dca7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:953df270-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:953e1c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perospirone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:953e4734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perospirone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:953e6f48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perospirone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:953e9766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perospirone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:953ebfe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:953ee7e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:953f1006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.462']} DrugCentral uuid:953f3810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:953f610a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:953f8a22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:953fb236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:953fda4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:95400448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:95402e78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:9540566e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.521']} DrugCentral uuid:95407e78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.088']} DrugCentral uuid:9540a6dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.733']} DrugCentral uuid:9540cedc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.481']} DrugCentral uuid:9540f6be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:95411eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.588']} DrugCentral uuid:95414880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:954170a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:954198b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9541c0c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacemide is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:9541e63c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacetin targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:95420a0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:95423218-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:95425a22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9542829a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9542aa9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9542f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:95437196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P83512 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine targets Enzyme (Snake venom metalloproteinase Bap1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:95439b26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9543c3bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:9543ebb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:954413da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:95443c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9544647a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:95448c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9544cbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9544cbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9544cbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9544cbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9544cbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9544cbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9544cbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:95454d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:95454d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:95454d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:95454d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:95454d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:95454d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:95454d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:9545c108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9545c108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9545f7e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9545f7e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:95463ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:95463ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:95463ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:95463ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:95463ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:95468f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phendimetrazine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:9546b36a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phendimetrazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9546db6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phendimetrazine is inhibitor of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:9546ffd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:954727c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.076']} DrugCentral uuid:954750c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:954778c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine is inhibitor of Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9547a0e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:9547c8f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9547f180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.836']} DrugCentral uuid:95481994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:9548419e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16853 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9548698a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9548922a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:9548ba20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9548e20c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:95490b42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9549350e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y478 biolink:molecularly_interacts_with DrugCentral:2126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenformin targets Kinase (5'-AMP-activated protein kinase subunit beta-1) DrugCentral uuid:95495976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenindamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9549818a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenindione is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) DrugCentral uuid:9549a548-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenindione targets Enzyme (Prothrombin) DrugCentral uuid:9549ca00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9549f200-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2131 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniprazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:954a171c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2131 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniprazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:954a3b20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:954a6028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:954a9002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:954a9002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:954a9002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:954ace0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenmetrazine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.298']} DrugCentral uuid:954af736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenmetrazine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.883']} DrugCentral uuid:954b1f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenmetrazine targets Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:954b4362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:954b6734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:954b934e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:954b934e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:954b934e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:954bd250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:954bd250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:954bd250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:954c10d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:954c39a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:954c61b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:954c8c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q834R3 biolink:molecularly_interacts_with DrugCentral:2135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:954cb45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:954cdf6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:954d09cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.456']} DrugCentral uuid:954d31ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:954d6a0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:954d6a0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:954d6a0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:954d6a0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:954d6a0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:954dc614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:954dc614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:954dc614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:954e0ce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:954e0ce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:954e0ce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:954e4c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenprocoumon targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:954e7438-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:2138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenprocoumon targets Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:954e9d78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:2138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenprocoumon targets Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:954ec5e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenprocoumon is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.745']} DrugCentral uuid:954ef5ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:954ef5ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:954ef5ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:954f2d9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentermine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:954f524a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentermine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.801']} DrugCentral uuid:954f7b4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:954fa36c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:954fcb62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.784']} DrugCentral uuid:954ff43e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.667']} DrugCentral uuid:95501c34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:95504448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.616']} DrugCentral uuid:95506d1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.684']} DrugCentral uuid:95509542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:9550bd60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:9550e574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:95510e78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:95513696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:95515f0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.71']} DrugCentral uuid:95518740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:9551b008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.94']} DrugCentral uuid:9551d826-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:95520026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:95522830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:9552513e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:9552793e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:9552a148-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9552c93e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.03']} DrugCentral uuid:9552f21a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:955321cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:955321cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:955321cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:95536916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:95536916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:95536916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9553a99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:9553d18a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08532 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9553f980-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Transporter (L-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:955422f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19111 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Enzyme (Intestinal alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:95544afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6DWJ6 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine is agonist of GPCR (Probable G-protein coupled receptor 139) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:955472fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09923 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Enzyme (Intestinal-type alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:95549b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P98170 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Unclassified (E3 ubiquitin-protein ligase XIAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9554c432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9554ec1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:955513f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16647 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Prostacyclin synthase) DrugCentral uuid:955537e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:955560a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8SPQ9 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:95558c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:95558c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9555bf72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:9555e7fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:955612ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:95563aba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9556633c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:95568c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9556b454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9556e514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9556e514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9556e514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:95572c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:95572c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:95572c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:955771fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:955771fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:955771fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9557b034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9557d8d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:955800de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:955824a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:95584c88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:95587596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:95589a8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:9558c28a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:9558ea94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:955913fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.166']} DrugCentral uuid:95593c10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:95596410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:95598c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9559b71c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9559df1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:955a0726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:955a3142-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:955a5992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:955a820a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:955aa5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:955aca44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:955aeeca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:955b12ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:955b3ac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:955b5eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:955b8862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:955bac48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:955bd02e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:955bffe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:955bffe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:955bffe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:955c3f1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phloroglucinol targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:955c6b10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:955c6b10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:955ca706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:955ca706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:955ca706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:955ce540-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:955d0d54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.37']} DrugCentral uuid:955d354a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:955d5fb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:955d878e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.17']} DrugCentral uuid:955db07e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:955dda86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.17']} DrugCentral uuid:955e0308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:955e2b12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:955e52fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:955e7bd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:955ea3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:955ecbd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:955ef3d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36196 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:955f1d56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:955f488a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:955f73aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:955f9be6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:955ffe4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:9560ceb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotin targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9560f8b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotin is blocker of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:95612196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotin is blocker of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:95614a22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:2163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotin targets Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:95617222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:956196da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:9561bad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9561e2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:95620ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:95623388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:95626c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:95626c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:95626c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:95626c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:95626c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:9562c1ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:9562ed14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:95631532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:95633d3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:95636618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:95638e04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilsicainide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:9563b6f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilsicainide is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.377']} DrugCentral uuid:9563ded6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus targets Cytokine (Interleukin-5) DrugCentral uuid:9564038e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus targets Cytokine (Interferon gamma) DrugCentral uuid:9564277e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:95644f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P60568 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus targets Cytokine (Interleukin-2) DrugCentral uuid:95647350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48454 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform) DrugCentral uuid:95649894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62658 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9564c0e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimethixene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:9564e8f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimethixene targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:95651102-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTS6 biolink:molecularly_interacts_with DrugCentral:2169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimethixene targets Enzyme (Histone-lysine N-methyltransferase SETD7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:956539ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:2171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimobendan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:956565c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimobendan is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:956565c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimobendan is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:95659938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9565c138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.862']} DrugCentral uuid:9565ea0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.798']} DrugCentral uuid:95661228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.842']} DrugCentral uuid:95663a46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:956662be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:95668de8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.63']} DrugCentral uuid:9566b76e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.559']} DrugCentral uuid:9566df5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.058']} DrugCentral uuid:95670822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.149']} DrugCentral uuid:95673022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.301']} DrugCentral uuid:95675818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.704']} DrugCentral uuid:9567809a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:9567ab6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:9567d374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:9567fb88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:95682388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.709']} DrugCentral uuid:95684c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:9568750e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.424']} DrugCentral uuid:95689d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:9568c536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9568edf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:956915ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95693de0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:95696d92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:95696d92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:95696d92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:9569ad7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9569d57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9569fd84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:956a2778-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:956a4f82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:956a7778-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:956a9f64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:956ac84a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:956af04a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:956b2786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:956b2786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:956b2786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:956b2786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:956b2786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:956b7dbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94782 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Enzyme (Ubiquitin carboxyl-terminal hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:956ba5bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EQ60 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:956bcdb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:956bf742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54898 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:956c1f42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60706 biolink:molecularly_interacts_with DrugCentral:2173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pinacidil targets Ion channel (ATP-binding cassette sub-family C member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:956c4706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:2173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pinacidil targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:956c6ede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pinacidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:956c6ede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pinacidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:956ca304-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol is partial agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:956ccb22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol is partial agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:956cf43a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:956d1d48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:956d45d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:956d6de8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:956d95fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.78']} DrugCentral uuid:956dbf5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:956dea5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.209']} DrugCentral uuid:956e1252-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:956e3a5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:956e6f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:956e6f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:956e6f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:956e6f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:956ec198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:956ec198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:956ec198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:956f00cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.943']} DrugCentral uuid:956f28b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:956f50a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:956f7890-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.455']} DrugCentral uuid:956fa25c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:956fca5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:956ff23e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.879']} DrugCentral uuid:95701a16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:957042fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:95706af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37238 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:957092f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88275 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9570baf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9570e3b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:95710bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:957133c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0K020 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:95715bb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:9571850e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5K1 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9571acfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9571d4e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.87']} DrugCentral uuid:9571fdd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:957226da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:95724ed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.461']} DrugCentral uuid:95727810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.351']} DrugCentral uuid:9572a0e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.992']} DrugCentral uuid:9572c8f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.256']} DrugCentral uuid:9572f11e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:95731932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:9573425e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:95736a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.105']} DrugCentral uuid:9573927c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.799']} DrugCentral uuid:9573ba90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.939']} DrugCentral uuid:9573e402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:95740c20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.189']} DrugCentral uuid:9574342a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:95745c16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:957484de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.848']} DrugCentral uuid:9574ad06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:9574d510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.429']} DrugCentral uuid:9574fd9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:95752858-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:957550a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:957578a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:9575a0a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:9575c9ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:9575f1b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:95761ab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:957643a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.324']} DrugCentral uuid:95766baa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.644']} DrugCentral uuid:9576945e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:9576bcfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.602']} DrugCentral uuid:9576e67a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:95770e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:957736d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:95775f10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:957787c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:9577b03c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:9577dbfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:9577dbfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:9578114e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:9578114e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:9578114e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:95784e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:95784e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:95787fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:95787fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:9578ad7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:9578d368-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9578fbe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:95793aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95793aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95793aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95793aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95793aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95793aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95793aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:95799d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O18276 biolink:molecularly_interacts_with DrugCentral:2188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperazine targets Ion channel (Gamma-aminobutyric acid receptor subunit beta) DrugCentral uuid:9579c124-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipotiazine palmitate is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:9579e91a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipotiazine palmitate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.553']} DrugCentral uuid:957a120a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2199 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirbuterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:957a35fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:957a5dfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:957a8604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:957aafe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:957ad7d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:957affd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:957b2a32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:957b5584-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:957b7d8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:957ba58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:957bce6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:957bf674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:957c1e88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:957c55e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:957c55e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:957c55e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:957c55e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:957c55e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:957cbe56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:957cbe56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:957cbe56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:957cbe56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:957cbe56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:957d14dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piretanide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:957d3cdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:2201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piretanide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:957d64dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:957d8ce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:957db5e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:957dddfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:957e0608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:957e2e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:957e59aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:957e8204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:957eaa0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:957ed2f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:957efb12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:957f231c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:957f4b08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28347 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:957f73d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:957f9bc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15562 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:957fc3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99594 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:957febda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:95801470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirmenol targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:95803860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:95806074-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:95808874-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:9580b646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:9580b646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:9580ed50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9580ed50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9581205e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirprofen targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:95814534-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirprofen targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:9581691a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitavastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.168']} DrugCentral uuid:95819188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitavastatin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:9581b99c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitavastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:9581e408-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:95820c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:95823494-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:95825cbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9582858e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:9582ada2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9582d5b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9582fdde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polythiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['9.09']} DrugCentral uuid:958326a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralidoxime is activator of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.59']} DrugCentral uuid:95834eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08725 biolink:molecularly_interacts_with DrugCentral:2232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralmorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:958376d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92847 biolink:molecularly_interacts_with DrugCentral:2232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralmorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) DrugCentral uuid:95839aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:9583c4f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9583edac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.121']} DrugCentral uuid:958415ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:95843e38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:9584670a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.925']} DrugCentral uuid:95849072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9584b886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.668']} DrugCentral uuid:9584e072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:95850962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.455']} DrugCentral uuid:95853162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:95855962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.282']} DrugCentral uuid:95858180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:9585acdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:9585d4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9585fd0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:95862a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:95862a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:958660fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:958660fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:958697dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:958697dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:9586cbc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9586f434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:95871c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9587442a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:95876f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:95879880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets Nuclear other (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9587c080-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:9587e880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2238 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9588118e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2238 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:95883b14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pravastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:95886314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pravastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:95888b28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:2239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pravastatin targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:9588bc56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9588bc56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9588bc56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9588f39c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 praziquantel targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:95891b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08515 biolink:molecularly_interacts_with DrugCentral:2241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 praziquantel targets Enzyme (Glutathione S-transferase class-mu 26 kDa isozyme) DrugCentral uuid:958940e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95US7 biolink:molecularly_interacts_with DrugCentral:2241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 praziquantel is blocker of Ion channel (High voltage-activated calcium channel beta subunit CavB1) DrugCentral uuid:958964da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q962H3 biolink:molecularly_interacts_with DrugCentral:2241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 praziquantel is blocker of Ion channel (High voltage-activated calcium channel beta subunit CavB2) DrugCentral uuid:958988e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednicarbate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:9589acd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9589d5f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Cytosolic other (Annexin A1) DrugCentral uuid:9589f9d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:958a21e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:958a49e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:958a72b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:958a9ab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:958ac2a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:958aeab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:958b1456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15104 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Enzyme (Glutamine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:958b3c42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:958b6456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:958b8c42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78536 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Unclassified (Disintegrin and metalloproteinase domain-containing protein 17) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:958bb514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:958bdd96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:958c02bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.28']} DrugCentral uuid:958c2ab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:958c5348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:958c7b52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:958ca3e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:958ccc42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:958d1698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:958d668e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:958db80a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15104 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Enzyme (Glutamine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:958e07ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:958e5940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:958ea9c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78536 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Unclassified (Disintegrin and metalloproteinase domain-containing protein 17) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:958eda1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:958f0688-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisone targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.772']} DrugCentral uuid:958f3306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:958f5fc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisone targets Cytosolic other (Annexin A1) DrugCentral uuid:958f8798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregabalin targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.801']} DrugCentral uuid:958fb402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:2255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregabalin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:958fe08a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O77773 biolink:molecularly_interacts_with DrugCentral:2255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregabalin targets Ion channel (Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:95900d8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:2255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregabalin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:959039f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregnenolone succinate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:95906672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregnenolone succinate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:959095ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregnenolone succinate targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:9590c57c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenalterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9590f330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenalterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.97']} DrugCentral uuid:959128d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:959128d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:959128d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:959176a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:959176a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:959176a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9591bc70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9591e8e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:95921558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:959241c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.194']} DrugCentral uuid:9592708e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:95929cee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.799']} DrugCentral uuid:9592d22c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:9592d22c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:9592d22c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:959318a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.668']} DrugCentral uuid:9593450e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.075']} DrugCentral uuid:95937182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:95939b3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:9593c790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9593f3dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.739']} DrugCentral uuid:95942050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:95944fa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:95947780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:9594a4e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9594d1a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35869 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Transcription factor (Aryl hydrocarbon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:9594fe3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:95952ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:95955740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Unclassified (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:95958cc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:95958cc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:95958cc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9595ca54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:2267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primidone is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9595f696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:95962440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:959650be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:95967d3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9596aa1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 8) DrugCentral uuid:9596d1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 11) DrugCentral uuid:9596f9d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:95972638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:95975324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:95977fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAW7 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Enzyme (UDP-glucuronosyltransferase 1-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.02']} DrugCentral uuid:9597ac3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:9597da24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.686']} DrugCentral uuid:959806e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95983352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95477 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol is inhibitor of Transporter (ATP-binding cassette sub-family A member 1) DrugCentral uuid:95985b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:95988960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:9598b5d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.86']} DrugCentral uuid:9598e32e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.812']} DrugCentral uuid:95991010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:95993c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 1) DrugCentral uuid:95996452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:95998c02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBC3 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 3B) DrugCentral uuid:9599b4f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a08e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:959a9304-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.569']} DrugCentral uuid:959abf64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.529']} DrugCentral uuid:959aec28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:959b13e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.222']} DrugCentral uuid:959b48da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:959b48da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:959b48da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:959b8ff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:959bbc52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:959be8a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.712']} DrugCentral uuid:959c151c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:959c4208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.764']} DrugCentral uuid:959c6f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.201']} DrugCentral uuid:959c9bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:959cc8fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:959cf554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.207']} DrugCentral uuid:959d21d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.402']} DrugCentral uuid:959d4e3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.229']} DrugCentral uuid:959d7c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:959da8aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:959dd514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:959e01f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:959e2e74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.622']} DrugCentral uuid:959e5ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.324']} DrugCentral uuid:959e8766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.611']} DrugCentral uuid:959eb42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.723']} DrugCentral uuid:959ee09e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.613']} DrugCentral uuid:959f0e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.956']} DrugCentral uuid:959f3bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.493']} DrugCentral uuid:959f6848-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:959f94d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.801']} DrugCentral uuid:959fc20c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:959fee9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:95a01afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:95a0474a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:95a07418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:95a0a0a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:95a0ce2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.245']} DrugCentral uuid:95a0fb90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:95a12804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:95a1546e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.919']} DrugCentral uuid:95a180f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.381']} DrugCentral uuid:95a1adba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:95a1da06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:95a20684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95a2333e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.337']} DrugCentral uuid:95a25f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:95a28bea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.907']} DrugCentral uuid:95a2b84a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:95a2e5b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:95a3122c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:95a35818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95a35818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95a35818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95a35818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95a35818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95a35818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95a35818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95a3d86a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:95a3d86a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:95a3d86a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a45e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a59448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95a67e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.174']} DrugCentral uuid:95a6aaa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:95a6d704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:95a7036e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:95a7305a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:95a75c92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:95a7846a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:95a7b1c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['9.876']} DrugCentral uuid:95a7e00e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:95a80c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.94']} DrugCentral uuid:95a838f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35610 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Enzyme (Sterol O-acyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:95a86704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:95a89382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:95a8bff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:95a8ecec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.441']} DrugCentral uuid:95a9197e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:95a945ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:95a97220-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:95a99f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:95a9ccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:95a9fd80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:95a9fd80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:95aa3da4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:95aa3da4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:95aa7b52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:95aaaa78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:95aad778-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:95ab03d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:95ab3024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is blocker of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:95ab5cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:95ab8970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:2281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proglumide targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.6']} DrugCentral uuid:95abb5da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:2281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proglumide is antagonist of GPCR (Gastrin/cholecystokinin type B receptor) DrugCentral uuid:95abdd94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0IJY2 biolink:molecularly_interacts_with DrugCentral:2282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proguanil targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:95ac072e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O02604 biolink:molecularly_interacts_with DrugCentral:2282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proguanil targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:95ac2fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proguanil is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:95ac57ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:2282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proguanil targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:95ac841a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.909']} DrugCentral uuid:95acb160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.704']} DrugCentral uuid:95acddd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:95ad0a52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.943']} DrugCentral uuid:95ad3748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:95ad63d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:95ad904e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.529']} DrugCentral uuid:95adbd76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:95aded1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.656']} DrugCentral uuid:95ae1adc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:95ae475a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:95ae7450-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.226']} DrugCentral uuid:95aea0c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:95aecd2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.799']} DrugCentral uuid:95aef9ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:95af2684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.551']} DrugCentral uuid:95af52ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.825']} DrugCentral uuid:95af7f62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.412']} DrugCentral uuid:95afac8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.056']} DrugCentral uuid:95afd8f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:95b00568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:95b031be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.796']} DrugCentral uuid:95b05ec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:95b08b32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:95b0b774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.427']} DrugCentral uuid:95b0e44c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:95b110a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:95b13d0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:95b16962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.344']} DrugCentral uuid:95b197b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.806']} DrugCentral uuid:95b1c40c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:95b1f058-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:95b21d58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:95b24abc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:95b27b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:95b27b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:95b2c636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:95b2c636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:95b2c636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:95b2c636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:95b2c636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:95b32cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:95b32cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:95b32cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:95b3740a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:95b3a04c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promegestone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:95b3ccc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promegestone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:95b3fb32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:95b427b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.609']} DrugCentral uuid:95b4542e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.592']} DrugCentral uuid:95b48142-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:95b4ae10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:95b4da66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:95b506da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:95b53560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:95b561de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:95b58e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.188']} DrugCentral uuid:95b5bb48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.948']} DrugCentral uuid:95b5e8b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:95b6108e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:95b63cee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:95b669da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:95b69658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.941']} DrugCentral uuid:95b6c2c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.823']} DrugCentral uuid:95b6ef40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.479']} DrugCentral uuid:95b71ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:95b74c7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.382']} DrugCentral uuid:95b77906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.975']} DrugCentral uuid:95b7a5fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:95b7d270-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.292']} DrugCentral uuid:95b7fed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.452']} DrugCentral uuid:95b82b30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:95b85812-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:95b88472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:95b8b0d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:95b8dfb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:95b90f82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:95b93dae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:95b96a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:95b996be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:95b9cb98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:95b9cb98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:95b9cb98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:95ba127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:95ba405a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:95ba6cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.3']} DrugCentral uuid:95ba9938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP23 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Cytosolic other (Calmodulin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:95bac958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pronetalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:95baf5fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:95bb28d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:95bb6c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:95bb9ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:95bbc6d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:95bbef2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:95bc1704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:95bc3ef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:95bc6b64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:95bc9abc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['7.056']} DrugCentral uuid:95bcc730-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.524']} DrugCentral uuid:95bcf390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.029']} DrugCentral uuid:95bd20e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.728']} DrugCentral uuid:95bd4d5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:95bd79e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:95bda664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:95bdd378-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:95bdffe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.498']} DrugCentral uuid:95be2c74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:95be59f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.337']} DrugCentral uuid:95be8656-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:95beb4b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.483']} DrugCentral uuid:95bee132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:95bf0e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:95bf3a6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:95bf66d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:95bf9410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:95bfc084-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.849']} DrugCentral uuid:95bfece4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:95c01944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:95c049e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.602']} DrugCentral uuid:95c07c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:95c07c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:95c0b53e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:95c0e388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:95c11024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:95c13c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.2']} DrugCentral uuid:95c16a56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:95c196ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:95c1c348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:95c1f520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:95c1f520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:95c1f520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:95c23ad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propentofylline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:95c26726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (D(1A) dopamine receptor) DrugCentral uuid:95c28f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (D(2) dopamine receptor) DrugCentral uuid:95c2b852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:95c2e03e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (5-hydroxytryptamine receptor 2C) DrugCentral uuid:95c30820-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:95c330ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:95c35852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:95c37ff8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:95c3a79e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:95c3d0de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:95c3f8f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (D(4) dopamine receptor) DrugCentral uuid:95c420c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:95c448ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiram is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:95c470d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.284']} DrugCentral uuid:95c49d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.417']} DrugCentral uuid:95c4c976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.031']} DrugCentral uuid:95c4f5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:95c5233a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.218']} DrugCentral uuid:95c54fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.005']} DrugCentral uuid:95c57bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:95c5a922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:95c5d564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.119']} DrugCentral uuid:95c6019c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:95c62df2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:95c6636c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:95c6636c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:95c6636c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:95c6b2ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:95c6b2ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:95c6b2ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c739c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95c82b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:95c82b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:95c82b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:95c87044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.919']} DrugCentral uuid:95c89c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:95c8ca1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:95c8f668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.913']} DrugCentral uuid:95c923cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:95c951d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.662']} DrugCentral uuid:95c97e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:95c9aae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:95c9d736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.699']} DrugCentral uuid:95ca0418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:95ca306e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.197']} DrugCentral uuid:95ca5ce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:95ca89ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:95cab62e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.319']} DrugCentral uuid:95cae284-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:95cb0ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:95cb3fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.297']} DrugCentral uuid:95cb6c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:95cb98a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.671']} DrugCentral uuid:95cbc578-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:95cbf1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:95cc1e92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.01']} DrugCentral uuid:95cc4b10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.05']} DrugCentral uuid:95cc7856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:95cca4c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:95ccd12a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.76']} DrugCentral uuid:95cd0762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:95cd0762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:95cd0762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:95cd4e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:95cd7a76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:95cda758-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:95cdd3e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:95ce0054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:95ce2d90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:2308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propylthiouracil is inhibitor of Enzyme (Thyroid peroxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:95ce59dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propylthiouracil targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:95ce8646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49895 biolink:molecularly_interacts_with DrugCentral:2308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propylthiouracil is inhibitor of Enzyme (Type I iodothyronine deiodinase) DrugCentral uuid:95ceae14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59533 biolink:molecularly_interacts_with DrugCentral:2308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propylthiouracil targets GPCR (Taste receptor type 2 member 38) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:95cedd44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:2309 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propyphenazone is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.481']} DrugCentral uuid:95cf0d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proquazone targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:95cf3514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proquazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:95cf621e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proquazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:95cf621e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proquazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:95cf9af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proscillaridin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.056']} DrugCentral uuid:95cfc754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proscillaridin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:95cfef18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protionamide targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:95d01c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin is agonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:95d048aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:95d07514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R297 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin targets GPCR (Protein Trhr2; Thyrotropin releasing hormone receptor 2; Thyrotropin-releasing hormone receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:95d0a318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21761 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:95d0d2fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERT1 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:95d0ff66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protokylol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:95d1273e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.928']} DrugCentral uuid:95d1556a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:95d181de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:95d1af4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:95d1dc56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:95d208c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:95d235c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:95d2622a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:95d291be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:95d2be14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:95d2ea6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:95d31742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:95d343a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:95d37016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:95d39c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pseudoephedrine targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:95d3c534-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pseudoephedrine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:95d3ed0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pseudoephedrine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:95d414d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pseudoephedrine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:95d43c80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:95d46cd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:95d49c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPB6 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Cyclopropane mycolic acid synthase 1) DrugCentral uuid:95d4c402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50575 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Amidase; Nicotinamidase; Nicotinamidase/pyrazinamidase; Pyrazinamidase; Pyrazinamidase/nicotinamidase; Pyrazinamidase/nicotinamidase PncA) DrugCentral uuid:95d4ec20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:95d5188a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P95029 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide is inhibitor of Enzyme (3-oxoacyl-ACP synthase; Fatty acid synthase Fas; Probable fatty acid synthase Fas (Fatty acid synthetase)) DrugCentral uuid:95d54062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:95d56ca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:95d599c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:95d5c60e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:95d5f28c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.952']} DrugCentral uuid:95d6219e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:95d65056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:95d67cb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:95d6a902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:95d6d5ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.751']} DrugCentral uuid:95d70262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.228']} DrugCentral uuid:95d72ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:95d75be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:95d7884a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:95d7b5d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:95d7e22c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:95d80fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:95d83c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.721']} DrugCentral uuid:95d8688c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:95d89550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.288']} DrugCentral uuid:95d8c1ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.409']} DrugCentral uuid:95d8ee24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:95d91aa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:95d947d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:95d97448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:95d9a09e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.602']} DrugCentral uuid:95d9cefc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:95d9fe54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:95da2ad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:95da5728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.009']} DrugCentral uuid:95da8522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine is inhibitor of Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:95dab182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27783 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:95dade0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08966 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:95db0b32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K0H1 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Unclassified (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:95db37a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:95db63fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06865 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Beta-hexosaminidase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:95db903e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07686 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Beta-hexosaminidase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:95dbc05e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3V050 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine is inhibitor of Unclassified (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:95dbed0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:95dc1978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8I1R6 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:95dc4678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1KRD8 biolink:molecularly_interacts_with DrugCentral:2335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrvinium targets Unclassified (Fumarate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:95dc7396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15056 biolink:molecularly_interacts_with DrugCentral:2335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrvinium targets Enzyme (Synaptojanin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:95dca000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43426 biolink:molecularly_interacts_with DrugCentral:2335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrvinium targets Enzyme (Synaptojanin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:95dccd00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrvinium targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:95dd0202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:95dd0202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:95dd0202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:95dd5004-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:95dd5004-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:95dd5004-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:95dda1a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:95dda1a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:95dda1a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:95dde87a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:95de1642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:95de42a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:95de6f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.483']} DrugCentral uuid:95de9b58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:95dec88a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.016']} DrugCentral uuid:95def4e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:95df2136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:95df4ea4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:95df7b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.131']} DrugCentral uuid:95dfa764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:95dfd3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:95e00088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:95e02ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.512']} DrugCentral uuid:95e05948-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.027']} DrugCentral uuid:95e0862a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.127']} DrugCentral uuid:95e0b29e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:95e0def4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:95e10b4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:95e13b9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:95e1687e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.037']} DrugCentral uuid:95e194de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.795']} DrugCentral uuid:95e1c1ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.266']} DrugCentral uuid:95e1ee0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.524']} DrugCentral uuid:95e21a6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:95e246b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:95e274e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:95e2a13a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.241']} DrugCentral uuid:95e2cd90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:95e2fc20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:95e32880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:95e354e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.506']} DrugCentral uuid:95e38140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:95e3ae04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:95e3da78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.866']} DrugCentral uuid:95e406e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.936']} DrugCentral uuid:95e434dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.06']} DrugCentral uuid:95e46240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:95e48ebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:95e4bc04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:95e4eb48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:95e517b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:95e5441c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:95e57158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:95e59dd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:95e5ca54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.542']} DrugCentral uuid:95e5f90c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:95e625ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.079']} DrugCentral uuid:95e65280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:95e67ef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.459']} DrugCentral uuid:95e6ae74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.445']} DrugCentral uuid:95e6dc3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.465']} DrugCentral uuid:95e708ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.575']} DrugCentral uuid:95e735e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.558']} DrugCentral uuid:95e76260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:95e78ede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.481']} DrugCentral uuid:95e7bb3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:95e7e83e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.994']} DrugCentral uuid:95e814b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.574']} DrugCentral uuid:95e84112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:95e86ebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:95e89e0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:95e8ca74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:95e8f6d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:95e927e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:95e927e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:95e9695c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:95e9695c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:95e9695c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:95e9bbf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:95e9bbf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:95e9bbf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:95e9bbf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:95ea0d8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00592 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Phospholipase A2 group 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:95ea3cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04055 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Phospholipase A2 group 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eaa344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:95eb7cce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:95eb7cce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:95eb7cce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:95ebc698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:95ebc698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:95ec07fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:95ec07fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:95ec07fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:95ec52a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2340 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.08']} DrugCentral uuid:95ec7f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2340 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.397']} DrugCentral uuid:95ecac0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:95ecd402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinethazone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:95ecfbd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quingestanol acetate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:95ed24b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:95ed5166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:95ed7920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:95eda0ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:95edc894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:95edf256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:95ee21fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:95ee5110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.125']} DrugCentral uuid:95ee7d7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:95eeaa3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:95eed824-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:95ef048e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.106']} DrugCentral uuid:95ef3170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:95ef5dda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:95ef8a26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.061']} DrugCentral uuid:95efb776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:95efef0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:95efef0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:95efef0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:95f03480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:95f0613a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63881 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:95f08da4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:95f0b9fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:95f0e696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is inhibitor of Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:95f11364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:95f140e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.102']} DrugCentral uuid:95f16d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.119']} DrugCentral uuid:95f19bd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:95f1c6d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:95f1f3a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:95f2248e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:95f2248e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:95f2588c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:95f284e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:95f2b160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:95f2de2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:95f30aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:95f33752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:95f36542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.321']} DrugCentral uuid:95f393dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:95f3c064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.408']} DrugCentral uuid:95f3ece2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.926']} DrugCentral uuid:95f419d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.205']} DrugCentral uuid:95f44642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:95f47298-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:95f49f70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:95f4cbda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.553']} DrugCentral uuid:95f4f984-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:95f5260c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:95f5553c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:95f581a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:95f5af28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:95f5dc0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:95f6086a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.538']} DrugCentral uuid:95f634ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.523']} DrugCentral uuid:95f6613e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.971']} DrugCentral uuid:95f68e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:95f6babc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:95f6e712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.321']} DrugCentral uuid:95f71534-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.193']} DrugCentral uuid:95f7434c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:95f76fac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:95f79c34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:95f7c902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:95f7f558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:95f82186-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:95f84e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:95f87b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.436']} DrugCentral uuid:95f8a782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:95f8d3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.876']} DrugCentral uuid:95f901b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13393 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Phospholipase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:95f92e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14939 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Phospholipase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:95f95a6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.827']} DrugCentral uuid:95f98742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.073']} DrugCentral uuid:95f9b3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.625']} DrugCentral uuid:95f9e020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:95fa0d84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:95fa3a66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:95fa66d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:95fa9344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:95fac4cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.73']} DrugCentral uuid:95fac4cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.73']} DrugCentral uuid:95fafda2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:95fb2a0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.66']} DrugCentral uuid:95fb56f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:95fb84ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltegravir is inhibitor of Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:95fbb152-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:2352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:95fbdda8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:2352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltegravir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:95fc0a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:2352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:95fc36ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:95fc6336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.678']} DrugCentral uuid:95fc9176-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:95fcbf84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:95fcebe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:95fd1830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.244']} DrugCentral uuid:95fd4512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:95fd7172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45352 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:95fd9dbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:95fdca78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:95fdf6ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:95fe231a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:95fe5060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:95fe7ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:95feab78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban is inverse agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:95fed7e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:95ff04ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XKD3 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban is antagonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:95ff31a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban is antagonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:95ff5e2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:2355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramelteon is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.9']} DrugCentral uuid:95ff8ab6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:2355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramelteon is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.39']} DrugCentral uuid:95ffb7b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramipril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.342']} DrugCentral uuid:95ffe416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramipril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:96001076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2357 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:96003eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.86']} DrugCentral uuid:96006b20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9600976c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9600c3f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9600f0cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:96011d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranolazine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:960149aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranolazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:96017646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranolazine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:96019e32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5YLN7 biolink:molecularly_interacts_with DrugCentral:2359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranolazine targets Unclassified (Voltage-gated sodium channel Nav1.5 cardiac isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9601ca92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rebamipide is agonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9601f846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:96022834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:9602550c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:9602816c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:9602af52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9602dbc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.194']} DrugCentral uuid:96030830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:960334c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:960361a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:96039264-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:96039264-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:9603cf9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.387']} DrugCentral uuid:9603cf9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.387']} DrugCentral uuid:96040c26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson is agonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:9604387c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.398']} DrugCentral uuid:960464be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9604918c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9604bdf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9604ea6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remifentanil is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:9605124c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remifentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:96053f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remifentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:96056b5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:96059866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:9605c638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9605f284-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:96061ef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:96064b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:96067858-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9606a4b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:9606d136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9607102e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9607102e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9607102e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9607102e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9607102e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96076e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09428 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide targets Ion channel (ATP-binding cassette sub-family C member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:96079d78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide targets Transporter (Solute carrier organic anion transporter family member 1B1) DrugCentral uuid:9607c7d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:9607f9c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:9607f9c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:96083792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:96083792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:960870b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2368 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reproterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:960898ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rescinnamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:9608c112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:9608ed72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.415']} DrugCentral uuid:96091a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.232']} DrugCentral uuid:960946a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:9609762a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.737']} DrugCentral uuid:9609a49c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:9609d106-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:9609fdfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:960a2a66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27963 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:960a56e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:960a8358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:960ab8f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:960ab8f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:960ab8f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:960affae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BRU6 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:960b2c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.836']} DrugCentral uuid:960b5d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:2372 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol acetate targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:960b89ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:2372 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol acetate targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:960bb656-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:960be342-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55263 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets Kinase (Adenosine kinase) DrugCentral uuid:960c0b1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22413 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets Enzyme (Ectonucleotide pyrophosphatase/phosphodiesterase family member 1) DrugCentral uuid:960c32e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49902 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets Enzyme (Cytosolic purine 5'-nucleotidase) DrugCentral uuid:960c5ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:960c8856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:960cb4c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:960ce134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin is inhibitor of Enzyme (NS5B protein) DrugCentral uuid:960d0aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:960d37a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WGY9 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin targets Enzyme (DNA-directed RNA polymerase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:960d70f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:960d70f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:960d70f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:960d70f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:960dbb86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:960de7c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:960e140a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:960e40d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:960e6d56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:960e99d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:960ec652-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin is inhibitor of Enzyme (DNA-directed RNA polymerase subunit beta) DrugCentral uuid:960ef0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:960f1d28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.29']} DrugCentral uuid:960f49c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:960f769c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:960fa360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:960fdc90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:960fdc90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:960fdc90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:960fdc90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:9610256a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:96105eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:96105eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:96105eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:96105eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:9610a74c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:9610d4f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:96110174-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:96112e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:96115b06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:96118784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:9611b3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:9611dbda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9612089e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.765']} DrugCentral uuid:961234fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9612614a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:96128af8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9612b7f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9612e55c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:96131248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:96133f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:96136cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21430 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Ion channel (Matrix protein 2) DrugCentral uuid:961394ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9613c18e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9613edee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63231 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine is inhibitor of Ion channel (Matrix protein 2) DrugCentral uuid:961415ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:96144280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Unclassified (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:96147228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05778 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:96149ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DOF8 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:9614cb74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimexolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:961533ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:96161e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risedronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:96164e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risedronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:96167d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q197X6 biolink:molecularly_interacts_with DrugCentral:2387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risedronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:9616a994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WS26 biolink:molecularly_interacts_with DrugCentral:2387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risedronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9616d662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:96170308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:96172f7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:96175bd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04274 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:961788be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9617b532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9617e19c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:96180ffa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:961840ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:96186e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:96189aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9618c79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9618f406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.788']} DrugCentral uuid:96192066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:96194db6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.443']} DrugCentral uuid:96197a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.364']} DrugCentral uuid:9619a6a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:9619d31c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:961a0418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:961a3078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:961a5ce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:961a89f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:961ab660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:961ae2ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.023']} DrugCentral uuid:961b0fca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:961b3c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:961b68bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:961b9530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.432']} DrugCentral uuid:961bc442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:961bf098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.538']} DrugCentral uuid:961c1d34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:961c4a7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:961c76e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:961ca358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.278']} DrugCentral uuid:961ccfc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:961cfca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:961d290e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:961d5582-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:961d8296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.687']} DrugCentral uuid:961daf14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:961ddb7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:961e07f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.967']} DrugCentral uuid:961e3524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:961e62ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:961e8f1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:961ebc06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:961ee9c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:961f1642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:961f42d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:961f7236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:961f9ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:961fcb14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:961ff81e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:9620249c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:962050e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:96207d5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:9620aa48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9620d68a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:962103da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:962131a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96216e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:96216e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:96216e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:96216e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9621c8d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:9621c8d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:9621c8d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:962216ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:962216ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:962216ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:96225d8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:96228a66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritodrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:9622b6d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritodrine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9622e344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.575']} DrugCentral uuid:962310f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:96233d4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:962369b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:96239618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:9623be5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:9623eac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:96241732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.303']} DrugCentral uuid:962443ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:96247056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.119']} DrugCentral uuid:96249e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:9624cac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.058']} DrugCentral uuid:9624fb2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir is inhibitor of Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:96252a8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:96255714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir is inhibitor of Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:962583ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:9625b038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9625dc98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:96260970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.47']} DrugCentral uuid:96263602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:96266262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:96268fbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:9626bd3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9626e994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:962715f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:962742ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:96276f22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96279b82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9627c7d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:9627f58c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:96282214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:96284e6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:96287b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9628aacc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9628d736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.854']} DrugCentral uuid:962903b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9629308c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:96295d14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9629897e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79400 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9629bb10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9629bb10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9629fc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9629fc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9629fc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:962a4f4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:962a4f4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:962a4f4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:962a4f4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:962aa50c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:962ad180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:962afe4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.466']} DrugCentral uuid:962b2ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:962b5704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:962b835a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:962bb06e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:962bdcd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:962c092e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:962c369c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:962c6306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolitetracycline targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:962c8f5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:2399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolitetracycline targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:962cbbbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolitetracycline targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:962ce894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43351 biolink:molecularly_interacts_with DrugCentral:2399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolitetracycline targets Nuclear other (DNA repair protein RAD52 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:962d14e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:962d4172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:962d6e90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:962d9b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:962dc78c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:962df3ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:962e2376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:962e4fe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:962e7c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:962eaa44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:962ed6ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:962f03cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:962f305e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:962f5d68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:962f89dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:962fb63c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:962fe418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:96301096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:96303896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:96306078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:963088c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:9630b0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:9630d882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:96310186-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:96312a1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:96315672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:963182dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9631b0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.391']} DrugCentral uuid:9631dfa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:96320c16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:96323880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:9632658a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:963291ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:9632be40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9632eb72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:963318f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.449']} DrugCentral uuid:96334540-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9633718c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9633a134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9633cd9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:9633f9fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:963426b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37238 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9634530e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:96347f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:9634abf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9634d90a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:96350614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:96353288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0K020 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:96355fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:96358c38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9635b8ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9635e534-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5K1 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:96361202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosuvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:96363e62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosuvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:96366ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43924 biolink:molecularly_interacts_with DrugCentral:2406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosuvastatin targets Enzyme (Phosphodiesterase 6D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.9']} DrugCentral uuid:963697ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9636c47c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:9636f0dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:96371d5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:96374bd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:96377976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9637a5ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9637d2cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxatidine acetate is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9637ff4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:2410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxithromycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:9638270e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:2410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxithromycin is agonist of GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:96385364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxithromycin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.261']} DrugCentral uuid:963880be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rupatadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.41']} DrugCentral uuid:9638ad28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:2413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rupatadine targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9638d97e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:96390750-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17708 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Enzyme (S-adenosylmethionine decarboxylase proenzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:963933ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C3SIU2 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Unclassified (Met repressor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:96396042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11086 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Enzyme (Phenylethanolamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:96398cac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22061 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Enzyme (Protein-beta-aspartate methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:9639b9ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:9639e60c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:963a128a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.95']} DrugCentral uuid:963a3fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6RYA0 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Salicylic acid-binding protein 2) DrugCentral uuid:963a678a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:963a93f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:963ac086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:963aef3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:963b1bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:963b4830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:963b759e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:963ba1ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:963bcf8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.36']} DrugCentral uuid:963bfbfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:963c293a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:963c55ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:963c825e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.41']} DrugCentral uuid:963cb044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:963cdcb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:963d0972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.004']} DrugCentral uuid:963d35dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:963d6296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:963d8ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:963dbb6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:963de9fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.408']} DrugCentral uuid:963e1664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:963e42ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:963e6f38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:963e9f62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.282']} DrugCentral uuid:963ecbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.699']} DrugCentral uuid:963ef84a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.555']} DrugCentral uuid:963f2518-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.556']} DrugCentral uuid:963f5182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:963f7932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.003']} DrugCentral uuid:963fa592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.153']} DrugCentral uuid:963fd2c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.187']} DrugCentral uuid:963fff24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.661']} DrugCentral uuid:96402b98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.684']} DrugCentral uuid:96405b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:9640878c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9640b3ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9640e056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:96410d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:9641398e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:96416602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9641933e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:9641bfc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9641ec3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:964222e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:964222e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:964222e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:96426854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:964294b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.86']} DrugCentral uuid:9642c196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9642ee0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:96431a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:964346de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:964373fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:9643a066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:9643ccb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:9643fa20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:96443792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:96443792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:96443792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:96443792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:96443792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:964498e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C3TDZ2 biolink:molecularly_interacts_with DrugCentral:2427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secnidazole targets Enzyme (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:9644c54a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:2428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secobarbital targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.578']} DrugCentral uuid:9644fa4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9644fa4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9644fa4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:96453872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.171']} DrugCentral uuid:964564fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.764']} DrugCentral uuid:964591a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:9645be28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:9645ee7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:96461e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:96464adc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:964677dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9646a8b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9646a8b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9646e17c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 seratrodast targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:96470e90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:2433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sermorelin is agonist of GPCR (Growth hormone-releasing hormone receptor) DrugCentral uuid:96473686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:96475e40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertaconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:96478ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:9647b9a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:9647e612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:96481286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.194']} DrugCentral uuid:96484094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:96486cfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:964899fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9648c672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9648f390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:96491fdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:96494c46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:96497a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:9649a9b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:9649d602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:964a03c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:964a30b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:964a5d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:964a8994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:964ab6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:964ae31c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:964b0fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:964b3be6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:964b6c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:964b98fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:964bc570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:964bf23e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:964c1eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:964c4b26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:964c8104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:964c8104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:964c8104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:964cd028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:964cd028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:964cd028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:964d157e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:964d42ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:964d6f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is inverse agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:964d9c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.965']} DrugCentral uuid:964dc8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:964df566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:964e220c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.54']} DrugCentral uuid:964e4e80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:964e7ba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.106']} DrugCentral uuid:964ea812-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.666']} DrugCentral uuid:964ed4a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.246']} DrugCentral uuid:964f024e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:964f2ecc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.082']} DrugCentral uuid:964f5bc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:964f8836-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:964fb4f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:964fe164-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.854']} DrugCentral uuid:96500da6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:96503c0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.187']} DrugCentral uuid:9650686e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:965095f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9650c2e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.475']} DrugCentral uuid:9650f1f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.365']} DrugCentral uuid:96511e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.885']} DrugCentral uuid:96514af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:965177c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:9651a440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9651d0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:9651fdc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:96522596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive modulator of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:96524d82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:9652756e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:96529e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:9652c622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:9652ee18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96535614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9654236e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.526']} DrugCentral uuid:96545000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:96547e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.962']} DrugCentral uuid:9654adc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:9654d714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.026']} DrugCentral uuid:96550374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9655304c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:96555ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.538']} DrugCentral uuid:9655890c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62897 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9655b616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9655e294-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:96560ef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:96563bfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Transporter (Multidrug resistance-associated protein 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:96566c3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9656987e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) DrugCentral uuid:9656c038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9656ecde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9657192a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:96574562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:965771cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13946 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:96579eea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51160 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:9657cb2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76083 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9657f78c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60658 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:965825f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.094']} DrugCentral uuid:96585272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54735 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:96587ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:9658ab5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9658d828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16586 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9659049c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11541 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:965930f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:96595dfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O77746 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:96598ebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:96598ebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:9659d462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9659d462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9659d462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9659d462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:965a3880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:965a3880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:965a3880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:965a3880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:965a930c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:965a930c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:965a930c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:965addbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:965addbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:965b2c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:965b2c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:965b2c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:965b2c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:965b2c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:965b2c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:965ba09e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:965ba09e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:965ba09e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:965be6e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:965c1326-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14099 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:965c3f72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:965c6c54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:965c98b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:965cc514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:965cf17e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:965d1eb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:965d4b4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.73']} DrugCentral uuid:965d77ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:965da704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:965dd5c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:965e0230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:965e2ea4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:965e5b7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:965e880e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:965eb482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:965ee1a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:965f0e32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:965f3bd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21447 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Transporter (P-glycoprotein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:965f68e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:965f9582-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14142 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:965fc200-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:965fe9d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:96601822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:966044aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:9660711e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:96609d92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q10283 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:9660cace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.431']} DrugCentral uuid:9660f738-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:96612398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9661521e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:96617ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:9661ab4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:9661d7a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00688 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9662047a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:966230bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:96625d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13451 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:96628a6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q53EL6 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Nuclear other (Programmed cell death protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9662b6b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06730 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Nuclear other (Eukaryotic translation initiation factor 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9662e336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26883 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:96630f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:2447 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sisomicin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:966339ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14740 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:96636658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:96639470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.774']} DrugCentral uuid:9663c166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28843 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:9663edc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:96641a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:966446ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:966473c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHL4 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:9664a036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9664cc8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:2449 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitafloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:9664f626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P72525 biolink:molecularly_interacts_with DrugCentral:2449 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitafloxacin targets Enzyme (DNA topoisomerase 4 subunit A) DrugCentral uuid:96652038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:96654ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:96657920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9665a616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:9665d262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9665fec2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:96662bb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:96665818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06746 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (DNA polymerase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:9666846e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:9666b1fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9666e18e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:96670e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:96673a6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:2452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sivelestat targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:96676726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24158 biolink:molecularly_interacts_with DrugCentral:2452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sivelestat targets Enzyme (Myeloblastin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9667937c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3UP87 biolink:molecularly_interacts_with DrugCentral:2452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sivelestat targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:9667bfe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9667ec5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:96681a9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.88']} DrugCentral uuid:96684704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9668736e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9668a140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9668cda0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9668fa14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:96692674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:96695400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:96698088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:9669ad10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:9669da1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:966a06a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:966a3316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:966a5f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:966a8e42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:966abaac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:966ae752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:966b143e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:966b40bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:966b6d3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:966b999a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:966bc6c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:966bf336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:966c1faa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:966c4d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:966c7ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:966ca754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:966cd3e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:966d0104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.68']} DrugCentral uuid:966d2ed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:966d5b68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:966d8890-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:966db504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:966de16e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:966e0dd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:966e3b46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:966e67c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:966e941a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:966ec0de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:966eed3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:966f19a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:966f4612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:966f72fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:966f9f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:966fcc68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:966ffad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:96702758-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:967053c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:96708072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9670acd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9670da7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:967106f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9671342c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:967160aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:96718d32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9671ba8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9671e99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:96721612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:96724272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53778 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:96726f4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:96729bbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9672c800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9672f51e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9673217e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:96734df2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:96737a5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9673a87e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9673d632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:96740292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:96742f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:96745bf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:96748866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9674b4da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9674e1e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:96750e58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:96753bc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:967569ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:96759918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9675c596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9675f1e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:96761ed8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96764b24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:967677a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9676a4ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9676d120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9676fe0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15264 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:96772a76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96775988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:967785fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:9677b270-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:9677df48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:96780b9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:967837fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:96786468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:96789190-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9678bdfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9678ea50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:96791822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:96794482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:967970ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:96799e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9679cae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9679f756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49336 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:967a2398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:967a5098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:967a7e42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:967aaaa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00526 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:967ad70c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:967b070e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:967b3634-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:967b62b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:967b8f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:967bbbea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:967be84a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:967c14aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVW4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase-like 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:967c41d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:967c6e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:967c9a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:967cc7ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:967cf44c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:967d20d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:967d4d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:967d7a20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:967da68a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:967dd308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:967e0134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:967e2dbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:967e5a30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:967e86a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:967eb796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5GIT4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:967ee702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:967f1362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8T9Z7 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:967f4030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:967f6c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05622 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:967f9904-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:967fc62c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:967ff2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:96801ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:96804b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:968078ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:9680a538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:2463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9680d18e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09250 biolink:molecularly_interacts_with DrugCentral:2463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9680fe7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XZT6 biolink:molecularly_interacts_with DrugCentral:2463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorivudine targets Kinase (Deoxynucleoside kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:96812c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00142 biolink:molecularly_interacts_with DrugCentral:2463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorivudine targets Kinase (Thymidine kinase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:968158c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:96818548-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9681b2a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:9681df02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:96820b8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:96823948-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.413']} DrugCentral uuid:96826cf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:96826cf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:9682a414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:9682a414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:9682d740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:2468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spectinomycin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:9682ff0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2469 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiclomazine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:96832b78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9683581e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:9683856e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9683b1ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9683de56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:96840c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:96843c34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:96846a42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9684976a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9684c46a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9684f0fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:96851d70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:96854a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.322']} DrugCentral uuid:96857716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9685a3b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9685d026-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9685fd80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:96862a26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:9686569a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:9686835e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.297']} DrugCentral uuid:9686aff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:9686ddc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:96870a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:9687377c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:968763fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:968791c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9687bf4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9687ebc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9688185e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:968844c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:968871a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.87']} DrugCentral uuid:96889e32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9688cab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:968908ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:968908ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:968908ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:968908ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:968908ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:968973fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:968973fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:968973fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:968973fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9689dc5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9689dc5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9689dc5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9689dc5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9689dc5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:968a4476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:968a4476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:968a4476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:968a9232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:968a9232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:968a9232-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:968ae930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:968ae930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:968ae930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:968ae930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:968ae930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:968b46e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02665 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Unclassified (Beta-casein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:968b7486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:968ba104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:968bcd78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spirapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:968bfa32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:2474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spirapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:968c27d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.227']} DrugCentral uuid:968c54be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:968c7caa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.884']} DrugCentral uuid:968ca98c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:968cd600-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.029']} DrugCentral uuid:968d0260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:968d2eac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:968d5c06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:968d887a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.663']} DrugCentral uuid:968db5f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:968de2ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.033']} DrugCentral uuid:968e0ef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.327']} DrugCentral uuid:968e3b62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:968e6876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:968e9062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.948']} DrugCentral uuid:968ebcae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:968ee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:968f1730-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.316']} DrugCentral uuid:968f4386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:2478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stavudine targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:968f6b72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stavudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:968f97c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stavudine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:968fc482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stiripentol targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:968fec5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:2480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stiripentol targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9690189c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stiripentol targets Enzyme (Cytochrome P450 1A2) DrugCentral uuid:9690411e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stiripentol targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:969068e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WH62 biolink:molecularly_interacts_with DrugCentral:2481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 streptomycin targets Ribosomal protein (30S ribosomal protein S12) DrugCentral uuid:969090b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:9690bd24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:9690eb96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:969119a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:96914622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:96917b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:96917b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:96917b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:9691c0f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07727 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9691ee56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYW0 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets GPCR (Taste receptor type 2 member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:96921b56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is agonist of GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.367']} DrugCentral uuid:96924798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:2487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 succinic acid targets Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:96927556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BXA5 biolink:molecularly_interacts_with DrugCentral:2487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 succinic acid is agonist of GPCR (Succinate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9692a1c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:9692e1b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:9692e1b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:9692e1b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:9692e1b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:9692e1b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:969334f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:969361be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:96938df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:9693ba88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:9693e76a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:969413ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96944cdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:96944cdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:96944cdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:96944cdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:9694a1aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:9694cf0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9694fb96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9695285a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:969554e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:969581c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:9695af50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9695dc6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13661 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase OXA-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:969608ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:96963542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:96966328-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:96969154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:9696bdaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9696ea0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:969716ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7X575 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:96974310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0VTR6 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:96976f7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0VTR8 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:96979c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D5HSX5 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9697c8b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P83111 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Serine beta-lactamase-like protein LACTB, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9697f4f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62594 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:969822a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0VTS0 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (ADC-18 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:96985278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00809 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:96987ed8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9698ab24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9698d86a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.819']} DrugCentral uuid:969904f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.155']} DrugCentral uuid:9699315c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:96995db2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:96998ae4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:9699b74e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.716']} DrugCentral uuid:9699e3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:969a1252-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.786']} DrugCentral uuid:969a422c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.977']} DrugCentral uuid:969a6eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.053']} DrugCentral uuid:969a9b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.142']} DrugCentral uuid:969ac800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.258']} DrugCentral uuid:969af474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.727']} DrugCentral uuid:969b20f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.144']} DrugCentral uuid:969b4e38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:969b7aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:969ba716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:969bd3a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:969bff36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:969c2dc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:969c5a30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:969c86d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:969cb340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:969cdf96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.431']} DrugCentral uuid:969d0bec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.738']} DrugCentral uuid:969d38f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:969d6542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:969d9198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.782']} DrugCentral uuid:969dbf74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:969debac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:969e180c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:969e443a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfacetamide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:969e70fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfacetamide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:969e98b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:2497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfacetamide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:969ec7ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q25704 biolink:molecularly_interacts_with DrugCentral:2499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfacytine is inhibitor of Kinase (7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase) DrugCentral uuid:969ef01a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:969f1c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:969f48b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08210 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) DrugCentral uuid:969f7094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:969f9ad8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:969fc828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZV3 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:969ff47e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadimethoxine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.206']} DrugCentral uuid:96a02156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadimidine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96a04924-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadimidine targets Enzyme (Lactoylglutathione lyase) DrugCentral uuid:96a07110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q25704 biolink:molecularly_interacts_with DrugCentral:2503 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadoxine is inhibitor of Kinase (7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase) DrugCentral uuid:96a098e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IAU3 biolink:molecularly_interacts_with DrugCentral:2503 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadoxine targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:96a0c5f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:2504 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaethidole targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:96a0f248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaguanidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:96a12736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:96a12736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:96a12736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:96a16ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2510 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamerazine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96a19694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfameter is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96a1be76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethizole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96a1e644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08192 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole targets Enzyme (Bifunctional protein FolC) DrugCentral uuid:96a20e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole is inhibitor of Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:96a23b08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:96a2675e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:96a2949a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:96a2c0f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfalene is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96a2e8d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:96a31550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:96a3441c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:96a37090-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:96a39d0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:96a3c9e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96a3f1be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:96a41e1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:96a44a74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:96a47788-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:96a4a410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96a4d264-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:96a4fff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:96a52cfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:96a55982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:96a585ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:96a5b2ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:96a5df38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:96a60bc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:96a638de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:96a66552-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:96a691d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:96a6be4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:96a6ec7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:96a718f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:96a7456c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:96a77244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:96a79eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:96a7cc26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:96a7f908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:96a82644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00921 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:96a8529a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:96a87f22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:96a8ac7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:96a8d8fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaphenazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:96a90564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaphenazole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96a92d3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfapyridine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96a95582-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q49184 biolink:molecularly_interacts_with DrugCentral:2524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfapyridine targets Enzyme (Dihydropteroate synthase type-1) DrugCentral uuid:96a97d5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:96a9a9ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:96a9d638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24752 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Acetyl-CoA acetyltransferase, mitochondrial) DrugCentral uuid:96a9fece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:96aa26a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Transporter (Cystine/glutamate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:96aa5306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:96aa80ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.707']} DrugCentral uuid:96aaad10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.628']} DrugCentral uuid:96aad97a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.533']} DrugCentral uuid:96ab05ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine is inhibitor of Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:96ab33f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.768']} DrugCentral uuid:96ab605c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.198']} DrugCentral uuid:96ab9144-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:96ab9144-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:96abc4c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:96abf120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:96ac1d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfathiazole is inhibitor of Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:96ac4b20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:2527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfathiazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.161']} DrugCentral uuid:96ac7a96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfathiazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:96aca700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25084 biolink:molecularly_interacts_with DrugCentral:2527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfathiazole targets Unclassified (Transcriptional activator protein LasR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:96acd34c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfinpyrazone targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:96acfb60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfinpyrazone targets GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:96ad27de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:2528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfinpyrazone is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:96ad542a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfinpyrazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:96ad808a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:96adad76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08210 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) DrugCentral uuid:96add53a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:96adfcfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:96ae2a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:96ae56ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:96ae834a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60760 biolink:molecularly_interacts_with DrugCentral:2531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfobromophthalein targets Enzyme (Hematopoietic prostaglandin D synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:96aeafaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulforidazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.611']} DrugCentral uuid:96aedc6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulforidazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:96af0900-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C0X1 biolink:molecularly_interacts_with DrugCentral:2533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesulfone is inhibitor of Enzyme (Dihydropteroate synthase 1) DrugCentral uuid:96af30c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesulfone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:96af58b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:96af85e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:96afb242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:96afde7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:96b00bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:96b03848-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (72 kDa type IV collagenase) DrugCentral uuid:96b06002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:96b08c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.362']} DrugCentral uuid:96b0b8e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:96b0e61c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:96b112fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:96b13fd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:96b16d62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:96b199cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:96b1c622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.307']} DrugCentral uuid:96b1f570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:96b221e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.857']} DrugCentral uuid:96b24e4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.508']} DrugCentral uuid:96b27b1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:96b2a786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.146']} DrugCentral uuid:96b2d3fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.606']} DrugCentral uuid:96b3005a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.053']} DrugCentral uuid:96b32d6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.965']} DrugCentral uuid:96b359c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.009']} DrugCentral uuid:96b3864c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.196']} DrugCentral uuid:96b3b4aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:96b3e40c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.426']} DrugCentral uuid:96b41076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:96b43cfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:96b469cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:96b4962c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:96b4c278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.141']} DrugCentral uuid:96b4efa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.645']} DrugCentral uuid:96b51bec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:96b54996-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:96b5760a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.121']} DrugCentral uuid:96b5a404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:96b5d078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96b5fcf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:96b62992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:96b6561a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:96b6827a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:96b6aee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:96b6dbee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:96b70862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:96b734a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:96b761fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:96b78eea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:96b7bb5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:96b7e976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GJU1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:96b815fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:96b84268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:96b86ef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:96b89bfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:96b8c85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:96b8f4c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:96b921ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:96b94e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:96b97ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:96b9a748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:96b9d524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:96ba1278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96ba1278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96ba1278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96ba1278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96ba1278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96ba718c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:96ba9e1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:96bacab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:96baf80a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:96bb27b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:96bb541c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:96bb80ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:96bbadc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:96bbda40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:96bc06c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.38']} DrugCentral uuid:96bc33c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:96bc605a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:96bc8cce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:96bcb94c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:96bce818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:96bd148c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:96bd410a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:96bd6df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:96bd9a60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:96bdc6b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:96bdf4b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:96be22fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:96be4f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:96be7c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:96bea9d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:96bed6b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:96bf033c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:96bf2f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2541 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.571']} DrugCentral uuid:96bf5cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2541 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultopride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:96bf891a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:96bfb58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:96bfe270-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:96c00eda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:96c03b30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:96c067b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:96c096e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:96c0bfe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:96c0e7c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:96c10fc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:96c1388c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:96c16082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:96c18878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:96c1b0e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:96c1d8e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79400 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:96c200d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:96c229b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:96c252f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:96c27df0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:96c2a7da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N2B7 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:96c2cfe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8MI13 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets Unclassified (5-hydroxytryptamine 1D receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:96c2f87a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:96c3207a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:96c3488e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:96c37070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:96c398d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.12']} DrugCentral uuid:96c3c0f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:96c3e8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:96c4117e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:96c43c80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96c46872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:96c490ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:96c4b8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:96c4e176-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.66']} DrugCentral uuid:96c5099e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:96c531e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:96c55a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:96c582ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:96c5aaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:96c5d2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:96c5fc3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:96c62888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:96c65330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:96c67b3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96c6a3ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:96c6cbe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:96c6f3e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:96c71be4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:96c7477c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:96c76f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:96c79790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:96c7bfa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:96c7ea7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:96c8127e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:96c83a9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:96c862ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:96c88b6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:96c8b382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:96c8dba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:96c9042c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:96c92c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:96c9544a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:96c97c36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:96c9a594-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:96c9cfe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:96c9f7ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:96ca2104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:96ca4aee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:96ca7384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.26']} DrugCentral uuid:96ca9ba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:96cac398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:96caec1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:96cb1424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:96cb3c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:96cb6424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:96cb8e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:96cbb690-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:96cbde90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:96cc069a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:96cc2f62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:96cc576c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:96cc7f76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:96cca780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:96cccfee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:96ccf7e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:96cd2002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:96cd48fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:96cd7156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:96cd9960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:96cdc160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:96cdea1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96ce1318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.26']} DrugCentral uuid:96ce3b40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:96ce6340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:96ce8bae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:96ceb3b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:96cedbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2H1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 38-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96cf03d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:96cf2e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:96cf56e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:96cf7ee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:96cfa6f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:96cfcf96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:96cff7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:96d01fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:96d048e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:96d07162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:96d09976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:96d0c180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:96d0e99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:96d114aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:96d13d4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:96d16554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:96d18e26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:96d1b63a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:96d1de58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:96d2075c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:96d22fde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:96d257de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:96d27ffc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:96d2a810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:96d2d0b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JI10 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:96d2f8ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:96d320d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:96d348e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96d3716e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:96d39982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:96d3c1b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:96d3e9be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:96d412ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:96d43ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:96d462d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:96d48ae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:96d4b5ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:96d4df7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:96d50790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:96d52f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:96d5588a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:96d58094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:96d5a89e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:96d5d094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:96d5f9fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:96d621f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:96d64b28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:96d67468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:96d69ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:96d6c4c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:96d6ece0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:96d7158a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:96d73da8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:96d765bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:96d78dda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:96d7b6d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:96d7defc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N752 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform alpha-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:96d806f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:96d82f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78368 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:96d85828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:96d88046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:96d8a85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:96d8d06e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:96d8f922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:96d9210e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:96d94922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:96d9712c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:96d9999a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:96d9c1ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:96d9eabc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:96da12c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:96da3c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:96da6442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:96da8c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:96dab532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:96dadd50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:96db0532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:96db2d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:96db55b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:96db7db4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:96dba5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:96dbcdb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:96dbf6ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:96dc1eb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:96dc4802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:96dc7020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:96dc98ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:96dcc0f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:96dce8fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:96dd1124-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:96dd399c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:96dd619c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:96dd8992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:96ddb1a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:96dddbb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:96de03cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:96de2bd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:96de546c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDC3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase BRSK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:96de7d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:96dea50c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:96decd0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:96def516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:96df1dac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:96df45ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:96df6dc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16566 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:96df9674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11799 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:96dfbf0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:96dfe70a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:96e00f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:96e037a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:96e05fbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:96e087be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCP0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:96e0afdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:96e0d868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:96e10072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:96e1287c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:96e15072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:96e179a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:96e1a194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IWQ3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase BRSK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:96e1ca98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:96e1f2a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:96e21b38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:96e24496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:96e26ca0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:96e294a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:96e2bd36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:96e2e536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96e30d54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:96e3355e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:96e360ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:96e38c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:96e3b448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:96e3dd06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:96e4051a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:96e42d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:96e4552e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:96e47d9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:96e4a592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:96e4cd9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80370 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Unclassified (Protein delta homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:96e4f628-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:96e51f36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:96e54740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:96e56f54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:96e59772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:96e5c0da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:96e5e8e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:96e610ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:96e63902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:96e66170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:96e6897a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:96e6b198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:96e6d9ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:96e70436-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:96e72c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:96e7545e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:96e77c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:96e7a508-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:96e7cd1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15208 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:96e7f51c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:96e81d12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:96e846ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43172 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Nuclear other (U4/U6 small nuclear ribonucleoprotein Prp4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:96e86ee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:96e896e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.23']} DrugCentral uuid:96e8c028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:96e8e850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:96e91050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:96e9385a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:96e960e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:96e989f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:96e9b1fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:96e9da12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:96ea028a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:96ea2a94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:96ea529e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:96ea7a9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96eaa49c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:96eaccba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:96eaf4ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.05']} DrugCentral uuid:96eb1ca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:96eb4532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:96eb6d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:96eb955a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:96ebbd78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:96ebe604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:96ec0e9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRH2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (SNF-related serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:96ec36ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:96ec5ecc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:96ec8a96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:96ecb5d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:96ece11c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:96ed0c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:96ed3428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H8M2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Unclassified (Bromodomain-containing protein 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:96ed5c46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:96ed8540-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.509']} DrugCentral uuid:96edadb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:96edd5d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.229']} DrugCentral uuid:96edfdea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.959']} DrugCentral uuid:96ee25f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:96ee5088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:96ee7888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suprofen targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.347']} DrugCentral uuid:96eea0b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47872 biolink:molecularly_interacts_with DrugCentral:2548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secretin human is agonist of GPCR (Secretin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:96eec89c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:96eef10a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:96ef18f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:96ef4114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:96ef6932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:96ef91a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04844 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Acetylcholine receptor subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:96efb996-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:96efe182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:96f00978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:96f03524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:96f05d24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:96f0851a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:96f0ad60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:96f0d54c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:96f0fd38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:96f1254c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32738 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Choline O-acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:96f14dc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:96f176a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:96f19ebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:96f1c6c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:96f1f044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01984 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Histamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:96f2183a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:96f24058-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:96f26858-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.61']} DrugCentral uuid:96f294c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:96f294c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:96f2cbea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:96f2cbea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:96f30e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:96f30e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:96f30e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:96f30e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:96f30e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:96f362c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.91']} DrugCentral uuid:96f38ac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:96f3b3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:96f3df44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:96f4073a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:96f42f1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:96f45794-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.398']} DrugCentral uuid:96f47f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P60568 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Cytokine (Interleukin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.72']} DrugCentral uuid:96f4a794-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48454 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:96f4d0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:96f4f92e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:96f52138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:96f54956-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13451 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:96f57174-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15393 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Nuclear other (Splicing factor 3B subunit 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:96f59adc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96AY3 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:96f5c2e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:96f5eafa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:96f612fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:96f63b7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:96f6637c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54735 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:96f68b90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:96f6b386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11541 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:96f6ef40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96f6ef40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96f6ef40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96f6ef40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96f6ef40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96f6ef40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:96f761be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:96f761be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:96f761be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:96f761be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:96f761be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:96f761be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:96f7ca3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f82c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:96f8e37c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:96f90b90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:96f93390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:96f95b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:96f98516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:96f9ad48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:96f9d5a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:96f9fdac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.915']} DrugCentral uuid:96fa25a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:96fa4d98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:96fa75fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:96fa9ee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:96fac6e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:96faeece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:96fb185e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:96fb431a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:96fb6b1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:96fb9ad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:96fb9ad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:96fb9ad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:96fbd938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:2560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 taltirelin is agonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:96fc0138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.807']} DrugCentral uuid:96fc291a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.001']} DrugCentral uuid:96fc516a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:96fc7960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.357']} DrugCentral uuid:96fca14c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:96fcc94c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.372']} DrugCentral uuid:96fcf3b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.335']} DrugCentral uuid:96fd1bc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:96fd43b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.139']} DrugCentral uuid:96fd6ba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:96fd9412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:96fdbbfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:96fde3fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:96fe0c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.907']} DrugCentral uuid:96fe3480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:96fe5d8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.158']} DrugCentral uuid:96fe858e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:96feadb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:96fed6d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.618']} DrugCentral uuid:96feff00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:96ff278c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.794']} DrugCentral uuid:96ff4faa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:96ff7818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.034']} DrugCentral uuid:96ffa022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.167']} DrugCentral uuid:96ffc818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.557']} DrugCentral uuid:96fff086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:9700187c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:97004090-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.731']} DrugCentral uuid:97006872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:970091ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.238']} DrugCentral uuid:9700ba48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.835']} DrugCentral uuid:9700e248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.858']} DrugCentral uuid:97010a3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:970132a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:97015a98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.407']} DrugCentral uuid:970182a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.611']} DrugCentral uuid:9701aa98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.204']} DrugCentral uuid:9701d32e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:9701fb2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:97022324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.328']} DrugCentral uuid:97024c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:97027694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9702a1aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Estrogen-related receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9702ccf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.449']} DrugCentral uuid:9702f8b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.069']} DrugCentral uuid:97032134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.095']} DrugCentral uuid:97034920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.923']} DrugCentral uuid:97037134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:9703998e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.038']} DrugCentral uuid:9703c1a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9703e9a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.913']} DrugCentral uuid:970411b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.821']} DrugCentral uuid:97043ac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.919']} DrugCentral uuid:970462ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.533']} DrugCentral uuid:97048ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.604']} DrugCentral uuid:9704b300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.761']} DrugCentral uuid:9704db6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.419']} DrugCentral uuid:9705040e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.515']} DrugCentral uuid:97052c0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.587']} DrugCentral uuid:9705540e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:97057c5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:9705a45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9705cc54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.061']} DrugCentral uuid:9705f454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY08 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Emopamil-binding protein-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:970621ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBM7 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Anti-estrogen binding site (AEBS)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:970621ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBM7 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Anti-estrogen binding site (AEBS)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:97065624-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:97067e38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9706a6ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.87']} DrugCentral uuid:9706cf14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9706f71e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:97071f32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.54']} DrugCentral uuid:970747aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:97076fbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:970797d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.24']} DrugCentral uuid:9707bfdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:9707e886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:9708109a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:970838ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:970860ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:97088958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9708bcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9708bcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9708bcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9708bcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:97090766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tandospirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:97092fca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tandospirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:97095838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tandospirone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:97098074-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:2571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9709a874-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:2571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9709d45c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9709fc48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:970a242a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.527']} DrugCentral uuid:970a4cb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.602']} DrugCentral uuid:970a7538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:970a9d24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59401 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:970ac510-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:970aed74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10424 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.524']} DrugCentral uuid:970b1556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q46991 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (IMI-1; IMI-1 carbapenemase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:970b3d4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:970b6542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6W9J1 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:970b8e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:970bb61e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P94958 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:970bde14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05193 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:970c0600-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4KCT8 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:970c2e8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:970c5664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:970c7e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:970ca65a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9F663 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Carbepenem-hydrolyzing beta-lactamase KPC) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:970cced2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:970cf6b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:970d1ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD64 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:970d468c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6GWS8 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:970d7094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:970d9b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0ZX81 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:970dc300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:970debfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B8R6A5 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:970e14a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2XPY6 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:970e3c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:970e6468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:970e8d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q670S6 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:970eb5ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:970eddc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 1A) DrugCentral uuid:970f01a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:970f29a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 1D) DrugCentral uuid:970f4e3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:970f765a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod is partial agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:970f9e78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:2580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teicoplanin aglycone is inhibitor of Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:970fc66e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:970fef22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:97101722-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:97103fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.31']} DrugCentral uuid:971067a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:97108ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:9710b7f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9710dff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:97110920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:97113116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temazepam targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:97115ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:97115ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:97115ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:971193fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temocapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.444']} DrugCentral uuid:9711bd98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temocapril is inhibitor of Enzyme (Angiotensin-converting enzyme) DrugCentral uuid:9711e160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:97120550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:9712292c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:97124d58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:97127120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide targets Transporter (Canalicular multispecific organic anion transporter 2) DrugCentral uuid:971294fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenofovir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9712bcf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:2592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenofovir targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9712e592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:2593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenofovir disoproxil targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:97130978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenofovir disoproxil is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:97132d36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2595 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenoxicam targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:97135112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2595 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenoxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.943']} DrugCentral uuid:971379b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.67']} DrugCentral uuid:9713a1d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.628']} DrugCentral uuid:9713c9b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.388']} DrugCentral uuid:9713f2de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:97141b4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:97144374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:9714673c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.662']} DrugCentral uuid:97148f46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52020 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:9714b890-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2598 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbutaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9714e0fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2598 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbutaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:971508fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.373']} DrugCentral uuid:971530fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:9715599e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.895']} DrugCentral uuid:971581bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.433']} DrugCentral uuid:9715a9bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:9715d37e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.216']} DrugCentral uuid:9715fc00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.599']} DrugCentral uuid:9716240a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.632']} DrugCentral uuid:97164c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.438']} DrugCentral uuid:9716743c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:97169e44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:9716c66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.862']} DrugCentral uuid:9716ee62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.338']} DrugCentral uuid:97171680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.511']} DrugCentral uuid:97173f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.718']} DrugCentral uuid:97176752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.504']} DrugCentral uuid:97178f48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:9717b748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.362']} DrugCentral uuid:9717dfc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:971807de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:97182bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.666']} DrugCentral uuid:971853c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.963']} DrugCentral uuid:97187caa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9718a4b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9718ccaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.612']} DrugCentral uuid:9718f536-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.102']} DrugCentral uuid:97191d5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.389']} DrugCentral uuid:97194572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:97196d7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:971995ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9719bed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.874']} DrugCentral uuid:9719e806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.687']} DrugCentral uuid:971a1024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:971a398c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:971a61dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.719']} DrugCentral uuid:971a89f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:971ab1fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:971adacc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:971b02e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:971b2af4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:971b5308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:971b7c20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:971ba416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:971bcc34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.693']} DrugCentral uuid:971bf434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.448']} DrugCentral uuid:971c1efa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:971c4902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.213']} DrugCentral uuid:971c710c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51589 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Enzyme (Cytochrome P450 2J2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:971c9916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:971cc1de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:971ce9c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.734']} DrugCentral uuid:971d11ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:971d39d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:971d69f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:971d69f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:971d69f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:971da946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:971dd128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:971dfa22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:971e2236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:971e4a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:971e725e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:971e9b08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:971ec326-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:971eeb3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:971f13a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:971f3bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:971f63c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:971f8d10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:971fb68c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:971fe1a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:97200a10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:97203206-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:97205aba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:972082d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:9720aace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9720d2e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:9720fb46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:97212364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:97214b78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terodiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:97217440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.087']} DrugCentral uuid:97219ede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:9721c710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:9721ef2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97221738-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97224096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:2606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testolactone is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:972268aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:972290be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:9722b922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:9722e118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:97230918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:97233136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:97235a58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:97238352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:9723ab70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.599']} DrugCentral uuid:9723d38e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9724002a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9724002a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9724334c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35627 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Nuclear hormone receptor (Constitutive androstane receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:97245b56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2608 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone undecanoate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:97247f1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:9724a778-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:9724cf78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:9724f782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97251f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27963 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:97254bc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:97257838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9725a894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:9725a894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:9725a894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:9725e746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:97260f5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.153']} DrugCentral uuid:97263764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.011']} DrugCentral uuid:97265f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.766']} DrugCentral uuid:97268804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9726aff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (Sodium channel protein type 8 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9726d818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:97270158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.499']} DrugCentral uuid:97272c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00194 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (cGMP-gated cation channel alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:97275d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:97275d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:97275d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9727a3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9727a3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9727a3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9727e1ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:2611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:972805b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:2611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:9728297a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29475 biolink:molecularly_interacts_with DrugCentral:2612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sapropterin targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.95']} DrugCentral uuid:972851f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00439 biolink:molecularly_interacts_with DrugCentral:2612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sapropterin is activator of Enzyme (Phenylalanine-4-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:97287ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:9728a2ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9728cb00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9728f422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:2615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:97291c2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:97294418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.432']} DrugCentral uuid:97296c0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:972994a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9729bc9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9729e49a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:972a0d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.393']} DrugCentral uuid:972a353a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:972a5d44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.85']} DrugCentral uuid:972a8558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:972aafce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:972ad80a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:972b003c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:972b283c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:972b50a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:972b7896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:972ba0a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:972bc8b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:972bf104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:972c1922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:972c4136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:972c6e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:972c6e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:972ca428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:972cd7d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:972cd7d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:972cd7d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:972cd7d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:972d290c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:972d290c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:972d290c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:972d66f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:972d8f0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60614 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:972db76e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS9 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Unclassified (Transmembrane domain-containing protein TMIGD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:972ddffa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.22']} DrugCentral uuid:972e0818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:972e2fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09508 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial) DrugCentral uuid:972e552a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:972e804a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:972eaade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AE18 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:972ed2de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:972f02ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f02ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f02ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f5114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f5114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f5114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f5114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f5114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f5114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972f5114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:972fb190-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:2624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamphenicol targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:972fd56c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamphenicol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:972ffd58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:2624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamphenicol targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9730602c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:9731154e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:97313d62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:973165e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:97318dda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:9731b5e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:9731dde4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:9732077e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97322fec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:973258f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:973280f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:9732a954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:9732cd1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:9732f0f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:973314ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:97333a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:97335e08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9733861c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9733ae12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.221']} DrugCentral uuid:9733d784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.912']} DrugCentral uuid:9733ff8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:9734236a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:97344746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) DrugCentral uuid:97346b04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:9734935e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) DrugCentral uuid:9734b726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00492 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) DrugCentral uuid:9734db84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.258']} DrugCentral uuid:9735037a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.792']} DrugCentral uuid:97352be8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26281 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Kinase (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.75']} DrugCentral uuid:97355bd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:97355bd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:97355bd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9735ce22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:97369e4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63734 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental is gating inhibitor of Ion channel (Potassium voltage-gated channel subfamily C member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9736c62e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioproperazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.347']} DrugCentral uuid:9736ee88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioproperazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:97371688-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:97373a5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:97376372-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:97378d52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.872']} DrugCentral uuid:9737b55c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:9737dd5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9738052a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:97382dc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.813']} DrugCentral uuid:973855b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:97387dc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9738a5ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:9738cf14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9738f71e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:97391f1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9739471e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9739728e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.466']} DrugCentral uuid:97399d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9739c50e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9739edcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:973a15d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.866']} DrugCentral uuid:973a3db8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:973a65ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.569']} DrugCentral uuid:973a8e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:973ab612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.595']} DrugCentral uuid:973ade12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:973b0612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:973b2ed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:973b56b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:973b7ebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:973ba6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.126']} DrugCentral uuid:973bcf48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.774']} DrugCentral uuid:973bf748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.751']} DrugCentral uuid:973c1f20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:973c4734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.686']} DrugCentral uuid:973c6f7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:973c9784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:973cc0e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:973ce8ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:973d12d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.712']} DrugCentral uuid:973d3c16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.531']} DrugCentral uuid:973d63f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.195']} DrugCentral uuid:973d8bee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.297']} DrugCentral uuid:973db484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:973ddc66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:973e0466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.284']} DrugCentral uuid:973e2c7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:973e54ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:973e7cc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:973ea4ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:973ecd60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:973ef74a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:973f1f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:973f56cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:973f56cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:973f56cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:973f56cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:973f56cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:973fb752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:973fb752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:973fb752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:973fb752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:97400964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:97400964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:97400964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:974056da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:974056da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:974056da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:974056da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:974056da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9740b4b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9740b4b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9740b4b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9740fae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9740fae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9740fae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:974138f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:97416386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2638 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiotepa is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:97418b90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.292']} DrugCentral uuid:9741b3c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.347']} DrugCentral uuid:9741dc3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:97420458-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:97422c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:97425476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:97427dca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:9742a728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.681']} DrugCentral uuid:9742cf28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.817']} DrugCentral uuid:9742f82c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.94']} DrugCentral uuid:974320c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:974348c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.412']} DrugCentral uuid:974370cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.583']} DrugCentral uuid:974398e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:9743c144-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.386']} DrugCentral uuid:9743e93a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.585']} DrugCentral uuid:97441130-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:97443930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:9744637e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:97448b74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.318']} DrugCentral uuid:9744b36a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:9744db56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.181']} DrugCentral uuid:97450400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:97452c0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.693']} DrugCentral uuid:9745540a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:97457c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:9745a482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.442']} DrugCentral uuid:9745cc8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor alpha) DrugCentral uuid:9745f068-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:97461868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:9746411c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:97466912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:974690fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Unclassified (THAP domain-containing protein 1) DrugCentral uuid:9746b4da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:9746de6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40926 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Enzyme (Malate dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:9747067e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:2648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiagabine is inhibitor of Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:97472fd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23978 biolink:molecularly_interacts_with DrugCentral:2648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:9747584a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31648 biolink:molecularly_interacts_with DrugCentral:2648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:97478068-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31651 biolink:molecularly_interacts_with DrugCentral:2648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent betaine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9747b04c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:9747b04c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:9747b04c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:9747f764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9747f764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9747f764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:97483878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tianeptine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:9748608c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.077']} DrugCentral uuid:97488896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.108']} DrugCentral uuid:9748b140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.756']} DrugCentral uuid:9748d94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiapride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:97490168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiaprofenic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9749295e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiaprofenic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:974951cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.317']} DrugCentral uuid:974979d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:9749a1e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:9749c5b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:9749ea4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:974a121a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Enzyme (Steryl-sulfatase) DrugCentral uuid:974a35ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.123']} DrugCentral uuid:974a5df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.542']} DrugCentral uuid:974a879a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:974ac336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:974ac336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:974ac336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:974ac336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:974ac336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:974ac336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:974ac336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:974b2312-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:974b4afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:974b72e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:974b9aea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.747']} DrugCentral uuid:974bc628-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.857']} DrugCentral uuid:974bee1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.767']} DrugCentral uuid:974c1740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.201']} DrugCentral uuid:974c3fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:974c67b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:974c8fcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine is antagonist of GPCR (P2Y purinoceptor 12) DrugCentral uuid:974cb39e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.175']} DrugCentral uuid:974cdc02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:974d0402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:974d2bf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:974d53e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tienilic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.494']} DrugCentral uuid:974d7c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tilidine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:974da470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:2664 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiliquinol targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:974dcc5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) DrugCentral uuid:974df02e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13488 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (V-type proton ATPase 116 kDa subunit a isoform 3) DrugCentral uuid:974e14c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:974e3da4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50281 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (Matrix metalloproteinase-14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:974e65c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:974e8dcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tinoridine is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.987']} DrugCentral uuid:974eb630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O69638 biolink:molecularly_interacts_with DrugCentral:2673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiocarlide targets Enzyme (Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:974ede26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2675 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:974f01ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:2675 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:974f29e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiopronin targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:974f5338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:974f7db8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:974fa5c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11.1']} DrugCentral uuid:974fcda4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:974ff658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:97501e4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:9750464e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:97506e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:975096a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1PT23 biolink:molecularly_interacts_with DrugCentral:2678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9750bf16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1PWR7 biolink:molecularly_interacts_with DrugCentral:2678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.94']} DrugCentral uuid:9750e72a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F1PGZ2 biolink:molecularly_interacts_with DrugCentral:2678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:97510f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiracizine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:97513e50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:2680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirofiban is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:97513e50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:2680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirofiban is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:97517190-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:97519972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine is agonist of GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:9751bf6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:9751e760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9752105a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:9752385a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9752608c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:2684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tobramycin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.824']} DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9752ab46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:97532652-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2693 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofisopam targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:97534e48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2693 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofisopam targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9753763e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazamide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.292']} DrugCentral uuid:9753a2da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) DrugCentral uuid:9753a2da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) DrugCentral uuid:9753d070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9753f87a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:97542098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9754491a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:97547124-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:9754a0fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9754a0fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9754a0fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9754e8de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9754e8de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9754e8de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9755281c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:2696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolbutamide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:9755501c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:2696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolbutamide is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:97557c72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:97557c72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:9755af8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.69']} DrugCentral uuid:9755d776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:9756011a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:9756291a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13118 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets Nuclear other (Krueppel-like factor 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9756517e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:9756799c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.569']} DrugCentral uuid:9756a2aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9756cabe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9756f2aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:97571ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:97574304-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:97576b18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:9757932c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9757bb2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9757e3a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:97580bcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:975833ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.667']} DrugCentral uuid:97585ba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:2701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolonium targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:97588516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:2701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolonium targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:9758ad02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9758d5e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9758fe06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:97592688-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:97594eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:975976a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolperisone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.253']} DrugCentral uuid:97599ea6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolperisone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:9759c6f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70634 biolink:molecularly_interacts_with DrugCentral:2703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolperisone targets Unclassified (SMR1-alpha3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:9759ef0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70635 biolink:molecularly_interacts_with DrugCentral:2703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolperisone targets Unclassified (BetaB2-crystallin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.474']} DrugCentral uuid:975a16e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:975a3ee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:975a684a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80276 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:975a902c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:975ab822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:975ae054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:975b084a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q91WR5 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldo-keto reductase family 1 member C21) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:975b305e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:975b5868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat is inhibitor of Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.509']} DrugCentral uuid:975b80b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:975ba8c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:975bd0ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.57']} DrugCentral uuid:975bfa2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:975c2414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:975c4fe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:975c7aa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:975ca2cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:975ccc48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:975cf45c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:975d1c70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:975d4484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:975d68ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:975d8c96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:975db07c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:975dd886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:975e0216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:975e2a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:975e522a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:975e7a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:975ea8ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:975ed0e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:975ef8f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:975f20e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:975f495a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:975f715a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:975f9964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:975fc24a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:975feaae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27139 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:976012a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:97603aae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.63']} DrugCentral uuid:97606326-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:97608b44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:9760b358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9760dc84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:976104fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:97612d24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:97615524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97617dc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9761a754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9761d08a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:9761f8a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:976220c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:97624948-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:97627936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:97627936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:97627936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:9762b428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9762b428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9762f74e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:9762f74e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:9762f74e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:9762f74e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:9762f74e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:97634d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:97634d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:97634d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:97634d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:97638f38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:9763b738-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:9763df4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.818']} DrugCentral uuid:97640760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:97642c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:97644fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:976473b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:97649770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:9764bbba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan is inhibitor of Enzyme (DNA topoisomerase I, mitochondrial) DrugCentral uuid:9764df82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.58']} DrugCentral uuid:9765076e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:97652f64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:976559f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:976583e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9765abba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04750 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Enzyme (DNA topoisomerase I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9765d388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:9765fbce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WIQ1 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Enzyme (UDP-galactopyranose mutase) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:976623a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 torsemide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:97664b92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toremifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:97667388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toremifene is modulator of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:976698d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:2709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toremifene targets Nuclear hormone receptor (Estrogen-related receptor gamma) DrugCentral uuid:9766bcc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05320 biolink:molecularly_interacts_with DrugCentral:2709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toremifene targets Unclassified (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:9766e4c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:97670d70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:97673886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:97676086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:976788a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:9767b0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:9767d958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:97680162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trandolapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:97682976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranexamic acid is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:976852d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60760 biolink:molecularly_interacts_with DrugCentral:2714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranilast targets Enzyme (Hematopoietic prostaglandin D synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:97687ac0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.229']} DrugCentral uuid:9768a2b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.225']} DrugCentral uuid:9768caca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:9768f482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:97691f3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9769472a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:97696f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97699856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9769c042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.88']} DrugCentral uuid:9769e842-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:976a1042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:976a387e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:976a606a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:976a887e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:976ab092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NB78 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Lysine-specific histone demethylase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:976adac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:976b02b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 travoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:976b2ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:2716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 travoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:976b52a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.428']} DrugCentral uuid:976b7ba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:976ba394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:976bcb8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.033']} DrugCentral uuid:976bf380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:976c1bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:976c44c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:976c6de2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:976c9754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:976cbf5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:976ce75e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:976d0f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.749']} DrugCentral uuid:976d37ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.551']} DrugCentral uuid:976d5fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:976d87a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.896']} DrugCentral uuid:976dafa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:976dd7fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.483']} DrugCentral uuid:976dfff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:976e27ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:976e4ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:976e7970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.153']} DrugCentral uuid:976ea166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:976ec970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:976ef170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.081']} DrugCentral uuid:976f19f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.083']} DrugCentral uuid:976f41f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:976f69d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:976f91ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:976fba2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:976fe22e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:97700a38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:97703332-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:97705dd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:977085c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:9770add0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9770d5a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:9770fe3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.642']} DrugCentral uuid:97712648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:97714e5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:97717698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Enzyme (11-cis retinol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97719e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35398 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9771c684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9771ee84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:977217f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:9772447e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:97726fee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:977297f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9772c070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92753 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is antagonist of Nuclear hormone receptor (Nuclear receptor ROR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.82']} DrugCentral uuid:9772e866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:97731048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9773383e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40220 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:97736098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:977388a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9773b098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62965 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9773d8ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22935 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:977403cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11416 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:97742be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:977453d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22605 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:97747be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18911 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9774a462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:9774cc58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9774f444-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49116 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear other (Nuclear receptor subfamily 2 group C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:97751c4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13526 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Unclassified (Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:977544bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear other (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:97756c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.27']} DrugCentral uuid:97759480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:9775bdc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9775e872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:9776109a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.76']} DrugCentral uuid:9776404c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:9776404c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:9776404c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:97768e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97768e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97768e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97768e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97768e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9776f5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9776f5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9776f5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9776f5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9776f5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9776f5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:97775f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97775f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97775f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97779fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:9777c84a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone targets Cytosolic other (Annexin A1) DrugCentral uuid:9777ec12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:97781016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone acetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9778383e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone acetonide targets Cytosolic other (Annexin A1) DrugCentral uuid:97785c10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone acetonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:97788424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2727 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone diacetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:9778a7ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Transporter (Solute carrier family 12 member 1) DrugCentral uuid:9778ccb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9778f4ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.436']} DrugCentral uuid:97791ca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08311 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Enzyme (Cathepsin G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:97794472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:97797672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97797672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97797672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9779b628-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:9779de14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.879']} DrugCentral uuid:977a068c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:977a363e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:977a363e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:977a363e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:977a7da6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:977a7da6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:977a7da6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:977ac48c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:977ac48c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:977ac48c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:977b0ad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:977b0ad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:977b0ad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:977b5320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:977b5320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:977b5320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:977b9aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:977b9aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:977b9aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977c12e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977d12dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:977dc77c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:977dc77c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:977dc77c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:977e0ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:977e0ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:977e0ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:977e56b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:977e56b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:977e56b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:977e9c9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:977e9c9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:977e9c9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:977ee382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:977ee382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:977ee382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:977f2504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:977f4d0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7']} DrugCentral uuid:977f74fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:977f9d5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:977fc572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:977fed68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:978015f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:97803e58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:97806676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:97808e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:9780b676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9780e056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:97810860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclabendazole targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97816a62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:97822178-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2737 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tridihexethyl is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:9782455e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2737 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tridihexethyl is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:97826944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:978292ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:9782bdfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:9782e8d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:978310ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:9783393c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:97836132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.31']} DrugCentral uuid:9783891e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:9783b11e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:9783da72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:9784027c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:97842a68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:97845268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:97847ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.841']} DrugCentral uuid:9784a4de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:9784cce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9784f4e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:97851d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:97854574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:97856d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.022']} DrugCentral uuid:9785956a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9785bde2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9785e5f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.849']} DrugCentral uuid:97860dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.536']} DrugCentral uuid:978636be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:97865fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.786']} DrugCentral uuid:9786883a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.251']} DrugCentral uuid:9786b044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9786d8b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:97870080-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.407']} DrugCentral uuid:97872880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:97875832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:97875832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:97875832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:978798ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:9787c0ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.27']} DrugCentral uuid:9787e8ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9788127c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:97883ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9788629a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06760 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (Beta-glucuronidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:97888a86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00697 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (Lysozyme C-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9788b2cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9788dae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:978902e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY08 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (Emopamil-binding protein-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:978932b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:978932b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:978932b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:97897928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97897928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:97897928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9789bece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:9789bece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:9789bece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:9789fe16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:978a25f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:978a4e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:978a7602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:978a9e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.456']} DrugCentral uuid:978ac670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:978aef6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:978b17b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:978b3fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:978b67e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:978b8fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:978bb8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:978be0d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:978c08d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:978c30be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:2743 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluridine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:978c594a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:2743 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluridine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.01']} DrugCentral uuid:978c81d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:978cab2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:978cd334-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.73']} DrugCentral uuid:978cfb98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:978d238e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:978d4b70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.99']} DrugCentral uuid:978d7366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.611']} DrugCentral uuid:978d9c74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26439 biolink:molecularly_interacts_with DrugCentral:2746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilostane is inhibitor of Enzyme (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2) DrugCentral uuid:978dc06e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alimemazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:978de468-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alimemazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:978e0c36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:2750 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetazidine targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:978e34e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethadione is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:978e58a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:978e7c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) DrugCentral uuid:978ea02e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:978ec89c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:978ef574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:978ef574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:978f22f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:978f4b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:978f756c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:978f9dd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:978fc5c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27713 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:978fedbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:97901666-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:97903e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:97906698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:97908e84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:9790b710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07807 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:9790df06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:97910706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:97912ee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O30463 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:97915850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:979180dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:9791a8fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:9791d172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27783 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9791f986-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04174 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:97922172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59487 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:97924a8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q81R22 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:97927316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27552 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:97929b02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00382 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9792c3e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:9792ebfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q54801 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:9793153c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UUP5 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:97933d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:97936550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:97938922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:9793b190-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9793d9ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:979401b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:979429ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9794524e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:97947a58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07807 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:9794a244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9794ca44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O30463 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9794f3f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:97951be8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:979543fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.827']} DrugCentral uuid:97956c10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:9795947e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:9795bc92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.423']} DrugCentral uuid:9795e474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:97960c60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trioxsalen targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.133']} DrugCentral uuid:9796351e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trioxsalen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.909']} DrugCentral uuid:97965d28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trioxsalen targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:9796851e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triparanol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9796ae22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triparanol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9796d7b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triparanol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:97970070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tripelennamine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9797287a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triprolidine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:979750de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triprolidine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.9']} DrugCentral uuid:979778ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.208']} DrugCentral uuid:9797a0ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.078']} DrugCentral uuid:9797c8ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.531']} DrugCentral uuid:9797f188-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.013']} DrugCentral uuid:97981aa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:979842aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:97986aa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9798944e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:9798bee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Aldose reductase) DrugCentral uuid:9798e2d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:97990abe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:97993322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54840 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Glycogen [starch] synthase, liver) DrugCentral uuid:979956ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.528']} DrugCentral uuid:97997ef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.691']} DrugCentral uuid:9799a6e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.907']} DrugCentral uuid:9799cf8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9799f780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:979a1f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:979a4776-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19224 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (UDP-glucuronosyltransferase 1-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:979a71a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:979a9988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:979ac26e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P39654 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Polyunsaturated fatty acid lipoxygenase ALOX15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:979aea64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2769 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troleandomycin is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:979b12d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:979b3ad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:979b62fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:979b8adc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:979bb390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:979bdb86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:979c0386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:979c2b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:979c573c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:979c7f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:979ca73c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.606']} DrugCentral uuid:979cd022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:979cf836-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:979d2022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:979d482c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:979d70ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:979d98b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:979dc0cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:979de9e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:979e13c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49582 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:979e3ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70212 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:979e6e3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:979e6e3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:979eaa8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:979eaa8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:979ee93e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:979ee93e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:979ee93e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:979ee93e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:979f3664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:979f3664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:979f6a12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:979f9212-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:979fba1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:979fe2f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trospium targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:97a006c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trospium is antagonist of GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:97a02ab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trospium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:97a04e6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trospium targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:97a0724a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.306']} DrugCentral uuid:97a09a9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.395']} DrugCentral uuid:97a0c68c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:97a0c68c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:97a0f81e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:97a0f81e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:97a12672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:2780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tryptophan is allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:97a14e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tryptophan targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:97a17672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6DWJ6 biolink:molecularly_interacts_with DrugCentral:2780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tryptophan is agonist of GPCR (Probable G-protein coupled receptor 139) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:97a19e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tryptophan targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:97a1c8d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:97a1f318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:97a21c30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:97a24430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:97a26ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2S1 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:97a294a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:97a2bcb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:97a2e5b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q401N2 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Zinc-activated ligand-gated ion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:97a30ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:97a3370a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:97a35ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:97a3882c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:97a3b018-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:97a3d822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:97a4040a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:97a4040a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:97a43f56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:97a43f56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:97a43f56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:97a4818c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:97a4818c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:97a4b85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:97a4b85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:97a4eff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:97a4eff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:97a526b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:97a526b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:97a568cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:97a568cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:97a568cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:97a568cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:97a5bc0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:97a5bc0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:97a5ef36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a650fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97a721b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:97a74cbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tulobuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:97a774e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tulobuterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:97a798c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:97a7c0ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['2.7']} DrugCentral uuid:97a7e8f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:97a810cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:97a838b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:H9TVJ1 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (TyR1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a89358-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97a95158-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:97a97958-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyrosine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:97a9a19e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:97a9c976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15144 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:97a9f248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28838 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:97aa1aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:97aa4356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15145 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:97aa6b74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96935 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (M1 family aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:97aa936a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VCT3 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:97aabb38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97629 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Leucyl-cystinyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:97aae608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O09175 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:97ab0e26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00727 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:97ab361c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97449 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:97ab5e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01693 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Bacterial leucyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:97ab869e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:97abaea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15684 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:97abd6a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55786 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Puromycin-sensitive aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:97abfe9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:97ac2752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ08 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Endoplasmic reticulum aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:97ac4f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urapidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:97ac7734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urapidil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:97ac9f52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urapidil is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:97acca90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urapidil is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:97acf5a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol targets Enzyme (Aldo-keto reductase family 1 member C2) DrugCentral uuid:97ad1b8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol is agonist of Nuclear hormone receptor (Bile acid receptor) DrugCentral uuid:97ad418c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:97ad6c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:97ad9452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:97adbc52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valaciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:97ade02e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:97ae09c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:97ae31c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.537']} DrugCentral uuid:97ae59aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:97ae82c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.37']} DrugCentral uuid:97aeadc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:97aed8d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:97af0346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:97af2baa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:97af56de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:97af7ede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:97afa6ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:97afd00a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:97aff80a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:97b0201e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:97b0481e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:97b072ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:97b09b48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:97b0c33e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:97b0ec7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:97b11636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:97b13e54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:97b16668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:97b18f12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:97b1b73a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:97b1df62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:97b20870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97b231ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:97b25cee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:97b2857a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:97b2ad7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:97b2d5e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:97b2fdfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:97b325de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O78749 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Cytochrome c oxidase subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:97b34dac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:97b3764c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:97b39e6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:97b3c660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:97b3ee6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:97b418ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:97b440fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:97b468ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:97b490fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:97b4b962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:97b4e162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valganciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:97b505d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51649 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid is inhibitor of Enzyme (Succinate-semialdehyde dehydrogenase, mitochondrial) DrugCentral uuid:97b529b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:97b55246-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:97b57a3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:97b5a228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:97b5ca28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:97b5f43a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:97b61d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:97b644f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35504 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (UDP-glucuronosyltransferase 1-5) DrugCentral uuid:97b668c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5RJP0 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Aldose reductase-related protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:97b690fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:2805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valrubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:97b6b4f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:97b6de0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:97b70604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:97b73296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:97b73296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:97b76586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vancomycin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:97b78d86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06241 biolink:molecularly_interacts_with DrugCentral:2807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vancomycin targets Enzyme (D-alanyl-D-alanine dipeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:97b7b770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17443 biolink:molecularly_interacts_with DrugCentral:2807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vancomycin targets Enzyme (UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:97b7e18c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:97b80978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:97b83560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:97b83560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:97b86cce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:97b86cce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:97b8a3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:97b8a3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:97b8dab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:97b8dab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:97b9126e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:97b9126e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:97b94964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:97b94964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:97b9830c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:97b9830c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:97b9ba2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:97b9ba2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:97b9f8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:97b9f8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:97b9f8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:97b9f8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:97ba465c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:97ba465c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:97ba84f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:97ba84f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:97ba84f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:97ba84f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:97bace9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:97baf674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.465']} DrugCentral uuid:97bb1f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:97bb476e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.041']} DrugCentral uuid:97bb722a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:97bb9a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:97bbc216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76083 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:97bbee4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:97bbee4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:97bc2dd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:97bc2dd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:97bc2dd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:97bc2dd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:97bc7a8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:97bc7a8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:97bcae4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin is agonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.59']} DrugCentral uuid:97bcd674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin is agonist of GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:97bcfe7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin is agonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:97bd2796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.78']} DrugCentral uuid:97bd4fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32307 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:97bd77d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.93']} DrugCentral uuid:97bd9fbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:97bdc818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48044 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:97bdf022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:97be1822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:97be4414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:97be4414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:97be77ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:97be9fd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:97bec7cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:97bef38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:97bef38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:97bf2a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:97bf2a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:97bf2a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:97bf6d08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:97bf6d08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:97bf9eb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:97bf9eb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:97bfd798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:97bfd798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:97bfd798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:97bfd798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:97c02220-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.051']} DrugCentral uuid:97c04ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.975']} DrugCentral uuid:97c072c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.652']} DrugCentral uuid:97c09aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:97c0c2ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.554']} DrugCentral uuid:97c0edf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:97c11676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:97c13e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97c16680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:97c18f7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:97c1b78e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:97c1df7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:97c2032e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:97c22bec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:97c253ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:97c27bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:97c2a4aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:97c2cca0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.763']} DrugCentral uuid:97c2f572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:97c31d90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:97c34608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:97c36e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.201']} DrugCentral uuid:97c39608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.594']} DrugCentral uuid:97c3be08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:97c3e694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:97c40ebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:97c436bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.88']} DrugCentral uuid:97c45e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:97c48860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:97c4ac6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (G protein-activated inward rectifier potassium channel 2) DrugCentral uuid:97c4d040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.485']} DrugCentral uuid:97c4f854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) DrugCentral uuid:97c51c6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:97c54462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:97c56d66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96PR1 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:97c5955c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:97c5bdde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.348']} DrugCentral uuid:97c5e5de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:97c60de8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:97c635fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:97c660a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:97c688a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:97c6b0a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:97c6d994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:97c701ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:97c729ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:97c751f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:97c779da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.071']} DrugCentral uuid:97c7aad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:97c7aad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:97c7aad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:97c7f0ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:97c7f0ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:97c7f0ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:97c82fec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:97c85800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:97c88000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22462 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:97c8a7f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULQ1 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Two pore calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:97c8d028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NHX9 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Two pore calcium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:97c8f832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:97c92014-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:97c94814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:97c974a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:97c974a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:97c9a7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (Transitional endoplasmic reticulum ATPase) DrugCentral uuid:97c9cb7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:97c9ef44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:97ca162c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:97ca3d46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:97ca610e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:97ca84e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16854 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Kinase (Deoxyguanosine kinase, mitochondrial) DrugCentral uuid:97caa8f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P60891 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Kinase (Ribose-phosphate pyrophosphokinase 1) DrugCentral uuid:97cacde2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:97caf5ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04400 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Adenylate cyclase type V) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:97cb1e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50247 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Adenosylhomocysteinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:97cb46c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80404 biolink:molecularly_interacts_with DrugCentral:2819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vigabatrin is inhibitor of Enzyme (4-aminobutyrate aminotransferase, mitochondrial) DrugCentral uuid:97cb6aae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50554 biolink:molecularly_interacts_with DrugCentral:2819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vigabatrin targets Enzyme (Gamma-amino-N-butyrate transaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:97cb92a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.76']} DrugCentral uuid:97cbbaae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.81']} DrugCentral uuid:97cbe48e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:97cc0c98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:97cc348e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:97cc5cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine is antagonist of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:97cc8524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:97ccad42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:97ccd10a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:97ccf4f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:97cd199e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.728']} DrugCentral uuid:97cd4180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.298']} DrugCentral uuid:97cd6962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97cdb1d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:97ce332e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:97ce5bc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:97ce83c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:97ceabd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.6']} DrugCentral uuid:97ced3ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:97cef854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:97cf1c26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:97cf3fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:97cf6b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:97cf6b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:97cf6b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97cfccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d03dcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vindesine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.607']} DrugCentral uuid:97d065d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:97d08db8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.271']} DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d0d566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:97d14744-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:97d171ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:97d199b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine is inhibitor of Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:97d1c5a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:97d1c5a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:97d1f8ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (11-cis retinol dehydrogenase) DrugCentral uuid:97d21cb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NR8 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (Retinol dehydrogenase 12) DrugCentral uuid:97d24072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NBN7 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (Retinol dehydrogenase 13) DrugCentral uuid:97d2644e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10745 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Surface antigen (Retinol-binding protein 3) DrugCentral uuid:97d288b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P82980 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 5) DrugCentral uuid:97d2ac88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96R05 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Cytosolic other (Retinoid-binding protein 7) DrugCentral uuid:97d2d05a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:97d2f83c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50120 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 2) DrugCentral uuid:97d31bf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94788 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (Retinal dehydrogenase 2) DrugCentral uuid:97d3418e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00352 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (Retinal dehydrogenase 1) DrugCentral uuid:97d36538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12271 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Transporter (Retinaldehyde-binding protein 1) DrugCentral uuid:97d38a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:97d3b268-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09455 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 1) DrugCentral uuid:97d3d6bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49116 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol is agonist of Nuclear other (Nuclear receptor subfamily 2 group C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:97d3fe94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60779 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Transporter (Thiamine transporter 1) DrugCentral uuid:97d422d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29401 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Enzyme (Transketolase) DrugCentral uuid:97d44688-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3S4 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Kinase (Thiamin pyrophosphokinase 1) DrugCentral uuid:97d46ae6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BU02 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Enzyme (Thiamine-triphosphatase) DrugCentral uuid:97d48f94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51854 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Enzyme (Transketolase-like protein 1) DrugCentral uuid:97d4b352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:97d4db66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A2RI47 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Transporter (Thiamine transporter ThiT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.91']} DrugCentral uuid:97d50546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30043 biolink:molecularly_interacts_with DrugCentral:2834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riboflavin targets Enzyme (Flavin reductase (NADPH)) DrugCentral uuid:97d52bac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969G6 biolink:molecularly_interacts_with DrugCentral:2834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riboflavin targets Kinase (Riboflavin kinase) DrugCentral uuid:97d55186-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:2834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riboflavin targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:97d57972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:97d5a19a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40261 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets Enzyme (Nicotinamide N-methyltransferase) DrugCentral uuid:97d5c54e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15274 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets Enzyme (Nicotinate-nucleotide pyrophosphorylase [carboxylating]) DrugCentral uuid:97d5e902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets Enzyme (Nicotinamide phosphoribosyltransferase) DrugCentral uuid:97d60cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80Z39 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:97d6354c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EP66 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:97d65d38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:97d6852e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:97d6ad1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Serine hydroxymethyltransferase, cytosolic) DrugCentral uuid:97d6d240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NVS9 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Pyridoxine-5'-phosphate oxidase) DrugCentral uuid:97d6f626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD0 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Pyridoxal phosphate phosphatase) DrugCentral uuid:97d719da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00764 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Kinase (Pyridoxal kinase) DrugCentral uuid:97d73d84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35520 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Cystathionine beta-synthase) DrugCentral uuid:97d76142-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y617 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Phosphoserine aminotransferase) DrugCentral uuid:97d78564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:2838 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergocalciferol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:97d7a94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2838 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergocalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:97d7cd12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:2838 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergocalciferol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:97d7f0e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:97d8195c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:97d83d38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.68']} DrugCentral uuid:97d864f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:97d8889c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02318 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol targets Enzyme (Sterol 26-hydroxylase, mitochondrial) DrugCentral uuid:97d8ad5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydrotachysterol targets Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:97d8d130-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:97d8faf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:97d922e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:97d94b2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35574 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:97d97338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose is inhibitor of Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:97d99b24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:97d9c324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['8.73']} DrugCentral uuid:97d9ebd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:97da13ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:97da3bc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['5.844']} DrugCentral uuid:97da63ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:97da8ef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:97dab6f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:97dadf02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:97db0716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6A2 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cholesterol 24-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:97db2f7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.98']} DrugCentral uuid:97db5766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.867']} DrugCentral uuid:97db7f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:97dba77a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16549 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin targets Enzyme (Proprotein convertase subtilisin/kexin type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:97dbd006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N0U8 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin targets Enzyme (Vitamin K epoxide reductase complex subunit 1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.284']} DrugCentral uuid:97dbf81a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xamoterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.75']} DrugCentral uuid:97dc2042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xamoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:97dc4978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xamoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:97dc7402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:97dc9c02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:97dcc402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:97dced42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:97dd1556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08709 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Coagulation factor VII) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:97dd3d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04070 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Vitamin K-dependent protein C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:97dd6556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:97dd8e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03951 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Coagulation factor XI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:97ddb600-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:97ddde14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:97de0614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.873']} DrugCentral uuid:97de2fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.114']} DrugCentral uuid:97de57d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.646']} DrugCentral uuid:97de7ffe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:97dea808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47712 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Cytosolic phospholipase A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:97ded06c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:97def9ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:97df21a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.419']} DrugCentral uuid:97df49a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.359']} DrugCentral uuid:97df7238-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:97df9a2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.452']} DrugCentral uuid:97dfc21a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:97dfea2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:97e014f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.269']} DrugCentral uuid:97e03ce0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:97e064cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:97e08d30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:97e0b51c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:97e0de16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:97e10616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:97e12eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:97e156a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:2856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zalcitabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:97e17a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zalcitabine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:97e1aa76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:97e1aa76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:97e1aa76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:97e1f1fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:97e1f1fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:97e1f1fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:97e23004-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16207 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:97e2580e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:97e28086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:97e2a89a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:97e2d090-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75VQ4 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:97e2f87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6Q793 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:97e32126-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:97e3493a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2LFS1 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:97e3713a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C4LRQ6 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:97e39a3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q20MD3 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:97e3c284-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:97e3ea66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:97e41248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ49 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Sialidase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:97e43a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3R4 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Sialidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:97e46478-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07599 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:97e48c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3S340 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:97e4b4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WWR8 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Sialidase-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.58']} DrugCentral uuid:97e4dd9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D5F1R0 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:97e50586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.76']} DrugCentral uuid:97e52d68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XV28 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:97e55554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:97e57e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:97e5a6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:97e5cec6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23919 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:97e5f6b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:97e61f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:97e64720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03362 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Polyprotein (Gag-Pro-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:97e66eee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72549 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:97e696da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:97e6bf7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:97e6e784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9PPP5 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:97e70f7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:97e73784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:97e76204-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:97e789dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:97e7b1be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.071']} DrugCentral uuid:97e7d9b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:97e8022c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20292 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Cytosolic other (Arachidonate 5-lipoxygenase-activating protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:97e82a22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:97e851fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:97e87b26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48999 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:97e8a330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:97e8cb08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zimeldine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.727']} DrugCentral uuid:97e8f2e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zimeldine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:97e91be4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zimeldine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:97e943c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:97e96bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:97e993a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:97e9bc52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:97e9e448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:97ea0c48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:97ea342a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:97ea5d9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:97ea8678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:97eaae78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:97ead682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.565']} DrugCentral uuid:97eb0044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:97eb2858-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:97eb5076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:97eb7876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:97eba134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:97ebc93e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:97ebf134-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:97ec193e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:97ec41ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:97ec6a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:97ec9274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:97ecba7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:97ece530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:97ed0d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:97ed351c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:97ed5dc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:97ed85da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.114']} DrugCentral uuid:97edadc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:97edd1a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:97edfa1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:97ee222e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:97ee4a2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.536']} DrugCentral uuid:97ee7238-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:97ee9b96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:97eec6a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:97eeeeac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:97ef1698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:97ef3f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:97ef672e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:97ef96e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:97ef96e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:97ef96e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:97efd57e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:97effd6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zofenopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:97f026a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:2866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zofenopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:97f04f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zofenopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:97f078e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:97f0a0ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:97f0c902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:97f0f120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:97f119de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:97f141f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:97f16a10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50281 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Matrix metalloproteinase-14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:97f192a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:97f1bb1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:97f1e300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:97f20b0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22939 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:97f232f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:97f25d8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12051 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:97f28580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:97f2ad80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00481 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Unclassified (Butyrophilin subfamily 3 member A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:97f2d544-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:97f2fe02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:97f32616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:97f34e16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:97f37652-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:97f39e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.4']} DrugCentral uuid:97f3c65c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:97f3f60e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:97f3f60e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:97f3f60e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:97f43902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:97f46396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:97f48ba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:97f4b44a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.703']} DrugCentral uuid:97f4dc5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:97f50454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:97f52c54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:97f554c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19969 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:97f5849c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:97f5849c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:97f5849c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:97f5cc04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:97f5cc04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:97f5cc04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:97f612e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:97f612e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:97f612e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:97f658e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:97f658e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:97f658e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f6d0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:97f7a8a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:97f7a8a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:97f7a8a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:97f7f3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:97f7f3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:97f7f3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:97f83a7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:97f83a7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:97f83a7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:97f880d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:97f880d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:97f880d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:97f8c8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:97f8c8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:97f8c8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:97f90752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:97f92f3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zomepirac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:97f95748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zomepirac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.367']} DrugCentral uuid:97f98344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zomepirac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:97f98344-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zomepirac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:97f9ba80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:97f9e03c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:97fa083c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:97fa2c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.252']} DrugCentral uuid:97fa54ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97fa7cae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:97faa4ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:97facd44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:97faf8a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:97fb20be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:97fb48dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:97fb7276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:97fb9cd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:97fbc50a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:97fbed1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:97fc15c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:97fc3ddc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:97fc6708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:97fc8f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:97fcb7b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:97fcdfda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:97fd07e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:97fd3002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:97fd5b4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:97fd850c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:97fdad3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:97fdd566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:97fdfe24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:97fe2aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:97fe2aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:97fe5f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:97fe87d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6NSN2 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:97feafcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:97fed7cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:97feffd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:97ff6386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:98003c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:98003c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:98003c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:98008298-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:98008298-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:98008298-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:9800c8b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:9800c8b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:9800c8b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:9801119a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:9801119a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:9801119a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:98015772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:98015772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:98015772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:98019fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:98019fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:98019fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9801e5fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:9801e5fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:9801e5fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:98022c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:98022c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:98022c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:98026a86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.394']} DrugCentral uuid:98029286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:9802bb9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:9802e3da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:98030bd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.686']} DrugCentral uuid:980333c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:98035c70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:98038452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9803ac66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:9803d466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9803fcd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:980424de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:98044cde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:980474de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.273']} DrugCentral uuid:98049d9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:9804c57e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.606']} DrugCentral uuid:9804ee64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:98051650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:98053ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.704']} DrugCentral uuid:980566d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:98058f54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:9805b740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:9805df9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:98060786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.585']} DrugCentral uuid:98062f7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:98065786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9806826a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.016']} DrugCentral uuid:9806accc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.441']} DrugCentral uuid:9806d4b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:9806fe5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.326']} DrugCentral uuid:9807268e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:98074e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:980776ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:98079f2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9807c72e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:9807ef2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:9808131e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:98083c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:980862b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol is antagonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:980888a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:9808ac8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:2878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) DrugCentral uuid:9808d056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02294 biolink:molecularly_interacts_with DrugCentral:2878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:9808f9e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54282 biolink:molecularly_interacts_with DrugCentral:2878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:980921d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotarolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:980949be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotarolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:9809722c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eledoisin is agonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:98099a36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29371 biolink:molecularly_interacts_with DrugCentral:2955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eledoisin targets GPCR (Neuromedin-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.66']} DrugCentral uuid:9809c222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gonadorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9809ea2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:2958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gonadorelin targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:980a13c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16235 biolink:molecularly_interacts_with DrugCentral:2958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gonadorelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:980a44b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:980a44b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:980a44b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:980a7bf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:2960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifamurtide is activator of Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) DrugCentral uuid:980a9fda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96EB6 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (NAD-dependent protein deacetylase sirtuin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:980ac834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15077 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['4']} DrugCentral uuid:980af02a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47900 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:980b182a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IXJ6 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (NAD-dependent protein deacetylase sirtuin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:980b4016-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:980b6870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:980b907a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:980bb83e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:980be0f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:980c0b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:980c33f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5VLE3 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (RmtA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:980c5bcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.749']} DrugCentral uuid:980c844e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15648 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (ATP-dependent 6-phosphofructokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980cd3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:980d6b8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.963']} DrugCentral uuid:980d9398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:980dbd46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80Z26 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (Nucleoside triphosphate diphosphohydrolase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:980de5a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35795 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (Ectonucleoside triphosphate diphosphohydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:980e0db4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49654 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:980e35aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49653 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:980e5de6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47824 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:980e85c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51578 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:980eadbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42224 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 1-alpha/beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:980ed5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42229 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:980efe5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51692 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 5B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:980f2668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triptorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.025']} DrugCentral uuid:980f4e54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:2968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triptorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:980f7654-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:980f9c42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:980fcadc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:980fcadc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:980fcadc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:9810022c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2975 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histrelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:98102658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:2977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caspofungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:98104e6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4WLT4 biolink:molecularly_interacts_with DrugCentral:2977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caspofungin is inhibitor of Enzyme (1,3-beta-glucan synthase catalytic subunit FksP) DrugCentral uuid:98107248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O13383 biolink:molecularly_interacts_with DrugCentral:2977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caspofungin targets Unclassified (1,3-beta-D-glucan synthase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:98109e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.65']} DrugCentral uuid:98109e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.65']} DrugCentral uuid:9810d5a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.873']} DrugCentral uuid:9810d5a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.873']} DrugCentral uuid:98110c9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.499']} DrugCentral uuid:98110c9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.499']} DrugCentral uuid:98114128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30988 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Calcitonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.086']} DrugCentral uuid:98116ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['12.7']} DrugCentral uuid:98119376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:9811bb8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47871 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon is agonist of GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9811e380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30082 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:98122764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:98122764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:98122764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:98122764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:98122764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:98122764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:98122764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:98122764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:98129d7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F8V479 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:9812c55c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35659 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.36']} DrugCentral uuid:9812ed52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lepirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['13']} DrugCentral uuid:9813155c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:98133eec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9813670a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:98138f00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.1']} DrugCentral uuid:9813b70a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9813eebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9813eebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9813eebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9813eebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9813eebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:98145250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:98145250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:98145250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:98145250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:98145250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9814a732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.46']} DrugCentral uuid:9814cf50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:9814f75a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:9815220c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:98154afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:9815741e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96529 biolink:molecularly_interacts_with DrugCentral:2999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrantel targets Enzyme (Acetylcholinesterase) DrugCentral uuid:981597f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:9815c072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9815e980-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:98161194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:981639c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban is antagonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:981662f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:98168eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:98168eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:98168eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9816ccc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.934']} DrugCentral uuid:9816f5be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:98171dbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.888']} DrugCentral uuid:981745b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.046']} DrugCentral uuid:98176db4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:9817960e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.269']} DrugCentral uuid:9817be0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.532']} DrugCentral uuid:9817e690-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.004']} DrugCentral uuid:98180e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:9818373a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.092']} DrugCentral uuid:98185f30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:98188726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:9818af1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:9818da50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.965']} DrugCentral uuid:98190250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.649']} DrugCentral uuid:98192a50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.115']} DrugCentral uuid:981952be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.681']} DrugCentral uuid:98197aaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.192']} DrugCentral uuid:9819a3a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:9819cba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969F8 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (KiSS-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9819f43a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bergapten targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:981a1c26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:3021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bergapten targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:981a4408-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bergapten targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:981a6bf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:981a9584-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:981abd70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:981ae55c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.299']} DrugCentral uuid:981b0e74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.651']} DrugCentral uuid:981b36ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:981b5ee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.843']} DrugCentral uuid:981b86e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.912']} DrugCentral uuid:981baece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.501']} DrugCentral uuid:981bd782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.365']} DrugCentral uuid:981bff96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:981c278c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:981c4fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.844']} DrugCentral uuid:981c7ac0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.195']} DrugCentral uuid:981ca572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.761']} DrugCentral uuid:981ccd5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:981cf572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:981d1e58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:981d464e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.212']} DrugCentral uuid:981d6e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.647']} DrugCentral uuid:981d97de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:981dbfca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.735']} DrugCentral uuid:981de7b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.498']} DrugCentral uuid:981e0fac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:981e38f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.809']} DrugCentral uuid:981e6394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.415']} DrugCentral uuid:981e8b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:981eb362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:981edba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:981f03b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:981f2b9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:981f538a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:981f7c0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:981fa3f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:981fcbd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6IQ20 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol is inhibitor of Unclassified (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:981ff3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:3042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 broxuridine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98201e28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:3042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 broxuridine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98204916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:3047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufexamac is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.97']} DrugCentral uuid:982073fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:3047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufexamac is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.91']} DrugCentral uuid:98209df8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufexamac targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9820c63e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:3047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufexamac targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:9820f5e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9820f5e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9820f5e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:98213de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:98213de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:98213de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:98217d54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9821a54a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9821cd36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:9821f608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:98221e08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:982245fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54577 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Tyrosine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:98226e08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35433 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:98229676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03887 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Unclassified (NADH-ubiquinone oxidoreductase chain 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:9822bef8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R4D5 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:9822e6ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q704Y3 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is activator of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:98230ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:98233784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16388 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:98235f7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63142 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9823878e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:9823b06a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9823da86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:98240290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NJH6 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Unclassified (Ace-orthologous acetylcholinesterase; Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:98242a90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7YWJ9 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:982452ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:K4JQ36 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:98247ad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05181 biolink:molecularly_interacts_with DrugCentral:3067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbon tetrachloride targets Enzyme (Cytochrome P450 2E1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.959']} DrugCentral uuid:9824a308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31327 biolink:molecularly_interacts_with DrugCentral:3068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carglumic acid is positive allosteric modulator of Enzyme (Carbamoyl-phosphate synthase [ammonia], mitochondrial) DrugCentral uuid:9824ced2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:9824ced2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:9824ced2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:98250f64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05193 biolink:molecularly_interacts_with DrugCentral:3082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetrimonium targets Structural (Dynamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:98253764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:3083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetylpyridinium targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:98255f64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42575 biolink:molecularly_interacts_with DrugCentral:3083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetylpyridinium targets Enzyme (Caspase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:98258868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxylenol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.928']} DrugCentral uuid:9825b2e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxylenol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.738']} DrugCentral uuid:9825dae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:3095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorquinaldol targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:982602fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:3096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cholic acid targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:98262b2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:3096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cholic acid is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9826531a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:98267c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9826a824-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:9826a824-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:9826e000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:9826e000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:98271714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:98271714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:98274e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:98274e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:982788e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:982788e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:9827bbec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28570 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Transporter (Creatine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:9827e3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:3101 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchophen targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.9']} DrugCentral uuid:98280d36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q695T7 biolink:molecularly_interacts_with DrugCentral:3102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinromide is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:982835c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98285da4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxiquine targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:98288586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:3114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxiquine targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:9828ae12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:3114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxiquine targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:9828ddc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9828ddc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9828ddc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98291bcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:3124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cynarine targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9829462e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:3126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demoxytocin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:98297dba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98297dba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98297dba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98297dba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:9829c7d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:9829ec0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibrompropamidine targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:982a1400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibrompropamidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:982a3bf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:3137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibrompropamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:982a63f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:3137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibrompropamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:982a8c8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 difluprednate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:982ab838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:982ab838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:982ab838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:982af622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:982b2106-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:982b49f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:3158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dioxadrol targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:982b7214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:3162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disufenton targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:982b9a00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:3162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disufenton targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:982bc264-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:3165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domitroban is antagonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:982bea78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30987 biolink:molecularly_interacts_with DrugCentral:3165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domitroban is antagonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:982c12a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:982c3b4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:982c6354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:982c8b54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.6']} DrugCentral uuid:982cb368-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:3173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edoxudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:982cdc94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:982d078c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:982d3072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:982d587c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:982d80ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:982da8d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:982dd0cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:982df8e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:982e2220-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDS5 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets GPCR (Oxoeicosanoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:982e4a20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear other (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:982e7220-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enilconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:982e9a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:982ec4be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:982eeffc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:982f1b58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:982f4362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.91']} DrugCentral uuid:982f6bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:982f93c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00489 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Glycogen phosphorylase, muscle form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:982fbbc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:982fe45c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:98300c70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9830345c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16232 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:98305c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50233 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:983084fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9830acf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:9830d4f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:9830fe46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:983126a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9CPU0 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:98314e96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eseridine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9831768c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eseridine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:98319e82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:3186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eseridine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:9831c72c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9831ef4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.748']} DrugCentral uuid:98321772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:98323f90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol is agonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:983269b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:983293d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.63']} DrugCentral uuid:9832bbe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.064']} DrugCentral uuid:9832e3e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:98330d8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:9833354e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:98335de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.062']} DrugCentral uuid:983385e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9833ae84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:9833d65c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9833fe5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9834265c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:98344f1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:98347710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:98349f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:9834c760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.181']} DrugCentral uuid:9834ef6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:9835176a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:3194 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacridine targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:98353f6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:3194 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacridine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9835685a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:98359046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:9835b832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P39086 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9835e032-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:9836092c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:98363136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9836592c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13002 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:98368122-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13003 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9836a9ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19491 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9836d1ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:9836fb84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16099 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:983723a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42260 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:98374c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22756 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9837746a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19490 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:98379c60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19492 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9837c474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:9837ef12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01812 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:9838176c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:98383f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42264 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:98387392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:98387392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:98387392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:98387392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:9838ccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:9838ccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:9838ccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:9838ccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:9838ccca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:9839294a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:9839294a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:9839294a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:98397e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:98397e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:98397e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:98397e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:98397e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:98397e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:98397e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:9839ed58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:983a156c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25044 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Enzyme (Tyrosine-protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:983a3d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7TSF2 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Transporter (Vesicular glutamate transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:983a660c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13822 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Enzyme (Ectonucleotide pyrophosphatase/phosphodiesterase family member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:983a8e16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08659 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Unclassified (Luciferin 4-monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:983ab5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:3219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exisulind targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.217']} DrugCentral uuid:983ade02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exisulind targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:983b0698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:3219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exisulind targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.859']} DrugCentral uuid:983b2e84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:983b5698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:983b80e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:983ba95e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.641']} DrugCentral uuid:983bd168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.377']} DrugCentral uuid:983bf97c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:983c21e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.824']} DrugCentral uuid:983c49fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:983c721c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.328']} DrugCentral uuid:983c9a1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:983cc2a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.688']} DrugCentral uuid:983ceac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:983d12da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:983d3af8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05121 biolink:molecularly_interacts_with DrugCentral:3224 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendosal is inhibitor of Secreted (Plasminogen activator inhibitor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:983d6618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoxazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:983d9034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04303 biolink:molecularly_interacts_with DrugCentral:3227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenticlor targets Enzyme (Uracil-DNA glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:983db834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:3229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fumaric acid targets Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:983de034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:3236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flusalan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:983e08a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:3236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flusalan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:983e30ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:3236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flusalan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:983e5ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:983e5ca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983eb95a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:983f5234-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fumagillin targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:983f7a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:983fa23e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:983fcab6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:983ff3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:98401ca0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:98404496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:98406e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:98409644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9840be44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:9840e658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:98410ffc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08590 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:98413806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:98415ff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:98418806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:9841b060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15661 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate is inhibitor of Enzyme (Tryptase alpha/beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:9841d860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:98420056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:98422860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:98425128-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:9842793c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9842a13c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:9842c928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:9842f420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:98431c2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:9843442a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:98436c70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:98439466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9843bc70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:9843e466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:98440d1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:98443524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:98445d24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:9844861e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9844afae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:9844d966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9845015c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:98452952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:984551d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:98457a60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.91']} DrugCentral uuid:9845a274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9845cac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:9845f454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:98461c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.89']} DrugCentral uuid:98464486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98466c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:9846953a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:9846bd1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:9846e530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01693 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Bacterial leucyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:98470d3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:3293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibufenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:984735ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:98475e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.969']} DrugCentral uuid:98478620-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:9847ae34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9847d738-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:9847ff4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.181']} DrugCentral uuid:9848274c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.859']} DrugCentral uuid:98485262-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.227']} DrugCentral uuid:98487b5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:9848a370-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9848cb5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:9848f42e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:98491c2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9849442e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.496']} DrugCentral uuid:98496c38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:98499500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9849bcf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9849e500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:984a0d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:984a3672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:984a5e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.79']} DrugCentral uuid:984a8686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:984aae7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:984ad6e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:984afeea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:984b26d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:984b4ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:984b776c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:984b9f44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:984bc884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:984bf070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:984c1bcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:984c4e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:984c4e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:984c4e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:984c8e4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:3309 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:984cb6cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3309 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:984cdee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:984d06fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:984d2f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88703 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:984d57e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60741 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:984d800c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL51 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) DrugCentral uuid:984da41a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P1Z3 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:984dcd14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 khellin targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:984df56e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:3317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenalidomide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.886']} DrugCentral uuid:984e1d64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:3317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:984e4582-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:3317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:984e6e22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:3317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.527']} DrugCentral uuid:984e960e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:984ebdfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:984ee5fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:984f0eb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:984f36d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:984f5ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05413 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Cytosolic other (Fatty acid-binding protein, heart) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:984f86f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:984fb0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:984fdb90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14721 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid is activator of Ion channel (Potassium voltage-gated channel subfamily B member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:98500476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:98502c4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:985054a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:98507cb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:9850a4bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5NUL3 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid is agonist of GPCR (Free fatty acid receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9850ccb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:3325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lodoxamide is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.793']} DrugCentral uuid:9850f570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:3328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lubeluzole targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:98511d66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:3328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lubeluzole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9851457a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestanolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:98516a96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestanolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.81']} DrugCentral uuid:985195fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesterolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.6']} DrugCentral uuid:9851bf3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesterolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:9851e728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O34667 biolink:molecularly_interacts_with DrugCentral:3347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methionine targets Unclassified (S-ribosylhomocysteine lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:98520f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.077']} DrugCentral uuid:985237be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.66']} DrugCentral uuid:98525fb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:985287be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9852b072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:9852d872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17708 biolink:molecularly_interacts_with DrugCentral:3362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoguazone targets Enzyme (S-adenosylmethionine decarboxylase proenzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9853005e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36633 biolink:molecularly_interacts_with DrugCentral:3362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoguazone targets Enzyme (Amiloride-sensitive amine oxidase [copper-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:98532c46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxestrol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:98532c46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxestrol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:985361d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:98538bb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9853b3dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9853dcfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9854056c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9854353c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9854353c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9854353c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:98547b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:98547b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:98547b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9854cd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9854cd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9854cd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9854cd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9854cd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9854cd26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:98552d34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:3377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neridronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9855553e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifenalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.88']} DrugCentral uuid:98557d52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:9855a53e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9855cd8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9855f55c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98561d3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:H9TVJ1 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine targets GPCR (TyR1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:98564656-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01705 biolink:molecularly_interacts_with DrugCentral:3399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleandrin targets Unclassified (Neurogenic locus notch homolog protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:98566eec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:98569700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:9856bf00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9856e804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:98571310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:98573b4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:98576338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:98578b2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01469 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Cytosolic other (Fatty acid-binding protein, epidermal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9857b428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9857dc32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98580432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07148 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:98582cdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:985854fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:98587cfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9858a504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5NUL3 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid is agonist of GPCR (Free fatty acid receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9858ce1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5T6X5 biolink:molecularly_interacts_with DrugCentral:3401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ornithine is agonist of GPCR (G-protein coupled receptor family C group 6 member A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9858ffea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9858ffea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9858ffea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:98593df2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.684']} DrugCentral uuid:98596674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.815']} DrugCentral uuid:98598e7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.046']} DrugCentral uuid:9859b67e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.372']} DrugCentral uuid:9859de7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.723']} DrugCentral uuid:985a0764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:985a2f78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.925']} DrugCentral uuid:985a57aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.533']} DrugCentral uuid:985a80ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.778']} DrugCentral uuid:985aa9a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.169']} DrugCentral uuid:985ad1d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.943']} DrugCentral uuid:985af9f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:985b21f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.449']} DrugCentral uuid:985b4a70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:985b728e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.676']} DrugCentral uuid:985b9aa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:985bc2a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.445']} DrugCentral uuid:985beb6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:985c1072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.728']} DrugCentral uuid:985c3886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.333']} DrugCentral uuid:985c6090-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:985c8afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:985cb374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.209']} DrugCentral uuid:985cdb6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:985d036a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.969']} DrugCentral uuid:985d2bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:985d5450-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:3412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybenzone targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:985d7c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:3413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycinchophen targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:985da45a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:3413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycinchophen targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.82']} DrugCentral uuid:985dcd04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:985df518-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine is modulator of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.76']} DrugCentral uuid:985e1d04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.658']} DrugCentral uuid:985e4504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.307']} DrugCentral uuid:985e71b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:985e9c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:985ec45c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:985eecd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.27']} DrugCentral uuid:985f2064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:985f2064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:985f2064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:985f2064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:985f7154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:985f7154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:985f7154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:985fb042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3467 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picloxydine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:985fd874-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:3467 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picloxydine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:98600088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:3474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adipic acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:98602a7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:986055b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:98608030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:9860a830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:9860d094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04015 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Unclassified (Regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9860f894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02550 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:98612080-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03118 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Unclassified (Regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.98']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98617efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98625676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:98625676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:98625676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:98629d16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:98629d16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9862d038-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03120 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Unclassified (Human papillomavirus regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.15']} DrugCentral uuid:9862f842-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polyestradiol phosphate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:98631c00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:98634086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['9.398']} DrugCentral uuid:9863689a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:986390a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9863b930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7Z1V1 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (Sterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:9863e2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:98640ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:986432fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98645be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.69']} DrugCentral uuid:9864845a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9864ac64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.98']} DrugCentral uuid:9864d464-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18762 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:9864fcdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.292']} DrugCentral uuid:986524e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.199']} DrugCentral uuid:986554c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:986554c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:986554c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:9865943a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:3493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9865bf78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:3493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9865ef70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:9865ef70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:9865ef70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:98662d5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:3500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protoporphyrin targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:986655aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:3500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protoporphyrin targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:98667d8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prucalopride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.629']} DrugCentral uuid:9866a58c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prucalopride targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9866cdaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:3502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prucalopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:9866f668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:3502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prucalopride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:98671e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:3505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homonicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98674668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51575 biolink:molecularly_interacts_with DrugCentral:3506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxal phosphate targets Ion channel (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:98676f44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:986797e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:9867c002-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9867e91a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9868119c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:986839c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:986861ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:986889e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9868b28c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9868db54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9869037c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:98692b7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:98695516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:98697d48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:9869a552-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9869cd66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrovalerone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9869f5c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrovalerone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:986a1dde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrovalerone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:986a45e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:986a6de8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:986a9674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:986abe74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:986ae66a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:986b0f96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:986b3a7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:986b62a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:986b8a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:986bb34c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:986be42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:986be42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:986be42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:986c225a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:986c4a64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:986c732c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:986c9b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:986cc336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:986ceb2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:986d16a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:986d4162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:986d69b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:986d920c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:986dba0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:986de2ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:986e0aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:986e334c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:986e5b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:986e8356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:986eab56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:986ed4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:986efd0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:986f250e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:986f4d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:986f7568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:986f9d5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:986fc662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:986fee76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:98701702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:98703eda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:987066bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:98708eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9870b950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9870e27c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:98710a86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:987132ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:98715ad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04745 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Alpha-amylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:987182d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:9871aae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9871d380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9871fb80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:98722394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08254 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Stromelysin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:98724b8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9872745c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:98729c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:9872c470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9872ec66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48147 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Prolyl endopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:987314ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:98733cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:987364ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:98738cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9873b68c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9873df18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:98740718-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:98742f18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04054 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Phospholipase A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98745916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9874810c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9874a90c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P39900 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Macrophage metalloelastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:9874d0ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45452 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Collagenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9874fa1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17538 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Chymotrypsinogen B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:98752224-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:98754a2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98757224-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:98759a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80276 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9875c26a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:9875ea4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06737 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Glycogen phosphorylase, liver form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9876122e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15046 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lysine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:98763ac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:987662b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:98768aa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9876b35a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9876dca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:987704b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:98772cae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:9877551c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:98777d12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:9877a526-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:9877ce3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9877f756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:98781f6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:98784756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:98786f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:98789814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9878c014-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9878e800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q965D5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Enoyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9879100a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:98793864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q91WR5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldo-keto reductase family 1 member C21) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9879608c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9879886e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9879b078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:9879dada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:987a0366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:987a2b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:987a5352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:987a7be8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:987aa3de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:987acbe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:987af3f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:987b1c38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:987b4424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10584 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Malate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:987b6c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21588 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (5'-nucleotidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:987b9532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q965D6 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (3-oxoacyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:987bbe72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q965D7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-hydroxyacyl-ACP dehydratase; Fatty acid synthesis protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:987be668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27986 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Phosphatidylinositol 3-kinase regulatory subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:987c0e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPH5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (NADPH oxidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:987c3708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:987c5f08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:987c86fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:987caeea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q1CTD3 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (D-alanine--D-alanine ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:987cd8a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC98 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase Nek6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:987d00b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96394 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arginase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:987d2c9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:987d2c9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:987d63bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15078 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 5/CDK5 activator 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:987d63bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15078 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 5/CDK5 activator 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:987da58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:987da58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:987da58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:987da58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:987df2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:987df2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:987e2a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:987e2a5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:987e5d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:987e856c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29477 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:987eaf24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00796 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Sorbitol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:987ed760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99895 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Chymotrypsin C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:987f003c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03114 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cell division protein kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:987f2800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:987f521c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07862 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (D-alanylalanine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:987f7a08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:987fa1f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01062 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Phosphodiesterase 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:987fc9ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:987ff28a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41921 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Glutathione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:98801b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:98804320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:98806af8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11168 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:98809366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14576 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Unclassified (ELAV-like protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9880bb84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15717 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Unclassified (ELAV-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9880e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:98810b7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:988135fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19357 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:98815e22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9881862c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFU5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Inositol polyphosphate multikinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9881aec2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHH9 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Inositol hexakisphosphate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9881d6c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:98820e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:98820e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:98820e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:98820e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:98820e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:98825a48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9882825c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9882ab4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9882d342-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9882fc14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:98832414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:98834c00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:98837482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.16']} DrugCentral uuid:98839d36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9883c54a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9883ed54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:98841568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:98843df4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:98846608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:98848e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9884baa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revaprazan is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:9884baa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revaprazan is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:9884e844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:3529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rioprostil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) DrugCentral uuid:98850c98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:98853484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.46']} DrugCentral uuid:98855d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.57']} DrugCentral uuid:988590d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:988590d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:988590d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:988590d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9885da06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WQX9 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast targets Enzyme (Phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:98860260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:98862a6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:9886535a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:98867b64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9886a40e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9886cc22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9886f422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:98871c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:988745e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:98876e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9887960c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9887be20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05771 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C beta type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:9887e67a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:98880e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:98883666-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22694 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:98885e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:988887d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9888afec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05129 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C gamma type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9888d7ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:98890064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9889286e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9889508c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9889788c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9889a10e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9889c918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9889f118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:988a1a12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:988a438e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:988a6eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:988a96ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:988abe86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:988ae730-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:988b0f12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:988b379e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:988b5f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:988b8820-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:988bb020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:988bd834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:988c003e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:988c2b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:988c5354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:988c7b54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:988ca34a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:988ccc12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:988cf41c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:988d1d66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:988d45c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:988d6dde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:988d95e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:988dbde8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JI10 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:988de700-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:988e131a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:988e3b2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:988e6338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:988e8be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:988eb3ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:988edbf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:988f03e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:988f2c46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:988f5450-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:988f7c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:988fa45a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:988fce12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:988ff608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:98901e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9890461c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:98906ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:9890969e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9890be94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9890e68a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:98910f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9891372a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:98915f20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y243 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (RAC-gamma serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9891872a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9891b286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9891da7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9892036c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:98922c5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:98925ac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:989282ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9892aac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9892d314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:9892fc4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9893245e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:98934c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:98937616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:98939e34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9893c648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9893ee48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:98941710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:98943f1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:98946724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:98948f2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:9894b788-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9894df9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:989507ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:98952fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:98955b48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:989585d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9895ade6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:9895d7bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9895ffd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:989627da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:98964fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9896782a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9896a03e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9896c82a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9896f034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:98971a14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:98974476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:98976c6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76039 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase-like 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:98979476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41743 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C iota type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9897bd0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9897e50c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60331 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:98980d0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:98983598-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:98985df2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:989885f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9898c8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9898c8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9898c8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9898c8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9898c8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9898c8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9898c8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9898c8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:98994ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:98994ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:98994ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:98994ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:989998e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:9899e384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:989a5e4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:989a8640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:989aae36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.454']} DrugCentral uuid:989ad726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:989aff1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:989b2712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:989b4f6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:989b776c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:989b9f44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:989bc730-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02769 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:989bef76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:989c1762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:989c4020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:989c67f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZQ4 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets GPCR (Neuromedin-U receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:989c9106-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03469 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:989cbd70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:989ce6d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:989d0ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:989d3750-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:989d5f46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:989d8732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:989dbebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:989dbebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:989dbebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:989dbebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:989dbebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:989e131e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:989e3b50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:989e64a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:989e8eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin is antagonist of GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:989ebac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:989ebac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:989eee7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:3548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitaxentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:989f1746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:3548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitaxentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:989f3f50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:3548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitaxentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:989f6746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stallimycin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:989f8f50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:3553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stallimycin targets Cytosolic other (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:989fbcbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stallimycin targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:989fbcbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stallimycin targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:989feff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:3557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbentine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:98a017ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:3557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbentine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:98a040b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:3574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulmazole targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:98a06c9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:3574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulmazole targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:98a06c9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:3574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulmazole targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:98a09fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxedrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:98a0c7a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZQ4 biolink:molecularly_interacts_with DrugCentral:3577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxedrine targets GPCR (Neuromedin-U receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:98a0f052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:98a11424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:3580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamibarotene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:98a13c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:3580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamibarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:98a1641a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:3580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamibarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:98a18c6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:98a1b474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:98a1dc56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:98a20618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:98a23070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:98a2587a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:98a280a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:98a2a960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:98a2d174-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) DrugCentral uuid:98a2f550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:98a31d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:98a34618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.09']} DrugCentral uuid:98a36e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:98a3974e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:98a3bf8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:98a3e870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:98a41854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:98a41854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:98a41854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:98a45e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98a45e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98a45e36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98a4b020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:98a4b020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:98a4b020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:98a4b020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:98a4b020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:98a4b020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:98a523f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:98a523f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:98a523f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:98a523f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:98a523f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:98a523f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:98a57802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:98a59fda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75936 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Gamma-butyrobetaine dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:98a5ca96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99685 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:98a5f598-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:98a62036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:98a6482c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:98a67284-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:98a69aa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:98a6c2b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:98a6eb60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:98a71356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:3604 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thyropropic acid targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.39']} DrugCentral uuid:98a73b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:3604 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thyropropic acid targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.72']} DrugCentral uuid:98a76374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:3604 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thyropropic acid targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:98a78c96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioxolone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:98a7b496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioxolone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:98a7dc78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioxolone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:98a80478-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:98a828c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:98a850ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:98a878ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80W54 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Enzyme (CAAX prenyl protease 1 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:98a8a0fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14091 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Enzyme (Cathepsin E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:98a8c976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DJD9 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Enzyme (Pepsin A-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98a8f194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:98a91994-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.39']} DrugCentral uuid:98a9419e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:98a96b60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.82']} DrugCentral uuid:98a9936a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:98a9bb74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:98a9e40a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:98aa0c78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:3613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Vitamin E targets Enzyme (Glutathione S-transferase P) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:98aa346e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49638 biolink:molecularly_interacts_with DrugCentral:3613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Vitamin E targets Transporter (Alpha-tocopherol transfer protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:98aa5d72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:3616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toliprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:98aa8586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:3616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toliprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:98aaae3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toliprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.36']} DrugCentral uuid:98aad630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:3616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toliprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.75']} DrugCentral uuid:98aafe44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3617 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolnaftate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.894']} DrugCentral uuid:98ab263a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3617 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolnaftate targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:98ab51be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:3617 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolnaftate targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:98ab7ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:98aba4ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:98abcd24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:98abfce0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:98abfce0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:98abfce0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:98ac43e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:98ac43e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:98ac43e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:98ac82d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclocarban targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:98acaabe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P95276 biolink:molecularly_interacts_with DrugCentral:3630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase; Epoxide hydrolase EphB) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:98acd2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07099 biolink:molecularly_interacts_with DrugCentral:3630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:98acfa82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D379 biolink:molecularly_interacts_with DrugCentral:3630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:98ad25ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:98ad50d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16152 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Carbonyl reductase [NADPH] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:98ad7be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6GI75 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:98ada630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:98adce26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q965D5 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.28']} DrugCentral uuid:98adf70c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54616 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:98ae1f02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6UCJ9 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-acyl carrier reductase; Enoyl-acyl carrier reductase ENR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:98ae47b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BJJ9 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-ACP reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:98ae6fac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9RMI3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADPH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:98ae97c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:98aebfb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:M9TGV3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NULLDH]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:98aee9e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:98af11f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:98af39f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15077 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:98af61e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:98af8ab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:98afb29a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:98afdaa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35811 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:98b002b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:98b02b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:98b0538a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:98b07bb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97321 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:98b0a39e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E1BI31 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Unclassified (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:98b0ce64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:98b0f6a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:98b11eaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:98b146b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:98b16f22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98b19740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b1de8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:98b25202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.86']} DrugCentral uuid:98b279ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:98b2a342-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:98b2cb56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:98b2f36a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:98b31b74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:98b343ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:98b36bd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:98b393ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:98b3bcaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:98b3e4be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:98b40cbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:98b434b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:98b45e08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:98b48676-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:98b4ae76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:98b4d66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98b4feb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:98b526c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:98b54fb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:98b577ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:98b5a042-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:98b5d828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:98b5d828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:98b5d828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:98b5d828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:98b5d828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:98b62d14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:98b65762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:98b680c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:98b6a8d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:98b6d138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:98b70108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:98b70108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:98b70108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:98b74708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:98b74708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:98b74708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:98b7994c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:98b7994c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:98b7994c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:98b7994c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:98b7994c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:98b7994c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:98b7f982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:98b8227c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.163']} DrugCentral uuid:98b84ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:98b872e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:98b89b44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:98b8c362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.106']} DrugCentral uuid:98b8eb76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:98b9138a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:98b93c5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:98b9645c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:98b98c70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:98b9b484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:98b9dd92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:98ba059c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.692']} DrugCentral uuid:98ba2d9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:98ba559c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:98ba7df6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:98baa60a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98bace28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:98baf646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:98bb1ef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:98bb46dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.182']} DrugCentral uuid:98bb6ed2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:98bb97ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:98bbc256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:98bbee5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:98bc17d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:98bc3fce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:98bc6864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:98bc90fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:98bcb918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:98bce1c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:98bd09e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:98bd31fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:98bd61e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98bd61e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98bd61e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98bdb2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98bdb2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98bdb2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98bdb2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98bdb2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98be0e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:98be0e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:98be0e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:98be5502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98be5502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98be5502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98be9300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:98bebba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:98bee4a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:98bf0cae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:98bf34ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacyclonol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:98bf6514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:98bf6514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:98bf6514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:98bfa312-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:98bfcb1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:98bff3a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:98c01bb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:98c044fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bropirimine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98c06d10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:3707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorthenoxazine targets Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:98c095ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciramadol is modulator of GPCR (Mu-type opioid receptor) DrugCentral uuid:98c0b98c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:3715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobenztropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:98c0e984-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:98c0e984-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:98c0e984-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:98c130e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:98c130e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:98c130e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:98c16f44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 myrtecaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.316']} DrugCentral uuid:98c19f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:98c19f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:98c19f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:98c1e2a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:98c1e2a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:98c215de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:3839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasosartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:98c23e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:98c2670a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98c28f14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:98c2b728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:98c2df28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:98c308b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:98c332b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:98c35ab6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:98c382d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:98c3ab1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:98c3d306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:98c3fb10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:98c4231a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:98c44bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:98c473ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:98c49bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:98c4c3ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:98c4ee4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:98c5163a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:98c53e26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:98c56734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:98c5907e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:98c5b888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:98c5e088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11416 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:98c60914-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:98c6311e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22605 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:98c65932-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18911 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:98c68132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05343 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:98c6aa2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22736 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear other (Nuclear receptor subfamily 4 group A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:98c6d56a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:98c6fdc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13133 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear other (Oxysterols receptor LXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:98c725ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:3871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 artemisinin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:98c74e8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:98c77682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:98c79e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:98c7c65a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:98c7ef0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:98c8170e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:3880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.843']} DrugCentral uuid:98c8430a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:3880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:98c8430a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:3880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:98c88310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:98c88310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:98c88310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:98c88310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:98c8ce92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biriperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:98c8f688-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biriperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:98c91ff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biriperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:98c947f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:3883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biriperone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:98c96ff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3911 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasone butyrate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:98c993cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:98c9bc6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:98c9e46c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.665']} DrugCentral uuid:98ca0c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.372']} DrugCentral uuid:98ca3462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:98ca5e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:98ca8728-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:98caaf1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:98cad70a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:98cb00ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:98cb28c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:98cb50cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:98cb78e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:98cba19e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:98cbc9a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.25']} DrugCentral uuid:98cc0116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:98cc0116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:98cc0116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:98cc0116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:98cc0116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:98cc5ed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:98cc5ed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:98cc5ed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:98cca58a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:98cca58a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:98cca58a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:98cce41e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:98cd0c3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:98cd343c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:98cd5d7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:98cd85a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:98cdadb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.79']} DrugCentral uuid:98cdd5d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:98cdfeee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:98ce2716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:98ce4f16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:98ce770c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:98ce9f66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:98cec770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:98ceef70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:98cf1770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:98cf4006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:98cf6806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.57']} DrugCentral uuid:98cf902e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:98cfb838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:98cfe222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:98d00a18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:98d03308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:98d05b1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:98d08380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolasetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.226']} DrugCentral uuid:98d0ab8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolasetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.698']} DrugCentral uuid:98d0d3a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:3944 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide phosphate is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:98d0f7a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:98d1206a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.928']} DrugCentral uuid:98d1487e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:98d1709c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.208']} DrugCentral uuid:98d198b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.971']} DrugCentral uuid:98d1c420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:98d1eee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.793']} DrugCentral uuid:98d21704-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.801']} DrugCentral uuid:98d23f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.748']} DrugCentral uuid:98d26754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:98d28f54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:98d2b7e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:98d2e094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.122']} DrugCentral uuid:98d30880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:98d3306c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:98d3601e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:98d3601e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:98d3601e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:98d3a1be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone butyrate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:98d3c9aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ilaprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:98d3c9aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ilaprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:98d3f844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:98d420a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:98d448b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:98d470a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.407']} DrugCentral uuid:98d498b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.125']} DrugCentral uuid:98d4c15c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.924']} DrugCentral uuid:98d4e970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.891']} DrugCentral uuid:98d5117a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.586']} DrugCentral uuid:98d53970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.244']} DrugCentral uuid:98d562b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.451']} DrugCentral uuid:98d58c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.539']} DrugCentral uuid:98d5b42c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is allosteric modulator of Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:98d5dc22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:98d6103e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:98d6103e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:98d6103e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:98d6103e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:98d6592c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P91730 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is modulator of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:98d67d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q25634 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is modulator of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:98d6a184-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11507 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Enzyme (Sarcoplasmic/endoplasmic reticulum calcium ATPase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:98d6c97a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06685 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Enzyme (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:98d6f152-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64578 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Enzyme (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:98d71948-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is allosteric modulator of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:98d74404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29029 biolink:molecularly_interacts_with DrugCentral:3976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kinetin targets Enzyme (Endochitinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:98d76bfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:98d794e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.65']} DrugCentral uuid:98d7bd4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98d7e558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00371 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Unclassified (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:98d80d6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11344 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:98d83576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:98d85e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2ZB02 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Unclassified (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:98d88710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Unclassified (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:98d8af6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00024 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Polyphenol oxidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:98d8d76a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75936 biolink:molecularly_interacts_with DrugCentral:3995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meldonium targets Enzyme (Gamma-butyrobetaine dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:98d900be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:3998 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octanoic acid targets GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:98d928dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:3998 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octanoic acid targets GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:98d95104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4002 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niperotidine is antagonist of GPCR (Histamine H2 receptor) DrugCentral uuid:98d974ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:98d99d3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan is antagonist of GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:98d9c544-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:98d9ed44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:98da1526-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:98da41b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98da41b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98da74d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:98da9cda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:98dac4da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:98daf072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:98db185e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:98db4054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:98db68d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14832 biolink:molecularly_interacts_with DrugCentral:4050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spaglumic acid is agonist of GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:98db91d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:98dbb9d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48147 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Enzyme (Prolyl endopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:98dbe1d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dc43f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:98dd17b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:98dd402a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:98dd6852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:98dd9066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.81']} DrugCentral uuid:98ddb87a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:98dde110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:98de0a14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.78']} DrugCentral uuid:98de3228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.44']} DrugCentral uuid:98de5a50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.807']} DrugCentral uuid:98de8462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.243']} DrugCentral uuid:98deb02c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.929']} DrugCentral uuid:98ded8c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.425']} DrugCentral uuid:98df00d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.857']} DrugCentral uuid:98df293a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:98df5126-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:98df7a48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.802']} DrugCentral uuid:98dfa252-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.952']} DrugCentral uuid:98dfcafc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.789']} DrugCentral uuid:98dff2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:98e01aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:98e042c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13674 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Enzyme (Prolyl 4-hydroxylase subunit alpha-1) DrugCentral uuid:98e068ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02809 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Enzyme (Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) DrugCentral uuid:98e08c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGH3 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Transporter (Solute carrier family 23 member 2) DrugCentral uuid:98e0b05c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHI7 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Transporter (Solute carrier family 23 member 1) DrugCentral uuid:98e0d438-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00689 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Enzyme (Pancreatic alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:98e0fc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:4074 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minodronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:98e1249c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:4074 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minodronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:98e14c88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22939 biolink:molecularly_interacts_with DrugCentral:4074 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minodronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:98e17474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12051 biolink:molecularly_interacts_with DrugCentral:4074 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minodronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:98e1a11a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamlodipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:98e1a11a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamlodipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:98e1cece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DJD9 biolink:molecularly_interacts_with DrugCentral:4106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sucralfate is inhibitor of Enzyme (Pepsin A-5) DrugCentral uuid:98e1f2fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is agonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:98e21c80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.99']} DrugCentral uuid:98e246b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:98e26e88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is allosteric modulator of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:98e2966a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:98e2bee2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is allosteric modulator of Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98e2e6e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:98e30ed8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:98e336c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:98e35f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:98e3878c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:98e3afaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:98e3db9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:98e3db9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:98e413aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QZN9 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:98e413aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QZN9 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:98e446c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:98e46eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:98e496f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:4110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:98e4bf08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:4110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:98e4e7a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:4110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:98e514f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:4111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 besifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:98e514f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:4111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 besifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:98e5475c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:4111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 besifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:98e5475c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:4111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 besifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:98e574f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.229']} DrugCentral uuid:98e59cf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:98e5c6aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:98e5ef68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:98e61772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:98e63f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.229']} DrugCentral uuid:98e667d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60741 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) DrugCentral uuid:98e68be4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL51 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) DrugCentral uuid:98e6afca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P1Z3 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3) DrugCentral uuid:98e6d3ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) DrugCentral uuid:98e6f796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:4113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasugrel is antagonist of GPCR (P2Y purinoceptor 12) DrugCentral uuid:98e71c12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:98e73fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:98e763de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98e78bf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:98e7b5c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:98e7ddd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:98e805dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:98e82ddc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:98e8564a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.75']} DrugCentral uuid:98e87e54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.187']} DrugCentral uuid:98e8a65e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:98e8ce90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.61']} DrugCentral uuid:98e8f762-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:98e91f6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.93']} DrugCentral uuid:98e94780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:98e9702a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.47']} DrugCentral uuid:98e99848-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:98e9c156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.73']} DrugCentral uuid:98e9e96a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:98ea11e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.644']} DrugCentral uuid:98ea39d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:98ea61ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:98ea8afa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.107']} DrugCentral uuid:98eab3ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.039']} DrugCentral uuid:98eadbcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.491']} DrugCentral uuid:98eb03d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.565']} DrugCentral uuid:98eb2bea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:98eb550c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:98eb7d20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:98eba534-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.504']} DrugCentral uuid:98ebcd52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:98ebf5c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:98ec1e4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:98ec466a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:98ec6e88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:98ec976e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralatrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:98ecbf8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:4117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralatrexate targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:98ece796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:4117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralatrexate targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:98ed0fb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:4117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralatrexate targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:98ed387c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:98ed6086-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:98ed889a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:98edb19e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:98edda2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.74']} DrugCentral uuid:98ee0248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:98ee2a66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:98ee5324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:98ee7b42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:98eea360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:98eecb7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:98eef4d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:98ef1ec6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:98ef46f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:98ef6f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:98ef97c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:98efbfe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.1']} DrugCentral uuid:98efe7fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.31']} DrugCentral uuid:98f01010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:98f038ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98f060f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:98f08a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:98f0b240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:98f0dbd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:98f103e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:98f12bf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98f1540c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:98f17c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:98f1a5ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:98f1cdc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:98f1f786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:98f22062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:98f2488a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:98f2709e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:98f29966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:98f2c198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:98f2e98e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:98f311a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:98f33a2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:98f36242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:98f38a56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:98f3b260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:98f3db00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98f40300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:98f42b0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:98f4530a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:98f47c54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:98f4a44a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:98f4cc5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:98f4f472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:98f51cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:98f544ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:98f56cf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:98f59616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:98f5bede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:98f5e6d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:98f60ee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:98f636f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Tyrosine-protein kinase ITK/TSK) DrugCentral uuid:98f65c22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:98f68576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:98f6ad9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:98f6d5b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:98f6fe20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:98f72620-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:98f74e34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:98f77634-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:98f79efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:98f7c706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:98f7ef2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:98f81850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:98f840b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:98f868d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:98f890d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:98f8b9c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:98f8e1c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:98f909d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:98f931ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:98f95a6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21127 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 11B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:98f98366-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ88 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:98f9ab7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:98f9d398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:98f9fc9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:98fa24b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6P3R8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase Nek5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:98fa4ca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:98fa74b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:98fa9d14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:98fac51e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:98faed28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:98fb1532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:98fb3e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:98fb6618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:98fb8e22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:98fbb62c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:98fbe160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:98fc0c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:98fc3764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:98fc6248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:98fc8b7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:98fcb3a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:98fcdba6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:98fd0400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:98fd2c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60331 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:98fd5504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:98fd7d0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:98fda644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:98fdce44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:98fdf64e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:98fe1e62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.328']} DrugCentral uuid:98fe470c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:98fe6f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.604']} DrugCentral uuid:98fe972a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.523']} DrugCentral uuid:98febf2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:98fee7ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:98ff0fac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.292']} DrugCentral uuid:98ff37ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:98ff5fde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:98ff8e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:98ff8e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:98ffc564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:98ffc564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:98fff89a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z2V5 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:990047b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9900dfda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14833 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:990107bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14831 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:99012fbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15303 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:99015b86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00222 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:99018624-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31423 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9901ae10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35349 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9901d610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9901fece-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:990226e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:99024ef6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:99027782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:99029f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.405']} DrugCentral uuid:9902c78c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:9902eb54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:99030f44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.922']} DrugCentral uuid:99033852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:99036052-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51788 biolink:molecularly_interacts_with DrugCentral:4123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lubiprostone is opener of Ion channel (Chloride channel protein 2) DrugCentral uuid:99038424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9903ac38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9903d4e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:9903fd00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9904264a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:99044ed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:990476e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:99049ef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9904c6e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:9904f05c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:990518d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:990540e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q94F81 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (HD2 type histone deacetylase HDA106; Histone deacetylase 2b; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:990568e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O09106 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:99059192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ZTP8 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9905b988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:9905e214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q70I53 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase-like amidohydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:99060a32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:990632a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7K6A1 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:99065a8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:99068278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9906ae60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9906ae60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9906e84e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9906e84e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99074316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9907e6fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9907e6fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9907e6fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9907e6fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:99083492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase (HDAC1 and HDAC2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99083492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase (HDAC1 and HDAC2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99087ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:99087ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:99087ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:99087ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:99087ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:99087ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:99087ec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:9908f0da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A5H660 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Unclassified (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:990918ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24527 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:990941a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:4125 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proline targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:990969ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:4125 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proline targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:990991ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:4126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asparagine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:9909b9a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9909e1e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:990a0ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07314 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Enzyme (Gamma-glutamyltranspeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:990a32f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63116 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Unclassified (Asc-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:990a5ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:990a8576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:4128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:990aad6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:4134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxal targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:990ad56c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisdexamfetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:990afa92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisdexamfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:990b1f18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:4135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisdexamfetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:990b42f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:990b6afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:990b92fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:990bbbee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.925']} DrugCentral uuid:990be416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:990c0bf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:990c340c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:990c5f04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.209']} DrugCentral uuid:990c8722-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:990caf18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.617']} DrugCentral uuid:990cd7ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.569']} DrugCentral uuid:990cffea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:990d27f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.635']} DrugCentral uuid:990d4fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:990d7876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:990da06c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.251']} DrugCentral uuid:990dc876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.916']} DrugCentral uuid:990df076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.061']} DrugCentral uuid:990e1a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:990e4274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:990e6a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.195']} DrugCentral uuid:990e9274-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.265']} DrugCentral uuid:990ebae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:990ee2d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.556']} DrugCentral uuid:990f0ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:990f32d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:990f5b46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:990f836e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:990fab8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:990fd38c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.809']} DrugCentral uuid:990ffe7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.975']} DrugCentral uuid:991028b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:991050d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:991078f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9910a172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.124']} DrugCentral uuid:9910caa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.241']} DrugCentral uuid:9910f2c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:99111b34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.945']} DrugCentral uuid:99114370-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:99116b70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.294']} DrugCentral uuid:991193a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.037']} DrugCentral uuid:9911bcc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:9911e4ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.416']} DrugCentral uuid:99120e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:99123636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:99125efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.084']} DrugCentral uuid:99128708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.628']} DrugCentral uuid:9912afb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.012']} DrugCentral uuid:9912d7d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9913003e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.233']} DrugCentral uuid:9913285c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.325']} DrugCentral uuid:9913505c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:99137870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:9913a1f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9913ca14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.701']} DrugCentral uuid:9913f228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 udenafil targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:99141618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:4141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 udenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.084']} DrugCentral uuid:99143ec2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:4142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine silver is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:99146294-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine silver targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:99148a8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:9914b280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.658']} DrugCentral uuid:9914daf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.85']} DrugCentral uuid:99150302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.21']} DrugCentral uuid:99152ada-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.96']} DrugCentral uuid:991552ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:99157c7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:9915a492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium lauryl sulfate targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9915cc88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium lauryl sulfate targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9915f492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone propionate is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:9916211a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:4146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone propionate targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:991649c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone propionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:991688da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:991688da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:991688da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:991688da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:991688da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:991688da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:991688da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:9916e816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9917100c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:99173906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:99176296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:99178aa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:9917b2be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9917dbf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:99180408-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:99182c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant is antagonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:99185412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:99187c6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:9918a070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.44']} DrugCentral uuid:9918c88e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9918f0b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:99191a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9919420a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2VKV7 biolink:molecularly_interacts_with DrugCentral:4152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 permethrin is blocker of Ion channel (Sodium channel protein) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:991984d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9919f77c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P39654 biolink:molecularly_interacts_with DrugCentral:4156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edaravone targets Enzyme (Polyunsaturated fatty acid lipoxygenase ALOX15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:991a2378-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lercanidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:991a2378-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lercanidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:991a5154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temsirolimus targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:991a7544-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:4161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temsirolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) DrugCentral uuid:991a9916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:4161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temsirolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:991ac102-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00688 biolink:molecularly_interacts_with DrugCentral:4161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temsirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP3) DrugCentral uuid:991aeb64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexlansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:991aeb64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexlansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:991b1918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:4162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexlansoprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:991b4136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:4162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexlansoprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991bff9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:991de54e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:991e0dc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22462 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:991e35ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liraglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.2']} DrugCentral uuid:991e5de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcaftadine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:991e81f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ulipristal is antagonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:991eab5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95470 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod targets Enzyme (Sphingosine-1-phosphate lyase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:991ed36e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:991efb82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:991f2396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:991f4c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:991f7418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923J1 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:991f9c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:991fc49a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.195']} DrugCentral uuid:991fecb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.305']} DrugCentral uuid:992014c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.967']} DrugCentral uuid:99203ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9920663e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:99208e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.69']} DrugCentral uuid:9920b698-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.003']} DrugCentral uuid:9920dfba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.328']} DrugCentral uuid:99211f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99211f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99211f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99211f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99211f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99211f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99211f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99217d26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:4170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tesamorelin is agonist of GPCR (Growth hormone-releasing hormone receptor) DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:9921c060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:992243fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:99226e84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:99229670-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:9922be5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:9922e6f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir is inhibitor of Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:99230ee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60911 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin L2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:992336c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43235 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin K) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:99235eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:99238710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBX1 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9923b3f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:9923b3f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:9923e6d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:99241036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9924387c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9924607c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNI1 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Chymotrypsin-like elastase family member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:99248872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9924b0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9924d8fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:992500f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir is inhibitor of Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:992528e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60911 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin L2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:99255144-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43235 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin K) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:992579a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9925a590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) DrugCentral uuid:9925a590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) DrugCentral uuid:9925d326-b1e3-11ec-aa8d-0242ac110002 UniProtKB:C1KIQ2 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9925fd9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0ZMF1 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9926259c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q91RS4 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:99264db0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:992675ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:99269a4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9926c236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9926eb6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:99271362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:99273bc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:992763d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:99278cac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9927b5ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97321 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9927e04e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:99280858-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99283076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:99285920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate is inhibitor of Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:9928810c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:9928a902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:9928d102-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11715 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 17A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9928f984-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:4177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin enacarbil is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) DrugCentral uuid:99291d6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:4177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin enacarbil is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) DrugCentral uuid:99294146-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9929693c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:992995a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9929bdce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:9929e5d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:992a0de2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:992a363c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:992a5e1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:992a8628-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:992aae28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:992ad678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:992aff0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:992b2722-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:992b4f22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:992b79c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:992ba1c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:992bc9b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:992bf1d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:992c1a56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:992c4256-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:992c6a42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:992c9292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:992cbbd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:992ce3dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:992d0bf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:992d3544-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:992d5f38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:992d8724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:992daf24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:992dd7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:992dffce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:992e27e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:992e4fce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:992e78b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:992ea0be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:992ec8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:992ef0dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:992f1a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:992f429e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:992f6b8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:992f938e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:992fbc42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:992fe442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:99300c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:99303456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:99305cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:993084ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9930acb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9930d49c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.34']} DrugCentral uuid:9930ffd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:993127c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99314fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:99317906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9931a110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9931c910-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9931f0fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:99321960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9932414c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9932696a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9932928c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9932bc4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9932e476-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:99330c76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9933346c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:99335dd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:993385d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9933ade8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9933d5fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9933fe6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:99342660-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:99344e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9934764c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9934a0d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9934c8cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9934f0d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:993518e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:99354194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99356980-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9935918a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9935b98a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9935e1f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:993609ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:993631ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:99365af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5VT25 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9936857c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9936ad7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9936d586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9936fe12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:99372608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:99374f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:99377734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:99379f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:9937c78e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9937ef84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:99381824-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:99384286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99386ae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9938940c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:9938bc34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:9938e4e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:99390cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:993934de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:99395ce8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:99398556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9939ad6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:9939d56a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9939fd6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:993a266e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:993a4e82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:993a7696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:993aab20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:993aab20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:993aab20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:993aab20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:993aebda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:993b14f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:993b3d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:993b6556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:993b8d42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z351 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine targets Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:993bb54c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivaroxaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:993bde0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:4182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivaroxaban targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:993c05f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O19045 biolink:molecularly_interacts_with DrugCentral:4182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivaroxaban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:993c2dd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:993c55ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:993c7e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:993ca63c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:993cce28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:993cf632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:4184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticagrelor is negative allosteric modulator of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:993d1ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:4184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticagrelor is inhibitor of Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:993d4696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EPX4 biolink:molecularly_interacts_with DrugCentral:4184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticagrelor targets GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:993d6e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:993d9664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:993dbf54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:993de754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:993e1062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:993e38da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:993e6184-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22830 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Enzyme (Ferrochelatase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:993e897a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:993eb17a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant is antagonist of GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:993ed998-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25023 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.11']} DrugCentral uuid:993f02ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70526 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.96']} DrugCentral uuid:993f2b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46663 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant is antagonist of GPCR (B1 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:993f530a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32299 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant is antagonist of GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:993f7b1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97583 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant is antagonist of GPCR (B1 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:993fa418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:993fcc22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:993ff404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:99401cf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:994044f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99406d44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9940953a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9940bda8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:9940e5a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99410d9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9941359e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:99415f06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9941888c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9941b096-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9941d88c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:9942014a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:99422936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99425140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:99427922-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:9942a17c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9942c97c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:9942f294-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:99431a94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9943444c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:99436c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9943944c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9943bc56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9943e50a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.26']} DrugCentral uuid:99440e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:99443640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99445e40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:994486ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9944af3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9944d730-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:99450034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:99452834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9945502a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:99457834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9945a0de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9945c8ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9945f0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:994618c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:99464156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.13']} DrugCentral uuid:99466960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:99469160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:9946b974-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9946e372-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:99470b7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9947337c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:99475b5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:994783cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:9947abe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9947d3ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9947fbea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:99482480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:99484c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:99487480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:99489c94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9948c5de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9948edf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:994915d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:99493dd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9949662e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:99498e38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:9949b624-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9949dffa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:994a07fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:994a3004-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:994a57e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:994a8112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:994aaa5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:994ad36a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:994afb60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:994b23c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:994b4c32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:994b7432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:994b9c28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:994bc4d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:994becc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:994c14be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:994c3caa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:994c66e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:994c8fc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:994cb7d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:994cdfc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:994d0838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:994d302e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:994d5842-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:994d801a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:994da8e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:994dd0c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:994df8b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:994e2092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:994e4c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:994e7650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:994e9e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:994ec7b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:994eefb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21127 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 11B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:994f17ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ88 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:994f3fae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:994f683a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:994f903a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:994fb83a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD19 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase Nek9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:994fe166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:99500b0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:99503300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:99505b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:995082f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:9950ab5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:9950d35a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9950fb5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99512364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:99514c0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:99517422-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:99519c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9951c3fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9951ed26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9952159e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99523d80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:99526580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:99528de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9952b6b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9952deb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99530742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:99532f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:99535742-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:99537f38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9953a850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9953d0d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9953f8d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:995420d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99544936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:99547136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:99549940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9954c140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9954e9d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:995511e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:995539ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:995561ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:99558aee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9955b410-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9955dc1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9956042e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62190 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:99562c88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02858 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:99565474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99567d5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9956a564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9956ce18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9956f622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9957220a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:9957220a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:995755cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15357 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Enzyme (Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:99577dc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9957a5d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NB16 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mixed lineage kinase domain-like protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9957cdcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9957f61c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:4188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deferiprone targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:99581ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:995846bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.261']} DrugCentral uuid:99586ec6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.573']} DrugCentral uuid:9958977a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9958bf98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9958e77a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.501']} DrugCentral uuid:99590f48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:99593900-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:9959611e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.664']} DrugCentral uuid:995988f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9959b0f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9959d946-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:995a0132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:995a2a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:995a524a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:995a7afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:995aa2fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:995acb12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:995af308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:995b1e3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:995b463c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:995b6f72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:995b97fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:995bbff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:995be7f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:995c1012-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.44']} DrugCentral uuid:995c38bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:995c60bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:995c88e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:995cb0da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:995cdab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:995d05e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:995d2ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:995d57f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:995d8064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:995da850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:995dd064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:995df940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:995e2280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:995e4a6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:995e7276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:995e9a76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:995ec578-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:995eed5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:995f155a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:995f3daa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:995f65be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:995f8db4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:995fb5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:995fde5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:99600668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:99602e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9960567c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99607f62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9960a76c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9960cf80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9960f780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:99611fd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:996147d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:996170fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:996198fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9961c1b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9961eab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:996212b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:99623ac8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:996264e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:99628d02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9962b4f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9962dd02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9963055c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99632d70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:99635566-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:99637d66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9963a61a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9963ce1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9963f61a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:99641eec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:996447b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:99646fb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:996497a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9964c09a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9964e87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:99651072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:99653868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:99656112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:996588fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9965b0ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9965d9c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:996603c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:99662ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:996656ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:99667ee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9966a752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9966cf52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9966f75c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:99671f52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9967493c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:99677146-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:99679950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9967c150-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9967ea4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99681254-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:99683a68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:9968625e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:99688acc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9968b2cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9968dae0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99690394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:99692b9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:996953a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:99697b8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9969a542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9969cd6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9969f574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:996a1d92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:996a45ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:996a6dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:996a95e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:996abde2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:996ae696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:996b0e96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:996b3722-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:996b5f2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:996b898e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:996bb418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:996bdc0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:996c0418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:996c2c7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:996c5486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:996c7c86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:996ca490-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:996ccd6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:996cf558-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:996d212c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:996d212c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:996d5a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:996d5a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:996d9260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:996d9260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:996dcd52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:996dcd52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:996dcd52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:996e0fc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:996e0fc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:996e42e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:996e6afa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:996e93ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:996ebb90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:996ee386-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.393']} DrugCentral uuid:996f0b9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.401']} DrugCentral uuid:996f367e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.271']} DrugCentral uuid:996f6112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.187']} DrugCentral uuid:996f8926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:996fb130-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:4192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafamidis is inhibitor of Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.936']} DrugCentral uuid:996fd99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:4192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafamidis is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:997001a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:4192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafamidis is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.627']} DrugCentral uuid:997029c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:4192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafamidis is binding agent of Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.812']} DrugCentral uuid:997051a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99707 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Enzyme (Methionine synthase) DrugCentral uuid:99707606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBK8 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Enzyme (Methionine synthase reductase) DrugCentral uuid:997099c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BXJ7 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Unclassified (Protein amnionless) DrugCentral uuid:9970bd8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96EY8 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Enzyme (Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial) DrugCentral uuid:9970e154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH4 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Enzyme (Methylmalonic aciduria type A protein, mitochondrial) DrugCentral uuid:997107ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20062 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Secreted (Transcobalamin-2) DrugCentral uuid:99712b82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20061 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Secreted (Transcobalamin-1) DrugCentral uuid:99714f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:4197 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vitamin A palmitate targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:99717772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:4197 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vitamin A palmitate targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:99719fd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4199 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 potassium chloride targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:9971c7f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium acetate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:9971f008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium acetate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.44']} DrugCentral uuid:99721c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium carbonate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:99721c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium carbonate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:99724b66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29218 biolink:molecularly_interacts_with DrugCentral:4207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium carbonate is inhibitor of Enzyme (Inositol-1(or 4)-monophosphatase 1) DrugCentral uuid:99726f42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9972974c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9972bf4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:9972e878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.582']} DrugCentral uuid:997310be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:997338dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:99736154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:9973897c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:9973b17c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9973d972-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9974026c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:99742a9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:997452b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:99747ab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.157']} DrugCentral uuid:9974a424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.394']} DrugCentral uuid:9974cc38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9974f50a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:99751d14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:99754596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:99756da0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:997595a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9975bdaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:9975e65e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:99760e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:99763672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:99765e90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:99768942-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:9976b16a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:9976d988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:99770192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99772a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:997759da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:997759da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:997759da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:99779fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:99779fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:99779fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:9977e83c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9977e83c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9977e83c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:99782e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:99782e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:99782e00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:997877f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:997877f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:997877f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9978b5fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02665 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Unclassified (Beta-casein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:9978de54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetic acid targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9979065e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetic acid targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:99792e68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15552 biolink:molecularly_interacts_with DrugCentral:4211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetic acid is agonist of GPCR (Free fatty acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:99795668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14843 biolink:molecularly_interacts_with DrugCentral:4211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetic acid targets GPCR (Free fatty acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:99797f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:9979a302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:4213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone acetate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9979d2e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:9979d2e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:9979d2e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:997a0a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium phosphate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:997a3484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:4220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telbivudine targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:997a5c70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:4220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telbivudine is inhibitor of Polyprotein (Protein P) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:997a8466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4221 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequinol is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:997aa82e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:997ad0ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:997af8a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:997b20c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:997b48d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:997b718c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:997b9982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:997bc18c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:997beb44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:997c145c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:997c3c52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:997c64de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:997c8d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:997cb52e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:997cde50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:997d0646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:997d2ee6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:997d56e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:997d7edc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:997da6dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:997dd4a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:997dd4a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:997e0fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:997e0fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:997e0fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:997e5550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:997e5550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:997e5550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:997e93da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:997ebbd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:997ee3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:997f0c66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:997f3498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.31']} DrugCentral uuid:997f5d9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:997f85a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:997fafe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:997fd7f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:997fffea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:998027fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:99805062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:99807880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9980a06c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:9980c862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.29']} DrugCentral uuid:9980f116-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:99811920-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9981412a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:998169c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9981927e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9981ba92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9981e288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:99820ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:99823404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99825c0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:99828418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9982acae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9982d4c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:9982fcd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.89']} DrugCentral uuid:99832576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:99834fce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:998377e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:99839fec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9983c7f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9983f050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9984183c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:99844050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:99846846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:998490e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:9984b8f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9984e0f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:998508f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:99853398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:99855b98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:99858384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9985ab7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9985d3d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9985fbd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:998623d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99864c74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:99867488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99869c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9986c44c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9986ed50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99871546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99873e40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:99876636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99878e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9987b67c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9987de68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:99880668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99883070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:99885866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9988807a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9988a8a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9988d16a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9988f992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9989219c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9989499c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9989720a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:99899a14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9989c20a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9989ea8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:998a1340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:998a3b40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:998a6336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:998a8b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:998ab520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:998add16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:998b050c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:998b2e42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:998b5656-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:998b7e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:998ba66a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:998bcf14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:998bf714-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:998c1f14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:998c473c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:998c7090-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:998c9b6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:998cc37e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:998ceb7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:998d1400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:998d3c0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:998d640a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:998d8c0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:998db4c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:998ddcd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:998e04e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:998e2e08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:998e5720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05129 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate is activator of Kinase (Protein kinase C gamma type) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.79']} DrugCentral uuid:998e7f3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05771 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate targets Kinase (Protein kinase C beta type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.836']} DrugCentral uuid:998ea72a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.197']} DrugCentral uuid:998ecf84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:998ef7ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:998f20ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate is activator of Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.328']} DrugCentral uuid:998f48b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62226 biolink:molecularly_interacts_with DrugCentral:4227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vismodegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:998f70a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15465 biolink:molecularly_interacts_with DrugCentral:4227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vismodegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:998f9996-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:4227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vismodegib is inhibitor of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.79']} DrugCentral uuid:998fc1c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56726 biolink:molecularly_interacts_with DrugCentral:4227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vismodegib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:998fea72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:4228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivacaftor is positive modulator of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9990138a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:4229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafluprost is agonist of GPCR (Prostaglandin F2-alpha receptor) DrugCentral uuid:99903784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:4234 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginesatide is agonist of Membrane receptor (Erythropoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.43']} DrugCentral uuid:99905fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avobenzone is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:9990837e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9990abb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9990d3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95237 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin targets Enzyme (Lecithin retinol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:9990fbe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.81']} DrugCentral uuid:999123f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48442 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:99914cbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:999174d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99919cb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:9991c4dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9991ee44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51787 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9992164e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:99923e62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:9992668a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:99928eee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9992b6f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:9992df16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99930838-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:999330e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:999358ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:999384ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bismuth subsalicylate is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:999384ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bismuth subsalicylate is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:9993b242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thymol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9993dec0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8R455 biolink:molecularly_interacts_with DrugCentral:4258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thymol targets Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:999406ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4QYD9 biolink:molecularly_interacts_with DrugCentral:4258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thymol targets Unclassified (Heat sensitive channel TRPV3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:99942eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfur targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9994572e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfur targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:99947f56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:4264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamide targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:9994a760-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentamicin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:9994cf56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:4265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentamicin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9994f814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:4265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentamicin is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:99952028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:999548be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:999570dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:99959a44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9995c24e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:9995ea4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9996124e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:99963aa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00720 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Endolysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:999662b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:99968ac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:9996b2da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9996db8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:9997049c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:99972cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:999754a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arbutin targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:99977f58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:4267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arbutin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9997aa0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11344 biolink:molecularly_interacts_with DrugCentral:4267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arbutin targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:9997d462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:99987f0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:9999fc1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tapentadol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:999a2438-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tapentadol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:999a4c4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tapentadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:999a74ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tapentadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:999a9ce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Florbetapir F-18 targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:999ac4ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:999aecce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:999b162c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:999b3e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:999b662c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:999b8e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDS5 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets GPCR (Oxoeicosanoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:999bb690-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6RI86 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:999bdefe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Nuclear other (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:999c083e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 potassium iodide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:999c3048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:4298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apixaban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:999c58ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apixaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:999c80e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O19045 biolink:molecularly_interacts_with DrugCentral:4298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apixaban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:999cb4b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:999cb4b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:999cb4b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:999cb4b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:999d0266-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:4300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elvitegravir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:999d2aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:4300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elvitegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:999d52ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:4300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elvitegravir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:999d7aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:4300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elvitegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:999da2fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4301 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Flutemetamol (18F) targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:999dcb1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.69']} DrugCentral uuid:999df356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.25']} DrugCentral uuid:999e1c50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:999e4478-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:999e6caa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.91']} DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999eb85e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:999f32ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:999f5b10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:999f8306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin targets Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:999faae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WWX8 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin targets Transporter (Sodium/myo-inositol cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:999fd3c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY91 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin targets Transporter (Low affinity sodium-glucose cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.87']} DrugCentral uuid:999ffc5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:4305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avanafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:99a0243c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51160 biolink:molecularly_interacts_with DrugCentral:4305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avanafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.201']} DrugCentral uuid:99a04c32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O77746 biolink:molecularly_interacts_with DrugCentral:4305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avanafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:99a077f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:4308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasofoxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:99a077f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:4308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasofoxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:99a0af74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasofoxifene is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:99a0d774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasofoxifene is agonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:99a10014-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:99a1285a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:99a1505a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:99a1785a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:99a1a064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:99a1c936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:99a1f12c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:99a2192c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:99a24136-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:99a26a9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:99a2958c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:99a2bdb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:99a2e5b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:99a30dfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99a33604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:99a35e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:99a385e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16555 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Dihydropyrimidinase-related protein 2) DrugCentral uuid:99a3abe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:99a3d3d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:99a3fbb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:99a4238e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:99a44c9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:99a4746a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:99a49c4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:99a4d3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:99a4d3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:99a4d3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:99a4d3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:99a4d3f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:99a5282e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:4317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 euflavine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:99a5501a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:4317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 euflavine targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:99a5787e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:4317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 euflavine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:99a5a074-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:99a5c892-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:99a5f1be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:99a61be4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:99a64632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:99a66e5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:99a69664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:99a6bec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99a6e6d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:99a70ed2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:99a737a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99a760da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99a788d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:99a7b0c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:99a7d8b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:99a80404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99a82c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99a853f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:99a87c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:99a8a440-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99a8cc36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:99a8f418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99a91cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:99a944c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:99a96ca4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:99a9949a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:99a9bdf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:99a9e88c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:99aa1082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:99aa3878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:99aa60dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:99aa88d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:99aab0be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:99aad8a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:99ab00fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:99ab29d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:99ab51c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:99ab79ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99aba456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:4322 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azilsartan medoxomil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:99abcc38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:4322 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azilsartan medoxomil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:99abf550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:99ac1d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:99ac45c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:99ac6dd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:99ac95dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:99acbddc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:99ace65e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:99ad0e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant is antagonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.52']} DrugCentral uuid:99ad3686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:99ad5fc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:99ad8992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:99adb192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:99add9a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:99ae028c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bazedoxifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:99ae2aa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bazedoxifene is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99aee90e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:99b08ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambrisentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:99b0b2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambrisentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.65']} DrugCentral uuid:99b0daf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4340 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alogliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:99b10306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:4342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zucapsaicin is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.71']} DrugCentral uuid:99b12bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.158']} DrugCentral uuid:99b153d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.936']} DrugCentral uuid:99b17bce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99b1a414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.726']} DrugCentral uuid:99b1cbf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.363']} DrugCentral uuid:99b1f40a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.958']} DrugCentral uuid:99b21c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43194 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets GPCR (G-protein coupled receptor 39) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:99b2448c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6QR73 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets GPCR (G protein-coupled receptor 39-1b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:99b26c78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPD8 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Unclassified (Ubiquitin-conjugating enzyme E2 T) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:99b2948c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99b2d3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99b2d3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99b2d3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99b2d3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99b2d3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99b2d3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99b2d3ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:99b33356-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.5']} DrugCentral uuid:99b35b4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Enzyme (Thioredoxin reductase 1, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:99b38392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.85']} DrugCentral uuid:99b3ac6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.85']} DrugCentral uuid:99b3d478-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6N5 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Unclassified (Sulfide:quinone oxidoreductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:99b3fc6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bilastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:99b42540-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:4357 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anidulafungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:99b44d2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:4358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arginine glutamate targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:99b4752c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99b49d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:99b4c680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:99b4eea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.54']} DrugCentral uuid:99b516bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:99b53e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:99b56734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:99b58f3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.23']} DrugCentral uuid:99b5b716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:99b5df16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:99b607ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:99b62fa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:99b65798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:99b67f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:99b6ab3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:99b6d632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:99b6fe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99b72696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99b74e8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:99b77682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:99b79f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:99b7c7e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.47']} DrugCentral uuid:99b7efea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:99b817ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:99b83fea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:99b869f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99b891f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:99b8b9fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:99b8e328-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:99b90be6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:99b933e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:99b95bfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:99b98454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99b9ace0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:99b9d4d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99b9fcf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.38']} DrugCentral uuid:99ba2508-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:99ba4f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99ba7792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:99ba9fb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:99bac7a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:99baf014-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:99bb1814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:99bb40a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:99bb6904-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99bb9226-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:99bbba30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:99bbe230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:99bc0be8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:99bc3456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:99bc5c60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:99bc844c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:99bcacc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:99bcd4c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:99bcfcc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:99bd24ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:99bd4d3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:99bd7550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:99bd9d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:99bdc564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:99bdee7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:99be169a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49761 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:99be3e9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:99be66ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:99be8f30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.89']} DrugCentral uuid:99beb85c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:99bee066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:99bf088e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:99bf30f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99bf5906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:99bf820a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:99bfaa14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.33']} DrugCentral uuid:99bfd5f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:99bffdfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:99c02610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:99c04e9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.04']} DrugCentral uuid:99c07692-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:99c09e92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99c0c692-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:99c0f1d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:99c11e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:99c14630-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:99c16e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99c19888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:99c1c2c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:99c1eac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:99c2133a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99c23ba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:99c263a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:99c28bb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99c2b3a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:99c2dc70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:99c30484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:99c32c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:99c3552e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99c3810c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:99c3a916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:99c3d120-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:99c3f97a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:99c42198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:99c449a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:99c471b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:99c49a56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:99c4c396-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:99c4ebaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:99c513be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99c53de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N752 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Casein kinase I isoform alpha-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:99c5676a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:99c58f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:99c5b756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:99c5dfba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:99c607c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:99c62fce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:99c657d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:99c68082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:99c6a88c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:99c6d078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:99c6f88c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:99c723e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:99c74bfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:99c774f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:99c79d64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:99c7c564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:99c7ed5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:99c81564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:99c83e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:99c86622-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:99c88e2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:99c8b62c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99640 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:99c8e05c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.29']} DrugCentral uuid:99c90a32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:99c93228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:99c95a3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:99c98296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:99c9aaa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99c9d2a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:99c9fab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99ca2354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99ca4b54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:99ca734a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99ca9b54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:99cac642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:99caee56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:99cb166a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:99cb3e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:99cb67dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:99cb8fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:99cbb7e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:99cbe068-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:99cc0886-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:99cc3090-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:99cc58a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:99cc81e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:99ccaad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.49']} DrugCentral uuid:99ccd2d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:99ccfade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16277 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:99cd231a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:99cd4b2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:99cd732e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:99cd9b38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:99cdc3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:99cdebf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:99ce1400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:99ce3c00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:99ce6540-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:99ce8d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:99ceb54a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:99cedd40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:99cf05ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:99cf2db8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:99cf56b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:99cf7ebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:99cfa810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:99cfd01a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:99cff81a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99d02010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:99d04ad6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:99d072c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:99d09acc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:99d0c47a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:99d0ec84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:99d11484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:99d13ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:99d1656a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:99d18d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.11']} DrugCentral uuid:99d1b592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:99d1dd9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:99d20646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:99d22e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:99d25646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:99d27e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:99d2a6be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:99d2cec8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQI3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:99d2f6c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:99d31ed2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:99d3486c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:99d37094-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:99d3989e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:99d3c0a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:99d3ef2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:99d3ef2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:99d4262e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:99d4262e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:99d45d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:99d45d2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:99d490a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05193 biolink:molecularly_interacts_with DrugCentral:4360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetrimide targets Structural (Dynamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:99d4b882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:4361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chenodiol is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:99d4e0a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:4361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chenodiol is agonist of Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:99d50940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:4361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chenodiol is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:99d53140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:4362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chiniofon targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:99d5592c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:4365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vernakalant targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:99d58118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vernakalant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:99d5aa62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZV8 biolink:molecularly_interacts_with DrugCentral:4365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vernakalant targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:99d5d596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vernakalant is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.875']} DrugCentral uuid:99d60020-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:4366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voclosporin is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:99d6283e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:4366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voclosporin is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:99d650ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:99d679ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:99d6a20a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.61']} DrugCentral uuid:99d6ca1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcaserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:99d6f3c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcaserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:99d71bd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcaserin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:99d74412-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcaserin is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:99d76c12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:99d79746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99d7bf8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:99d7e7a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:99d80faa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:99d8380e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29973 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium is blocker of Ion channel (cGMP-gated cation channel alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:99d86018-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16280 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium is blocker of Ion channel (Cyclic nucleotide-gated olfactory channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:99d88822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:4379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 degarelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:99d8b036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desvenlafaxine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.325']} DrugCentral uuid:99d8d8f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desvenlafaxine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:99d90108-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desvenlafaxine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:99d9291c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapoxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.95']} DrugCentral uuid:99d95216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirabegron is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.65']} DrugCentral uuid:99d97a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:99d9a252-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:99d9ca7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99d9f2fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:99da1b10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:99da4310-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:99da6b06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:99da939c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:99dabcaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:99dae4aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:99db0cbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:99db3702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:99db63b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:99db63b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:99db9b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:99db9b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:99dbd504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:99dbd504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:99dbd504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:99dbd504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:99dc1f5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:99dc5308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99dc5308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99dc5308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99dc5308-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99dca11e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:99dca11e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:99dcdc06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:99dcdc06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:99dcdc06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:99dd1ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:99dd42cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.026']} DrugCentral uuid:99dd6ac2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:99dd9452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:99ddbc52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:99dde024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99de0810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:99de2bec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:99de5072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.582']} DrugCentral uuid:99de7872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.639']} DrugCentral uuid:99dea054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.321']} DrugCentral uuid:99dec84a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25025 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (C-X-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.024']} DrugCentral uuid:99def388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.029']} DrugCentral uuid:99df1b74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.154']} DrugCentral uuid:99df4388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.335']} DrugCentral uuid:99df6be2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.219']} DrugCentral uuid:99df9400-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofenotane targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:99dfbc14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clopenthixol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:99dfe41e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltrombopag targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:99e00cdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:4399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:99e034d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:4401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 casopitant targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:99e05d04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 casopitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:99e084f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7DHH4 biolink:molecularly_interacts_with DrugCentral:4402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftobiprole medocaril targets Enzyme (MecA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:99e0adb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61073 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor is partial agonist of GPCR (C-X-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:99e0d6ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:99e0fee4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48061 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor targets Cytokine (Stromal cell-derived factor 1) DrugCentral uuid:99e122ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor is antagonist of GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:99e14b06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08565 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor targets GPCR (C-X-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:99e172fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25106 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor is agonist of GPCR (Atypical chemokine receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:99e19c78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.118']} DrugCentral uuid:99e1c496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.157']} DrugCentral uuid:99e1ed4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:99e2157c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.308']} DrugCentral uuid:99e23d9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.977']} DrugCentral uuid:99e265a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.915']} DrugCentral uuid:99e28e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.677']} DrugCentral uuid:99e2b6da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:99e2def8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.085']} DrugCentral uuid:99e30702-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.478']} DrugCentral uuid:99e32f7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:99e35798-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.262']} DrugCentral uuid:99e37fac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:99e3a7a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.126']} DrugCentral uuid:99e3d060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.131']} DrugCentral uuid:99e3f874-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.781']} DrugCentral uuid:99e42074-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.065']} DrugCentral uuid:99e4487e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.931']} DrugCentral uuid:99e47470-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diamorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:99e49f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:4412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diamorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:99e4cad8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:4412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diamorphine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:99e4f3a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibutylphthalate is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:99e51ba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocryptine is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:99e543a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocryptine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:99e56cb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:4420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocryptine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:99e59580-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:99e5bd76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.018']} DrugCentral uuid:99e5e56c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.652']} DrugCentral uuid:99e60d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.092']} DrugCentral uuid:99e6380a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.604']} DrugCentral uuid:99e6612c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.775']} DrugCentral uuid:99e68940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:99e6b2b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:99e6dbca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:99e70406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:99e72c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:99e75442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:99e77ce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:99e7a4e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:99e7ccec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:99e7f604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:99e81e22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:99e84640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:99e8721e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:99e8721e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:99e8a9a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:99e8a9a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:99e8e302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:99e8e302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:99e8e302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:99e8e302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:99e92e2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:99e961c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99e961c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99e961c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99e961c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:99e9aefe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:99e9aefe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:99e9ed74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:99e9ed74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:99e9ed74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:99ea2be0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:99ea5408-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30988 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Calcitonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:99ea8054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.53']} DrugCentral uuid:99ea8054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.53']} DrugCentral uuid:99eab754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.082']} DrugCentral uuid:99eab754-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.082']} DrugCentral uuid:99eaee5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.706']} DrugCentral uuid:99eaee5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.706']} DrugCentral uuid:99eb222a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone sodium phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:99eb4782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.179']} DrugCentral uuid:99eb6f78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Cytosolic other (Annexin A1) DrugCentral uuid:99eb9354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:99ebbd52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.599']} DrugCentral uuid:99ebe58e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:99ec0d98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.818']} DrugCentral uuid:99ec369c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:99ec5f00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:99ec87be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:99ecafdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone cypionate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:99ecd3c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4456 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone succinate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:99ecf834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:4456 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone succinate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:99ed205c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:4458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfisoxazole acetyl is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:99ed4438-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:99ed6c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:99ed9618-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:4458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:99edbe04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:4466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eosin targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:99ede5f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5VLE3 biolink:molecularly_interacts_with DrugCentral:4466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eosin targets Enzyme (RmtA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:99ee2574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:99ee2574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:99ee2574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:99ee2574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:99ee2574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:99ee2574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:99ee2574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:99ee8f78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosaprepitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:99eeb818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trisodium citrate dihydrate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:99eee022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trisodium citrate dihydrate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:99ef082c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium citrate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:99ef3040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium citrate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:99ef5a70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19111 biolink:molecularly_interacts_with DrugCentral:4480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 potassium phosphate, monobasic targets Enzyme (Intestinal alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99ef8572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:99efb63c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:99efb63c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:99efb63c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:99effcd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99effcd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99effcd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99f04430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:99f04430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:99f04430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:99f07b58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:99f0a40c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:99f0cc02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28062 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:99f0f416-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:99f11cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:99f146fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:99f16ef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:99f196dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28065 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99f1bf40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40306 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:99f1e736-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:99f20fd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:99f237cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:99f2606c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:99f28876-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:99f2b06c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:99f2d862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:99f30242-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4485 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflorasone diacetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.536']} DrugCentral uuid:99f32d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4485 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflorasone diacetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:99f3553a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alclometasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:99f3792a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol decanoate is inverse agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:99f3a198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol decanoate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:99f3c9a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol decanoate targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:99f3f198-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:4496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol decanoate targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:99f419ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol acetate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:99f43e32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4498 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone palmitate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:99f46646-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4498 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone palmitate is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:99f48a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4498 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone palmitate is antagonist of GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:99f4ae12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.921']} DrugCentral uuid:99f4d806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:99f5002e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.497']} DrugCentral uuid:99f52810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:99f54bd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets Enzyme (Cytochrome P450 1A2) DrugCentral uuid:99f57130-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:99f59502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:99f5bd0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4504 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone valerate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:99f5e0fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline fenofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:99f609a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:4505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline fenofibrate targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:99f631b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:4505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline fenofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:99f659a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:4505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline fenofibrate targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:99f681b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4507 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halcinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.135']} DrugCentral uuid:99f6ab36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4507 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halcinonide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:99f6d32c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4507 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halcinonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.917']} DrugCentral uuid:99f6fb4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racepinefrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:99f72458-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racepinefrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:99f74ce4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racepinefrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:99f77976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium citrate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:99f77976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium citrate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:99f7a70c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29218 biolink:molecularly_interacts_with DrugCentral:4512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium citrate is inhibitor of Enzyme (Inositol-1(or 4)-monophosphatase 1) DrugCentral uuid:99f7cae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:4514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:99f7f392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49190 biolink:molecularly_interacts_with DrugCentral:4514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:99f81b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P70555 biolink:molecularly_interacts_with DrugCentral:4514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:99f8437e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25961 biolink:molecularly_interacts_with DrugCentral:4514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:99f86b7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4516 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracosactide targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.19']} DrugCentral uuid:99f89720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4516 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracosactide is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.268']} DrugCentral uuid:99f8c0d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:99f8e496-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:99f90d04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:99f930ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92953 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine is blocker of Ion channel (Potassium voltage-gated channel subfamily B member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:99f958ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:99f988a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:99f988a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:99f988a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:99f9c79e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:99f9ef8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbendazole targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.496']} DrugCentral uuid:99fa176c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10424 biolink:molecularly_interacts_with DrugCentral:4536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbendazole targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:99fa3f76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.12']} DrugCentral uuid:99fa683e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:99fa9034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:99fab924-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:99fae28c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:99fb0a96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:99fb3278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:99fb5a78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:99fb8318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:99fbab2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:99fbdebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:99fbdebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:99fbdebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:99fbdebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:99fc3092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99fc3092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99fc3092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99fc728c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium oxybate is agonist of GPCR (GABA-B receptor) DrugCentral uuid:99fc728c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium oxybate is agonist of GPCR (GABA-B receptor) DrugCentral uuid:99fca00e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6RY99 biolink:molecularly_interacts_with DrugCentral:4566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium oxybate targets Unclassified (Gamma-hydroxybutyrate receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:99fcc836-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochloric acid targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:99fcf054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone probutate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:99fd14c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4573 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:99fd3cbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:4573 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:99fd6552-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:4573 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:99fd8d3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:4573 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:99fdc0ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:99fdc0ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:99fdc0ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:99fdc0ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:99fe0e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:99fe3752-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:99fe5f52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:99fe873e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88944 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is inhibitor of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:99feaf98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97414 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is inhibitor of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:99fed784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:99feff70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:99ff27fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:99ff4ff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:99ff77fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFU5 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Kinase (Inositol polyphosphate multikinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:99ff9fe8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHH9 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Kinase (Inositol hexakisphosphate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:99ffc950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tonzonium targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:99fff29a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:4605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tonzonium targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:9a001a90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clocortolone pivalate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:9a003e62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:4608 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trypan blue targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:9a00669e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25044 biolink:molecularly_interacts_with DrugCentral:4608 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trypan blue targets Enzyme (Tyrosine-protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:9a008eb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone enantate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:9a00b28e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9a00daa2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:9a010338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9a012b42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9a015342-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9a017b4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27471 biolink:molecularly_interacts_with DrugCentral:4615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 N-Acetylglucosamine targets Unclassified (Killer cell lectin-like receptor subfamily B member 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a01a5fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9a01ce1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9a01f626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:9a021e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9a024694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9a026f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9a02972a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:9a02bf16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.1']} DrugCentral uuid:9a02e7c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a030fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05413 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Cytosolic other (Fatty acid-binding protein, heart) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.56']} DrugCentral uuid:9a0337d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:9a035fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9a038a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:9a03b236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:9a03da18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:9a040222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:4619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9a042a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:4619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenol targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:9a04525e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:4619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9a047a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:4621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomefolic acid targets Enzyme (Thymidylate synthase) DrugCentral uuid:9a049e1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23897 biolink:molecularly_interacts_with DrugCentral:4622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linaclotide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:9a04c6da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25092 biolink:molecularly_interacts_with DrugCentral:4622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linaclotide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.907']} DrugCentral uuid:9a050244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:9a050244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:9a050244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:9a050244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:9a050244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:9a050244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:9a055abe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:4624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylacetic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:9a05832c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:9a05ab5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:9a05d372-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9a05fbfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:9a062426-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9a064c26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63931 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:9a0678a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9a0678a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9a06ac0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4628 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enzalutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.31']} DrugCentral uuid:9a06d40c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4628 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enzalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:9a06fc02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:4630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium pyrophosphate targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9a0725f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:9a075774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:9a075774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:9a075774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:9a075774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:9a079860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trabectedin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9a07c0ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O54915 biolink:molecularly_interacts_with DrugCentral:4633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trabectedin is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9a07e964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide is inhibitor of Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9a081178-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9a08398c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9a086222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35435 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:9a088a2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q54A96 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:9a08b240-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:4635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Choline C-11 targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9a08db3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9a09059c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9a092d92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99895 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Enzyme (Chymotrypsin C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9a095574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16278 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9a097d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O06446 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Unclassified (Protein translocase subunit SecA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9a09a5f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2FUW6 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Unclassified (Protein translocase subunit SecA 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a09ce0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:4641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9a09f60a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:4641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:9a0a1dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:4641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9a0a46b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:4641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levmetamfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9a0a6eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:9a0a97ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:9a0ac10c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:9a0ae916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:9a0b110c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid is agonist of GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9a0b3902-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorometholone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:9a0b618e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eugenol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9a0b8998-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eugenol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:9a0bb1a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eugenol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:9a0bd98e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9a0c0206-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0c2a1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:9a0c5210-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0c7a24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9a0ca5da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9a0ccdf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0cf5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9a0d1dee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0d4648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0d6e52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib is inhibitor of Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9a0d9648-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0dbe34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0de6ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0e0ea2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0e36a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0e5e70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0e89a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0eb488-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0edc92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9a0f04e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a0f2cce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:4655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tedisamil is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:9a0f54d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metamizole is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.041']} DrugCentral uuid:9a0f7cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:9a0fa51e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:4660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:9a0fcd3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:4660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.59']} DrugCentral uuid:9a0ff528-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:4660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:9a101d1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:4663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoin targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9a10464a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:4663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoin targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:9a107048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:4664 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoic acid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:9a109852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:4664 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoic acid targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a10c066-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:4664 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9a10e91a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.932']} DrugCentral uuid:9a111138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.776']} DrugCentral uuid:9a113938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:9a11616a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.779']} DrugCentral uuid:9a1189d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.248']} DrugCentral uuid:9a11b214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.428']} DrugCentral uuid:9a11da14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:4671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metizoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:9a120296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:4671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metizoline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:9a122c1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:4671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metizoline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:9a12541c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:4671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metizoline targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:9a127c30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9a12a430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.14']} DrugCentral uuid:9a12ccb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:9a12f4a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:9a131c94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9a13448a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9a136ce4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:9a1394e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:9a13bcda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:9a13e548-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:9a140f82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:9a14378c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9a146072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:9a148908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9a14b0e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9a14d8f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9a1500f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:9a1529a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obidoxime targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.67']} DrugCentral uuid:9a1551a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:9a1579a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9a15a180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A5H660 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat targets Unclassified (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9a15cb74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9a15f4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:9a161d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9a164662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:9a166f02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9a16973e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:9a16bf5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9a16e78e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:9a171092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:9a1738d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:9a176196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:9a1789b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:9a17b466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9a17dc52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9a1804a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9a182d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:9a1855ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9a187de2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a18a5c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O35678 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a18ce6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O08914 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9a190230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9a190230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9a190230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9a190230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9a194b32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:4690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pleconaril targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9a197486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:4690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pleconaril targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9a199c72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7T664 biolink:molecularly_interacts_with DrugCentral:4690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pleconaril targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:9a19c45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:4696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remikiren is inhibitor of Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:9a19ec4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9a1a14b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9a1a3cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:9a1a64cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:9a1a8cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.93']} DrugCentral uuid:9a1ab594-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:9a1add80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 semustine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.744']} DrugCentral uuid:9a1b059e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.074']} DrugCentral uuid:9a1b2d94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:9a1b53f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.624']} DrugCentral uuid:9a1b7e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:9a1ba634-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:9a1bcf60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32241 biolink:molecularly_interacts_with DrugCentral:4710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatorelin is agonist of GPCR (Vasoactive intestinal polypeptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9a1bf8dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:9a1c20f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9a1c4918-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:9a1c71ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9a1c99e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9a1cc1f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a1cea12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9a1d1384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:9a1d3bb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a1d63ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:9a1d8be8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9a1db438-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9a1ddc60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9a1e046a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9a1e2c88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9a1e5528-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:9a1e7d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9a1ea550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9a1ecd5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a1ef76c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:9a1f220a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9a1f4a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9a1f721e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9a1f9a6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9a1fc296-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:9a1feb9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a2013ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9a203c62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9a206480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9a208c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9a20b494-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9a20dfa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62137 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:9a2107a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9a212faa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:9a215822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a218428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:9a218428-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:9a21c078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:9a21c078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:9a21c078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:9a220380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9a220380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9a2236ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63272 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a2262a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.391']} DrugCentral uuid:9a2262a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.391']} DrugCentral uuid:9a229b7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:9a229b7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:9a22ceaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.907']} DrugCentral uuid:9a22f6b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:9a231eb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9a2347fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9a237008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9a239808-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:9a23c008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9a23e8bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:9a2410bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9a2438da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.337']} DrugCentral uuid:9a2461b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.947']} DrugCentral uuid:9a248cea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:9a24b706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.456']} DrugCentral uuid:9a24df1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.845']} DrugCentral uuid:9a25077e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.886']} DrugCentral uuid:9a252f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:9a25579c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.432']} DrugCentral uuid:9a257f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.903']} DrugCentral uuid:9a25a828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Breakpoint cluster region protein) DrugCentral uuid:9a25cc0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9a25f404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9a261c04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:9a2645a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:9a26700a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:9a269800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:9a26bfe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.268']} DrugCentral uuid:9a26e850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:9a271230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.658']} DrugCentral uuid:9a273a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:9a276244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:9a278b0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:9a27b316-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9a27db3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49336 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Cyclin-dependent kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.17']} DrugCentral uuid:9a28037a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9a282dbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9a2859a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9a2859a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9a288cf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9a28b61c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95838 biolink:molecularly_interacts_with DrugCentral:4718 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teduglutide is agonist of GPCR (Glucagon-like peptide 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9a28de12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z0W0 biolink:molecularly_interacts_with DrugCentral:4718 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teduglutide targets GPCR (Glucagon-like peptide 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.1']} DrugCentral uuid:9a2905fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:9a2929da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:9a294e38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:9a297214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:9a2995f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:9a29b9e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55157 biolink:molecularly_interacts_with DrugCentral:4721 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomitapide is inhibitor of Cytosolic other (Microsomal triglyceride transfer protein large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:9a29e2f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:4723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 succinimide targets Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.58']} DrugCentral uuid:9a2a0b16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 succinimide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9a2a3320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:4727 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.5']} DrugCentral uuid:9a2a5b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.573']} DrugCentral uuid:9a2a83a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:9a2aaba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:9a2ad384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9a2afc7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9a2b2514-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O97554 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9a2b4d14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O02768 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9a2b78e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9a2b78e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9a2babf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48050 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap is activator of Ion channel (Inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2c108c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a2ce8cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:9a2ce8cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:9a2ce8cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:9a2d30c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:9a2d30c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:9a2d30c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:9a2d76b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:9a2d76b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:9a2d76b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:9a2db84c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioctic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9a2de434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:4732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioctic acid targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9a2de434-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:4732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioctic acid targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9a2e176a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:4732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioctic acid targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:9a2e3fe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:9a2e680a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.971']} DrugCentral uuid:9a2e9014-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.035']} DrugCentral uuid:9a2eb832-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:9a2ee12c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.071']} DrugCentral uuid:9a2f094a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:9a2f315e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.135']} DrugCentral uuid:9a2f597c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:9a2f8244-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.718']} DrugCentral uuid:9a2faa76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:9a2fd280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9a2ffb52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9a30235c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9a304cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9a3075f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a309e72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a30c69a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9a30eed6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:9a3116ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.111']} DrugCentral uuid:9a3140ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9a3168ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q932Y6 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:9a3190d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9a31d45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:9a31d45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:9a31d45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:9a31d45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:9a31d45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:9a31d45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:9a31d45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:9a31d45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:9a323b92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5TIX5 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline targets Enzyme (ATP synthase subunit c) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:9a326388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00845 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline targets Enzyme (ATP synthase subunit c) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9a328c64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:4744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crofelemer is inhibitor of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:9a32b482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5XXA6 biolink:molecularly_interacts_with DrugCentral:4744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crofelemer is inhibitor of Ion channel (Anoctamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:9a32dc78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pomalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9a330482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pomalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9a332fb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:4746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pomalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.577']} DrugCentral uuid:9a3357a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ospemifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.082']} DrugCentral uuid:9a337fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobetaxolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9a33a856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobetaxolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:9a33d06a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:4757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyl fumarate targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9a33f950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14145 biolink:molecularly_interacts_with DrugCentral:4757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyl fumarate is inhibitor of Cytosolic other (Kelch-like ECH-associated protein 1) DrugCentral uuid:9a341d36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.658']} DrugCentral uuid:9a344680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9a346e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:4758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canagliflozin targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9a34969e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9a34be94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:9a34e7f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9a35116e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:9a35395a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9a3562a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9a358b12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9a35b330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9a35db6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:4778 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ridaforolimus is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:9a36036c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.289']} DrugCentral uuid:9a362c20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:9a36542a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.961']} DrugCentral uuid:9a367c20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.477']} DrugCentral uuid:9a36a420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.111']} DrugCentral uuid:9a36ccde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:9a36f4fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:9a371cfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:9a37451a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium propionate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.29']} DrugCentral uuid:9a376d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B2GV46 biolink:molecularly_interacts_with DrugCentral:4796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium propionate targets GPCR (Free fatty acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9a379588-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['1.2']} DrugCentral uuid:9a37bda6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.08']} DrugCentral uuid:9a37e6b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:4797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['1.9']} DrugCentral uuid:9a380f72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilanterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9a383790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilanterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9a385f7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilanterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9a388880-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9a38b288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:9a38da88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:9a390292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9a392aec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:9a3952ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9a397ace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:9a39a350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9a39cbf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9a39f3e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:9a3a1bf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:9a3a4404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9a3a6c9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9a3a94ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trametinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9a3abcb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trametinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:9a3ae4c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trametinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.036']} DrugCentral uuid:9a3b0d1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trametinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:9a3b365c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4804 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palifermin is agonist of Kinase (Fibroblast growth factor receptor 2) DrugCentral uuid:9a3b5a2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9a3b822e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9a3babfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9a3bd418-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:9a3bfc0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9a3c2436-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.131']} DrugCentral uuid:9a3c4eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:9a3c76c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9a3c9eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9a3cc6de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9a3cef60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9a3d1774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9a3d3f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9a3d6846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9a3d9050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9a3db850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9a3de064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35563 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9a3e09cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9a3e31e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:9a3e59ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:9a3e8212-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:9a3eaa80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:9a3ed2a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:9a3efba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:9a3f23e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.268']} DrugCentral uuid:9a3f4ca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:4807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riociguat targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 7B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:9a3f74ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riociguat is positive allosteric modulator of Enzyme (Guanylate cyclase soluble subunit beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'MEC', 'has_quantitative_value': ['7.523']} DrugCentral uuid:9a3f9dd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9a3fc5aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9a3fefe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9a4017f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.658']} DrugCentral uuid:9a403fee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.569']} DrugCentral uuid:9a406816-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 macitentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:9a4090ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 macitentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.408']} DrugCentral uuid:9a40b8ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9a40e0fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9a4108f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:9a4132e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:9a415b40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:9a418340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9a41ac26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9a41d642-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9a41fe9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:9a4226a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRX8 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Unclassified (Redox-regulatory protein FAM213A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9a424f14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:9a427732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.495']} DrugCentral uuid:9a429f50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.721']} DrugCentral uuid:9a42c778-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:9a42f022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.387']} DrugCentral uuid:9a43184a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:9a43405e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.194']} DrugCentral uuid:9a43691c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:9a4392f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:9a43baf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:9a43e2f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9a440afc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.155']} DrugCentral uuid:9a443360-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:9a445b56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:9a448374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.143']} DrugCentral uuid:9a44ab9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sofosbuvir is inhibitor of Enzyme (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9a44d45a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sofosbuvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC90', 'has_quantitative_value': ['6.959']} DrugCentral uuid:9a44fc50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9a4528b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9a4528b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9a455c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:9a458486-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6GYR8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir is inhibitor of Polyprotein (Polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:9a45acae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:9a45d4b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:4813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luliconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:9a45f916-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olodaterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:9a46212a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olodaterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9a464970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olodaterol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:9a46718e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lixisenatide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.845']} DrugCentral uuid:9a469a2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:9a46c24c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:9a46eb96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.796']} DrugCentral uuid:9a4713b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.824']} DrugCentral uuid:9a473cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.222']} DrugCentral uuid:9a4765bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a478dbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a47b5ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9a47dede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9a4806f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin is inhibitor of Enzyme (DNA-directed RNA polymerase subunit beta) DrugCentral uuid:9a482ae2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 florbetaben F18 targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:9a48530a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:4820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasimelteon is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.45']} DrugCentral uuid:9a487bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:4820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasimelteon is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:9a48a404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 seractide is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.009']} DrugCentral uuid:9a48cc18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:4822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laninamivir octanoate hydrate targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:9a48f40e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:4822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laninamivir octanoate hydrate targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9a491eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:9a4946c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:9a496eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9a4996b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9a49bf9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y3R4 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Sialidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:9a49e7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D5F1R0 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9a4a0fba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9a4a385a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:9a4a6082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9a4a88aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9IGQ6 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:9a4ab0d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etilefrine pivalate is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:9a4ad56c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48357 biolink:molecularly_interacts_with DrugCentral:4826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metreleptin is agonist of Membrane receptor (Leptin receptor) DrugCentral uuid:9a4af952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:4829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9a4b2166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:4829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9a4b4970-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08493 biolink:molecularly_interacts_with DrugCentral:4829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:9a4b7300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.131']} DrugCentral uuid:9a4b9b14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M3M2 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.959']} DrugCentral uuid:9a4bc300-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0PJK1 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:9a4beb14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.081']} DrugCentral uuid:9a4c13d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WWX8 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin targets Transporter (Sodium/myo-inositol cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:9a4c3c72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.244']} DrugCentral uuid:9a4c649a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxegol is antagonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:9a4c888a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4833 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemigliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.328']} DrugCentral uuid:9a4cb328-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4833 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemigliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9a4cde34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:4834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eliglustat is inhibitor of Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.827']} DrugCentral uuid:9a4d062a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9a4d2e3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9a4d56ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9a4d7eca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:9a4da6fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33033 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:9a4dcede-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41149 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:9a4df792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56450 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:9a4e1f6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01727 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:9a4e477e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:9a4e6f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:4839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprotinin is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9a4e9a58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:4839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprotinin is inhibitor of Enzyme (Plasma kallikrein) DrugCentral uuid:9a4ec06e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:4846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ecallantide is inhibitor of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.602']} DrugCentral uuid:9a4ee896-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:4848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatropin is agonist of GPCR (Growth hormone receptor) DrugCentral uuid:9a4f0c68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:4853 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cridanimod targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:9a4f34cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3TBT3 biolink:molecularly_interacts_with DrugCentral:4853 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cridanimod targets Unclassified (Stimulator of interferon genes protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9a4f5cea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conjugated estrogens is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:9a4f81d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conjugated estrogens is agonist of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:9a4fa5b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:4857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone sulphate targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:9a4fce6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:4857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone sulphate targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:9a4ff682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone sulphate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:9a501a68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone sulphate is agonist of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:9a503e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q60748 biolink:molecularly_interacts_with DrugCentral:4858 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9a5067b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47866 biolink:molecularly_interacts_with DrugCentral:4858 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9a508fac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13324 biolink:molecularly_interacts_with DrugCentral:4858 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9a50b7ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34998 biolink:molecularly_interacts_with DrugCentral:4858 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.481']} DrugCentral uuid:9a50e394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenibut is agonist of GPCR (GABA-B receptor) DrugCentral uuid:9a50e394-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenibut is agonist of GPCR (GABA-B receptor) DrugCentral uuid:9a511170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9a513966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:9a5178fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a5178fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a5178fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a5178fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a5178fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a5178fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a5178fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9a51e53c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.951']} DrugCentral uuid:9a520d6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.035']} DrugCentral uuid:9a5236d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebanazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:9a525ad0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebanazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:9a527eb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9a52a6b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9a52d014-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:9a52f800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9a532000-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9a534800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9a5370b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9a5398be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9a53c0c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9a53e8d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9a541348-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9a543e86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:9a5466d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9a548ecc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9a54b726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9a54df26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:9a550712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9a552f12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9a5557b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9a557fbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:9a55a7b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:9a55cfb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9a55f898-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:9a5620ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:9a5648b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9a56712e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9a56992e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9a56c21e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9a56ea28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9a5712be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9a573abe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41212 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Transcription factor (Transcription factor ETV6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9a5762d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:9a578b4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:9a57b64c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.155']} DrugCentral uuid:9a57e022-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:9a58084a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:9a583054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9a5858d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9a5880ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9a58a926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9a58d162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9a58fa34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:9a592248-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:9a594a5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:9a59727a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9a599d68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9a59c978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:9a59c978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:9a59f72c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25116 biolink:molecularly_interacts_with DrugCentral:4870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorapaxar is antagonist of GPCR (Proteinase-activated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.092']} DrugCentral uuid:9a5a1f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tedizolid phosphate targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9a5a47ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tedizolid phosphate targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9a5a6fb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F2SHH3 biolink:molecularly_interacts_with DrugCentral:4874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efinaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:9a5a94a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:9a5abd56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.64']} DrugCentral uuid:9a5ae574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.64']} DrugCentral uuid:9a5b0d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.046']} DrugCentral uuid:9a5b3592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.301']} DrugCentral uuid:9a5b5f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9a5b879a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9a5bafa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9a5bd7d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a5c006c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9a5c292a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:9a5c515c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9a5c7998-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:9a5ca26a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:9a5cca88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.67']} DrugCentral uuid:9a5cf288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9a5d1a88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9a5d4724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.569']} DrugCentral uuid:9a5d7046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9a5d986e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a5dc0f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9a5de8fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:9a5e1118-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26637 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Leucine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:9a5e3936-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F2SF18 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole is inhibitor of Enzyme (Leucine-tRNA ligase) DrugCentral uuid:9a5e5dd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9a5e86c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NEB9 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 3-kinase catalytic subunit type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9a5eaed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.086']} DrugCentral uuid:9a5ed6d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.248']} DrugCentral uuid:9a5f0046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.051']} DrugCentral uuid:9a5f286e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.602']} DrugCentral uuid:9a5f5082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:4879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxaparin sodium is activator of Secreted (Antithrombin-III) DrugCentral uuid:9a5f745e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58308 biolink:molecularly_interacts_with DrugCentral:4881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suvorexant targets GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:9a5f9ce0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58307 biolink:molecularly_interacts_with DrugCentral:4881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suvorexant targets GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9a5fc512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:4881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suvorexant is antagonist of GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9a5fed44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43614 biolink:molecularly_interacts_with DrugCentral:4881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suvorexant is antagonist of GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:9a601576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:9a603dda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9a6065f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:9a608e02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9a60b6a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9a60e104-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9a610940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9a613172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:9a615990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dulaglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) DrugCentral uuid:9a617de4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16233 biolink:molecularly_interacts_with DrugCentral:4886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetilistat is inhibitor of Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.225']} DrugCentral uuid:9a61a5f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:4888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiroxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:9a61cdf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:4888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiroxostat is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.276']} DrugCentral uuid:9a61f602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:4889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asunaprevir targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:9a621e70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asunaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:9a62468e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:9a626fa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8C3K6 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:9a6297c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53790 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:9a62c2b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q923I7 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:9a62eabc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.727']} DrugCentral uuid:9a6312c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.132']} DrugCentral uuid:9a633c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luseogliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.399']} DrugCentral uuid:9a63649c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luseogliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.646']} DrugCentral uuid:9a638cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4892 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofogliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.073']} DrugCentral uuid:9a63b4ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4892 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofogliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.538']} DrugCentral uuid:9a63dd28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07650 biolink:molecularly_interacts_with DrugCentral:4893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipiracil targets Enzyme (Thymidine phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9a640546-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19971 biolink:molecularly_interacts_with DrugCentral:4893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipiracil is inhibitor of Enzyme (Thymidine phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:9a642d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:4894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iguratimod targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9a645564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14740 biolink:molecularly_interacts_with DrugCentral:4895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.54']} DrugCentral uuid:9a647efe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.585']} DrugCentral uuid:9a64a73a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.268']} DrugCentral uuid:9a64cf62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teneligliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.432']} DrugCentral uuid:9a64f76c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:4896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:9a651fda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.167']} DrugCentral uuid:9a6547e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:9a656fe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9a65988e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edoxaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.252']} DrugCentral uuid:9a65c124-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4898 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 netupitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.022']} DrugCentral uuid:9a65e94c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ledipasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:9a661142-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ledipasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:9a663956-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ledipasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:9a666336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ledipasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.509']} DrugCentral uuid:9a668b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:4900 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diquafosol is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9a66b32c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:4900 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diquafosol is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.469']} DrugCentral uuid:9a66db36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin glargine is agonist of Kinase (Insulin receptor) DrugCentral uuid:9a66ff76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4902 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imidafenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['8.384']} DrugCentral uuid:9a67278a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4902 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imidafenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['9.499']} DrugCentral uuid:9a674f9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:9a6777b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:9a67a034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:9a67c834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9a67f02a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:9a68183e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:9a6842a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9a686ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.21']} DrugCentral uuid:9a6892aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9a68bab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9a68e304-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9a690c3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.38']} DrugCentral uuid:9a693458-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.02']} DrugCentral uuid:9a695cc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:9a6984c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9a69acee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9a69d4ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9a69fe10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9a6a2624-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9a6a4f5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:9a6a7764-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9a6a9ffa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9a6ac804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9a6af036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9a6b1840-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9a6b4130-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9a6b693a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:9a6b914e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9a6bb962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9a6be28e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:9a6c0c00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9a6c3414-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9a6c5c1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9a6c84aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9a6caca0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9a6cd48c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9a6cfc96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9a6d2504-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9a6d4d22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:9a6d755e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9a6d9d68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9a6dc6e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9a6deeee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:9a6e16ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9a6e4056-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9a6e686a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9a6e9060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9a6eb860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9a6ee0d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a6f0a18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9a6f322c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:9a6f5a4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9a6f8498-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9a6faf18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9a6fd72c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9a6fff4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9a7027b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9a704fc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:9a7077cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9a709fd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.66']} DrugCentral uuid:9a70c83a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9a70f04e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:9a711858-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:9a714076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9a716ba0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:9a7193a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9a71bbb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9a71e404-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:9a720c90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9a72358a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9a725d8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9a728616-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.29']} DrugCentral uuid:9a72ae16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9a72d62a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9a72fe2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:9a73276a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9a734f6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9a73777e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9a739f7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9a73c7f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:9a73eff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9a741800-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9a743ff6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9a746850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9a749050-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:9a74b85a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:9a74e190-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9a750bac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9a7533b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49840 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Glycogen synthase kinase-3 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9a755bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:9a7583d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9a75ac60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9a75d456-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9a75fc60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9a762550-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9a764dc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9a7675d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9a769e40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:9a76c73a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:9a76f174-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9a77199c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:9a7741ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9a776a3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:9a779250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9a77ba46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9a77e25a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9a780ab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:9a7832c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9a785ad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:9a7882dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9a78ade8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9a78d926-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9a790446-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9a792c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:9a7954e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9a797d04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9a79a4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:9a79cd0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9a79f568-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9a7a1e80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9a7a4694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9a7a6ea8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9a7a99d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:9a7ac1f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9a7aeb26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9a7b13b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:9a7b3bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a7b63da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:9a7b8bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9a7bb452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:9a7bdc70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9a7c0484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:9a7c2c84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:9a7c55ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9a7c7dc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:9a7ca5d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:9a7ccdf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9a7cf68c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9a7d1e96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9a7d46a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:9a7d6ebe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9a7d974a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9a7dbf4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9a7de84e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9a7e104e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9a7e39a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:9a7e61a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9a7e89ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9a7eb1ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a7eda38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9a7f0224-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.07']} DrugCentral uuid:9a7f2a42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16566 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9a7f5314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9a7f7b3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9a7fa364-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:9a7fcb6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9a7ff512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9a801f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9a804792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9a806f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9a809814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9a80c14a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9a80e954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9a811172-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a8139cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9a8161cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9a8189e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9a81b1ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9a81dce2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a8204f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9a822d0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9a825532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9a827dbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9a82a5c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9a82cdf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9a82f5fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9a831e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:9a834686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9a836e9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9a839780-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9a83c138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a83e94c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9a84114c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9a8439d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a8461ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9a848a0a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9a84b214-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a84da96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9a8502aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:9a852abe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9a8552c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9a857cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:9a85a7f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:9a85d34c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9a85fbe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9a86246e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9a864c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9a867482-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:9a869c78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9a86c626-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9a86ee30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9a87164e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9a873e4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9a876a72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9a87929a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9a87baa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a87e31c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:9a880b1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9a883330-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:9a885b4e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9a8883a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9a88abc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.74']} DrugCentral uuid:9a88d3c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9a88fbe4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:9a892542-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9a894d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9a89756a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:9a899e82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9a89c70e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:9a89ef2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.983']} DrugCentral uuid:9a8a1740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9a8a3f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9a8a67ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:9a8a9012-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:9a8ab826-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adalimumab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:9a8adc20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4905 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pegaptanib is antagonist of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:9a8b02b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:4906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fimasartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.377']} DrugCentral uuid:9a8b2dba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9a8b57f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9a8b809e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9a8ba92a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9a8bd13e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9a8bf966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2NL67 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Unclassified (Poly [ADP-ribose] polymerase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9a8c2170-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5Y8 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Unclassified (Mono [ADP-ribose] polymerase PARP16) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9a8c49c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:9a8c71c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9a8c9b14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9a8cc45e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:9a8cec68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acotiamide is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:9a8d147c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31358 biolink:molecularly_interacts_with DrugCentral:4909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alemtuzumab is antibody binding of Surface antigen (CAMPATH-1 antigen) DrugCentral uuid:9a8d386c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4910 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felypressin is agonist of GPCR (Vasopressin V1a receptor) DrugCentral uuid:9a8d5cac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ombitasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.85']} DrugCentral uuid:9a8d84ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WMX2 biolink:molecularly_interacts_with DrugCentral:4912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ombitasvir targets Unclassified (Genome polyprotein [Cleaved into: Core protein p21) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.92']} DrugCentral uuid:9a8dadba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ombitasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.301']} DrugCentral uuid:9a8dd5c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ombitasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.854']} DrugCentral uuid:9a8dfe3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4914 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasabuvir targets Enzyme (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:9a8e2628-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4914 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasabuvir targets Unclassified (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:9a8e4e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:4915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blinatumomab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:9a8e7e2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9a8e7e2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9a8e7e2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9a8ebdea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aflibercept is inhibitor of Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['12.301']} DrugCentral uuid:9a8ee612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49763 biolink:molecularly_interacts_with DrugCentral:4916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aflibercept is inhibitor of Secreted (Placenta growth factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.409']} DrugCentral uuid:9a8f0e30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49765 biolink:molecularly_interacts_with DrugCentral:4916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aflibercept is inhibitor of Secreted (Vascular endothelial growth factor B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.717']} DrugCentral uuid:9a8f36d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4917 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramucirumab is antibody binding of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:9a8f5eee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:9a8f86da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:9a8faec6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.71']} DrugCentral uuid:9a8fd7e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:9a9007ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9a9007ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9a9007ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9a9045f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:9a906f8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:4923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nivolumab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.14']} DrugCentral uuid:9a909a3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:4924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pembrolizumab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:9a90c658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 becaplermin is agonist of Kinase (Platelet-derived growth factor receptor) DrugCentral uuid:9a90c658-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 becaplermin is agonist of Kinase (Platelet-derived growth factor receptor) DrugCentral uuid:9a90f3da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32301 biolink:molecularly_interacts_with DrugCentral:4927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albiglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9a911d6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albiglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:9a91456a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23945 biolink:molecularly_interacts_with DrugCentral:4928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 follitropin is agonist of GPCR (Follicle-stimulating hormone receptor) DrugCentral uuid:9a916978-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:4929 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lutropin alfa is agonist of GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.9']} DrugCentral uuid:9a919182-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16473 biolink:molecularly_interacts_with DrugCentral:4930 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thyrotropin alfa is agonist of GPCR (Thyrotropin receptor) DrugCentral uuid:9a91b5d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9a91ddf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:9a920734-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:9a922f5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Adrenocorticotropic hormone receptor) DrugCentral uuid:9a92554a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q64326 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.8']} DrugCentral uuid:9a92816e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:4933 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocilizumab is antibody binding of Membrane receptor (Interleukin-6 receptor) DrugCentral uuid:9a92816e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:4933 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocilizumab is antibody binding of Membrane receptor (Interleukin-6 receptor) DrugCentral uuid:9a92af40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16552 biolink:molecularly_interacts_with DrugCentral:4934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secukinumab is antibody binding of Cytokine (Interleukin-17A) DrugCentral uuid:9a92d34e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03420 biolink:molecularly_interacts_with DrugCentral:4935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palivizumab is antibody binding of Surface antigen (Fusion glycoprotein F0) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.357']} DrugCentral uuid:9a92fbda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:4936 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parathyroid hormone is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) DrugCentral uuid:9a931fca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9a9347e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:9a936ffc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9a93989c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:9a93c0ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.721']} DrugCentral uuid:9a93e91e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.319']} DrugCentral uuid:9a941132-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:4938 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripasudil is inhibitor of Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9a943b3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4938 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripasudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.292']} DrugCentral uuid:9a946362-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4938 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripasudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.721']} DrugCentral uuid:9a948b6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:9a94b452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:9a94dc7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:K7XJL6 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9a9505a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.301']} DrugCentral uuid:9a952dd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99IB8 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:9a95565a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01589 biolink:molecularly_interacts_with DrugCentral:4940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 basiliximab is antibody binding of Membrane receptor (Interleukin-2 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:9a957e64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9a95a678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9a95ce78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9a95fc18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9a95fc18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9a96330e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (CDK2/Cyclin A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9a96330e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (CDK2/Cyclin A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9a966a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (CDK6/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9a966a04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (CDK6/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9a969dbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib is inhibitor of Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.097']} DrugCentral uuid:9a96c5c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib is inhibitor of Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:9a96ede4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:9a9715e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:9a973e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:9a9767ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:9a97900a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.409']} DrugCentral uuid:9a97b81e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:9a97e3b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9a980be8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9a98341a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.658']} DrugCentral uuid:9a985d32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.398']} DrugCentral uuid:9a98856e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:9a98ae7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.292']} DrugCentral uuid:9a98d6a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:9a98ff1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arformoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:9a992726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arformoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:9a994fc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arformoterol is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.947']} DrugCentral uuid:9a9977ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arformoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.538']} DrugCentral uuid:9a99a16a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10']} DrugCentral uuid:9a99c960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin is agonist of GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9a99f16a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin is agonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9a9a1992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:9a9a421e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9a9a6a32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63931 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:9a9a925a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam targets Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9a9aba78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam targets Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9a9ae2dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.155']} DrugCentral uuid:9a9b0b04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9a9b3322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.699']} DrugCentral uuid:9a9b5b54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y275 biolink:molecularly_interacts_with DrugCentral:4949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belimumab is antibody binding of Cytokine (Tumor necrosis factor ligand superfamily member 13B) DrugCentral uuid:9a9b84c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:4950 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abciximab is antibody binding of Adhesion (Integrin alpha-IIb/beta-3) DrugCentral uuid:9a9b84c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:4950 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abciximab is antibody binding of Adhesion (Integrin alpha-IIb/beta-3) DrugCentral uuid:9a9bb28e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofatumumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.92']} DrugCentral uuid:9a9bdab6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01584 biolink:molecularly_interacts_with DrugCentral:4952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canakinumab is antibody binding of Cytokine (Interleukin-1 beta) DrugCentral uuid:9a9c06f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:9a9c06f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:9a9c06f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:9a9c4500-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetuximab is antibody binding of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.41']} DrugCentral uuid:9a9c6e22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panitumumab is agonist of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:9a9c9640-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bevacizumab is antibody binding of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:9a9cba94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4957 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pertuzumab is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:9a9cde7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16410 biolink:molecularly_interacts_with DrugCentral:4958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipilimumab is antibody binding of Surface antigen (Cytotoxic T-lymphocyte protein 4) DrugCentral uuid:9a9d03b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20701 biolink:molecularly_interacts_with DrugCentral:4959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efalizumab is antibody binding of Adhesion (Leukocyte adhesion glycoprotein LFA-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.4']} DrugCentral uuid:9a9d2bdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin degludec is agonist of Kinase (Insulin receptor) DrugCentral uuid:9a9d518e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13423 biolink:molecularly_interacts_with DrugCentral:4961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raxibacumab is antibody binding of Secreted (Protective antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.556']} DrugCentral uuid:9a9d7a4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28908 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is binding agent of Membrane receptor (Tumor necrosis factor receptor superfamily member 8) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9dbd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9a9e2f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14788 biolink:molecularly_interacts_with DrugCentral:4965 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denosumab is antibody binding of Cytokine (Tumor necrosis factor ligand superfamily member 11) DrugCentral uuid:9a9e570a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29460 biolink:molecularly_interacts_with DrugCentral:4966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-12) DrugCentral uuid:9a9e570a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29460 biolink:molecularly_interacts_with DrugCentral:4966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-12) DrugCentral uuid:9a9e88e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:4966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:9a9e88e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:4966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:9a9eb68c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 golimumab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:9a9eda86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 certolizumab pegol is antibody binding of Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.046']} DrugCentral uuid:9a9f02a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:4969 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eculizumab is antibody binding of Secreted (Complement C5) DrugCentral uuid:9a9f2d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05556 biolink:molecularly_interacts_with DrugCentral:4970 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-1) DrugCentral uuid:9a9f2d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05556 biolink:molecularly_interacts_with DrugCentral:4970 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-1) DrugCentral uuid:9a9f5e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4970 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) DrugCentral uuid:9a9f5e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4970 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) DrugCentral uuid:9a9f8c42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranibizumab is antibody binding of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:9a9fb0b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01854 biolink:molecularly_interacts_with DrugCentral:4972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omalizumab is antibody binding of Antibody (Ig epsilon chain C region) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.16']} DrugCentral uuid:9a9fd9c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide targets Enzyme (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9aa001cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide targets Cytokine (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9aa029ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.135']} DrugCentral uuid:9aa05258-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.365']} DrugCentral uuid:9aa07a76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:9aa0a294-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.022']} DrugCentral uuid:9aa0cac6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:9aa0f51e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.108']} DrugCentral uuid:9aa11fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infliximab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:9aa143b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4975 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rituximab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:9aa16daa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone hexacetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:9aa19230-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:4977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siltuximab is antibody binding of Cytokine (Interleukin-6) DrugCentral uuid:9aa1b60c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4978 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etanercept is inhibitor of Cytokine (Tumor necrosis factor) DrugCentral uuid:9aa1da06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4979 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:9aa1fe00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20138 biolink:molecularly_interacts_with DrugCentral:4980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemtuzumab ozogamicin is antibody binding of Surface antigen (Myeloid cell surface antigen CD33) DrugCentral uuid:9aa2227c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin aspart is agonist of Kinase (Insulin receptor) DrugCentral uuid:9aa24a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vedolizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9aa24a54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vedolizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9aa27d9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obinutuzumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) DrugCentral uuid:9aa2a1b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4984 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibritumomab tiuxetan is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.854']} DrugCentral uuid:9aa2cc68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4985 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin detemir is agonist of Kinase (Insulin receptor) DrugCentral uuid:9aa2f328-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pegfilgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:9aa31786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:9aa33b62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:4988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deoxycholic acid is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:9aa363e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:4988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deoxycholic acid targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:9aa38bda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:4988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deoxycholic acid is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:9aa3b3b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07445 biolink:molecularly_interacts_with DrugCentral:4988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deoxycholic acid targets Unclassified (Steroid Delta-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:9aa3dcd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa42054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9aa49228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4991 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lipegfilgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:9aa4ba1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vonoprazan is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9aa4ba1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vonoprazan is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9aa4ed68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:4995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoetin alfa is agonist of Membrane receptor (Erythropoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11.15']} DrugCentral uuid:9aa51572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:4996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romiplostim is agonist of Membrane receptor (Thrombopoietin receptor) DrugCentral uuid:9aa53a2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NBP7 biolink:molecularly_interacts_with DrugCentral:5000 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evolocumab is inhibitor of Enzyme (Proprotein convertase subtilisin/kexin type 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.72']} DrugCentral uuid:9aa56220-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:9aa58a16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:9aa5b2e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:9aa5dc96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:9aa604dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9aa62cfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:9aa65540-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5002 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin lispro is agonist of Kinase (Insulin receptor) DrugCentral uuid:9aa67b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5003 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin human targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:9aa6a3e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15127 biolink:molecularly_interacts_with DrugCentral:5003 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin human targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.71']} DrugCentral uuid:9aa6cbe2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5003 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin human is agonist of Kinase (Insulin receptor) DrugCentral uuid:9aa6efdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:5005 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirodenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.469']} DrugCentral uuid:9aa7189a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:5006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cangrelor is antagonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9aa7418a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6NS65 biolink:molecularly_interacts_with DrugCentral:5006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cangrelor is antagonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:9aa769a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:5006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cangrelor is antagonist of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.627']} DrugCentral uuid:9aa791bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoetin theta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:9aa7b610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q62226 biolink:molecularly_interacts_with DrugCentral:5008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sonidegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9aa7de1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sonidegib is antagonist of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.222']} DrugCentral uuid:9aa8062e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecasermin targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:9aa82e60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecasermin is agonist of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9aa85944-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5010 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumacaftor is pharmacological chaperone of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.456']} DrugCentral uuid:9aa8891e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:9aa8891e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:9aa8891e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:9aa8c064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:5012 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sacubitril is inhibitor of Enzyme (Neprilysin) DrugCentral uuid:9aa8e508-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trelagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.398']} DrugCentral uuid:9aa90d8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9aa935c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9aa95e48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:9aa98774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9aa9af7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:9aa9d792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:9aa9ffa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:9aaa292c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:9aaa5140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:9aaa794a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.857']} DrugCentral uuid:9aaaa154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.721']} DrugCentral uuid:9aaacca6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:9aaaf49c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:9aab202a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:9aab48b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9aab7200-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9aab9a28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:9aabc250-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:9aabeb90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:9aac143a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:9aac3d0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.025']} DrugCentral uuid:9aac6520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.201']} DrugCentral uuid:9aac8e10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:9aacb64c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:9aacde60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:9aad0692-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.523']} DrugCentral uuid:9aad2f32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.921']} DrugCentral uuid:9aad576e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.328']} DrugCentral uuid:9aad80a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pegvisomant is antagonist of GPCR (Growth hormone receptor) DrugCentral uuid:9aada4a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NBP7 biolink:molecularly_interacts_with DrugCentral:5016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alirocumab is inhibitor of Enzyme (Proprotein convertase subtilisin/kexin type 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:9aadd180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPH3 biolink:molecularly_interacts_with DrugCentral:5017 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anakinra is antagonist of Membrane receptor (Interleukin-1 receptor, type I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9aadd180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPH3 biolink:molecularly_interacts_with DrugCentral:5017 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anakinra is antagonist of Membrane receptor (Interleukin-1 receptor, type I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9aae04b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.93']} DrugCentral uuid:9aae2cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.516']} DrugCentral uuid:9aae5556-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:9aae7d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:9aaea59c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.049']} DrugCentral uuid:9aaecdb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.054']} DrugCentral uuid:9aaef70e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.093']} DrugCentral uuid:9aaf1f2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9aaf47e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:9aaf73fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sargramostim is agonist of Membrane receptor (Granulocyte macrophage colony-stimulating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9aaf73fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sargramostim is agonist of Membrane receptor (Granulocyte macrophage colony-stimulating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9aafad5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5026 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oprelvekin is agonist of Membrane receptor (Interleukin-11 receptor) DrugCentral uuid:9aafad5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5026 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oprelvekin is agonist of Membrane receptor (Interleukin-11 receptor) DrugCentral uuid:9aafdb10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:5027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolapitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:9ab00324-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:5031 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mogamulizumab is antibody binding of GPCR (C-C chemokine receptor type 4) DrugCentral uuid:9ab0278c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9ab04faa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:9ab077be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9ab09fd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9ab0c854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9ab0f176-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9ab1199e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:9ab141c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:9ab16bba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:9ab195ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is partial agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.07']} DrugCentral uuid:9ab1bde0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:9ab1e5ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9ab20e80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:9ab236a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:9ab25eda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:9ab286f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.48']} DrugCentral uuid:9ab2af66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.12']} DrugCentral uuid:9ab2d874-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9ab3006a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9ab3287e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9ab3540c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9ab37f0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9ab3a772-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9ab3cfd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9ab3f7cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9ab41ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9ab447ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9ab4704e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9ab498d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9ab4c0da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:9ab4e8d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:9ab511f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6XA80 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Unclassified (Leukotriene C4 synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9ab539fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatrem is agonist of GPCR (Growth hormone receptor) DrugCentral uuid:9ab55dec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:9ab581d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobimetinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:9ab5aa68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobimetinib is allosteric modulator of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9ab5d290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:9ab5fab8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saroglitazar is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.187']} DrugCentral uuid:9ab622c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saroglitazar is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:9ab64b08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9ab6731c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:9ab69b30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9ab6c42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9ab6efe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9ab717f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P58406 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9ab74012-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:9ab7683a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9ab790b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9ab7b89e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:9ab7e0d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant is inverse agonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.796']} DrugCentral uuid:9ab808ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9ab8317a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9ab859a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9ab881d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9ab8a9e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9ab8d530-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9ab8fd44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9ab92562-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:9ab94dc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:9ab97602-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:9ab99e0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:9ab9c634-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:9ab9eeca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.469']} DrugCentral uuid:9aba1710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9aba3fce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.469']} DrugCentral uuid:9aba67d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omarigliptin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:9aba9168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28843 biolink:molecularly_interacts_with DrugCentral:5054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omarigliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:9ababa8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omarigliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:9abae29e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin glulisine is agonist of Kinase (Insulin receptor) DrugCentral uuid:9abb06a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:5059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lusutrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.076']} DrugCentral uuid:9abb2efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5060 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esflurbiprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9abb56f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:5060 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esflurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9abb7f24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:5061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepolizumab is antibody binding of Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:9abba74c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:9abbcfa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9abbf7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9abc1fc4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:9abc47c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53634 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Enzyme (Dipeptidyl peptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:9abc71cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9abc9b20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:9abcc352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:5063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daratumumab is antibody binding of Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9abcebd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:5064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 climbazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9abd1442-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trenbolone hexahydrobenzylcarbonate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:9abd3c56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:5065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trenbolone hexahydrobenzylcarbonate targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:9abd6460-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenecteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:9abd8846-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:5067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.509']} DrugCentral uuid:9abdb0aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:5067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:9abdd8c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:5067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:9abe00d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02563 biolink:molecularly_interacts_with DrugCentral:5068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivaracetam is inhibitor of Unclassified (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9abe28dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L0J3 biolink:molecularly_interacts_with DrugCentral:5068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivaracetam is modulator of Transporter (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9abe5398-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 necitumumab is antibody binding of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.49']} DrugCentral uuid:9abe7bca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NQ25 biolink:molecularly_interacts_with DrugCentral:5072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elotuzumab is antibody binding of Membrane receptor (SLAM family member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9abea4ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:5075 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lesinurad is inhibitor of Transporter (Solute carrier family 22 member 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.432']} DrugCentral uuid:9abecdd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:5075 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lesinurad is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.137']} DrugCentral uuid:9abef5d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9abf1de6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9abf45fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9abf6e5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9abf9668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:9abfbe7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9abfe6a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:9ac00ff8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lobeglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:9ac037e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lobeglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:9ac05fd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:9ac087bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:9ac0b034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.523']} DrugCentral uuid:9ac0d82a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:9ac10034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.523']} DrugCentral uuid:9ac12802-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:9ac1505c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:K7XJL6 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:9ac17870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q0ZMF1 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:9ac1a07a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.301']} DrugCentral uuid:9ac1c870-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.398']} DrugCentral uuid:9ac1f1ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.523']} DrugCentral uuid:9ac219ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16552 biolink:molecularly_interacts_with DrugCentral:5083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixekizumab is antibody binding of Cytokine (Interleukin-17A) DrugCentral uuid:9ac2458e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:9ac2458e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:9ac2458e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:9ac27f86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06729 biolink:molecularly_interacts_with DrugCentral:5088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alefacept is inhibitor of Surface antigen (T-cell surface antigen CD2) DrugCentral uuid:9ac2a376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33681 biolink:molecularly_interacts_with DrugCentral:5089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD80) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9ac2cba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42081 biolink:molecularly_interacts_with DrugCentral:5089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD86) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9ac2f3e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33681 biolink:molecularly_interacts_with DrugCentral:5091 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD80) DrugCentral uuid:9ac31856-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42081 biolink:molecularly_interacts_with DrugCentral:5091 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD86) DrugCentral uuid:9ac33ce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:5093 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reslizumab is antibody binding of Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.092']} DrugCentral uuid:9ac3650e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13423 biolink:molecularly_interacts_with DrugCentral:5094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obiltoxaximab is antibody binding of Secreted (Protective antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.481']} DrugCentral uuid:9ac38d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01583 biolink:molecularly_interacts_with DrugCentral:5105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilonacept is inhibitor of Cytokine (Interleukin-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.854']} DrugCentral uuid:9ac3b716-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18510 biolink:molecularly_interacts_with DrugCentral:5105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilonacept is inhibitor of Unclassified (Interleukin-1 receptor antagonist protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.215']} DrugCentral uuid:9ac3e1c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01584 biolink:molecularly_interacts_with DrugCentral:5105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilonacept is inhibitor of Cytokine (Interleukin-1 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['12.301']} DrugCentral uuid:9ac409dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urokinase is activator of Enzyme (Plasminogen) DrugCentral uuid:9ac42db8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9ac455fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9ac47dfe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HCG7 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9ac4a5f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9ac4cdea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35573 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9ac4f63a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09848 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:9ac51e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16278 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:9ac54608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59750 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9ac56e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02401 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:9ac596ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UUZ4 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Alpha-galactosidase C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:9ac5beee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q42656 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Alpha-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9ac5e6d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D3ZUM4 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:9ac60ebc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8VNN2 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:9ac6373e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06280 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat is pharmacological chaperone of Enzyme (Alpha-galactosidase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9ac6601a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chromic chloride targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:9ac68810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chromic chloride targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:9ac6b006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:5133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venetoclax is inhibitor of Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:9ac6d8b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92843 biolink:molecularly_interacts_with DrugCentral:5133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venetoclax is inhibitor of Cytosolic other (Apoptosis regulator Bcl-W) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:9ac700ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:5133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venetoclax is inhibitor of Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:9ac72d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9ac72d06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9ac76064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 interferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9ac76064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 interferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9ac7920a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 interferon beta-1b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9ac7920a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 interferon beta-1b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9ac7c112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:9ac7e50c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimavanserin is inverse agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9ac80dc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimavanserin is inverse agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9ac835ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:5143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9ac85de8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O88587 biolink:molecularly_interacts_with DrugCentral:5143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9ac88610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:5143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:9ac8ae7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:5144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gluconolactone targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:9ac8d6a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:5149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choriogonadotropin alfa is agonist of GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:9ac8fab4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atezolizumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.39']} DrugCentral uuid:9ac922c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:9ac94dfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:9ac97606-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.796']} DrugCentral uuid:9ac99e06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.854']} DrugCentral uuid:9ac9c610-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99IB8 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.979']} DrugCentral uuid:9ac9ee7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.046']} DrugCentral uuid:9aca17aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q81495 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:9aca3fd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9DHD6 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:9aca685e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O91936 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.426']} DrugCentral uuid:9aca9072-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5I2N3 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.097']} DrugCentral uuid:9acab854-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:5155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obeticholic acid targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9acae05e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:5155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obeticholic acid is agonist of Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.004']} DrugCentral uuid:9acb09f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darbepoetin alfa is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:9acb31e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon alfa-2a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9acb31e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon alfa-2a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9acb5f84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5160 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoetin beta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:9acb8766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon alfa-2b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9acb8766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon alfa-2b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9acbb59c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxy polyethylene glycol-epoetin beta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:9acbd982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:5167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenograstim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:9acbfd72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:5169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eldecalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:9acc2162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:5169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eldecalcitol is agonist of Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:9acc4a02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoetin zeta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:9acc6dde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05362 biolink:molecularly_interacts_with DrugCentral:5174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lifitegrast targets Unclassified (Intercellular adhesion molecule 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:9acc99e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05107 biolink:molecularly_interacts_with DrugCentral:5174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lifitegrast is antagonist of Adhesion (Integrin alpha-L/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:9acc99e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05107 biolink:molecularly_interacts_with DrugCentral:5174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lifitegrast is antagonist of Adhesion (Integrin alpha-L/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:9accd5d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:9accd5d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:9accd5d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:9acd12de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NAC3 biolink:molecularly_interacts_with DrugCentral:5179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodalumab is antibody binding of Membrane receptor (Interleukin-17 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:9acd12de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NAC3 biolink:molecularly_interacts_with DrugCentral:5179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodalumab is antibody binding of Membrane receptor (Interleukin-17 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:9acd461e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:5181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etelcalcetide is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:9acd6e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eteplirsen is binding agent of RNA (exon 51 of dystrophin pre-mRNA) DrugCentral uuid:9acd9380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaratumab is antibody binding of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.4']} DrugCentral uuid:9acdbb94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallium (68Ga) edotreotide is antagonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:9acde43e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18177 biolink:molecularly_interacts_with DrugCentral:5186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezlotoxumab is antibody binding of Enzyme (Toxin B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:9ace0c48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 radotinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.514']} DrugCentral uuid:9ace34a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:9ace5cac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13946 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole targets Enzyme (High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9ace9064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9ace9064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9ace9064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9ace9064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9acedbc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9acf03dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9acf2bf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9acf545e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.87']} DrugCentral uuid:9acf7c72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.276']} DrugCentral uuid:9acfa47c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.229']} DrugCentral uuid:9acfcc72-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.244']} DrugCentral uuid:9acff4d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9ad01ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:9ad044e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:9ad06cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9ad0968e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:9ad0be7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q460N5 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9ad0e67a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:9ad10e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9ad1380a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:9ad1601e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9ad18814-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:5208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plecanatide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9ad1b00a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19438 biolink:molecularly_interacts_with DrugCentral:5208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plecanatide targets Unclassified (Tumor necrosis factor receptor superfamily member 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:9ad1d882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25092 biolink:molecularly_interacts_with DrugCentral:5208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plecanatide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.721']} DrugCentral uuid:9ad20078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icotinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:9ad22878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olmutinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9ad251a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olmutinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.036']} DrugCentral uuid:9ad27ae4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9ad2a2ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.368']} DrugCentral uuid:9ad2cb0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.276']} DrugCentral uuid:9ad2f384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.886']} DrugCentral uuid:9ad31ba2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9ad34492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17752 biolink:molecularly_interacts_with DrugCentral:5214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telotristat ethyl is inhibitor of Enzyme (Tryptophan 5-hydroxylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9ad36cb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclabuvir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:9ad3951e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O39930 biolink:molecularly_interacts_with DrugCentral:5215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclabuvir targets Unclassified (RNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9ad3bd3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9ad3e564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9ad40d78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.47']} DrugCentral uuid:9ad436f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:9ad45f12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:9ad48712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:9ad4afbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:5218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribociclib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:9ad4d834-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribociclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.409']} DrugCentral uuid:9ad50142-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribociclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9ad52992-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naldemedine is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:9ad551b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naldemedine is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:9ad57a28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5221 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avelumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) DrugCentral uuid:9ad59e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9ad5c604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9ad5ee04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9ad6185c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9ad6407a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9ad6687a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9ad690a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q460N5 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:9ad6b906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:9ad6e110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:9ad70938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:9ad73156-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:5223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ocrelizumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.08']} DrugCentral uuid:9ad75b22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24394 biolink:molecularly_interacts_with DrugCentral:5224 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dupilumab is antibody binding of Membrane receptor (Interleukin-4 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11.06']} DrugCentral uuid:9ad78322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:5226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deutetrabenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:9ad7a708-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:5227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valbenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:9ad7cf26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:5227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valbenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.523']} DrugCentral uuid:9ad7fa28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8T9Z7 biolink:molecularly_interacts_with DrugCentral:5229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 forodesine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:9ad82354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55859 biolink:molecularly_interacts_with DrugCentral:5229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 forodesine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.64']} DrugCentral uuid:9ad84b90-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:5229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 forodesine is inhibitor of Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.143']} DrugCentral uuid:9ad8741c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9ad89c1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9ad8c426-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9ad8ed48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:9ad915fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:9ad93e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9ad9662e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9ad98e2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9ad9b7aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9ad9dfd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9ada07f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9ada300e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9ada587c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9ada80a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9adaa8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9adad0cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:9adaf9b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9adb21d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9adb49ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9adb7202-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9adb9d2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9adbc77a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9adbef84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9adc17ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9adc3fde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9adc67d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9adc8fd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9adcb892-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9adce18c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9add0982-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9add3196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9add5b08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22694 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9add8402-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9addac16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9addd420-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9addfc84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:9ade25b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:9ade4dce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9ade75e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9ade9ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9adec6a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:9adeeea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9adf16aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9adf418e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9adf6cd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9adf9710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9adfbf24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9adfe788-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9ae00f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9ae0379c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9ae06078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9ae08882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9ae0b17c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9ae0d97c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9ae1030c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9ae12daa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:9ae155be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9ae17dbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9ae1a636-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9ae1ce40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9ae1f668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:9ae21e5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9ae2471c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9ae26f26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9ae2973a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9ae2bf30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9ae2e9ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9ae314a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9ae33cc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9ae364c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9ae38d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9ae3b520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9ae3dd2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9ae406ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49761 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9ae42f78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9ae457a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9ae47fa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9ae4a976-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9ae4d180-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9ae4f99e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9ae521bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9ae54a7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9ae5727a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9ae59a84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9ae5c298-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9ae5eb10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9ae6132e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:9ae63b42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9ae6634c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9ae68d54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9ae6b72a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9ae6df3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9ae70748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9ae73010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9ae75806-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49840 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Glycogen synthase kinase-3 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9ae78010-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9ae7a810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:9ae7d07e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:9ae7f888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9ae82092-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9ae8489c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:9ae87290-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9ae89a86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9ae8c29a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9ae8eb58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:9ae91380-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9ae93b8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9ae9639e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9ae98c34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9ae9b448-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:9ae9dc52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9aea057e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9aea2e3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9aea5632-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9aea7e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9aeaa650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9aeacf7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9aeaf786-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9aeb1f9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9aeb47ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9aeb706c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9aeb9862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9aebc076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9aebe86c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9aec131e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:9aec3c4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9aec6454-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9aec8c5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9aecb4cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:9aecdccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9aed04c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9aed2ce0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:9aed5594-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9aede64e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y243 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (RAC-gamma serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9aee1376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9aee3b80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9aee638a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9aee8c0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9aeeb42a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:9aeedc3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:9aef0538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9aef2d4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9aef5560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9aef7d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9aefa6a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDC3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase BRSK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9aefcea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9aeff6aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9af01ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9af04952-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9af07148-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9af09a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9af0c27e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9af0eb3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9af11350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9af13b78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9af16382-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9af18e16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9af1ba08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9af1e26c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IWQ3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase BRSK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9af20a8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9af2330c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9af25b0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9af2830c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9af2ab16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.13']} DrugCentral uuid:9af2d3de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9af2fbf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9af32406-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9af34d1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9af37686-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9af39e9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9af3c69a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:9af3eef4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9af416f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9af43f08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9af4671c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9af492be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9af4be6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:9af4e674-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9af50e88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9af53930-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9af5643c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9af58c5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9af5b46e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9af5dce6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9af604f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9af62cfa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9af656bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9af67eda-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43172 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Nuclear other (U4/U6 small nuclear ribonucleoprotein Prp4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:9af6a6ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:9af6cf02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9af6f84c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9af722fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9af74b26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9af7733a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9af79ba8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00750 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9af7c3d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75747 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9af7ebd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:9af813da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9af83ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:9af865c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9af88dd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9af8b664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:9af8e0f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9af90c18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9af936d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9af95ee8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51817 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit PRKX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9af98774-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:9af9afa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9af9d7e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:5232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abaloparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9afa0078-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:9afa28a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:9afa50b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.137']} DrugCentral uuid:9afa78c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:9afaa1ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.721']} DrugCentral uuid:9afacd1e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.222']} DrugCentral uuid:9afaf7d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5234 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 durvalumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) DrugCentral uuid:9afb1bca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5235 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenegermin is agonist of Kinase (High affinity nerve growth factor receptor) DrugCentral uuid:9afb4028-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08138 biolink:molecularly_interacts_with DrugCentral:5235 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenegermin is agonist of Membrane receptor (Tumor necrosis factor receptor superfamily member 16) DrugCentral uuid:9afb681e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarilumab is antibody binding of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.1']} DrugCentral uuid:9afb681e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarilumab is antibody binding of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.1']} DrugCentral uuid:9afb9b54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evogliptin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:9afbc354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evogliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:9afbebea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polmacoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9afc1516-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polmacoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9afc3e24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:5240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polmacoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.081']} DrugCentral uuid:9afc6638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polmacoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.081']} DrugCentral uuid:9afc909a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betrixaban targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9afcb8c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:5241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betrixaban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:9afce0d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:5241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betrixaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:9afd0908-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxilaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.42']} DrugCentral uuid:9afd31c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q81495 biolink:molecularly_interacts_with DrugCentral:5242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxilaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.18']} DrugCentral uuid:9afd5a02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5244 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pibrentasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.19']} DrugCentral uuid:9afd8216-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WMX2 biolink:molecularly_interacts_with DrugCentral:5244 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pibrentasvir targets Unclassified (Genome polyprotein [Cleaved into: Core protein p21) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9afdaaca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23945 biolink:molecularly_interacts_with DrugCentral:5245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corifollitropin alfa is agonist of GPCR (Follicle-stimulating hormone receptor) DrugCentral uuid:9afdd338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5246 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guselkumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:9afdd338-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5246 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guselkumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:9afe00f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20273 biolink:molecularly_interacts_with DrugCentral:5247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inotuzumab ozogamicin is antibody binding of Membrane receptor (B-cell receptor CD22) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9afe290a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:9afe52a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:5248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.801']} DrugCentral uuid:9afe7d88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9afea72c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:5250 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imrecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:9afecf40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5250 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imrecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:9afef7b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5250 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imrecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:9aff1fcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enasidenib targets Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9aff47d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enasidenib targets Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9aff6ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48735 biolink:molecularly_interacts_with DrugCentral:5251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enasidenib is inhibitor of Enzyme (Isocitrate dehydrogenase [NADP], mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9aff9894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9affc09e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:9affe89e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9b0011b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9b003cea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9b00677e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9b008f92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9b00b828-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b00e046-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9b010850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9b01305a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9b015940-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9b018140-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b01a94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9b01d15e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9b01fb98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9b0223ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9b024bc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9b0273ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9b029c4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:9b02c460-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9b02ec7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9b0314a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b033d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9b03655a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:9b038d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9b03b564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9b03e098-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9b0409ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b0431ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9b0459ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:9b048278-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:9b04aa82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9b04d28c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:9b04fa96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b052340-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9b054b54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9b057354-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:9b059c80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9b05c502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9b05ed16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:9b061502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9b063d7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9b066570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9b068d70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:9b06b57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9b06de24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9b070638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9b072e2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9b075638-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9b078054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9b07aa52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9b07d374-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78368 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Casein kinase I isoform gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:9b07fc96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6M4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Casein kinase I isoform gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9b082518-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9b084d2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:9b08752c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b089d40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:9b08c608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:9b08ee30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9b091644-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9b093e62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9b096748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9b098f70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:9b09b784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9b09dffc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:9b0a0810-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9b0a3024-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9b0a582e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9b0a810a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9b0aa9a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9b0ad1b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9b0af9d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:9b0b22b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9b0b4acc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9b0b72f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9b0b9afe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b0bc376-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9b0bec70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9b0c1484-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:9b0c3ca2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9b0c6560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:9b0c8d7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9b0cb592-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9b0cddb0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9b0d07fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b0d2ff4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:9b0d57fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9b0d7ffe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9b0da894-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:9b0dd1d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9b0df9f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9b0e2206-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:9b0e4ace-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:9b0e72e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9b0e9b00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9b0ec42c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9b0eeea2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9b0f16b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9b0f3ed4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY57 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 32B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9b0f6756-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.62']} DrugCentral uuid:9b0f8f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.036']} DrugCentral uuid:9b0fb792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.229']} DrugCentral uuid:9b0fe082-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:9b10094a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.432']} DrugCentral uuid:9b103168-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.194']} DrugCentral uuid:9b105990-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:9b1081ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:9b10ab5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:5257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butylphthalide is blocker of Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:9b10d35c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.65']} DrugCentral uuid:9b10fb52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:9b112352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.764']} DrugCentral uuid:9b114bd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.788']} DrugCentral uuid:9b1173e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.375']} DrugCentral uuid:9b119be8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.866']} DrugCentral uuid:9b11c3f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.524']} DrugCentral uuid:9b11ec92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.678']} DrugCentral uuid:9b1214b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.796']} DrugCentral uuid:9b123cba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:9b1264ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:9b128fbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9b12b7bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9b12dfc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b13082a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b13303e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9b135866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:9b13808e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:9b13aa82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:9b13d3ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9b13fb9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:9b1423b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9b144d84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:9b147822-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.032']} DrugCentral uuid:9b14a04a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.434']} DrugCentral uuid:9b14c872-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.292']} DrugCentral uuid:9b14f0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:5261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprostene bunod targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:9b151912-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:5261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprostene bunod is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:9b154900-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:9b154900-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:9b154900-b1e3-11ec-aa8d-0242ac110002 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:9b15880c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01344 biolink:molecularly_interacts_with DrugCentral:5263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benralizumab is antibody binding of Membrane receptor (Interleukin-5 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.959']} DrugCentral uuid:9b15b034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:5267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 semaglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.42']} DrugCentral uuid:9b15d8ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:5268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emicizumab is antibody binding of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.73']} DrugCentral uuid:9b1600f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00740 biolink:molecularly_interacts_with DrugCentral:5268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emicizumab is antibody binding of Enzyme (Coagulation factor IX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b162afa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 netarsudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:9b165322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 netarsudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.377']} DrugCentral uuid:9b167b36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:5270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertugliflozin targets Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.94']} DrugCentral uuid:9b16a336-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NY91 biolink:molecularly_interacts_with DrugCentral:5270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertugliflozin targets Transporter (Low affinity sodium-glucose cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.06']} DrugCentral uuid:9b16cbb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:5270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertugliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.708']} DrugCentral uuid:9b16f3d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:5270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertugliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.057']} DrugCentral uuid:9b171bea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92847 biolink:molecularly_interacts_with DrugCentral:5271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 macimorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:9b1744e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II is agonist of GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.2']} DrugCentral uuid:9b176dc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:9b1795d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:9b17bdfc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9b17e5f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II is agonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9b1810fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bictegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:9b1838ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bictegravir targets Unclassified (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:9b186112-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:5274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bictegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.125']} DrugCentral uuid:9b188980-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lutetium (177Lu) oxodotreotide is agonist of GPCR (Somatostatin receptor type 2) DrugCentral uuid:9b18ada2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tezacaftor is pharmacological chaperone of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9b18d598-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12908 biolink:molecularly_interacts_with DrugCentral:5277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elobixibat is inhibitor of Transporter (Ileal sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.276']} DrugCentral uuid:9b18fdc0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apalutamide is antagonist of Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9b1926b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apalutamide is inhibitor of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:9b194eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01730 biolink:molecularly_interacts_with DrugCentral:5279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibalizumab is antibody binding of Membrane receptor (T-cell surface glycoprotein CD4) DrugCentral uuid:9b19741c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9b199c26-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:9b19c57a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9b19edd4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib is inhibitor of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.092']} DrugCentral uuid:9b1a15fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib is inhibitor of Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.387']} DrugCentral uuid:9b1a4220-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tildrakizumab is antibody binding of Cytokine (Interleukin-23) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:9b1a4220-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tildrakizumab is antibody binding of Cytokine (Interleukin-23) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:9b1a75d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZV9 biolink:molecularly_interacts_with DrugCentral:5282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 burosumab is antibody binding of Secreted (Fibroblast growth factor 23) DrugCentral uuid:9b1a99f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:5283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosnetupitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.022']} DrugCentral uuid:9b1ac696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erenumab is antibody binding of GPCR (Calcitonin-gene-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.699']} DrugCentral uuid:9b1ac696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erenumab is antibody binding of GPCR (Calcitonin-gene-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.699']} DrugCentral uuid:9b1afb98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:5285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avatrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:9b1b2384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q25634 biolink:molecularly_interacts_with DrugCentral:5286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxidectin is inhibitor of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:9b1b477e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9b1b6f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9b1b98e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is agonist of GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:9b1bc15e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:9b1be986-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9b1c1190-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:9b1c39f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9b1c6208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5S1 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:9b1c89fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:9b1cb1fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is inhibitor of Ion channel (Transient receptor potential cation channel subfamily V member 1) DrugCentral uuid:9b1cd67a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is antagonist of GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9b1cfe7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:5289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encorafenib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9b1d268e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:5289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encorafenib is inhibitor of Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:9b1d4e98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.328']} DrugCentral uuid:9b1d7878-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 binimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9b1da302-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 binimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:9b1dcb16-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33815 biolink:molecularly_interacts_with DrugCentral:5291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tecovirimat is inhibitor of Viral envelope protein (Envelope protein F13) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.382']} DrugCentral uuid:9b1df32a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5292 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivosidenib is inhibitor of Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.149']} DrugCentral uuid:9b1e1b84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elagolix targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9b1e4384-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8SPZ1 biolink:molecularly_interacts_with DrugCentral:5293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elagolix targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:9b1e6bb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:5293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elagolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:9b1e93ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:5295 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doravirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9b1ebc6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:5295 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doravirine targets Unclassified (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9b1ee578-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:5295 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doravirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:9b1f0eae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b1f36cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9b1f62f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.638']} DrugCentral uuid:9b1f8b40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:9b1fb372-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:9b1fdbe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9b2003f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9b202c08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:9b205430-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:9b207cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.133']} DrugCentral uuid:9b20a520-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talazoparib tosylate is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:9b20cd5c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talazoparib tosylate is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:9b20f570-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:5301 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baloxavir marboxil is inhibitor of Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.854']} DrugCentral uuid:9b211eec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9b2146f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.959']} DrugCentral uuid:9b216f28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:9b219746-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9b21bfaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:9b21e7dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:9b220fe6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9b2237f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:9b22609a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.854']} DrugCentral uuid:9b2288ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:9b22b194-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.569']} DrugCentral uuid:9b22d9d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:9b2303ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:9b232c14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9b235432-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:9b237c6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9b23a5c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:9b23cdea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P56726 biolink:molecularly_interacts_with DrugCentral:5304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glasdegib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9b23f608-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glasdegib is antagonist of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9b241ed0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 larotrectinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.187']} DrugCentral uuid:9b2446e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 larotrectinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.092']} DrugCentral uuid:9b246f02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 larotrectinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.975']} DrugCentral uuid:9b24975c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:9b24c0ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:9b24ea04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9b25133a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9b253b30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9b2563b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b258c3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9b25b466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:9b25dc84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:5307 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evocalcet is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.032']} DrugCentral uuid:9b260524-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04275 biolink:molecularly_interacts_with DrugCentral:5308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caplacizumab is antibody binding of Unclassified (von Willebrand factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.509']} DrugCentral uuid:9b262d60-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:5309 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanadelumab is antibody binding of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:9b265560-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:5311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:9b267e46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O02662 biolink:molecularly_interacts_with DrugCentral:5311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9b26a8da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q28524 biolink:molecularly_interacts_with DrugCentral:5311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:9b26d152-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:5311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vibegron is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:9b26f9fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omidenepag isopropyl is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.081']} DrugCentral uuid:9b272210-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:5313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 patisiran is antisense inhibitor of RNA (transthyretin (TTR) mRNA) DrugCentral uuid:9b274678-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20273 biolink:molecularly_interacts_with DrugCentral:5314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxetumomab pasudotox is binding agent of Membrane receptor (B-cell receptor CD22) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:9b276ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5315 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fremanezumab is antibody binding of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:9b2796be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galcanezumab is antibody binding of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9b27bef0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:5317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cemiplimab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.102']} DrugCentral uuid:9b27e7cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:5319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inotersen is antisense inhibitor of RNA (transthyretin (TTR) mRNA) DrugCentral uuid:9b280bbc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:5320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emapalumab is antibody binding of Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.1']} DrugCentral uuid:9b2833e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:5322 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ravulizumab is antibody binding of Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.357']} DrugCentral uuid:9b285ffe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tagraxofusp is binding agent of Membrane receptor (Interleukin-3 receptor) DrugCentral uuid:9b285ffe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tagraxofusp is binding agent of Membrane receptor (Interleukin-3 receptor) DrugCentral uuid:9b2890dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:9b28c0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:9b28c0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:9b28c0c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:9b290710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:9b290710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:9b290710-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:9b294cde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:9b294cde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:9b294cde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:9b298ad2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.088']} DrugCentral uuid:9b29b480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:5325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.432']} DrugCentral uuid:9b29dca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:5325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.848']} DrugCentral uuid:9b2a04c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.125']} DrugCentral uuid:9b2a2dde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3']} DrugCentral uuid:9b2a56a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95136 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:9b2a7eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.409']} DrugCentral uuid:9b2aa6e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.009']} DrugCentral uuid:9b2aced8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:9b2af75a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:9b2b1f6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.434']} DrugCentral uuid:9b2b4796-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:9b2b7036-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.921']} DrugCentral uuid:9b2b9868-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.602']} DrugCentral uuid:9b2bc162-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.244']} DrugCentral uuid:9b2be962-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9b2c12a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b2c3aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9b2c62c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Z1L0 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9b2c8ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.337']} DrugCentral uuid:9b2cb34c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:9b2cdb7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:9b2d03a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.02']} DrugCentral uuid:9b2d2b9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Adrenocorticotropic hormone receptor) DrugCentral uuid:9b2d5054-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:9b2d796c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14980 biolink:molecularly_interacts_with DrugCentral:5330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selinexor is inhibitor of Nuclear other (Exportin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:9b2da18a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P60880 biolink:molecularly_interacts_with DrugCentral:5331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prabotulinumtoxinA is blocker of Cytosolic other (Synaptosomal-associated protein 25) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2de596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b2e56ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40259 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is antibody binding of Tumour-associated antigen (B-cell antigen receptor complex-associated protein beta chain) DrugCentral uuid:9b2e7ac4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darolutamide is antagonist of Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9b2ea346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:5334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darolutamide is antagonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:9b2ec74a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darolutamide is inhibitor of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.187']} DrugCentral uuid:9b2eef54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02656 biolink:molecularly_interacts_with DrugCentral:5335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 volanesorsen is antisense inhibitor of RNA (apolipoprotein C-III (apoC-III) mRNA) DrugCentral uuid:9b2f148e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risankizumab is inhibitor of Cytokine (Interleukin-23 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:9b2f417a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropeginterferon alfa-2b is binding agent of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9b2f417a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropeginterferon alfa-2b is binding agent of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:9b2f6f24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:5339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:9b2f974c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:5339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.444']} DrugCentral uuid:9b2fc154-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9b2fec10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9b30141a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9b303c24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9b30649c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9b308c9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:9b30b492-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:9b30dd78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:9b31060e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9b312e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9b315604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9b317e0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b31a7e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9b31cfee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9b31f7e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:9b321ff8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9b324852-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9b327048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9b329848-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9b32c048-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9b32e906-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:9b331110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:9b333910-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:9b336200-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9b3389f6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9b33b2aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9b33daa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:9b34030e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9b342b0e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9b34530e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9b347b04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9b34a390-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9b34cdac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b34f5c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9b351db6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9b35476e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9b356f78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9b3597a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.796']} DrugCentral uuid:9b35bfbe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8RL90 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9b35e818-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2PUH3 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:9b361040-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9X5A7 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9b3638e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q93LQ9 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9b3660f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q93DC4 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:9b3689bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:B1PL86 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9b36b1d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9b36d9d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:9b3701d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:9b372aac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:9b3752ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9b377ab6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.56']} DrugCentral uuid:9b37a2b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:9b37cb24-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.88']} DrugCentral uuid:9b37f306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9b381af2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:9b384388-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9b386b7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:9b38936a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9b38bc82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9b38e55e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:9b390d5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.67']} DrugCentral uuid:9b393554-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:9b395dc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9b39861c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9b39ae58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9b39d662-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9b39fe76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:9b3a2748-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b3a4f70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:9b3a7784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9b3a9f98-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 upadacitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9b3acb12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:9b3af574-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:9b3b1e14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9b3b4614-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:9b3b6e6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9b3b9682-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:9b3bbe8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9b3be696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:9b3c0f5e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9b3c3768-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9b3c5f68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:9b3c8844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9b3cb472-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:9b3cdf42-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:9b3d0724-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9b3d2f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9b3d5792-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9b3d7f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9b3da79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9b3dd05a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9b3df850-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b3e2064-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9b3e4864-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9b3e729e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9b3e9cf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:9b3ec50a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b3eed00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:9b3f155a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b3f3d50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9b3f6532-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:9b3f8d14-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9b3fb5dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9b3fddd2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9b4005dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9b402ddc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:9b405956-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:9b408192-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9b40ab68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9b40d3ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9b40fbf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9b4123ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:9b414bf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b41748a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:9b419c94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:9b41c52a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:9b41ed3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b4216b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9b423ec4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9b4266c4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b428ed8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9b42b732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:9b42df32-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b430732-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9b432f46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9b4357f0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:9b437ffa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:9b43a7fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b43cff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:9b43f8ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9b4420ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b4448a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9b4470a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:9b449a34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9b44c23e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:9b44ea3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9b4512ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9b453aca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9b4562de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:9b458ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b45b3ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9b45de6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:9b46066c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:9b462e62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9b465694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9b467e94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:9b46a7c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:9b46cfb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9b46f860-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:9b472060-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9b47486a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b47706a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9b479a18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:9b47c222-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:9b47ea2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9b481218-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:9b483a7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b486272-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:9b488b58-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:9b48b3ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9b48dcac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9b4904c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9b492cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:9b4954c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:9b497fd6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:9b49a7e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b49cfe0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9b49f844-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9b4a2044-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b4a4830-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9b4a701c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9b4a98d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:9b4ac0e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9b4ae8ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9b4b10da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9b4b3a7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b4b64cc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b4b8ccc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:9b4bb4e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b4bdd30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9b4c0512-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9b4c2d12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:9b4c5508-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b4c7f88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9b4ca788-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9b4ccf9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b4cf79c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:9b4d229e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9b4d4a9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9b4d72a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9b4d9ab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b4dc334-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:9b4deb34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b4e132a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9b4e3bf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:9b4e63f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:9b4e8bf2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9b4eb3d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:9b4edcf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:9b4f078a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9b4f2f80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:9b4f57f8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9b4f8070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9b4fa866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9b4fd05c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9b4ff85c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9b502110-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9b5048fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9b5071e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9b5099d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9b50c444-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9b50ecd0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9b5114da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9b513ce4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9b51655c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b518d52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9b51b53e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:9b51dd48-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9b5205e8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:9b522df2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9b5255fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9b527f3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9b52aa2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9b52d234-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b52fa3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9b5322ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:9b534ade-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:9b5372fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:9b539ae8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9b53c392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9b53eb88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9b54137e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9b543b88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:9b54654a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:9b548d54-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9b54b540-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9b54dd40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9b5505ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9b552dae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9b5555ae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9b557dae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b55a66c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:9b55ce6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:9b55f6e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9b561eee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9b564a9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9b5672a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:9b569aae-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:9b56c29a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:9b56eafe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:9b5712fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9b573b08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:9b5763bc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b578bb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9b57b3b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9b57dbb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9b5804fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:9b582d74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:9b585790-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6P3R8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9b587fa4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD19 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:9b58a7fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b58d008-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9b58f81c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9b59201c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b5948da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:9b5970e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:9b5998e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9b59c0ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:9b59e9b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H4B4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b5a11ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b5a39ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:9b5a61a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:9b5a8a06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9b5ab206-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b5ada06-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b5b01f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:9b5b2a9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:9b5b5292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:9b5b7a92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:9b5ba292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:9b5bce0c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:9b5bf8aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9b5c20b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9b5c49fe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.05']} DrugCentral uuid:9b5c71f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:9b5c9a80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b5cc276-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:9b5ceb20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9b5d1320-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b5d3b3e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b5d632a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9b5d8c1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:9b5db424-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9b5ddc2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9b5e042e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9b5e2c74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b5e55a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:9b5e7d96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:9b5ea5aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:9b5ece68-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:9b5ef672-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9b5f1e7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15208 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9b5f4668-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:9b5f7138-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:9b5f9942-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:9b5fc14c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b5fe938-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b60119c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:9b603a78-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b60626e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:9b608b04-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9b60b318-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:9b60db22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9b610322-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9b612c8a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:9b61578c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9b618284-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9b61acaa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O76039 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase-like 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:9b61d4fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9b61fcf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9b6224d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b624cc8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:9b627572-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9b629d7c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:9b62c590-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:9b62eda4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:9b6317fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9b63407e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:9b636888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9b63907e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQI3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:9b63b8d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:9b63e0ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NRH2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (SNF-related serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:9b6408ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9b64331c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b645b3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b64833a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9b64ab44-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:9b64d452-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:9b64fd2e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:9b652538-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.79']} DrugCentral uuid:9b654d38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:9b6575a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9HC98 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:9b659da6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:9b65c5a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51957 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:9b65edce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q58F21 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Unclassified (Bromodomain testis-specific protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9b661664-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96PY6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b663e8c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:9b666696-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:9b668ea0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9b66b7e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:9b66dffe-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b670812-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P26433 biolink:molecularly_interacts_with DrugCentral:5349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenapanor targets Transporter (Sodium/hydrogen exchanger 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:9b67301c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48764 biolink:molecularly_interacts_with DrugCentral:5349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenapanor is inhibitor of Transporter (Sodium/hydrogen exchanger 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.06']} DrugCentral uuid:9b67588a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:5350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9b678076-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:5350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:9b67a862-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:5350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:9b67d062-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:5351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasmiditan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:9b67fa38-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9b682260-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q07806 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9b684a6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9b687350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b689e66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G1C775 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:9b68c684-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6T4V3 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:9b68ee8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:H4I819 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase MrdA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9b69171a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0A0W8ASI8 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase MrdA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:9b693f4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A6T4M7 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9b69677e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:G3XD46 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:9b698f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:D0CCM7 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:9b69b882-b1e3-11ec-aa8d-0242ac110002 UniProtKB:A0A5E6DR09 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:9b69e08c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanubrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:9b6a08a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13196 biolink:molecularly_interacts_with DrugCentral:5354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 givosiran is antisense inhibitor of RNA (aminolevulinate synthase1 (ALAS1) mRNA) DrugCentral uuid:9b6a2dc6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:5355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:9b6a571a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:5355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:9b6a80fa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:5355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:9b6aa904-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:5355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:9b6ad12c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:5356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:9b6af9a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:5356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:9b6b21b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:9b6b4a08-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:5356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxelotor is inhibitor of Transporter (hemoglobin subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:9b6b7208-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5357 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 golodirsen is antisense inhibitor of RNA (exon 53 of dystrophin pre-mRNA) DrugCentral uuid:9b6b96a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:9b6bbeac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:9b6be7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:9b6c0fd8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:9b6c3a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:9b6c62e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:9b6c8b20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:9b6cb33e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:9b6cdc4c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:9b6d0474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:9b6d2c88-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99572 biolink:molecularly_interacts_with DrugCentral:5359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brilliant Blue G is antagonist of Ion channel (P2X purinoceptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9b6d547e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P37840 biolink:molecularly_interacts_with DrugCentral:5359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brilliant Blue G targets Transporter (Alpha-synuclein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9b6d7d28-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lemborexant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:9b6da53c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:5360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lemborexant is antagonist of GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9b6dcd5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O43614 biolink:molecularly_interacts_with DrugCentral:5360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lemborexant is antagonist of GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b6df564-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubrogepant is antagonist of GPCR (Calcitonin gene-related peptide type 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.2']} DrugCentral uuid:9b6e1f12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9BQB4 biolink:molecularly_interacts_with DrugCentral:5362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romosozumab is binding agent of Glycoprotein (Sclerostin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.7']} DrugCentral uuid:9b6e4726-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brolucizumab is inhibitor of Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9b6e6f3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95390 biolink:molecularly_interacts_with DrugCentral:5364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luspatercept is binding agent of Cytokine (Growth/differentiation factor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.13']} DrugCentral uuid:9b6e97c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O14793 biolink:molecularly_interacts_with DrugCentral:5364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luspatercept is binding agent of Cytokine (Growth/differentiation factor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.69']} DrugCentral uuid:9b6ebfee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16109 biolink:molecularly_interacts_with DrugCentral:5365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizanlizumab is inhibitor of Adhesion (P-selectin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f06fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:9b6f7b3c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96NY8 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Nectin-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.24']} DrugCentral uuid:9b6fa350-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab deruxtecan is binding agent of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:9b6fcc2c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:5367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab deruxtecan is inhibitor of Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:9b6ff6ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P60880 biolink:molecularly_interacts_with DrugCentral:5368 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 botulinum toxin type A is blocker of Cytosolic other (Synaptosomal-associated protein 25) DrugCentral uuid:9b701ab0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:5371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxadustat targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:9b7042ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:9b706b46-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9b709346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:9b70bb5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5372 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elexacaftor targets Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:9b70e35a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:5375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cepharanthine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9b710c40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cepharanthine is inhibitor of Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) DrugCentral uuid:9b713030-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:5375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cepharanthine is inhibitor of Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) DrugCentral uuid:9b7154d4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DTD1 biolink:molecularly_interacts_with DrugCentral:5376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remdesivir is inhibitor of Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b717cca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefuparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9b71a61e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefuparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:9b71d166-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P05532 biolink:molecularly_interacts_with DrugCentral:5379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avapritinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:9b71faa6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avapritinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.57']} DrugCentral uuid:9b7222ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avapritinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:9b724b50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75530 biolink:molecularly_interacts_with DrugCentral:5380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazemetostat targets Unclassified (Polycomb protein EED) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9b727346-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92800 biolink:molecularly_interacts_with DrugCentral:5380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazemetostat is inhibitor of Enzyme (Histone-lysine N-methyltransferase EZH1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:9b729b64-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15910 biolink:molecularly_interacts_with DrugCentral:5380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazemetostat is inhibitor of Enzyme (Histone-lysine N-methyltransferase EZH2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9b72c36e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimegepant is antagonist of GPCR (Calcitonin gene-related peptide type 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.56']} DrugCentral uuid:9b72ec36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P53396 biolink:molecularly_interacts_with DrugCentral:5382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bempedoic acid is inhibitor of Enzyme (ATP-citrate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:9b731576-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9b733d76-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:9b73656c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95136 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:9b738e7a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:9b73b68e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9b73de8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:9b74068e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15539 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:9b742efc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15393 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:9b745706-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30099 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:9b747f10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9b74a72e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:9b74d014-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:5385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isatuximab is binding agent of Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9b74f954-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eptinezumab is binding agent of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.82']} DrugCentral uuid:9b75217c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10092 biolink:molecularly_interacts_with DrugCentral:5386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eptinezumab is binding agent of GPCR (Calcitonin gene-related peptide 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.24']} DrugCentral uuid:9b754a3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teprotumumab is antagonist of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9b7574ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selumetinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:9b759d6e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selumetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9b75c596-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selumetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:9b75edf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tucatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:9b761604-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tucatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:9b7641ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tucatinib is inhibitor of Kinase (ERBB2/ERBB3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:9b7641ec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tucatinib is inhibitor of Kinase (ERBB2/ERBB3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:9b767522-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:9b769e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9b76c73e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:9b76ef52-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:9b771766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55899 biolink:molecularly_interacts_with DrugCentral:5391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sacituzumab govitecan is antibody binding of Membrane receptor (IgG receptor FcRn large subunit p51) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.71']} DrugCentral uuid:9b7742e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:5391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sacituzumab govitecan is binding agent of Enzyme (DNA topoisomerase 1) DrugCentral uuid:9b7766ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09758 biolink:molecularly_interacts_with DrugCentral:5391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sacituzumab govitecan is antibody binding of Tumour-associated antigen (Tumor-associated calcium signal transducer 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.58']} DrugCentral uuid:9b778f02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capmatinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.88']} DrugCentral uuid:9b77b720-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selpercatinib is inhibitor of Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:9b77dfac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selpercatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:9b7807ca-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9b782fde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:9b785928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:9b788466-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:9b78af22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b78d740-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:9b79008a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:5395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoroestradiol F 18 is binding agent of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.07']} DrugCentral uuid:9b7928a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:5396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flortaucipir F 18 is binding agent of Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:9b7950d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inebilizumab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:9b7978ee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inebilizumab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.8']} DrugCentral uuid:9b79a94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9b79a94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9b79a94a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:9b79efc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b79efc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b79efc2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:9b7a3766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9b7a3766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9b7a3766-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:9b7a7eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:9b7a7eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:9b7a7eba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:9b7ad52c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:9b7ad52c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:9b7ad52c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:9b7ad52c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:9b7ad52c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:9b7ad52c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:9b7ad52c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:9b7b3fb2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:5401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostemsavir is inhibitor of Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.08']} DrugCentral uuid:9b7b6866-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32320 biolink:molecularly_interacts_with DrugCentral:5402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inqovi is inhibitor of Enzyme (Cytidine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:9b7b9070-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b7bb884-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:9b7be0a2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:9b7c0960-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b7c3160-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51685 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9b7c5988-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafasitamab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.39']} DrugCentral uuid:9b7c81ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P55899 biolink:molecularly_interacts_with DrugCentral:5405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (IgG receptor FcRn large subunit p51) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:9b7caaf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12314 biolink:molecularly_interacts_with DrugCentral:5405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (High affinity immunoglobulin gamma Fc receptor I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:9b7cd32c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9b7cfc80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02223 biolink:molecularly_interacts_with DrugCentral:5405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belantamab mafodotin is binding agent of Tumour-associated antigen (Tumor necrosis factor receptor superfamily member 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:9b7d248a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9b7d4d02-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:9b7d750c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:9b7d9d2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:9b7dc53e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:9b7dedde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9b7e15fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine is agonist of GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:9b7e3e1a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9b7e666a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viltolarsen is binding agent of RNA (exon 53 of dystrophin pre-mRNA) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:9b7e9586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5409 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 satralizumab is antagonist of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9b7e9586-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5409 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 satralizumab is antagonist of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9b7ec8c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clascoterone is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9b7ef0e4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copper dotatate Cu-64 is binding agent of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.69']} DrugCentral uuid:9b7f1a74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:9b7f4288-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9b7f6a92-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9b7f9292-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:9b7fbbdc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9b7fe3dc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9b800bf0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:9b80340e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:9b805e70-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:9b80890e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:9b80b212-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somapacitan targets GPCR (Growth hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.04']} DrugCentral uuid:9b80da30-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Cytosolic other (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9b8102b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9b812aa8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01111 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase NRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:9b8152b2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9b817ab2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:9b81a76c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9b81a76c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:9b81da8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UJM8 biolink:molecularly_interacts_with DrugCentral:5415 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumasiran is antisense inhibitor of RNA (Hydroxyacid oxidase 1 (HAO1) mRNA) DrugCentral uuid:9b81fe7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9b82278c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9b824faa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:9b8277d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:9b829ff0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:9b82c87c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:9b82f0a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.68']} DrugCentral uuid:9b8318e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:5417 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bulevirtide is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:9b834c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:9b834c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:9b834c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:9b834c8e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:9b838ed8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:9b83b6e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9b83deec-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:9b8408b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9b8430c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:9b8459c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:9b848306-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:9b84ab7e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:9b84d3a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:9b84fbba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:9b8523ce-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:9b854cb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:9b85750e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9b859d18-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Enzyme (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:9b85c612-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Unclassified (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:9b85ee62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8N543 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Unclassified (Prolyl 3-hydroxylase OGFOD1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9b861680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Unclassified (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:9b863e9e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:9b86672a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.93']} DrugCentral uuid:9b868f34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:9b86b77a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5421 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.46']} DrugCentral uuid:9b86dfac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5421 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:9b870888-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5421 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:9b8730b0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:5422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 borofalan (10B) is substrate of Transporter (L-type amino acid transporter 1) DrugCentral uuid:9b875518-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9b877e12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9b87a770-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9b87d006-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:9b87f7fc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:9b881ff2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:9b884950-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:9b88715a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:9b889964-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b88c178-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:9b88ea22-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:5424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tepotinib is inhibitor of Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:9b891236-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tepotinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:9b893a4a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9b89625e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:9b898d56-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:9b89b826-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:9b89e314-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:9b8a0e20-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:9b8a363e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:9b8a5f74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:9b8a879c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:9b8ab06e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:9b8ad88c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9b8b00aa-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:9b8b28d2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:9b8b5280-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:5428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sofpironium bromide is inhibitor of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:9b8b776a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07288 biolink:molecularly_interacts_with DrugCentral:5429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallium (68Ga) gozetotide is binding agent of Surface antigen (Prostate-specific antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:9b8b9f9c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:5430 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 berotralstat is inhibitor of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:9b8bc7ba-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirbanibulin is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:9b8bf352-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirbanibulin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9b8c1b84-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirbanibulin is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:9b8c4474-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirbanibulin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:9b8c6c6a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:9b8c94d8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:9b8cbcf6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:5432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:9b8ce51e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ansuvimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:9b8d0d5a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 margetuximab is antagonist of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.55']} DrugCentral uuid:9b8d382a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 margetuximab is antagonist of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:9b8d608e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atoltivimab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:9b8d88ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atoltivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:9b8db0de-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maftivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:9b8dd9e2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5438 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 odesivimab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:9b8e0228-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5438 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 odesivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:9b8e2a50-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P20595 biolink:molecularly_interacts_with DrugCentral:5439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vericiguat is activator of Enzyme (Guanylate cyclase soluble subunit beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:9b8e52e6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:5439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vericiguat is activator of Enzyme (Guanylate cyclase soluble subunit beta-1) DrugCentral uuid:9b8e76d6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabotegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b8e9ee0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabotegravir targets Unclassified (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b8ec712-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:5440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabotegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:9b8ef034-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:9b8f1ba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:9b8f443a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:9b8f6cf8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.21']} DrugCentral uuid:9b8f95b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9b8fbdde-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9b8fe5f2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:9b900f00-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b9038a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:9b9060b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:9b9088e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:9b90b0f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:9b90db10-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6ZWH5 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Serine/threonine-protein kinase Nek10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.57']} DrugCentral uuid:9b910342-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:9b912b74-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:9b915392-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 casimersen is antisense inhibitor of RNA (exon 53 of dystrophin pre-mRNA) DrugCentral uuid:9b917836-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9NZB8 biolink:molecularly_interacts_with DrugCentral:5444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosdenopterin targets Enzyme (Molybdenum cofactor biosynthesis protein 1) DrugCentral uuid:9b919c12-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:9b91c426-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b91ec1c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:9b9214a8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:9b923cee-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P47871 biolink:molecularly_interacts_with DrugCentral:5447 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasiglucagon is agonist of GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:9b926502-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9Y5C1 biolink:molecularly_interacts_with DrugCentral:5449 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evinacumab is inhibitor of Secreted (Angiopoietin-related protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:9b928d34-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:5450 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estetrol is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:9b92b782-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:5450 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estetrol is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:9b92dfa0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:5451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dostarlimab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:9b9307be-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loncastuximab tesirine is antibody binding of Surface antigen (B-lymphocyte antigen CD19) DrugCentral uuid:9b932b9a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5453 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bamlanivimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.15']} DrugCentral uuid:9b935462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etesevimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:9b937c6c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5455 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 casirivimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.34']} DrugCentral uuid:9b93a480-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5456 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imdevimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.33']} DrugCentral uuid:9b93cca8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01024 biolink:molecularly_interacts_with DrugCentral:5457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pegcetacoplan is inhibitor of Unclassified (Complement C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:9b93f69c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04609 biolink:molecularly_interacts_with DrugCentral:5458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piflufolastat F-18 is binding agent of Enzyme (Glutamate carboxypeptidase 2) DrugCentral uuid:9b941a82-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9b94426e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b946adc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:9b94934a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:9b94bb36-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9b94e32c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b950ba4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b9533b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9b955bb8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9b9583c2-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b95ac62-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9b95d462-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9b95fdac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9b9625c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9b964f96-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b967804-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9b96a00e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9b96c82c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:9b96f0a4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9b9718b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b9740e0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b9768f4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b9791c6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9b97b9d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9b97e2c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9b980ad4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9b9835b8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:9b985dcc-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b9885ea-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:9b98adf4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:9b98d680-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9b98fe94-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:9b992694-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b994f2a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:9b9977b6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:9b999fb6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:9b99c7c0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:9b99f114-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b9a1928-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9b9a413c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9b9a693c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:9b9a9196-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:9b9ab9a0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:9b9ae1b4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:9b9b09c8-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:9b9b327c-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:9b9b5a86-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:9b9b8286-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:9b9bab80-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:9b9bd75e-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:9b9c00d0-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:9b9c28da-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:9b9c5102-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:9b9c7966-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:9b9ca17a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:9b9cc984-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:9b9cf1ac-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) DrugCentral uuid:9b9d1650-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) DrugCentral uuid:9b9d3a40-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) DrugCentral uuid:9b9d5e3a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) DrugCentral uuid:9b9d822a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 samidorphan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.28']} DrugCentral uuid:9b9dacb4-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:5460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 samidorphan is partial agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:9b9dd72a-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 samidorphan is partial agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:9b9dff66-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5461 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotorasib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:9b9e2784-b1e3-11ec-aa8d-0242ac110002 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:5462 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrexafungerp is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:9b9e5088-b1e3-11ec-aa8d-0242ac110002 UniProtKB:Q6FTN8 biolink:molecularly_interacts_with DrugCentral:5462 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrexafungerp is inhibitor of Enzyme (1,3-Beta-D-glucan-UDP glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:9b9e78a6-b1e3-11ec-aa8d-0242ac110002 UniProtKB:P87204 biolink:molecularly_interacts_with DrugCentral:5462 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrexafungerp is inhibitor of Enzyme (1,3-Beta-D-glucan-UDP glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.97']} DrugCentral